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Abstract
This project was aimed to elucidate the sub-cellular and molecular
regulation of Lipopolysaccharide (LPS) induced muscle protein turnover
(protein synthesis (PS) and protein degradation) in two in vitro models, C2C12
murine myotubes and avian primary skeletal muscle cell line. In addition, the
effect of natural challenge of chicken with Salmonella serotypes gallinarium or
Enteritidis on mRNA expression levels in skeletal muscle was assessed.
 >W^  ? ? ʅŐŵů-1) transiently decreased PS rate by 50% compared with
control cells. This effect was mediated via decreased phosphorylation of
translation initiation mediators (p70
S6K
, 4E-BP1 and eIF-4E). This effect was
preceded by decreased Akt and mTOR phosphorylation. Although, LPS
significantly increased p38, Erk1/2 and their down stream target Mnk1,
however, this effect was not sufficient to abolish LPS-induced decreased PS.
The role of Akt and MAPKs (p38 or Erk1/2) was verified using specific
pathway inhibitors. Inhibition of Akt by LY0294002 (PI3-K/Akt inhibitor)
dramatically decreased PS by 80% compared with control cells. Incubation of
C2C12 myotubes with SB203580 (p38 inhibitor) or with PD098059 (MEK/Erk
inhibitor) alone significantly decreased the PS rate at the 3 h time point by -63
r 12.48% and -64 r 5.05% respectively compared with control cells (P < 0.01).
/ŶĐŽŶƚƌĂƐƚ ?>W^ ? ?ʅŐŵů-1) significantly increased the chymotrypsin-like
enzyme at all the time points. This effect was preceded by a significant
increase in the Ik ?ɲƉŚŽƐƉŚŽƌǇůĂƚŝŽŶĂŶĚŶƵĐůĞĂƌƚƌĂŶƐůŽĐĂƚŝŽŶŽĨE& ?Ŭ ?ĂŶĚ
ƐŝŐŶŝĨŝĐĂŶƚŝŶĐƌĞĂƐĞŝŶdE& ?ɲ ?ĂƚƌŽŐŝŶ ? ? ?DƵZ& ?ĂŶĚd>Z ?ŵZEĞǆƉƌĞƐƐŝŽŶ ?KĨ
note, increased atrogin-1 mRNA is the prominent feature of our septic model.
The data presented in chapter 4 and 5 showed that, there is no absolute
correlation between the expression levels of atrogens (atrogin-1 and MuRF1)
and the overall proteolytic activity in LPS-stimulated C2C12 myotubes.
The beneficial roles of the curcumin were evaluated LPS-stimulated
C2C12 myotubes for 3 h. Incubation of C2C12 ŵǇŽƚƵďĞƐ ǁŝƚŚ >W^  ? ? ʅŐŵů-1)
ĂŶĚĐƵƌĐƵŵŝŶ ? ? ?ʅD ZƐŝŐŶŝĨŝĐĂŶƚůǇĚĞĐƌĞĂƐĞĚƚŚĞ>W^ ?ŝŶĚƵĐĞĚĐŚǇŵŽƚƌǇƉƐŝŶ ?
Abstract
x
like enzyme activity. This effect was mediated via decreased p38 and Ik ?ɲ
phosphorylation. Although, curcumin blocked LPS-induced decreased Akt and
p70S6K phosphorylation and significantly increased Erk1/2 phosphorylation,
however, curcumin still had no effect on LPS-induced decreased protein
synthesis.
The effect of the LPS on the muscle protein turnover in the avian
primary skeletal muscle was summarised in chapter (7). Incubation of avian
ƉƌŝŵĂƌǇ ƐŬĞůĞƚĂů ĐĞůůƐ ǁŝƚŚ >W^  ? ? ʅŐŵů-1) for 3 h, significantly decreased the
proteasomal activity and increased PS rate. The difference in response to LPS
between C2C12 myotubes and avian primary skeletal muscle cells could be
attributed to the different incubation parameters mainly the presence of
insulin in case of avian primary cells.
Finally, the effect of natural challenge of chicken with S. Gallinarum or
S. Enteritidis on skeletal muscle mRNA expression was summarised in chapter
9. Natural challenge of chicken with S. Gallinarum or S. Enteritidis had no
effect on the expression of many atrophic genes in chicken skeletal muscle
(gastrocnemius and pectoral muscle).
The data collected from this project showed that, LPS is a strong
catabolic stimulus significantly decreased PS along with increased protein
breakdown rates in skeletal muscle. This effect was mediated via two main
pathways PI3-K/Akt and MAPKs (p38 or Erk1/2) and the cross talk between
them is exists. The better understanding of these signalling cascades and their
cross talk will be the starting point for developing the appropriate and safe
therapeutic intervention in order to decrease the sepsis-induced muscle
proteolysis.
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1 General Introduction
1.1 Introduction
Salmonella enterica is a facultative intracellular pathogen capable of
causing disease in a broad range of host species. Amongst S. enterica
serotypes, S. Typhimurium and S. Enteritidis are the most important
salmonellae and can cause enteritis in many species, and these serotypes are
responsible for the majority of Salmonella food-borne infections in man (for
more details, Kaiser et al., 2000).
The genus Salmonella includes more than 2,463 serotypes. Historically,
S. enterica serovar Typhimurium is the most common serovar isolated from
poultry and it covers 40% of all Salmonella isolations from poultry, followed
by S. enterica serovar Enteritidis (6%), serovar Pullorum (4%) and serovar
Gallinarum (3%) (Sojka et al., 1977). However, during the 1980s, the S.
enterica serovar Enteritidis phage type4 (PT4) became the predominant
serovar isolated from poultry.
The classification of the genus Salmonella has been initiated from the
initial one serotype one species model proposed by the Kauffmann and
White Scheme (Kauffmann 1963, 1966, 1972, 1978) based on the somatic
antigen (O), flagellar antigen (H) and in some cases capsular antigen (Vi).
Further advances in Salmonella taxonomy occurred in 1973 when Corsa et al
(1973) demonstrated by DNA-DNA hybridisation that, all serotypes and
ƐƵďŐĞŶĞƌĂʳ ?ʳʳĂŶĚʳsŽĨSalmonella and all serotypes of Arizona were related
and are in fact a single species. The single exception, is S. bongori (previously
known as subspecies V), with DNA-DNA hybridisation showed to be a
separate species (Reeves et al., 1989). Salmonella enterica has been divided
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into six subspecies (Le Minor and Propoff 1987; Reeves et al., 1989). The
following table illustrated the Salmonella classification
Table (1.1) Salmonella species, subspecies, serotypes and their usual
habitats, Kauffmann-White scheme.
Salmonella species and subspecies No. of species Usual habitat
S. enterica subsp. enterica (I)
1,454 Warm-blooded animals
S. enterica subsp. salamae (II)
489 Cold-blooded animals
and environment
S. enterica subsp. arizona (IIIa)
94 Cold-blooded animals
and environment
S. enterica subsp. diarizonae (IIIb)
324 Cold-blooded animals
and environment
S. enterica subsp. houtnae (IV)
70 Cold-blooded animals
and environment
S. enterica subsp. indica (VI)
12 Cold-blooded animals
and environment
S. bongo (V)
20 Cold-blooded animals
and environment
Total 2,463
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1.2 Morphology of Salmonella
Salmonella are Gram negative (G-ve) bacteria predominantly motile by
ƉĞƌŝƚƌŝĐŚŽƵƐ ĨůĂŐĞůůĂ ? ŶŽŶ ?ĞŶĐĂƉƐƵůĂƚĞĚ ? ŶŽŶ ?ƐƉŽƌƵůĂƚĞĚ ? ďĂĐŝůůŝ ?  ? ? ? ʅŵ ůŽŶŐ
ĂŶĚ  ? ? ? ? ? ? ? ʅŵ ǁŝĚĞ  ?<ƌŝĞŐ ĂŶĚ ,Žůƚ  ? ? ? ? Z ? dŚĞ ŽƌŐĂŶŝƐŵ ŚĂƐ ƚŚĞ ĂďŝůŝƚǇ ƚŽ
grow under both aerobic and anaerobic conditions in ordinary media at 37
ƕ
C,
and develops small colonies 2-4 mm in diameter, which are smooth and
homogenous. The metabolic features of Salmonella usually include the
utilization of citrate as a singular carbon source and the production of gas from
glucose (Krieg and Holt 1984; Andrews et al., 1995).
1.3 Distribution
Salmonella serotypes are distributed worldwide, and can infect many
mammals and birds, and the main route of infection is the ingestion of
contaminated foodstuff (faecal oral route). In poultry some Salmonella
serotypes such as S. Enteritidis and S. Typhimurium infect the ovaries, and
therefore they can be isolated from eggs and may be transmitted vertically
to the next generation (Guan et al., 2006). Only S. enterica subspecies
enterica is of a clinical significance, and its subspecies include the pathogen
associated with the typhoid fever (Bhan et al., 2005). The other subspecies
and S. bongori are usually isolated either from environment or reptiles and
therefore are of little clinical important (Bopp et al., 2003).
The intestinal tract of humans and animals, particularly poultry and
swine is considered as the main reservoir for Salmonella. The microorganism
is excreted in the faeces and transmitted by insects and other creatures, soil,
water, and kitchen surfaces. Eggs, poultry and meat products are considered
the most important source of Salmonella infection in humans, with the S.
Typhimurium and S. Enteritidis being the most commonly isolated food-
borne serovars (Jay 1996). Moreover, during recent years several countries
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have reported a high incidence rate of Salmonella in animals feed especially
bone and meat meal and feed.
1.4 Pathogenesis of salmonellosis
There are two main groups of the genus Salmonella from the
pathogenesis perspective. The first group produces a systemic disease, and in
the absence of systemic disease, they colonise the intestine poorly, do not
contaminate the carcass surface, and are not often implicated in human food
poisoning. This group includes Salmonella serovars Pullorum, and
Gallinarium, which causes pullorum disease and fowl typhoid in poultry
respectively (Chao et al., 2007).
The second group produces food poisoning in humans and is able to
produce systemic disease under certain circumstances when the host
immunity is decreased such as during parturition, in lay, in very young or old
animals, or after some viral infection (McMeechan et al., 2007). This group
consists of Salmonella enterica mainly serovars Typhimurium and Enteritidis.
These serovars can colonise in the gut and cause gastroenteritis infection in a
wide range of hosts including humans.
Understanding of the pathogenesis of Salmonella is mainly derived
from the studies using the S. Typhimurium-infected rat model (Barrow 2007).
The severity of the infection depends up on many factors including the
virulence of the Salmonella strain, the route of the infection, the innate
resistance, the immune response of the host and the genetic background of
the bird. The forms of systemic infection in chickens encompass three main
phases. The first is invasion via the gastrointestinal tract. The second is the
establishment of systemic infection (intracellular infection of the
macrophages). Finally, clearance of the infection by the immune system, or
the carrier state may develop (Chappell et al., 2009). The main route of
Salmonella infection in animals and humans is the oral route. Following
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ingestion, a proportion of the organisms resist the low pH of the stomach,
and reach the distal ileum and caecum and invade the mucosa and replicate
in the submucosa and Peyers patches (Carter and Collins 1974). In young
chickens extensive bacterial infection occurs in the caeca (Cooper et al.,
1994). In addition, invasion can occur via M cells with the contribution of the
invasion genes within pathogencity island 1 (SP-1) or via the transportation
of the bacteria within CD18-expressing phagocytes from the gastrointestinal
tract to the bloodstream (Vazquez-Torres et al., 1999). Following the
systemic infection, the microorganism reaches the phagocytes of the liver,
spleen and the bone marrow. Activation of the bacterial surface or the
presence of opsonising serum antibodies improve the uptake of micrograms
by phagocytes (Liang-Takasaki et al., 1983; Saxen et al., 1987). The majority
of Salmonella are coupled with macrophages and polymorphonuclear
phagocytes and the ability of the Salmonella to survive in and grow in these
cells is one of the most important determinants of Salmonella virulence
(Hoiseth and Stocker 1981; Lissner et al., 1983; Fields et al., 1986; Dunlap et
al., 1991; Mastroeni et al., 1995; Richter-Dahlfors et al., 1997).
There is a considerable variation in virulence for day-old chickens
between strains inoculated via the oral route, not associated with the phage
type of the strain (Smith et al., 1985). The mortality following the oral route
inoculation varies from 0-100 percent with some breeds of birds more
susceptible than others do. Moreover, there is no correlation between oral
and parenteral virulence, and the cause of death is most likely a combination
of anorexia and dehydration resulting from general malaise and diarrhoea. of
note, diarrhoea is not observed in chickens inoculated intramuscularly
(Barrow et al., 1987).
1.5 Host Resistance to Salmonellosis
There is a paucity in the understanding of the mechanism of natural
resistance and long-term protective immunity to Salmonellosis in chickens.
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Innate immunity is the non-specific first line of defence against the invading
pathogens. Innate immunity dose not provide the host with a long-lasting
immunity. It dose not specifically react with the microbial pathogens via
receptors, and can not serve to distinguish between the different types of
pathogens (Medzhitov and Janeway 2000). The innate immune system
includes macrophages, neutrophils, mast cells, dendritic cells, and natural
killer cells, for more details see (Kirby et al., 2002). The recognition of LPS by
the pathogen recognition receptors (PRR) mainly Toll-like receptor-4 (TLR-4),
is the first step in the signal transduction and later stimulation of the innate
immune system followed by the release of the pro-inflammatory and
chemokines (Totemeyer et al., 2003) including the tumor necrosis factor-
ĂůƉŚĂ  ?dE& ?ɲ Z ĂŶĚ ŝŶƚĞƌůĞƵŬŝŶ ? ?  ?/> ? ? Z  ?>ĞŵďŽet al., 2003). In addition, the
cellular immunity plays a significant role in host defence against Salmonella
mainly controlled by the T lymphocytes (direct effect cytotoxic T lymphocytes
(CTLs) and indirect effect T helper (Th) (Lillehoj 1993; Schat 1994). The role of
cell-mediated immune mechanisms in systemic clearance of S. Enteritidis has
been recently investigated in chickens (Farnell et al., 2001). Also, clearance of
S. Typhimurium in chickens is correlated with high cell-mediated responses
(delayed type hypersensitivity reaction) and not with antibody levels (Hong
et al., 2006). Thus, the assumption that cell-mediated immunity plays a more
important part than humoral responses in protection against Salmonella is
still the most acceptable dogma (Mastroeni et al., 1993; Barrow 2007).
Recent studies have highlighted the role of Th1 in immunity against
Salmonella infection. The interperitoneal administration of interferon-
ŐĂŵŵĂ ?/&E ?ɶ ZŵŝŶŝŵŝƐĞƐƚŚĞŽƌŐĂŶĐŽůŽŶŝƐĂƚŝŽŶĂĨƚĞƌS. Enteritidis infection
(Farnell et al.,  ? ? ? ? Z ?,ŝŐŚůĞǀĞůƐŽĨ /&E ?ɶĂƌĞĐŽƌƌĞůĂƚĞĚǁŝƚŚŚŝŐ ĐůĞĂƌĂŶĐĞ
rates (Beal et al.,  ? ? ? ? Z ? dŚĞŚŝŐŚ ůĞǀĞůƐ ŽĨ /&E ?ɶ ĂƌĞ ĂůƐŽ ĂƐƐŽĐŝĂƚĞĚ ǁŝƚŚ Ă
strong T-cell response (Withanage et al.,  ? ? ? ? Z ? /Ŷ ĐŽŶƚƌĂƐƚ ? /&E ?ɶ ŬŶŽĐŬŽƵƚ
mice and mice administrated with neutralising antibodies to IL-12 attenuate
host protection against Salmonella attenuated strain. Therefore, the Th1
cytokines, which enhance cell-mediated responses are more important than
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the humoral responses in the protection against Salmonella infection
(Eckmann and Kagnoff 2001; Raupach and Kaufmann 2001). The role of early
CD8
+
T cells in the protection against primary Salmonella infection in young
chicks has been shown (Berndt and Methner 2001). In contrast, the role of
IgA responses and polymorhonuclear leukocytes as a key players in intestinal
clearance of Salmonella is still confusing (Nagaraja and Rajashekara 1999).
IgA plays a significant role against intestinal colonisation as show follows.
Chemical bursectomy of chickens infected with S. Enteritidis that mainly
affects the cells types other than B cells resulted in an increase in the faecal
excretion and higher caecal counts of Salmonella, while having normal
counts in internal organs (Desmidt et al., 1998). In contrast, surgical removal
of the bursa (affects mainly B-cell maturation) has no effect on the clearance
rate of S. Typhimurium between the bursectomised and non-bursectomised
chickens (Beal et al., 2006). Combined, this suggests that the antibody
response is not essential for gut clearance. While, in case of poultry, the
situation is not similar. In chickens, heterophilic granulocytes accumulate in
the propria mucosae of the caeca within 18 h post experimental infection
with S.Enteritidis field strain (Van Immerseel et al., 2000a, 2000b), but in case
of infection with S. Typhimurium it is accompanied by acute
enteropathogenic responses characterized by expression of CXC chemokines
and a polymorhonuclear (PMN) cell influx (Withanage et al., 2005).
Heterophils in response to S. Enteritidis infection have been shown to up-
regulate mRNA expressions for pro-inflammatory chemokines, IL-6 and the
ĂŶƚŝ ?ŝŶĨůĂŵŵĂƚŽƌǇ ĐǇƚŽŬŝŶĞ ƚƌĂŶƐĨŽƌŵŝŶŐ ŐƌŽǁƚŚ ĨĂĐƚŽƌ ?ɴ ? ? ǁŚĞƌĞĂƐ
ĞǆƉƌĞƐƐŝŽŶŽĨ/> ? ? ?ĂŶĚ/&E ?ɶǁĂƐĚŽǁŶ ?ƌĞŐƵůĂƚĞĚ ?<ŽŐƵƚ et al., 2003).
1.6 The role of cytokines in Salmonella pathogenesis
Cytokines are a large and diverse family of polypeptides produced
mainly by cells of the immune system. Cytokines are signalling molecules
involved in cell communication and signal transduction between the cells.
Infection with Salmonella enhances the production of the early stage
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cytokines including IFN-J (Ramarathinam et al., 1991; Klimpel et al., 1995),
dE& ?ɲ ?ƌŶŽůĚĂŶĚ,Žůƚ ? ? ? ? Z ?/&E ?J is responsible for the activation of anti-
microbial activity of macrophages in the case of infection with S.
Typhimurium (Foster et al., 2003).
dE& ?ɲ ĞŶŚĂŶĐĞĚ ƚŚĞ ŝŵŵƵŶŝƚǇ ĂŶĚ ĚĞĐƌĞĂƐĞĚ ƚŚĞ ŶƵŵďĞƌ ŽĨ S.
Typhimurium in the peritoneal cavity of infected rats, for more detail see
(Nakano et al., ? ? ? ? Z ?DŽƌĞŽǀĞƌ ?dE& ?ɲĐŽŶƚƌŝďƵƚĞĚƚŽƚŚĞŵĂƚƵƌĂƚŝŽŶŽĨƚŚĞ
dendritic cells in mice orally infected with Salmonella (Lembo et al., 2003).
ĞƐŝĚĞ /&E ?ɶ ĂŶĚ dE& ?ɲ ? ŝŶĨĞĐƚŝŽŶ ǁŝƚŚS. Typhimurium stimulated the
production and release of many other cytokines with various functions such
as IL-6, IL-8, and IL-12. IL-6 mRNA significantly increased in intestinal tissue
following the secondary infection with S. Typhimurium (Withanage et al.,
2005). S ? dǇƉŚŝŵƵƌŝƵŵ ĂůƐŽ ƵƉ ?ƌĞŐƵůĂƚĞƐ ďŽƚŚ /> ? ?ɴ ĂŶĚ /> ? ? ŝŶ ĂǀŝĂŶ
epithelial cells (Kaiser et al., 2000).
IL-6 is a pro-inflammatory cytokine involved in the activation of T and
B Lymphocytes and the development of macrophages (Hirano 1998; Lynagh
et al., 2000). IL-8 is an inflammatory chemokine secreted by several body
cells, in particular macrophages. IL-8 is chemoattractant attracting the
neutrophils to the site of infection and thus is known as neutrophils
chemotactic factor, for further details see Köhidai and Csaba (1998). IL-12 is
mainly produced by the dendritic cells (Kalinski et al., 1997). IL-12 known as T
cell stimulating factor stimulates the growth and the function of the T cells,
involved in the differentiation of the naïve T cells to Th0 cells, which later
develop into Th1 or Th2 cells. The production of IL-12 enhances the cell-
mediated immune response against S. Typhimurium (Yrlid et al., 2000). With
regard to the role of cytokines in LPS-induced muscle wasting of particular
ŝŶƚĞƌĞƐƚŝƐƚŚĞƌŽůĞŽĨdE& ?ɲĂŶĚ/> ? ? ?&ƵƌƚŚĞƌĚĞƚĂŝůƐĂďŽƵƚƚŚĞŝƌĨƵŶĐƚŝŽŶĂƌĞ
given later.
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1.7 The clinical features in chickens infected orally with virulent
strain strains of Salmonella Typhimurium and Pullorum
Salmonella infection in poultry is still a major problem worldwide. Many
Salmonella outbreaks with the mostly frequent isolated serovars S.
Typhimurium, S. enteritidis, S. Gallinarum, S. Pullorum, S. newport, S. Cerro, S.
Montevideo, and S. Agona have been reported worldwide (Konrad et al.,
1994). The severity of the infection depends on many factors including, the
strain of Salmonella, the standard of hygiene, age of the bird, route of
infection, and immune status of the birds. Generally the greatest severity of
infection was seen in young birds; the younger the birds the higher mortality
rate. For instance, a higher mortality rate was seen in young birds infected
with pullorum disease and fowl typhoid, while the adult birds develop the
carrier state and the infection persists in the reproductive tract of the birds
(Chao et al., 2007), and are involved in vertical transmission (Gast 1997).
The general signs of infection in chicks are depression, loss of
appetite, ruffled feathers, dehydration, thirst, and yellow or green diarrhoea.
The mortality rate is higher especially in young chicks (one to three weeks old
chicks) (Wigley et al., 2002). In the adult birds, the signs vary from
depression, weight loss, decreased egg production, and low fertility rate. The
post-mortem lesions include grey nodules in lungs, liver, gizzard wall and
heart, intestinal or caecal inflammation, splenomegaly, caecal cores, and
urate crystals in ureters. Of note, diarrhoea is absent in chickens inoculated
intramuscularly (Barrow et al., 1987).
The mortality rate varies according to the strain of Salmonella, age
and the immune status of the host. For example Jones and associates have
reported a 60% mortality rate in experimentally infected 3 week old
outbreed chickens with S. Gallinarum (Jones et al., 2001). Infection with S.
Pullorum causes a considerable mortality, but is less frequent in birds more
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than a week old (Wigley et al., 2001). Infection of chickens with S. entreica
serovar Typhimurium and Enteritidis is associated with transient systemic
infection mainly in newly hatched chicks (Barrow 2000).
The microorganism can be isolated from the alimentary tract and
most organs other than blood, breast muscle, yolk sac, and brain where a
little isolation was made. The number of isolated Salmonella increased when
birds became clinically infected with Salmonella. The presence of the
organism in the viscera is not a result of septicaemia as low numbers were
isolated from the blood demonstrating that Salmonella is mainly an
intracellular parasite (Suter and Ramseiar 1964; Popiel and Turnbull 1985).
The high counts in the lung were likely to be raised from intracellular
locations rather than oral infection. In the case of Salmonella Pullorum, the
development of the carrier cases is the most common feature of the disease
in birds. The microrgansim infects the reproductive tract, and persists until
sexual maturity leading to reproductive tract abnormalities and infection of
progeny without disease (Chappell et al., 2009).
1.8 Food-borne infection
The members of genus Salmonella are one of the most important
pathogenic bacteria that are identified to cause mass food-poisoning
incidents (Krieg and Holt 1984). Human Salmonella infection is still a major
problem, in terms of both morbidity and economic cost (Barnass et al.,
1989). Amongst the genus Salmonella, S. enterica serovar Enteritidis has
become a worldwide problem, arising in the main in poultry (Rodrigue et al.,
1990). There are nearly 70 Salmonella associated deaths each year in the UK
(Anon. 1997). In 1985 there were 80,000 cases notified in the UK rising to just
over 90.000 in 1997, but falling to about 68,000 in 2000, with highest rates of
infection in ages over 70 and under 20, particularly infants (Cogan and
Humphrey 2003). Human food poisoning occurs because of consumption of
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contaminated poultry products (meat and eggs) with S. enterica especially S.
Typhimurium and S. Enteritidis is considered as a major public health
problem. Salmonellosis is a food-poisoning syndrome, caused by
consumption of contaminated food and meat and their by-products with
pathogenic Salmonellae. The disease is a serious bacterial toxi-infection
syndrome associated with gastroenteritis and fever, and less frequently with
vomiting, these symptoms usually last 4-7 days (Jay 1996). The disease is self-
limiting and the majority of cases recover without treatment, but it can be
more serious in the elderly, infants and people with chronic conditions. If
Salmonella gets into the bloodstream, it can be serious or even life
threatening, and a course of antibiotics is the usual treatment.
1.9 Stimulation of host immune defence and
lipopolysaccharide
The immune and non-immune cells have the ability to recognise the
pathogens and pathogens particles by secreting several proteins called Toll-
like receptors (TLRs) which are similar to that were first discovered in
Drosophila (Delneste et al., 2007). Mammals secrete a dozen of proteins
homologous to Toll protein secreted by Drosophila, and these proteins were
scattered in many tissues and skeletal muscle is one (Carpenter and O'Neill
2007). TLRs are considered the first line of defence against the bacterial cell
components including LPS (Gao et al., 2008). Skeletal muscle and C2C12
myocytes produce mRNAs for TLR1 to TLR7, but not TLR9 or TLR10, thus
skeletal muscle, whether in vivo or in vitro can respond to a wide array of
bacterial cell wall components including LPS, Flagellin, Lipopeptides, single
and double strand RNA, viruses, but not bacterial DNA (Frost et al., 2006).
TLR4 is a member of a family of receptors that recognise pathogen-
associated molecular patterns (PAMPS) mainly LPS. LPS can be recognised by
TLR4 and the role of TLR2 is crucial in mice harbouring a mutation of TLR4
(Frost et al., 2006). The recognition of LPS by TLR4 in cultured skeletal muscle
cells (C2C12) is the same either in the absence or in the presence of serum
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components (such as LPS-binding protein and soluble CD14) (Frost et al.,
2002).
Lipopolysaccharide (LPS) or bacterial endotoxin are an integral part of
Gram-negative bacterial cell wall, and are very strong activators of the innate
immune system recognised mainly by TLR4 (Raetz 1990). LPS binds to the
plasma LPS-binding protein and the complex is associated with CD14
(Alexander and Rietschel 2001). The interaction of LPS with TLR4 is the first
step in the signal transduction and later stimulation of inflammatory cytokine
gene expression (Kaisho and Akira 2000).
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Figure (1-1) Schematic diagram illustrates the structure of Lipopolysaccharide
molecule. LPS composed of three parts. Lipid core (lipid A, responsible for biological
effect of LPS and can alone reproduce its toxicity), core polysaccharide part, and O-
part (variable part responsible for LPS heterogeneous response among bacterial
species).
O-specific polysaccharide
chain of 40 repeating sugar unit
Outer core region, different sugars
Inner core region, different sugars
Core polysaccharide
Phosphate
Diglucosamine
Fatty acids
Lipoid A
(Lipid part)
O - part
Chapter 1 General introduction
14
The LPS molecules are composed of three main parts (Fig. 1-1). The
first is the lipid core (lipid A), which is responsible for most of the biological
effects of LPS and can alone produce its toxicity (Raetz 1996; Wyckoff et al.,
1998). The second part, is core oligosaccharide, and the third part is O-
antigen, which is the only variable part of LPS molecule and it is the main
cause of the heterogeneity of the response to LPS from different strains of
bacteria (Rietschel and Brade 1992; Rietschel et al., 1994). The interaction of
the LPS with cells such as macrophages, granulocytes, dendritic cells or mast
cells leads to the formation and liberation of many inflammatory mediators
that are essential for the early innate and subsequent adaptive anti-bacterial
defence (Beutler et al., 2003; Freudenberg et al., 2003). However, these
strong inflammatory responses to LPS can themselves be threatening and
may lead to endotoxic shock and even death (Freudenberg et al., 2008). The
ĚĞǀĞůŽƉŵĞŶƚ ŽĨ >W^ ŚǇƉĞƌƐĞŶƐŝƚŝǀŝƚǇ ŝƐ ŵĞĚŝĂƚĞĚ ďǇ /&E ?ɶ Žƌ /&E ?ɲ ?ɴ
depending on the inducing microbial agent (Freudenberg et al., 2003). For
example, the sensing of LPS by TLR4 leads to activation of nuclear factor-kB
(NF-kB) and mitogen-activated protein kinase (MAP kinase) (JNK, P38)
pathways (Medzhitov 2001), which in turn leads to stimulation of a number
of host defence genes as pro-inflammatory cytokines IL-1, IL-6, IL-8, IL-12 and
other chemokines and co-stimulatory modules CD80 and CD86 (Medzhitov et
al., 1997; Takeuchi et al., 1999; Schnare et al., 2001).
Administration of LPS affects the transcription and release of several
pro-inflammatory cytokines. Interperitoneal (i.p) injection of LPS significantly
ŝŶĐƌĞĂƐĞĚƚŚĞĞǆƉƌĞƐƐŝŽŶŽĨŵZEŽĨdE& ?ɲĂŶĚ/> ? ?ɴ ?/> ? ?ɴŝƐĂŵĞŵďĞƌŽĨ
IL-1 super family which has role in the immune defence against infection as a
pro-inflammatory cytokine (Lang et al., 2003). Also, direct injection of LPS
significantly increased the expression of IL-6 mRNA in skeletal muscle (Frost
et al., 2006). LPS increased IL-6 and IL-6 mRNA as well as increased mRNA for
other inflammatory cytokines and decreased the expression of IGF-ImRNA in
septic skeletal muscle (Lang and Frost 2005). In addition, LPS stimulated NO
synthase-2 (NOS2) mRNA expression in C2C12 myoblasts and primary
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cultures of human myocytes (Frost et al., 2004). The enzyme nitric oxide
synthase 2 (NOS2) which is often called inducible NOS (iNOS), is a member of
NOS family first described in macrophages and now it has been detected in
nearly every cell type; playing a central role in the inflammatory response to
infection or tissue damage (Galea and Feinstein 1999). Further details on
how LPS affecting the muscle protein balance (protein synthesis and protein
degradation) are given later in details.
1.10 Structure of skeletal muscle
Skeletal muscles comprise 60-70% of the whole lean body mass, and
the main function of the muscle is the contraction and hence movement.
Skeletal muscle is considered as the natural reserve of amino acids and
energy for time of need (Frost and Lang 2008). Skeletal muscle is considered
as an important component of the bodys response towards sepsis and injury
because of its bulk. A minor change in muscle protein metabolism has a
major impact on whole body metabolism. The reduction of muscle protein
content can affect the myofibrillar compartment, and this has important
implications in term of wound healing, morbidity, and mortality.
Skeletal muscle composed of repeated bundles of muscle fibres
separated by a connective tissue called perimysium. Each fascicle is made up
of a muscle fibre, which is separated by a connective tissue called
endomysium. Muscle fibres are multinucleated and straighted in appearance.
The muscle fibre is composed of subunits called myofibrils; each myofibril is
made of myofilaments. The myofilaments are composed mainly of two
proteins, the thick filament (myosin) and the thin filament (actin). The
specific arrangement of both thin and thick filament forms the main
contraction unit of the muscle (sarcomere) (Fig. 1-2).
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Figure (1-2) diagram illustrates the structure of the myofibrils and the
arrangement of the thin filaments (actin) and thick filament (myosin) that
forms the contraction unit (sarcomere).
The myosin molecule is composed of 6 polypeptides, 2 heavy chains
and 4 light chains. The heavy chains contain the myosin head that interacts
with actin to force the muscle to contract (Scott et al., 2001). The myosin
heavy chain is considered as the mechanochemical enzyme, or motor
protein. In the head region it contains the ATP binding sites that serves as an
enzyme (ATPase) for the hydrolysis of ATP to the ADP and inorganic
phosphate, and this provides the energy required for the muscle contraction
(Stevens et al., 2006). In the presence of the ATP, the myosin head binds and
pulls the actin filament along this allowing the sarcomere to shorten. Thus,
the interaction between the actin and myosin represents the basis for force
generation and contractile functions.
I band
A band
Myosin thick filaments
I band
Actin thin filaments
H zone
Z line Z line
Sarcomere
Myosin cross bridge
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Skeletal muscles can be categorised according their colour into red
and white muscle fibre. In addition, muscle fibres can be classified according
to their contraction capability into fast and slow twitch-muscle fibres. To be
more concise, the muscle can be subdivided into two broad groups, slow-
twitch (type-1) and fast-twitch (type-2), the latter can be subdivided into tye-
2A, type-B and type-2X fibre. The fast twitch muscle fibre responds more
quickly the stimulus and expresses a more rapid relaxation compared with
the slow-twitch fibre. In addition, type-2X fibres utilise the glycolysis as a
means of cellular respiration (Zierath and Hawley 2004), while slow-twitch
fibres are largely dependent upon the mitochondrial respiration. The better
understanding the difference of the muscle fibres composition helps in the
better understanding the muscle plasticity and how the skeletal muscle can
respond to a wide verity of stimuli.
1.10.1 C2C12 murine-derived myotubes and avian primary skeletal
muscle cell cultures
Skeletal muscle is made up of many muscle fibres which differ in their
physiological and metabolic parameters. The skeletal muscle can diversely
respond to many stimuli and this response termed as muscle plasticity. Two
main models that have been extensively used in muscle research will be
employed in the present studies, the C2C12 murine-derived myotubes model
and the primary cell line model (avian primary skeletal muscle cell line).
1.10.1.1 C2C12 murine-derived fully differentiated myotubes
C2C12 murine-derived myotubes is a well-established commercial
model used extensively in muscle research and is a sub clone of differentiated
C2 cells (adult C3H leg muscle) (Yaffe and Saxel 1977; Blau et al., 1985). C2C12
myoblasts and fully differentiated myotubes have been extensively used as in
vitro model in many muscle research works. This because C2C12 myoblasts
and myotubes have the same functional operating receptor recognition
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system as skeletal muscle. These cells express the mRNA of TLR1 through TLR4
and not TLR9 or TLR10 (Frost and Lang 2008). Therefore, the C2C12 cells can
respond to the external stimuli similarly as the skeletal muscle.
1.10.1.2 The avian primary skeletal muscle cells
The in vitro culture of the skeletal muscle as a primary cultures
established cell lines has previously been demonstrated (Yaffe 1968). The
primary cultures of skeletal muscle have been used as a model to study of the
muscular and neuromuscular diseases and parasitic cytogenesis (Fong et al.,
1990; Metzinger et al., 1993; Passaquin et al., 1993; Bouzakri et al., 2003;
Guimaraes et al., 2008). Herein, we have used the avian primary skeletal
muscle cells that were obtained from the broiler chickens. These birds have
been genetically selected for rapid growth and in particular the accretion of
muscle mass (Nakashima et al., 2009). These chickens are characterised by a
lower protein degradation rate than that observed in layers (Hayashi et al.,
1985; Maeda et al., 1987). This because of the fractional rates of protein
synthesis in the broiler chicken are greater than in the layers (Maeda et al.,
1984). In the context, there is no clear data regarding the direct effect of LPS
on the protein turnover in these cells. Thus, we assume that, the effect of the
LPS will different in these cells compared with the C2C12 myotubes model.
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1.11 Protein turnover
Protein synthesis, involves two main steps at the molecular levels:
transcription and translation (Fig. 1-3). Transcription is the formation of
mature messenger RNA (mRNA) from the DNA (nuclear code) in the nucleus,
while the translation is the formation of specific protein from the mRNA. The
translation step of protein synthesis includes three main phases: initiation,
elongation, and termination which are regulated by eukaryotic initiation,
elongation and releases factors, respectively (Proud 2007). The rate of protein
turnover varies between tissues; with some tissues like liver and gut having a
greater rate of protein breakdown and synthesis compared to skeletal muscle,
and this variation in addition has been demonstrated in the fractional protein
synthesis rate between individual proteins (Wagenmakers 1999). Planas et al.
have demonstrated that the rate of protein synthesis was higher in the liver
and diaphragm and lower in skeletal muscle of septic rat compared to the
control (Planas et al., 1995). Increased rate of protein synthesis in liver was
derived from accelerated formation of the acute phase protein (Frost and
Lang 2008). In addition, the difference in protein synthesis rates was varied
according to species, age, status of nutrition, and the method of
measurement. Within the same species i.e. rats, the protein synthesis rate
was varied in individual tissues with the highest rate was seen in the pancreas
and the lowest was in muscle (Waterlow 2006). The study carried out by
Marway et al., (1993) demonstrated that the rate of protein synthesis was
significantly decreased from the mouth to rectum. In skeletal muscle, a little
part of the discrepancy in the protein turnover rates can be attributed to
fibre-type composition of the muscle (Maltin et al., 1989). Catabolic insults
like sepsis altered the protein synthesis rate according the muscle fibre type,
Vary and Kimball demonstrated that sepsis decreased the protein synthesis in
fast-twitch but not in the slow-twitch muscle (Vary and Kimball 1992).
Similarly, in vivo studies using C2C12 septic model, Frost el al., have
demonstrated that LPS alone could not change the protein synthesis while in
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ĐŽŵďŝŶĂƚŝŽŶǁŝƚŚ/&E ?ɶŝƚŝŶĚƵĐĞĚ ? ?A?ĚĞĐƌĞĂƐĞŝŶƉƌŽƚĞŝŶƐǇŶƚŚĞƐŝƐ ?&ƌŽƐƚet
al., 2009).
Under normal conditions, the total lean body mass is maintained by the
balance between the protein synthesis and protein degradation. In case of
catabolic diseases such as sepsis, the protein degradation rate is increased
while the protein synthesis in decreased (Rennie et al., 1983; Sjolin et al.,
1990). The major portion of protein breakdown was originated primarily from
the skeletal muscle. Sepsis decreased synthesis of myofibrillar and
sarcoplasmic proteins (Vary et al., 1996) and this effect was mediated via the
alteration of the translation initiation step of protein synthesis mainly
decreasing the availability of the active eukaryotic initiation factor-4G (eIF-
4G)-eIF-4E complex (Vary and Kimball 2000).
In skeletal muscle, the proteins can be categorised into two major
groups, sarcoplasmic and myofibrillar proteins (myosin and actin), and
recently the importance of the mitochondrial protein has been given more
consideration (Stump et al., 2003). The protein turnover rates between
individual proteins in the same group are still contradictory. Zak et al. (1977)
ŚĂǀĞ ĚĞŵŽŶƐƚƌĂƚĞĚ ƚŚĂƚ ŵǇŽƐŝŶ ŚĞĂǀǇ ĐŚĂŝŶ ? ɲ ?ĂĐƚŝŶŝ ĂŶĚ ƚƌŽƉŽŵǇŽƐŝŶ
turnover faster than actin and myosin light chains. While, Fiorotto et al.
(2000) showed that under nutrition caused a similar 30% decreases in
synthesis rates of seven different myofibrillar proteins. Increased net protein
degradation was resulted primarily from accelerated rate of amino acid fluxes
from the tissues (Biolo et al., 2000). It has been previously demonstrated that
amino acids act as signalling molecules enhancing protein synthesis by
accelerating the translation initiation (Vary and Kimball 2000). Leucine (Leu),
is one of the amino acids that has been shown to regulate the protein
synthesis. Leu enhanced protein synthesis acting by enhancing the
phosphorylation of 4E-binding protein1 (4E-BP1) and p70
S6K
, and thus it
enhance the association of the eIF-4E with eIF-4G and switch on the mRNA
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translation initiation (Crozier et al., 2005). Further details about these factors
are given later in this chapter.
Amino acids are the precursor of protein synthesis and the end
product of the protein breakdown. Two main methods have been used to
measure the protein synthesis in vivo using labelled amino acid tracer, the
constant infusion method and flooding dose method. In case of constant
infusion method protein synthesis is measured by calculating the plateau
labelling of the tracer and the increase in tissue incorporation of tracer at a
single point at the end of the infusion (Smith and Rennie 1996). While, the
flooding methods includes the administration of a large (flooding) dose, to
equilibrate the tracer in all the intra-and extracellular amino acids pools i.e.
using large pools of leucine or phenylalanine (Smith et al., 1992). Fractional
protein breakdown rates have been measured by discerning dilution of free
intracellular amino acids. This technique offers the study of both the protein
synthesis and protein breakdown in one study (Phillips et al., 2002; Zhang et
al., 2002). In vitro, protein synthesis has been generally determined by
measuring the direct incorporation of
3
H-phenylalanine into protein
(Vandenburgh et al., 1991; Frost et al., 2009), and the protein degradation
determined by measuring the chymotrypsin-like enzyme activity (proteasomal
activity) (Orino et al., 1991; Whitehouse and Tisdale 2003).
1.11.1 Protein turnover in C2C12 murine-derived myotubes and the
avian primary skeletal muscle cells
Protein turnover is the ratio between the protein synthesis and the
protein degradation. In normal conditions, all the body proteins are in a
constant state of turnover. Sepsis is an acute inflammatory condition
characterised by accelerated rate of protein degradation much of which
originated from the skeletal muscle and decreased rate of protein synthesis.
(Jepson et al., 1986; Hummel et al., 1988; Ash and Griffin 1989; Hasselgren et
al., 1989; Gracey et al., 2004). The accelerated rate of protein degradation
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from the skeletal muscle aimed mainly to afford the liver with the required
amino acids to form the acute phase protein and for the production of glucose
by gluconeogenesis. Skeletal muscle has the ability to respond to various
external stimuli including LPS, and this effect is mainly mediated through TLRs
mainly TLR4. Thus, skeletal muscle can respond directly to LPS, the majority of
injected LPS has been taken by the liver, and a considerable amount has been
taken by the muscle, thus muscle is considered a significant store for LPS
(Mathison et al., 1980). LPS stimulated cytokines production and release in
both classical immune and non-immune cells including, skeletal muscle (Frost
et al., 2003). Direct injection of LPS in the skeletal muscle of the dog
significantly increased the level glucose-6-phoshate, phosphocreatine and ATP
within 5 min (Myrvold et al.,  ? ? ? ? Z ? ĂŶĚ ŵZE ŽĨ dE& ?ɲ ĂŶĚ /> ? ?ɴ ŵZE
within 30 min (Lang et al., 2003). In addition, LPS directly and indirectly
ƚŚƌŽƵŐŚ dE& ?ɲ ĂƵƚŽĐƌŝŶĞ ŵĂŶŶĞƌ ƐƚŝŵƵůĂƚĞĚ ƚŚĞ /> ? ?ŵZE ƉƌŽĚƵĐƚŝŽŶ ĂŶĚ
release in septic skeletal muscle (Frost et al., 2006; Crossland et al., 2008).
Regarding the in vitro studies, the use of C2C12 myotubes is the most suitable
and acceptable model to evaluate the effect of LPS on skeletal muscle. The
C2C12 fully differentiated myotubes are behave and respond to the external
stimuli in a similar way to that of skeletal muscle. LPS in combination with IFN-
Ȗ was able to induce the nitric oxide (NO) production (Williams et al., 1994),
and decreased the protein synthesis rate by 80% (Frost et al., 2009) in C2C12
myotubes. The accelerated protein degradation in muscle is mainly due to the
increased activity of ubiquitin-proteasome pathway (Hershko and
Ciechanover 1998) and this effect is mainly associated with increased activity
of both atrogin-1 and MuRF1 mRNA (E3 ubiquitin ligases ) (Li et al., 2003; Li et
al., 2005; Jin and Li 2007). Further details regarding the adverse effects of
sepsis on skeletal muscle protein metabolism are given later.
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1.12 The effect of LPS (bacterial endotoxin) on the protein
synthesis and degradation
In normal conditions, the balance between the rate of muscle protein
turnover and the muscle protein synthetic rate governs the maintenance of
skeletal muscle protein metabolism. The loss of lean body mass is one of the
most important consequences of severe infection and sepsis (Macallan et al.,
1996). Sepsis, endotoxin, excess inflammatory cytokines, and glucocorticoid
administration are characterised by a reduction in the rate of muscle protein
synthesis (Jepson et al., 1986; Hummel et al., 1988; Ash and Griffin 1989;
Hasselgren et al., 1989; Gracey et al., 2004) and/or an increased rate of
protein breakdown. The mechanism by which the protein synthesis is
decreased is either transcriptional or translational (Macallan et al., 1996),
with the translational regulation being the foremost mechanism in acute
sepsis (Jepson et al., 1986). Skeletal muscle is considered as a significant
store for LPS (Mathison et al., 1980), and can respond directly to LPS (Frost el
al 2006). The administration of LPS in sub-lethal doses causes activation of
ĐǇƚŽŬŝŶĞƐ ĐĂƐĐĂĚĞƐ ? ǁŝƚŚ ƌĂƉŝĚ ƌĞůĞĂƐĞ ŽĨ ůĂƌŐĞ ĂŵŽƵŶƚƐ ŽĨ dE& ?ɲ ŝŶƚŽ ƚŚĞ
circulation which in turn associated with the development of the a classical
acute phase response (Sharma et al., 1992). In addition, LPS significantly
ŝŶĐƌĞĂƐĞĚƚŚĞĞǆƉƌĞƐƐŝŽŶůĞǀĞůŽĨŵĂŶǇĐǇƚŽŬŝŶĞƐŵZEŝŶĐůƵĚŝŶŐdE& ?ɲĂŶĚ
/> ? ?ɴ ŵZE ? dE& ?ɲ ĂŶĚ /> ? ?ɴ ĂƌĞ ƚǁŽ ŵĂŝŶ ŵĞĚŝĂƚŽƌƐŝŶǀŽůǀĞĚ ŝŶ ŵƵƐĐůĞ
wasting Lang et al ?  ? ? ? ? ? Z ? ůĞǀĂƚĞĚ ůĞǀĞůƐ ŽĨ /> ? ?ɴ ĂŶĚ dE& ?ɲ ƐŝŐŶŝĨŝĐĂŶƚůǇ
induce muscle wasting via activation of atrogin-1 in a p38-dependent manner
(Li et al., 2005; Li et al., 2009). LPS administration was associated with a 10%
loss of body weight in the first 24 h post-treatment (Ash and Griffin 1989;
Hasselgren et al., 1989), and this effect was because of the reduction of food
intake (Sharma et al., 1992; Macallan et al., 1996). In contrast, LPS
significantly decreased the protein synthetic rate in the skeletal muscle of
neonatal pigs (Orellana et al., 2002). Similarly, in vitro a mixture of LPS and
/&E ?ɶƐŝŐŶŝĨŝĐĂŶƚůǇĚĞĐƌĞĂƐĞĚƚŚĞƉƌŽƚĞŝŶƐǇŶƚŚĞƐŝƐƌĂƚĞŝŶ ? ? ?ĐĞůůƐďǇ ? ?A?
(Frost et al., 2009), and LPS alone significantly decreased the rate of PS by a
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60% compared with the control in the same cell line (Russell et al. 2010).
Together, the regulation of LPS-induced muscle wasting requires the
interaction of many signalling cascades and transcriptional factors. This
makes the overall elucidation of these process is a hard task requires further
investigation in order to develop an appropriate therapeutic intervention.
The major proteolytic systems implicated in skeletal muscle atrophy
in many catabolic models are lysosomal, calcium-dependent and the ATP-
dependent ubiquitin-proteasome pathway (Finn and Dice 2006). The ATP
dependent ubiquitin-proteasome pathway is considered the predominant
biological mechanism controlling the protein degradation in myofibrillar
proteins in skeletal muscle (Attaix et al., 2005). Further details on the role of
these proteasomal systems are given in details later.
The decrease in body lean mass is mainly because of the loss of
skeletal muscle protein (Goldberg et al., 1988). The biochemical mechanism
of muscle wasting involves complex interactions among several mediators,
which are not fully understood. Therefore, a better understanding of these
interactions is important for developing successful therapies to retard the
loss in lean body mass and lessen morbidity and mortality (Fernandez-
Celemin et al., 2002). Further details about how LPS-induced decreased
protein synthetic rate and the possible contribution of Akt and other
translation initiation mediators mainly (mammalian target of rapamycin
(mTOR), eIF-4E and 4E-BP1 are given later.
1.13 Signalling pathways regulating protein synthesis
Muscle wasting is a common result of severe catabolic diseases such
as sepsis, cancer, and AIDS. Sepsis is an inflammatory condition that causes
severe and rapid loss of body lean mass, much of which originates from
skeletal muscle (Hasselgren 1995). LPS are an integral part of cell wall
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components of Gram-negative bacteria, and are potent activators of the
innate immunity system through recognition by TLR4 (Raetz 1990).
The dynamic balance between rates of protein synthesis (PS) and
protein degradation determines skeletal muscle protein mass. To date, most
studies investigating the effects of LPS upon skeletal muscle protein
metabolism have examined the regulation of catabolic pathways involved in
muscle protein loss (Potter et al., 2001; Ravindranath et al., 2003; Cai et al.,
2004). Recently, two main in vitro studies (Frost et al., 2009; Russell et al.,
2010) and one in vivo study (Orellana et al., 2002) have examined the effect
of LPS on PS. The regulation of PS in skeletal muscle can be at either the
transcriptional or translational level (Macallan et al., 1996), but, the latter is
the main mechanism in acute conditions (Jepson et al., 1986).
One of the most studied anabolic pathways is the
phosphatidylinositol 3-kinase (PI3-K)/Akt pathway. Akt (protein kinase B), is a
family of serine-theronine protein kinases (Datta et al., 1999) which are
stimulated by a number of receptor tyrosine kinases and often mediated by
the action of PI3-K (Walsh 2006). Akt has also been shown to be activated by
Salmonella enterica serovar Typhimurium in epithelial cells (Steele-Mortimer
et al., 2000). In skeletal muscle, acute activation of Akt for 2 weeks leads to a
dramatic increase in the skeletal muscle size, which occurs via an increase in
the PS pathways (Lai et al., 2004). The involvement of PI3K-Akt pathway and
the mTOR, and their down stream targets P70
S6K
and 4E-BP1 in the process of
PS was reviewed in (Glass 2005), which plays a crucial role in the up-
regulation of PS (Wang et al., 2001). Akt mainly regulated the protein
synthesis via the regulation of the translation initiation process (Fig. 1-4).
The process of PS translation is conventionally divided into three
main stages: initiation elongation and termination. mTOR controls the
initiation and elongation process stage of translation (Wang and Proud 2006)
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through its downstream effectors, including ribosomal S6Kinase (S6K1) and
4E-BP1 (Wang and Proud 2006).
The mitogen Activated Protein Kinases (MAPKs) family plays an
indispensable role in the regulation of cell growth and differentiation. In vitro
stimulation of MAPK-integrating kinase1 (Mnk1) (downstream target of both
p38 and Erk1/2 MAP kinases) regulates the translation initiation process
through eIF-4E (Fukunaga and Hunter 1997). Further details about these
signalling cascades and their roles are given later.
1.13.1 Role of Akt in Protein synthesis
Akt (Protein kinase B), is a serine/theronine kinase that is stimulated
by a variety of growth factors including insulin through the PI3-K-dependent
mechanism (Chan et al., 1999; Walsh 2006). Currently, three mammalian
ŝƐŽĨŽƌŵƐŽĨŚŝŐŚĚĞŐƌĞĞŽĨƐĞƋƵĞŶĐĞŚŽŵŽůŽŐǇ ?Ŭƚ ? ?W<ɲ ?Ŭƚ ? ?W<ɴĂŶĚ
Ŭƚ ? ?W<ɶ ZŚĂǀĞďĞĞŶŝĚĞŶƚŝĨŝĞĚ ?ƌŽĚďĞĐŬet al., 1999 2001). These isoforms
vary in their functions. Akt1 and Akt2 are ubiquitously expressed, whereas
the expression of Akt3 is mainly restricted to heart, kidney, brain, testis, lung
and skeletal muscle (Brodbeck et al., 1999; Brodbeck et al., 2001). Akt1 is
most important to the growth both in utero and after birth (Cho et al., 2001),
while Akt2 is required for insulin to maintain normal glucose homeostasis.
The absence of Akt2 significantly decreased the insulin stimulated glucose
uptake in muscle and the whole glucose disposal from the body (Cho et al.,
2001). In skeletal muscle acute activation of Akt for 2 weeks increased the
skeletal muscle size, which occurs via an increase in the PS pathways (Lai et
al. 2004). Moreover, nearly in all the previous studied models of muscle
hypertrophy, the amount of phosphorylated Akt was higher throughout the
hypertrophy process. In case of Insulin-induced hypertrophy model for
instance, stimulation of myotubes with insulin associated with activation of
PI3-K/Akt pathway, which in turn leads to the stimulation of mTOR and its
downstream targets P70
S6K
and 4E-BP1, this promotes the protein synthesis
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via increased translation initiation and elongation (Terada et al., 1994; Lin
and Lawrence 1996; Rommel et al., 2001).
Akt has the ability to phosphorylate and change the activity of many
vital metabolic targets. Thus, Akt is considered as the key player in the
regulation of muscle protein synthesis and degradation signals for more
details see (Glass 2005; Wu et al., 2010). Regarding the role of Akt in the PS
process, Akt stimulates the protein synthesis in many ways. First, activation
ŽĨŬƚ ?ƉŚŽƉŚŽƌǇůĂƚĞƐĂŶĚŝŶŚŝďŝƚƐƚŚĞŐůǇĐŽŐĞŶƐǇŶƚŚĂƐĞŬŝŶĂƐĞ ?ɴ ?'^< ? ?ɴ Z ?
(Jefferson et al., ? ? ? ? Z ?ƚŚĞƉŚŽƐƉŚŽƌǇůĂƚŝŽŶŽĨ'^< ? ?ɴƌĞůĞĂƐĞƐŝƚƐŝŶŚŝďŝƚŝŽŶ
of the translation initiation factor eIF-2B (Rhoads 1999) and this switches on
the translation initiation step pf PS. Second, another possible in vivo
mechanism, Akt stimulates P70
S6K
and 4E-BP1 most likely via mTOR and the
phosphorylation of 4E-BP1 facilitates the binding of eIF-4E to eIF-4G and
provokes translation initiation induction fully described by Glass (2003).
Increased Akt1 and Akt2 activity in vivo significantly increased the
phosphorylation of p70
S6K
, glycogen accumulation and muscle fibre
hypertrophy (Cleasby et al., 2007), and inhibits the dexamethasone-induced
expression of atrogin-1 in cultured myotubes (Sandri et al., 2004). In
addition, constitutive Akt activity increased basal and insulin-induced glucose
and amino acids uptake and protein synthetic rate in L6 myotubes (Hajduch
et al., 1998; Ueki et al., 1998). Akt plays a pivotal role in the prevention of
the muscle atrophy; phosphorylation of Akt suppresses the expression of
atrogin-1/MAFbx (Muscle Atrophy F box) and MuRF1 (Muscle Ring Factor)
through Foxo (Forked head box O) transcription family-dependent way
(Bodine et al., 2001; Sandri et al., 2004; Whitman et al., 2005). Activation of
Akt inactivates Foxo proteins through ser-thr phosphorylation; Foxo
translocated to cytosol, degraded by the proteasome, and thus suppresses
the expression of atrogin-1 and MuRF1 (Fig. 1-4).
Atrogin-1 and MuRF1 are skeletal muscle specific E3 ubiquitin ligases
that involved in muscle atrophy nearly in all muscle atrophy models (Plas and
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Thompson 2003). Conversely, inhibition of the Akt activity activates the Foxo
proteins, which later translocated to the nucleus, and activate atrogin-1 and
MuRF1 transcription (Van Der Heide et al., 2004). For example, in vivo LPS-
induced sepsis decreased Akt phosphorylation and subsequently activated
the expression of atrogin-1 mRNA in the rat skeletal muscle (Crossland et al.,
2008). There are many recent findings suggesting that, decreased activity of
PI3-K/Akt signalling pathways leads to muscle atrophy (Bodine et al., 2001),
and reduced the size of myotubes (Rommel et al., 2001). In contrast,
induction of Akt activity can modulate muscle structure and cellular
signalling. Increased Akt activity increases muscle fibre size and muscle mass
in adult muscle (Lai et al., 2004; Izumiya et al., 2008; Ouchi et al., 2008). In
addition, activation of Akt1 can prevent denervation-induced muscle atrophy
in adult skeletal muscle (Pallafacchina et al., 2002), and can produce type IIb
myofibre atrophy and increase muscle strength (Izumiya et al., 2008). For
more details on how the Akt activity controls both the hypotrophy and
atrophy signalling pathways for more details see Glass ( 2005) and Wu et al.
(2010). Although, activation of Akt has been involved in the regulation of
muscle protein synthesis and the prevention of muscle protein breakdown,
however recent studies showed that proteolysis induced factor (PIF-1)
significantly increased the proteasomal and lysosomal proteolytic activity via
transient activation of Akt and Akt inhibition by LY0294002 prevents PIF-
induced protein degradation (Russell et al., 2008). They argue this finding
that, transient Akt phosphorylation was aimed to increase PS and hence
increase the production of the proteasome subunits involved in the muscle
proteolysis. Moreover, inhibition of Akt prevents PIF-induced
phosphorylation and proteasomal degradation of IKɲ ĂŶĚ ŶƵĐůĞĂƌ
translocation of NF-kB (Wyke et al., 2005), and Akt activation could mediated
PlF-1-induced E3 expression via NF-kB manner (Li et al., 2009). Thus, the
proper activation of Akt is pivotal in the regulation of muscle protein
metabolism and muscle mass (Wu et al., 2010).
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1.13.2 Role of mTOR in Protein synthesis
The mammalian target of rapamycin (mTOR), is a 289KD
serine/threonine protein kinase that regulates many cellular functions
including cell growth, cell proliferation, cell motility, cell survival, protein
synthesis, and transcription (Asnaghi et al., 2004; Hay and Sonenberg 2004).
mTOR is considered as a central key regulator of cell development (Schmelzle
and Hall 2000).
The protein synthesis in all eukaryotic cells is a highly regulated
multitask process, which involves the interaction between several mediators,
and mTOR is one of the key elements regulating this process. mTOR plays a
pivotal role as a regulator of protein synthesis and translation initiation
(Gingras et al., 2001). mTOR controls the protein synthesis by two
mechanisms. Firstly, mTOR controls the transcription of ribosomal proteins
and the synthesis of ribosomal and RNA transfer (Hardwick et al., 1999;
Powers and Walter 1999). Anabolic stimuli including, growth stimulating
factors and amino acids increased mTOR phosphorylation, and this activates
ribosomal S6 kinase (p70
S6K
) and the binding protein eIF-4E (4E-BP1) (Fig. 1-
4). mTOR stimulates the activity of p70
S6K
and inactivates the 4E-BP1; this
stimulates the protein translation initiation (Hara et al., 1998; Proud 2004).
The activity of p70
S6K
is required to maintain the normal size of the muscle
fibre (Ohanna et al., 2005). Rapamycin (mTOR specific inhibitor) inhibits
p70
S6K
phosphorylation and this decreases the activity of the 40S ribosomal
protein S6, this suggests that mTOR regulates the translation initiation step
of protein synthesis (Gingras et al., 2001). Increased mTOR phosphorylation
enhanced the cap-dependent translation and formation of eIF4F complex via
the phosphorylation and subsequent inactivation 4E-BP1 (Schmelzle and Hall
2000). Therefore, mTOR is considered as a pivotal player the regulation of
protein synthesis via the control of the translation initiation process (Asnaghi
et al., 2004) (Fig. 1-4).
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mTOR has been shown to control the activity of two diverse signalling
pathways: the first is the cell survival pathway through its upstream
regulators PI3-K, and the second is the apoptotic pathway through the
phosphorylation and inhibition of anti-apoptotic Bcl-2 protein enhancing the
programmed cell death (Haldar et al., 1998; Chadebech et al., 1999). In case
of skeletal muscle, LPSinduced protein synthesis decrease are mainly
mediated through PI3-K/Akt/mTOR and their downstream substrates P70
S6K
and 4E-BP1 and this has been demonstrated in many in vitro and in vivo
studies (Kimball et al., 2003; Lang and Frost 2005; Orellana et al., 2007; Eley
et al., 2008). Combined, the activity of Akt/mTOR and their downstream
target 4E-BP1 and eIF-4E are involved in the regulation of protein synthesis
and skeletal muscle growth (Bodine et al., 2001; Matheny and Adamo 2009).
1.13.3 Role of translation initiation mediators (eIF-4E and 4E-BP1) in
Protein synthesis
Protein synthesis in the eukaryotic cell is a complex multi-steps
process. The production of protein from the transcripted mRNA involves
three distinct steps initiation, elongation and termination. A number of
protein factors regulate the process of engagement of mRNA by the
ribosome functionally classified as eukaryotic initiation factors (eIFs) (Shah et
al., 2000). In addition, a group of eukaryotic elongation factors (eEFs) and
releasing factor (RF) are responsible for regulation of the elongation and
termination process respectively. Two main steps are crucial in the control of
protein synthesis in vivo. First, the formation of 43S preinitiation complex
and this step is regulated by a group of eukaryotic factors, mainly (eIF) 2 and
eIF-2B. The formation of this complex decreased in skeletal muscle in case of
sepsis because of the diminished activity of eIF-2B (Vary et al., 1994; Voisin et
al., 1996; Vary et al., 1998). Second, the binding of mRNA with the 43S
preinitiation complex which is mediated by eIF-4E (subunit of eIF-4F) to form
eIF4E-mRNA complex, this is followed by the binding of the eIF-4G, eIF-4A
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with eIF-4E-mRNA to from the active eIF-4F complex. The formation of the
eIF-4F complex allows the cap-dependent translation initiation to goes on
(Rhoads et al., 1994; Lang and Frost 2007; Rhoads 2009). Consequently,
increased eIF-4E phosphorylation correlated with improved protein synthesis
rate in stimulated cell cultures with various anabolic stimuli (Morley and
Traugh 1990). LPS altered the phosphorylation of 4E-BP1 and consequently
decreased the protein translation initiation via decrease the availability of
free eIF-4E was shown in (Fig. 1-4)
In skeletal muscle, sepsis reduced the amount of the active eIF4E-
eIF4G complex by 65% compared to the control (Lang and Frost 2007). In
skeletal muscle, the cap-dependent translational translation repressor
protein (4E-BP1) controls the interaction between the eIF4E mRNA and eIF4G
to form the active eIF-4 G complex. The binding of 4E-BP1 to eIF-4E limits its
availability to form the eIF4E-eIF4G active complex and this effect is
withdrawn by the phosphorylation of 4E-BP1 (Flynn and Proud 1996). The 4E-
Binding Protein (4E-BP1) is one of a family of small, acid-and heat-stable
proteins forms inactive complex with eIF-4E (Bennett et al., 1994).
4E-BP1 is the main translational repressor protein in skeletal muscle;
it regulates the availability of eIF-4E. The decrease in protein synthesis during
sepsis is mainly due to the defect in translational efficiency (translation
initiation) (Vary et al., 1994; Jurasinski et al., 1995), not the reduction in
elongation (Vary and Kimball 1992). Increased activity related
phosphorylation of 4E-BP1 release it form the eIF-4E and this later facilitates
the formation of eIF-4F active complex. Hence, 4E-BP1 considered as the
main regulator of the cap-dependent translation initiation in skeletal muscle.
Sepsis and endotoxaemia decreased 4E-BP1 phosphorylation and this limits
the availability of eIF-4E to from the active eIF-4E complex (Lang et al., 2000;
Svanberg et al., 2000; Lang and Frost 2004). In addition, sepsis increased the
amount of inactive eIF4E 4E-BP1 complex in gastrocenmius muscle by 80%
compared with the control non-septic rat muscle (Lang and Frost 2007). in
vitro , Atherton and associates demonstrated that, cyclic stretch increased
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the activity related phosphorylation of 4E-BP1 in L6 cells despite there being
a decrease in the protein synthesis (Atherton et al., 2009). Whereas, Frost
and his colleagues showed that, LPS alone could not alter the status of 4E-
BP1, while LPS with IFN-Ȗ was able, and this effect was sufficient to induce a
80% decrease in PS rate in C2C12 myotubes (Frost et al., 2009). Many studies
have shown a low correlation between the amount of eIF-4E associated with
4E-BP1 and the formation of eIF4E-eIf-4G active complex (Vary and Kimball
2000; Shen et al., 2002), and this suggests that the regulation of dissociation
of 4E-BP1 from the eIF-4E is differentially regulated from the association of
eIF4F with eIF4G (Shen et al., 2005). This suggests that the translation
initiation is mostly dependent upon the formation of eIF4E-eIF4G active
complex not on the amount of phosphorylated 4E-BP1. Therefore, the
paradoxical data regarding the effect of the endotoxin on the
phosphorylation status of 4E-BP1 and its effect on the PS need further deep
investigation The dogma that, measuring both the effect of LPS on the
anabolic signalling and the PS together in the same model under the same
conditions is the appropriate approach that we have undertake in our C2C12
model of sepsis.
1.13.4 Protein synthesis in skeletal muscles From LPS to mitogen-
activated protein kinases (MAPKs)
The mitogen-activated protein kinases (MAPKs) family is considered
the most important intercellular signalling system involved in the regulation
of many processes such as, cell growth, differentiation, and survival (Seger
and Krebs 1995). MAPKs play an important role in interorgan communication
in many physiological and behavioral phenomena through various cytokines
(Kahn et al., 2005; Long and Zierath 2006). In muscle the effect of MAPKs is
controversial, some think that it is mitogenic and prevents differentiation,
others believe that it is not involved in differentiation, while others still think
that it may promote differentiation (Eran Gredinger et al., 1998).
Chapter 1 General introduction
33
1.13.4.1 P38 MAP kinase and muscle protein metabolism
p38 MAPK has been recognised as one of the MAPKs signalling family
that is activated in response to a wide array of environmental stress factors
(Lang and Frost 2005), including ultraviolet light (Han et al., 1994; Yeow et
al., 2002), osmotic stress (Moriguchi et al., 1995; Shapiro and Dinarello
1995), heat shock, and inflammatory cytokines (Haneda et al., 1995;
Raingeaud et al., 1995; Karem et al., 1996; Kohn et al., 1996; Modur et al.,
1996; Cuenda et al., 1997; Hajduch et al., 1998; Igarashi et al., 1999; Hong et
al., 2006). Four members of p38 MAP Kinases have been characterised: p38 (
Ɖ ? ?ɲ Z  ?,ĂŶet al., 1994; Hong et al.,  ? ? ? ? Z ? Ɖ ? ?ɴ  ?:ŝĂŶŐet al.,  ? ? ? ? Z ? Ɖ ? ?ɶ
(Erk6, SAPK3 stress- activated protein kinase) (Lechner et al., 1996; Cuenda et
al.,  ? ? ? ? ?>ŝĂŶĚZĞŝĚ  ? ? ? ? Z ?ĂŶĚƉ ? ?ɷ  ?^W< ? Z  ?:ŝĂŶŐet al., 1997; Kumar et
al.,  ? ? ? ? Z ? ŵŽŶŐ ƚŚĞ Ɖ ? ? DW< ŝƐŽĨŽƌŵƐ ? Ɖ ? ?ɲ ŝƐ Ă ǁĞůů ŝĚĞŶƚŝĨŝĞĚ ĂŶĚ
expressed in most cell types (Remy et al., 2009). Activation of the p38
pathway may accompanied with many terminal changes in cell function,
including modulation of gene expression, cytoskeletal reorganisation, cell
cycle arrest, the immune response and cell death (New and Han 1998).
In skeletal muscle, increased p38 activity has been reported in many
pro-catabolic diseases. The role of p38 in sepsis mediated muscle protein
ďƌĞĂŬĚŽǁŶ ƌĞǀĞĂůĞĚ ĨƌŽŵ ? dE& ?ɲ ĂŶĚ /> ? ? ? ŬŶŽǁŶ ŵĞĚŝĂƚŽƌƐ ŽĨ ŵƵƐĐůĞ
wasting (Jackman and Kandarian 2004) stimulates the activity of p38 and
enhances the nuclear translocation of NF-kB (Zarubin and Han 2005).
Increased p38 activity associated with increased expression level of the
atrogin-1 mRNA (Li et al., 2005), whereas, the increase of nuclear
translocation of NF-kB is associated with increased expression of MuRF1
mRNA (Cai et al., 2004). In contrast, inhibition of the p38 activity significantly
ĚĞĐƌĞĂƐĞĚ ƚŚĞ dE& ?ɲ ?ŝŶĚƵĐĞĚ ƵƉ ?ƌĞŐƵůĂƚŝŽŶ ŽĨ ĂƚƌŽŐŝŶ ? ? ŵZE ŶŽƚ DƵZ& ?
(Jin and Li 2007). Therefore, the inhibition of p38 is considered as one of the
most therapeutic targets to lessen or minimise the sepsis induced muscle
protein breakdown (Fig. 1-5).
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1.13.4.2 ERK1/2 and muscle protein metabolism
The MAPKs signalling factors include two closely related MAP kinases,
known as extracellular-signal-related kinase 1 (Erk1, p44) and 2 (Erk2, p42).
Activation of these Erks is involved in the regulation of many cellular
functions including cellular proliferation and differentiation (Olson 1992;
Pages et al., 1993). The activation of the Erk pathway has been recognised as
a part of the early biochemical events that are initiated by LPS treatment of
macrophages or their infection by virulent and attenuated Salmonella strains
(Procyk et al., 1999). It has been reported that, the activation of p38 and Erk
occurred within 15 min after stimulation with LPS, and rapidly returned to
normal basal levels within 30 min (Cho et al., 2007). Increased Erk activity has
ďĞĞŶƌĞƉŽƌƚĞĚŝŶƌĞƐƉŽŶƐĞƚŽdE& ?ɲ ?ĂĐĂƚĂďŽůŝĐĨĂĐƚŽƌƚŚĂƚĂĐƚŝǀĂƚĞĚŶĞĂƌůǇ
in all catabolic conditions (Tantini et al., 2002). In contrast, it has been shown
that, p38 and Erk activation was involved in the PS process in vitro mediated
via Mnk1 (MAPK-integrating kinase1/ MAPK-interacting kinase) (Fukunaga
and Hunter 1997; Waskiewicz et al., 1997; Scheper and Proud 2002).
Moreover, Plaisance and associates demonstrated that activation of Erk1/2
and its downstream target Mnk1 mediated the TNF-Į-induced protein
synthesis in C2C12 myotubes (Plaisance et al., 2008). Although, the
physiological function of Mnk1 remains relatively unknown, however, several
studies have demonstrated that one of the Mnk1 substrates is the eIF-4E
(Gingras et al., 1999). Combined, this suggests that activation of Erk can
modulate many cellular processes such as protein synthesis and protein
degradation. Taken together, the MAPKs (p38 or Erk1/2) signalling is
considered as one of the signalling cascade involved in LPS-induced muscle
wasting. Moreover, inhibition of their activities can be considered as a
therapeutic intervention in sepsis-induced muscle wasting.
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Figure (1-3) Schematic diagram illustrates the transcriptional and translational
regulation of protein synthesis. DNA transcribed into mRNA in the nucleus, and
mature mRNA leaves the nucleus and then translated into a protein in the
cytoplasm. LPS-induced decreased protein synthesis via the alteration of protein
translation initiation.
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Figure (1-4) Schematic diagram shows the signalling pathways that control the
protein synthesis and degradation. LPS-TLR4 legend formation followed by signal
transduction. LPS decreased Akt activity. Decreased Akt activity altered the protein
synthesis via decreased phosphorylation of mTOR and its downstream targets
p70
S6K
, 4E-BP1 (translation initiation mediators). Decreased phosphorylation of 4E-
BP1 inhibits the formation of eIF-4F complex and consequently decreased the
translation initiation. In contrast, decreased Akt activity significantly increased
protein degradation via up-regulation of the ubiquitin ligases (atrogin-1 and
MuRF1), and this is regulated via Foxo-dependent way. This diagram is adopted
from (Glass 2005).
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Figure (1-5) Schematic diagram showing the regulation of protein degradation in
ƉĂƌƚŝĐƵůĂƌ dE& ?ɲ ƐŝŐŶĂůůŝŶŐ ƉĂƚŚǁĂǇ ĂŶĚ ƚŚĞ ŝŶǀŽůǀĞŵĞŶƚ ŽĨ /k ?ɲ ? E& ?Ŭ ĂŶĚ
ubiquitin ligases (atrogin-1 and MuRF1). LPS via TLR4, enhanced p38
ƉŚŽƐƉŚŽƌǇůĂƚŝŽŶ ĂŶĚ dE& ?ɲ ƐĞĐƌĞƚŝŽŶ ? dE& ?ɲ ŵĞĚŝĂƚĞĚ ƉƌŽƚĞŝŶ ƚƵƌŶŽǀĞƌ ǀŝĂ Ɖ ? ?
mediated atrogin-1 up-regulation and via IkB/NF-kB signalling cascade it mediates
ƚŚĞ DƵZ& ? ŵZE ƵƉ ?ƌĞŐƵůĂƚŝŽŶ ? dE& ?ɲ ƐĞĐƌĞƚĞĚ ŚĂƐ ĂƉ ƌĂĐƌŝŶĞ ĂŶĚ ĂƵƚŽĐƌŝŶĞ
functions. The activation of the ubiquitin ligases (MuRF1) leads to acceleration of
the muscle protein breakdown rate.
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1.14 LPS significantly increases the protein degradation in
cultured myotubes
Muscle wasting is one of the well-known features of severe acute
conditions such as sepsis, cancer, AIDS, (Hasselgren 1995; Tisdale 1997).
Sepsis is an inflammatory condition that causes severe and rapid loss of body
protein, much of which originates from skeletal muscle (Rosenblatt et al.,
1983), and other catabolic diseases are well characterised by a reduction in
the rate of muscle protein synthesis and an increase in the rate of protein
breakdown (Jepson et al., 1986; Hummel et al., 1988; Ash and Griffin 1989;
Hasselgren et al., 1989; Gracey et al., 2004).
Loss of lean body mass results in the main from accelerated protein
degradation via the ubiquitin-proteasome pathways (Jagoe and Goldberg
2001). The degradation of the protein by these mechanism started with
marking of the targeted protein particle by a chain of ubiquitin molecules,
and later degrading of the protein in the central core of 26S proteasome
(Hershko and Ciechanover 1998). Selecting a particular protein to be
ubiquitinated is primarily the function of ubiquitin ligases (E3 proteins).
There are three E proteins known to regulate ubiquitin conjugation in
ĐĂƚĂďŽůŝĐ ƐƚĂƚĞƐ P  ?ɲ ? ĂƚƌŽŐŝŶ ? ? ĂŶĚ DƵZ& ? ? ƚƌŽŐŝŶ ? ? ĂŶĚ DƵZ& ? ĂƌĞ ƌĂƚĞ
limiting for muscle protein loss in many catabolic conditions. The expression
of those two genes is up-regulated in various models of muscle atrophy, in
particular sepsis (Bodine et al., 2001). Individual knockout of atrogin-1 or
MuRF1 results in attenuation of denervation-induced muscle atrophy
(Bodine et al., 2001). This suggests that atrogin-1 and MuRF1gene are crucial
to muscle protein loss, and makes these genes as important targets for
therapeutic intervention in order to lessen the adverse outcomes of sepsis
mainly morbidity and mortality (Jin and Li 2007).
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Concentrated research has been done to elucidate of the signalling
cascade that control the expression of these two ubiquitin ligases. Akt is one
of the most studied pathway, Akt regulates the activity of the Foxo, Foxo a
transcription factor family has been shown to control atrogin-1 and MuRF1
expression (Glass 2005). Various anabolic and catabolic signals either activate
or suppress Akt. Anabolic signals such as IGF-I activate Akt, resulting in the
suppression of atrogin-1 and MuRF1expression. Conversely, catabolic signals
such as glucocorticoids suppress the Akt activity resulting in the up-
regulation of atrogin-1 and MuRF1 expression (Lai et al., 2004; Sandri et al.,
2004) (Fig. 1-4). Moreover, NF-kB, an inflammatory stimulus-activated
transcription factor that mediates muscle protein through multiple
components of the ubiquitin proteasome pathway the up-regulation of
MuRF1 expression (Li and Reid 2000; Li et al., ? ? ? ? Z ?ZĞĐĞŶƚůǇ ?dE& ?ɲǀŝĂƉ ? ?
MAPK-dependent mechanism up-regulated atrogin-1 mRNA in C2C12
myotubes and inhibition of p38 blocked this effect (Li et al., 2005). p38
increased activity has been reported in a number of pro-catabolic states
(Childs et al., 2003; Koistinen et al., 2003; Di Giovanni et al., 2004). Take in
ĐŽŶƐŝĚĞƌĂƚŝŽŶƚŚĞĨĂĐƚƚŚĂƚƉ ? ?ĂŶĚE& ?ŬĂƌĞĂĐƚŝǀĂƚĞĚďǇdE& ?ɲĂŶĚ/> ? ?ɴ ?
two known mediators of muscle catabolism (Jackman and Kandarian 2004).
Moreover, the inflammatory conditions induce oxidative stress through the
enhancing the production of free radicals such as NO (nitric oxide) (Buck and
Chojkier 1996) which have been linked to the pathogenesis of muscle
wasting. The mechanism how nitric oxide (NO) mediates muscle wasting
remains largely unknown but previously shown that LPS stimulate the activity
of NoS (Griffiths et al., 1995; Ravindranath et al., 2003). Nitric oxide (NO) is
involved in both inflammatory and non inflammatory-induced muscle
catabolism through either decreasing protein synthesis or enhancing
proteolysis.
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1.15 Signalling pathways involved in protein degradation
There are many signalling cascades and transcription factors families
involved in sepsis-induced muscle protein turnover. These factors includes,
dE& ?ɲ ?E& ?Ŭ ?/> ? ?ĂŶĚƉƌŽƚĞĂƐŽŵĞ ?
1.15.1 The role of TLR4 in the LPS signals transduction
Skeletal muscle can respond directly to various microbial components
during the course of infection. These molecules represent the pathogen-
associated molecular patterns (PAMPS) that can be recognised by the host
defence system (Netea et al., 2004). TLRs are a transmembrane signalling
proteins considered to be the main class in recognising of the PAMPS
(Underhill and Ozinsky 2002; Kopp and Medzhitov 2003). TLR considered as
the first line of defence against bacterial cell components, such as LPS,
lipopeptides, as well as RNA and DNA from viruses and proteins from
protozoa in a relatively specific manner (Leaver et al., 2007). Mouse C2C12
cell line and the mouse skeletal muscle express the mRNA of TLR1 through
TLR4 and not TLR9 or TLR10 (Frost and Lang 2008). TLR4 is an essential
component in the host defence through the stimulation of cytokines
production. LPS and heat-shock proteins (Hsps) are recognized by TLR-4
(Akira and Hemmi 2003). The recognition of LPS requires TLR4 and TLR4-
accessory molecule, MD-2 (Shimazu et al., 1999). The interaction of the
PAMPS with the TLR-4 (TLR-PAMP interaction) leads to activation of the
nuclear factor (NF-kB), a critical component in many pro-inflammatory
pathways and the innate host defence, through the tumor necrosis factor
(TNF) receptorassociated factor-6 (TRAF6) signalling pathway in the
presence of specific adaptors (MyD88 and Mal) (Akira 2000). This interaction
of TLR4 with LPS leads to production and release of many catabolic factors
ŝŶĐůƵĚŝŶŐdE& ?ɲĂŶĚE& ?Ŭ ?
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1.15.2 dŚĞƌŽůĞŽĨdE& ?ɲŝŶƐĞƉƐŝƐ ?ŝŶĚƵĐĞĚŵƵƐĐůĞƉƌŽƚĞŝŶďƌĞĂŬĚŽǁŶ
dƵŵŽƵƌŶĞĐƌŽƐŝƐĨĂĐƚŽƌ ?ɲ ?dE& ?ɲ ZŝƐĂƉƌŽ ?ŝŶĨůĂŵŵĂƚŽƌǇĐǇƚŽŬŝŶĞ ?ǁĂƐ
originally called cachectin, and is an intensively studied cytokines plays an
indispensable role in the host defence against invading pathogens (Tisdale
 ? ? ? ? Z ?ůƐŽ ?ŚŝŐŚůĞǀĞůƐŽĨdE& ?ɲŚĂǀĞďĞĞŶƌĞƉŽƌƚĞĚŝŶŵŽƐƚĐĂƚĂďŽůŝĐƐƚĂƚĞƐ
(Garcia-Martinez et al.,  ? ? ? ? Z ? ĂŶĚ dE& ?ɲ ŽǀĞƌ ĞǆƉƌĞƐƐŝŶŐ ŝŶ ƚƌĂŶƐŐĞŶŝĐ
animals are associated with accelerated rate of protein degradation (Kubota
et al., ? ? ? ? Z ?/ŶĐŽŶƚƌĂƐƚ ?ĂĚŵŝŶŝƐƚƌĂƚŝŽŶŽĨĂŶƚŝ ?dE& ?ɲĂŶƚŝďŽĚŝĞƐŽƌŽĨdE& ?ɲ
soluble receptor attenuates this catabolic response (Sharma et al., 1992;
Ksontini et al.,  ? ? ? ? Z ? /ƚ ŚĂƐ ďĞĞŶ ƐŚŽǁŶ ƚŚĂƚ ? dE& ?ɲ ĚŝƌĞĐƚůǇ ƐƚŝŵƵůĂ ĞƐ
muscle protein loss in cultured myotubes (Li et al., 1998), and decrease
protein synthesis (Lang et al., 1996; Cooney et al., 1999). In addition, the
ĚŝƌĞĐƚ ŝŶĨƵƐŝŽŶŽĨdE& ?ɲĚĞĐƌĞĂƐĞƐƚŚĞƉƌŽƚĞŝŶƐǇŶƚŚĞƚŝĐƌĂƚĞ  ?ŽŽŶĞǇet al.,
1999; Lang et al., ? ? ? ? Z ?dE& ?ɲŐĞŶĞƌĂƚĞƐŝƚƐĐĂƚĂďŽůŝĐĞĨĨĞĐƚƚŚƌŽƵŐŚǀĂƌŝŽƵƐ
ǁĂǇƐ ? dE& ?ɲ ĂĐƚƐ ĚŝƌĞĐƚůǇ ŽŶ ŵƵƐĐůĞ ǀŝĂ ŝƚƐ ƌĞĐĞƉƚŽƌƐ ƚŽ ŝŶĚƵĐĞ ŵƵƐĐůĞ
catabolism (Langen et al., 2001; Ladner et al., 2003; Lang and Frost 2005) via
the up regulation of the ubiquitin-proteosome pathway in particular atrogin-
 ?  ?>ŝĂŶĚZĞŝĚ  ? ? ? ? Z ?dE& ?ɲĐĂŶƐƚŝŵƵůĂƚĞƐŬĞůĞƚĂůŵƵƐĐůĞĐĂƚĂďŽůŝƐŵĞŝƚŚĞƌ
by modifying hormones that regulate protein turn over such as IGF-I (Tracey
et al., 1990; Tracey and Cerami 1993; De Rossi et al., 2000), or by increasing
the production of other cytokines (Tracey and Cerami, 1993) or by inducing
anorexia (Tracey et al., ? ? ? ? Z ?^ƚŝŵƵůĂƚŝŽŶŽĨŵǇŽƚƵďĞƐǁŝƚŚdE& ?ɲ ?ůĞĂĚƐƚŽ
stimulation of Reactive Oxygen Species (ROS) production in skeletal muscle
fibres (Alisantosa et al., 2000) and activates redox-sensitive transcription
factors and protein kinases such as, NF-kB and MAPKs (P38, Erk1/2 and JNK)
 ?'ĂƌŐ ĂŶĚ ŐŐĂƌǁĂů  ? ? ? ? Z ? dE& ?ɲ ŝŶĚƵĐĞƐ ƵƉ ?ƌĞŐƵůĂƚŝŽŶ ŽĨ hďĐ, ? ŐĞŶĞ  ?
E2k20 protein) mediated via NF-kB (Li et al., 2003), and atrogin-1 mRNA via
p38 MAPK dependent mechanism (Li et al., 2005). Furthermore, high
ĐŽŶĐĞŶƚƌĂƚŝŽŶƐ ŽĨ dE& ?ɲ ŝŶŚŝďŝƚ W/ ? ?< ĂŶĚ ĐŽŶƐĞƋƵĞŶƚůǇ ŝƚƐ ĚŽǁŶƐƚƌĞĂŵ
targets (Hotamisligil et al., 1996), this later increases the expression of
atrogin-1 mRNA through Akt/Foxo4-dependent mechanism (Moylan et al.,
 ? ? ? ? Z ? /Ŷ ĐŽŶƚƌĂƐƚ ? dE& ?ɲ ŝŶŚŝďŝƚƐ ŝŶƐƵůŝŶ ƐƚŝŵƵůĂƚĞĚ ƉƌŽƚĞŝŶ ƐǇŶƚŚĞƐŝƐ ǀŝĂ
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Erk1/2 dependent ways (Williamson et al., 2005). This effect was mediated
via the regulation of binding of capped mRNA to the 43S preinitiation
ĐŽŵƉůĞǆ ?dE& ?ɲŝƐŝŶǀŽůǀĞĚŝŶƚŚĞƐĞƉƐŝƐ ?ŝŶĚƵĐĞĚ ? ?A ŝŶĐƌĞĂƐĞŽĨƚŚĞŝŶĂĐƚŝǀĞ
eIF4E 4E-BP1 complex and 65% decrease in the eIF4E eIF4G active complex
 ?>ĂŶŐĂŶĚ&ƌŽƐƚ ? ? ? ? Z ?dŚƵƐ ?dE& ?ɲŝƐĐŽŶƐŝĚĞƌĞĚĂƐĂŬĞǇĞůĞŵĞŶƚƌĞŐƵůĂƚŝŶŐ
the translation initiation and the protein synthesis, and this effect is still
unchanged even when septic rats were administrated insulin (Vary et al.,
2001).
ůƚŚŽƵŐŚƚŚĞƉƌĞǀŝŽƵƐŵĞŶƚŝŽŶĞĚƐƚƵĚŝĞƐŚĂǀĞƐŚŽǁŶƚŚĂƚdE& ?ɲŝƐĂ
strong catabolic stimulus significantly decreasing protein synthetic rate and
increased protein turnover either in vivo or in vitro. However, Plaisance et al.
 ? ? ? ? ? Z ŚĂǀĞ ĚĞŵŽŶƐƚƌĂƚĞĚ ƚŚĂƚ ŝŶĐƵďĂƚŝŽŶ ŽĨ  ? ? ? ŵǇŽƚƵďĞƐ ǁŝƚŚ dE& ?ɲ
significantly increased protein synthesis mediated either via Erk1/2-Mnk1-
Ğ/& ? ? ƐŝŐŶĂůůŝŶŐ ĐĂƐĐĂĚĞ ? Žƌ ǀŝĂ Ŭƚ ĂŶĚ ŝƚƐ ƐƚŝŵƵůĂƚŝŽŶ ƚĂƌŐĞƚƐ ? '^< ? ?ɴ ?
p70
S6K
and 4E-BP1, without changing the protein breakdown rate and with
out changing cell number.
1.15.3 The potential role of NF-kB and Ik ?ɲŝŶǀŽůǀĞŵĞŶƚ
NF-kB is a transcriptional factor family involved in the regulation of
many cellular functions such as, innate immune response, cellular
proliferation and differentiation and cell survival (Baldwin 1996). NF-kB, is
more classically involved in the transcriptional regulation of many genes
involved in the immune response, cell growth and cell death (Li et al., 1998).
NF-kB activation is defined as a momentary response mainly initiated by the
phosphorylation and subsequent degradation of the NF-kB inhibitory protein
 ?/< ?ɲ Z ůĞĂĚŝŶŐ ƚŽ ŶƵĐůĞĂƌ ŝŵƉŽƌƚ ŽĨ E& ?Ŭ ? ĂŶĚ ĂĐĐƵŵƵůĂƚŝŶŐ ǁŝƚŚ ƚŚĞ
resynthesis of the Ik ?ɲĂŶĚƐƵďƐĞƋƵĞŶƚĂĐƚŝǀĂƚŝŽŶŽĨƚŚĞƚƌĂŶƐĐƌŝƉƚŝŽŶĨĂĐƚŽƌ
(Ladner et al., 2003) (Fig. 1-5). LPS stimulates the degradation of The Ik ?ɲŝŶ
C2C12 (Frost et al., 2002; Frost et al., 2003), but IK ?ɲ ŝƐ ƌĂƉŝĚůǇ
resynthesized to moderate the response of NF-kB. The rapid (with in 4 h)
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activation of NF-kB in septic muscle during suggesting that NF-kB plays a role
in the pathogenesis of this (Penner et al., 2001). Sepsis increased the activity
of NF-kB (Penner et al., 2001), and NF-kB blockade significantly decreased
the muscle protein breakdown in C2C12 (Li and Reid 2000). NF-kB activation
mediated cytokines-induced skeletal muscle protein loss (Baldwin 1996;
Ladner et al., 2003). Moreover, the transient activation of NF-kB is
responsible for the predominant early response of the rat to the LPS (Penner
et al., 2001; Frost et al ? ?  ? ? ? ? Z ? /ŶĂĚĚŝƚŝŽŶ ?dE& ?ɲƐƚŝŵƵůĂƚĞƐ ƚŚĞĂĐƚŝǀŝƚǇŽĨ
NF-kB (von Haehling et al., 2002), and this inhibits the myocyte
differentiation in C2C12 cells (Guttridge et al., 2000; Langen et al., 2001;
Ladner et al., 2003). Increased NF-kB activity in isolated muscles is associated
with increased the muscle atrophy via increased the amino acids excretion
and tyrosine turnover (Cai et al., 2004). NF-kB mediated sepsis-induced
muscle breakdown via up-regulation of MuRF1 not atrogin-1, and NF-kB
inhibition significantly decreased the proteasomal expression associated with
muscle atrophy (Wyke et al., 2004).
In summary, NF-kB is an important transcription factor significantly
increased in most catabolic conditions which mediates muscle protein
turnover via MuRF1 up-regulation. This makes NF-kB a therapeutic target to
minimise the adverse consequences of sepsis.
1.15.4 The role of IL-6 in sepsis-induced muscle protein degradation
Interleukin-6 (IL-6) is an important cytokine that possessing both pro-
and anti-inflammatory properties (Ikemoto et al., 2000) and is mainly
secreted from classical immune tissues such as, liver, spleen (Luo et al.,
2003), and non-immune tissues including skeletal muscle with various local
and systemic effects. The role of IL-6 in the regulation of muscle protein
degradation in various muscle wasting conditions is still controversial. Some
studies showed no role (Garcia-Martinez et al., 1994; Williams et al., 1998),
whereas others proved its contribution (Strassmann et al., 1992; Haddad et
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al., 2005). IL-6 produced locally in muscle may play a role in the regulation of
acute phase protein production in liver (Luo et al., 2003). Skeletal muscle
produces and releases many cytokines including IL-6 in response to various
ƐƚŝŵƵůŝŝŶĐůƵĚŝŶŐ>W^ ?>W^ĂŶĚdE& ?ɲŝŶĐƌĞĂƐĞĚƚŚĞĞǆƉƌĞƐƐŝŽŶŽĨ/> ? ?ŵZEŝŶ
a way mediated via the increased activity of NF-kB (Zhang et al., 1990;
Dendorfer et al., 1994). Recently, reactive oxygen species (ROS) significantly
increased the expression and release of IL-6 mRNA especially in
differentiated myotubes, and the activation of p38 and IK ?ɲĂŶĚƐƵďƐĞƋƵĞŶƚ
activation of NF-kB is essential for the ROS-IL-6 release (Kosmidou et al.,
2002). Although, the precise role of IL-6 in skeletal muscle in vitro is still
unclear. However, it has been shown that IL-6 enhances insulin-stimulated
glucose uptake (Stouthard et al., 1996) and glycogen synthesis (Weigert et
al., 2004; Weigert et al., 2005) in myotubes via activation of AMP-activated
protein kinase (AMPK) (Carey et al., 2006). How the inflammatory stimuli
ŝŶĐůƵĚŝŶŐ dE& ?ɲ ? /> ? ?ɴ ĂŶĚ >W^ ƐƚŝŵƵůĂƚĞ ƚŚĞ /> ? ? ƉƌŽĚƵĐƚŝŽŶ ĂŶĚ ƚŚĞ
signalling cascades involved in this mechanism is showed in (Fig. 1-6).
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Figure (1-6) Schematic diagram illustrates the possible mechanism of IL-6
ĂĐƚŝǀĂƚŝŽŶ ? >W^ ĂŶĚ dE& ?ɲ ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ ƚŚĞ ƉŚŽƐƉŚŽƌǇůĂƚŝŽŶ ŽĨ Ɖ ? ? ĂŶĚ
Ik ?ɲ ?ĂŶĚ ůĂƚĞƌĞŶŚĂŶĐĞĚƚŚĞŶƵĐůĞĂƌƚƌĂŶƐůŽĐĂƚŝŽŶŽĨE& ?Ŭ ?E& ?ŬĞŶŚĂŶĐĞĚƚŚĞ
transcription of many genes including IL-6. IL-6 secreted locally at skeletal muscle
has many local and systemic actions.
Inflammatory stimuli
71)Į,/ȕ/36
,.%Į p38
NF.kB
p
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1.15.5 The role of the proteasome in the skeletal muscle protein
degradation
There is a balance between the rate of the rate of muscle protein
synthesis and the rate of muscle protein breakdown, and this balance
determine the skeletal muscle growth (Goll et al., 1992). In skeletal muscle,
one of the main mechanisms involved in the atrophying process is the
activation of the proteolytic pathways (Dean et al., 1997; Grune et al., 1997;
Chevion et al., 2000). The protein degradation in the eukaryotic cells requires
the activation of one or more of the major four catabolic systems, the
caspases, cathepsins, calcium-dependent calpains, and the ubiquitin-
proteasome system (UPS).
1.15.5.1 Caspase-mediated protein degradation
Caspases, or cysteine-aspartic proteases or cysteine-dependent
aspartate-directed specific proteases are a family of cysteine proteases that
specifically cleave the C-terminal bond of aspartate residues, which plays an
essential role in many cellular processes including, apoptosis, necrosis and
inflammation For review see (Chang and Yang 2000). There are three classes
of caspases exist; initiator caspases, capable of activating the procaspases;
effector caspases, responsible for the proteolysis of cellular proteins
(Buendia et al., 1999); and inflammatory caspases, aiding in the formation of
cytokines (Wang et al., 1998). The precise role of caspases in regulation of
skeletal muscle proteolysis is still relatively unclear. However, it has been
recently shown that caspase-3 plays an important initial role in the skeletal
muscle protein degradation via cleaving of actomyosin in vitro (L6 myotubes)
and in gastrocnemius muscle of rat (Du et al., 2004). In addition, this study
has shown that inhibition of caspase-3 activity suppresses acute diabetes-
induced accelerated muscle proteolysis and the accumulation of actin
fragments. Furthermore, mice deficient in caspase-3 were protected from
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the denervation induced muscle atrophy (Plant et al., 2009). Similarly, in
C2C12 myotubes, attenuation of the activity of caspase-3 and caspase-8
significantly decreased the protein degradation and increased the protein
synthesis: for more details see (Russell et al., 2010). In contrast, Wei et al
demonstrated that, the mRNA and processed active caspase-3 activity are
still unchanged in skeletal muscle after a septic challenge (Wei et al., 2005).
In conclusion, although the most important catabolic pathway activated in
most cases of muscle protein breakdown is the ubiquitin-proteasome
pathway (Lecker et al., 1999). However, the contribution of the caspase still
exists and further studies are required both in vivo and in vitro to speculate
this role.
1.15.5.2 Lysosomes-mediated protein degradation
Cathepsins also referred to as lysosomal proteolytic enzymes, a
member of the lysosomal cysteine protease family. The cathepsins members
include, cathepsins A, G (serine protease), cathepsins D, E (aspartic protease)
and cathepsins L. Elevated cathepsins enzyme levels in serum have been
linked to many pathological conditions including Alzheimer's, cancer and
arthritis. Although, the limited input of the lysosomal pathway in muscle
protein breakdown in case of sepsis. However, it has been shown that the
activation of the lysosomal enzymes and the ubiquitin proteasome pathways
may be involved in the sepsis-induced muscle protein turnover (Drew et al.,
1988; Mitch and Goldberg 1996). In addition, Helliwell and associates have
shown that increased labelling for lysosomal enzymes and ubiquitin have
been seen in fibre atrophy and the collapse of cytoskeleton (Helliwell et al.,
1998). Furthermore, elevated level of the cathepsins mRNA has been
reported in many catabolic conditions including sepsis (Hummel et al., 1988;
Voisin et al., 1996; Deval et al., 2001). In contrast, incubation of septic rat
skeletal muscle with curcumin and cathepsin L inhibitor significantly
decreased the cathepsin activity by 40% compared with the control group
(Poylin et al., 2008). Although, the findings of Deval et al. (2001) with the
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others findings are encouraging the use of the elevated cathepsin L mRNA as
a clinical marker of muscle loss, yet the potential role of cathepsins in sepsis
induced muscle breakdown in vitro needs further investigation.
1.15.5.3 Calpain-mediated protein degradation
The major catabolic pathway activated in most catabolic cases is the
proteasome pathway and is reviewed in detail later. The accelerated rate of
muscle protein breakdown has been prevented by inhibition of the activity of
20S proteasome (Tawa et al., 1997; Jagoe et al., 2002). Although,
proteasome can degrade many proteins within the muscle, yet the
proteasome was unable to degrade the intact myofibrils, while the protease
ĂĐƚŝǀŝƚǇŽĨƵďŝƋƵŝƚŝŽƵƐĐĂůƉĂŝŶƐʅ ?ĐĂůƉĂŝŶĂŶĚŵ ?ĐĂůƉĂŝŶǁĂƐĂďůĞ ?,ƵĂŶŐĂŶĚ
Forsberg 1998). The calpains are a family of calcium-dependent, non-
lysosomal cysteine proteases. The expression of the two ubiquitous calpains,
ʅ ?ĐĂůƉĂŝŶĂŶĚŵ ?ĐĂůƉĂŝŶŚĂƐďĞĞŶŶĞĂƌůǇĚĞƚĞĐƚĞĚŝŶĂůůƚŝƐƐƵĞƐ ?ĂŶĚƚŚĞǇƉůĂǇ
a pivotal role in many cellular functions including cell differentiation (Cottin
et al., 1994), cell cycle (Raynaud et al., 2004), cell migration and adhesion
(Glading et al., 2002; Franco et al., 2004). Considered as targets of calpain
increased activity, several studies demonstrated that increased calapin
activity affects the activity of several kinases, phosphatases, membrane
associated proteins and transcription factors for more details see (Goll et al.,
2003). In vitro activation of calpains initiated the degradation of many
myofibrillar proteins including desmin, filamen, C-proteins, tropomysin,
troponin T, troponin I, titin and nebulin (Koohmaraie 1992). In contrast,
ĐĂůƉĂŝŶƐĚŽŶŽƚĚĞŐƌĂĚĞƚŚĞɲĂĐƚŝŶ ?ɲĂĐƚŝŶŝŶ ?ŵǇŽƐŝŶŚĞĂǀǇĐŚĂŝŶ ?dĂŶet al.,
1988). Inhibition of m-calpain was associated with a 30% reduce in skeletal
muscle protein degradation full reviewed in (Huang and Forsberg 1998).
The potential role of the calapin in the sepsis induced muscle wasting
has been demonstrated in many studies (Bartoli and Richard 2005; Costelli et
al., 2005; Smith et al., 2008). Sepsis increased the cellular concentrations of
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Ca
2+
(Fischer et al., 2001), and calpain has been shown to be activated by
calcium (Goll et al., 2003). The activated calpain cleaved the myofibrils and
released the myofilaments which later ubiquitinated and degraded by the
26S proteasome (Solomon and Goldberg 1996; Huang and Forsberg 1998;
Solomon et al., 1998; Hasselgren and Fischer 2001). Therefore, the activation
of the calpain is considered as the initial step for the activation of 26S
proteasome (Menconi et al., 2004; Smith and Dodd 2007; Smith et al., 2008).
In conclusion, although the previous studies have shown the importance of
the caspases, cathepsins and calcium-dependent calpains in sepsis-mediated
protein breakdown, yet the ubiquitin proteasome pathway is still the most
important proteolytic system activated in response to many muscle wasting
conditions.
1.15.5.4 Ubiquitin-proteasome pathway
Proteasome is present in the nucleus and the cytosol of all eukaryotic
cells examined and within the cytoskeleton (Scherrer and Bey 1994). It
represents 1% of the cell protein (Tanaka et al., 1986). The degradation of
muscle protein in eukaryotic cells was mediated by several specialised
systems, mainly the ubiquitin-proteasome system (UPS), which is the most
active system. In general, the proteasome is a multicatalytic high molecular
weight protease complex responsible for ubiquitin-dependent protein
degradation within the cells fully reviewed in (Peters 1994; Coux et al., 1996;
Hilt and Wolf 1996). The proteasome is able to do complete proteolysis of
protein substrates and activation of protein function through limited
proteolytic process (Palombella et al., 1994). The physiologically active form
of the ubiquitin-proteasome system is the 26S proteasome. 26S proteasome
is a large proteolytic complex that hydrolyses protein conjugates, mainly
composed of 19S cap structure attached to 20S core (Hayter et al., 2005).
The 20S (700kDa) proteasome is the active proteolytic machinery in which
the proteolysis takes place; 20S can degrade peptide and certain protein
substrates independently of the presence of ATP (Fig. 1-7). The 20S
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proteasome thought to have five main catalytic peptidase activities, the
trypsin-like, chymotrypsin-like, peptidylglutamyl peptidase, branched-chain
amino acid-preferring, and small neutral amino acid-preferring activities
(Orlowski et al., 1993), amongst the chymotrypsin- like activity is the most
important (Fenteany and Schreiber 1996). Increased ubiquitin-proteasome
activity has been observed in many catabolic diseases including sepsis (Jin
and Li 2007). In addition, in muscle atrophy the unregulated ubiquitin
proteasome activity was significantly blocked by the proteasomal inhibitor
(MG-132) (Tawa et al., 1997). The most important ubiquitin proteasome
system involved in the degradation of skeletal muscle protein is the ubiquitin
ligases (Hershko and Ciechanover 1998). Further details about the
involvement of the ubiquitin ligases in the process of muscle protein
breakdown are in the following part about the role of atrogin-1 and MuRF1.
1.15.6 Skeletal muscle protein degradation from LPS to atrogin-1 and
MuRF1
Loss of lean body mass results predominantly from accelerated
protein degradation rate via the ubiquitin-proteasome pathways (Jagoe and
Goldberg 2001). Selecting a particular protein to be ubiquitinated is primarily
a function of ubiquitin ligases (E3 proteins). The ubiquitin ligases protein
(also called an E3 ubiquitin ligases) is a protein in combination with an E2
(Ubiquitin-conjugating enzyme) which causes the attachment of ubiquitin to
a lysine on a target protein substrates for degradation by proteasome. The
E3 proteins are a rate limiting for ubiquitin conjugation (Bodine et al., 2001).
dŚĞ ?ɲƉƌŽƚĞŝŶƐ ?ĂƚƌŽŐŝŶ ? ?ĂŶĚDƵZ& ?ĂƌĞƌĂƚĞ ůŝŵŝƚ ŶŐĨŽƌŵƵƐĐůĞƉƌŽƚĞŝŶ
ůŽƐƐ ŝŶŵĂŶǇĐĂƚĂďŽůŝĐĐŽŶĚŝƚŝŽŶƐ ? /ŶĐƌĞĂƐĞĚĞǆƉƌĞƐŝŽŶŽĨ ?ɲƉƌŽƚĞŝŶƐŚĂƐ
been shown in sepsis (Voisin et al., 1996; Fischer et al., 2000). The activity of
atrogin-1 and MuRF1 is reciprocal to the activity of Foxo transcription family,
and Akt activity controls the Foxo transcription family activity. Decreased
activity of Akt in C2C12 myotubes was shown to activate (dephosphorylates)
Foxo transcription family, which in turn increases the activity ubiquitin E3
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ligases mainly atrogin-1 and MuRF1 (Dehoux et al., 2003; Sandri et al., 2004;
Stitt et al., 2004) and vice versa (Royle et al., 2003; Sandri et al., 2004).
LPS injection was associated with a dramatic increase in the
expression of muscle genes atrogin-1 and MuRF1, and mice harbouring
mutation in both atrogin-1 and MuRF1 are resistant to denervation-induced
muscle atrophy (Bodine et al., 2001). Interestingly, the both groups of
knockout mice appeared phenotypically normal with normal growth
patterns, weight, and morphology under normal conditions (Bodine et al.,
2001). This gives the evidence that both atrogin-1 and MuRF1 are pivotal for
muscle degradation process across the various catabolic conditions (Lecker et
al., 2004). Many studies concerning the regulation of ubiquitin proteasome
ƐǇƐƚĞŵƌĞƉŽƌƚĞĚƚŚĂƚdE& ?ɲĂŶĚ/'& ?I play a pivotal role in its regulation.
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Figure (1-7) Schematic diagram showing the process of protein ubiquitination and
subsequent degradation in the 26S proteasome. The protein of interest labelled
with four ubiquitin molecules and later it degraded in the central core of 26S
proteasome. This process fully controlled by the activity ubiquitin ligases protein
(atrogin-1 and MuRF1). The figure is adopted from (Kessler 2006).
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1.15.6.1 Atrogin-1/ MAFbx (Muscle atrophy F box)
The 42KDa protein atrogin-1 is a muscle specific ubiquitin ligase plays
a fundamental role in muscle proteolysis (Bodine et al., 2001). Atrogin-1 is a
part of Skp, Cullin and F-box (SCF) containing complex group of ubiquitin
ligases (Gomes et al., 2001), that catalysing the ubiquitination of proteins
destined for proteasomal degradation (Deshaies 1999). The linking of protein
substrate with the rest of ubiquitin ligases is the responsibility of the F-box
protein (Cardozo and Pagano 2004). While, SKp1 is required for stabilising of
this link in vivo (Gomes et al., 2001). The presence of atrogin-1 sequences in
the muscle nucleus suggests the role of atrogin-1 as a cell-signalling molecule
added to its role in muscle proteolysis (Sandri et al., 2004). The atrogin-1
controls the activity of many substrates particularly, calcineurin A (Li et al.,
2004) and MyoD (Tintignac et al., 2005), which are integrated in the
maintenance or restoring of muscle mass. Calcineurin A is responsible for the
activation of nuclear factor activated T cell (NFAT) family members and leads
to muscle hypertrophy (Li et al., 2004). MyoD is a muscle specific
transcription factor required for skeletal muscle differentiation (Edmondson
and Olson 1993; Kitzmann et al., 1998; Tintignac et al., 2004) and myogenic
stem cell function in skeletal muscle (Megeney et al., 1996). MyoD initiates
the expression of muscle specific genes and consequently cells start entering
a myogenic lineage (Weintraub 1993). The atrogin-1 degrades the MyoD in
proliferating myoblasts (Tintignac et al., 2005). Recently, it has been
demonstrated under the experimental conditions proposed by Lagirand-
Cantaloube and associates, that MyoD is a target of atrogin-1 in skeletal
muscle atrophy (Lagirand-Cantaloube et al., 2009). Atrogin-1 is the most
important ubiquitin ligase that activated in most cases of muscle atrophy
(Bodine et al., 2001; Gomes et al., 2001), and its knockout significantly
decreased the muscle protein turnover (Bodine et al., 2001). There are many
in vitro studies regarding the effect of sepsis and other catabolic stimuli on
the atrogin-1 mRNA expression and regulation (Li et al., 2005; Jin and Li
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2007; Murton et al., 2009). Whereas, the regulation of atrogin-1 in vitro still
unclear and needs further investigation. There are many signalling control
the activity of atrogin-1 either in vivo or in vitro. Glass demonstrated that Akt
is the key regulator of the atrogin-1 mRNA expression in skeletal muscle
ŵĞĚŝĂƚĞĚ ǀŝĂ &ŽǆŽ ƚƌĂŶƐĐƌŝƉƚŝŽŶ ĨĂŵŝůǇ  ?'ůĂƐƐ  ? ? ? ? Z ? /Ŷ ĂĚĚŝƚŝŽŶ ? dE& ?ɲ
significantly increased the atrogin-1 mRNA up-regulation mediated via p38 (Li
et al., 2005; Jin and Li 2007). Yet, there are many hidden aspects regarding
the regulation of atrogin-1 activity in skeletal muscle in case of sepsis need
further investigation.
1.15.6.2 MuRF1 (Muscle Ring Finger Protein 1)
MuRF1 is a 40KDa ubiquitin ligase exclusively expressed in skeletal
and cardiac muscles (Bodine et al., 2001). MuRF1 is mainly composed of
RING domain, amino-terminal end and two coiledcoil domains in its central
region (Centner et al., 2001). Similar to atrogin-1, MuRF1 plays a role in
regulation of cell signalling pathways (McElhinny et al., 2002). Because of the
expression of atrogin-1 and MuRF1 governed by the activity of Foxo family of
transcription factors. Prolonged sepsis increased the expression of atrogin-1
not MuRF1 mRNA (Frost et al., 2007). In contrast, the activation of NF-kB is
associated with the up-regulation of the MuRF1 not the atrogin-1 mRNA (Cai
et al., 2004). Thus, the separation between the role of atrogin-1 and MuRF1
and the factors that regulating their activity became increasingly important.
MuRF1 plays an important role in the ubiquitination and degradation of titin
(single polypeptide, important in the contraction of striated muscle tissues),
and may be other proteins in the Z-band resulting in releasing of actin and
myosin (Wray et al., 2003). In contrast, mice lacking MuRF1 were protected
from denervation-induced muscle atrophy to a lesser degree than mice
harbouring a negative mutation in atrogin-1 (Bodine et al., 2001). In response
to glucocorticoids, MuRF1 interacts with glucorticoids modulatory element
binding protein-1(GMEB-1), a nuclear protein regulates transcription in
response to glucocorticoids (McElhinny et al., 2002). MuRF1 degrades
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troponin 1 in cardiomyocytes (Li et al., 2004). The interaction between the
MuRF1 and the myofibrillar proteins (titin and troponin) may explain the role
of the MuRF1 in muscle atrophy. MuRF1 interacts with the giant muscle
proteins such as nebulin and titin (Centner et al., 2001; Witt et al., 2005).
Furthermore, MuRF1 plays a role in the maintaining of energy metabolism of
skeletal muscle by ubiquitination and degradation of the CK (Koyama et al.,
2008). LPS-induced toxaemia in rodents resulted in the reduction of total Akt
protein levels, decreased cytosolic Foxo1 and Foxo3 phosphorylation, and
increased levels of atrogin-1 protein and MuRF1 mRNA in skeletal muscle
(Crossland et al., 2008). Recently, the LPS-induced toxaemia in rats was
associated with increased levels of both atrogin-1 and MuRF1 mRNA in
skeletal muscle not in myocardium muscle (Murton et al., 2009).
Taken together, we can conclude that the most important pathway
activated in most cases of muscle atrophy is the ubiquitin proteasome
pathway. In addition to the direct role of both of atrogin-1 and MuRF1 in the
muscle protein degradation, MuRF1 plays an essential role in maintaining the
energy metabolism in skeletal muscle. Furthermore, considering the atrogin-
1 and MuRF1 as therapeutic targets is one of the most important ways to
minimise the sepsis-induced protein breakdown. However, the absolute use
of both atrogin-1 and MuRF1 and a unique markers of muscle proteolysis
either in vivo or in vitro is considered relatively incorrect for more details
reviewed in (Attaix and Baracos 2010).
1.16 LPS stimulates the release of Creatine kinase (CK)
Creatine kinase/phosphocreatine kinase is an enzyme that catalyses
the conversion of creatine to phosphocreatine utilizing ATP in a reversible
reaction. Although, the mechanism of CK release from the muscle is still
unclear. However, CK release has been used as an index of muscle damage in
the in vitro and in vivo studies (Maglara et al., 2003). The relationship
between the availability of muscle ATP and increased efflux of CK has been
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established (Jackson et al., 1984). Skeletal muscle considered as the most
important reserve of ATP and respond to various catabolic stimuli by
decreasing the energy consumption. Skeletal muscle lack creatine kinase (CK)
exhibited no physiological or pathological changes, but significant alteration
of the energy metabolism has been shown (van Deursen et al., 1993;
Ventura-Clapier et al., 1995). LPS significantly increased the glucose-6-
phosphate, phosphocreatine and ATP in the skeletal muscle within 5 min
(Myrvold et al., 1975). To date, the studies concerning the creatine kinase are
mainly focused on the relationship between the creatine and the energy
metabolism in skeletal muscle. Koyama and associates recently
demonstrated that, MuRF1 maintain the energy metabolism of the muscle by
ubiquitination and degradation of CK for more details (Koyama et al., 2008).
Furthermore, Zhao et al showed that MuRF1 ubiquitinated and later
degraded the oxidised form of the creatine kinase in vitro, this mean that,
under abnormal conditions the skeletal muscle decreases the energy
consumption mainly via degradation of the creatine kinase mediated most
likely via MuRF1 (Zhao et al., 2007).
1.17 LPS-stimulates nitric oxide (NO) production in skeletal
muscle
Nitric oxide (NO) is one of the few known gaseous signalling
molecules synthesized from the amino acid L-arginine and oxygen in a
reaction catalysed by NO synthase enzymes (NOS). NO is an important
messenger molecule taking a part in many physiological and pathological
processes, for example as an antiproliferative agent for smooth muscle
cells (Baumgarten et al., 2001). In skeletal muscle, NO increases the blood
flow (Clark et al., 2003) and glucose uptake (Etgen et al., 1997; Bradley et
al., 1999). NO is toxic to infectious agents and when it reacts with
superoxide to form NO intermediates it can cause tissue damage (Murrant
and Reid 2001). Skeletal muscle produces nitric oxide as part of the host
immune defence to kill the invading microorganisms, but on the other
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hand, excess NO production leads to muscle wasting (Sambe et al., 1998).
Skeletal muscle contains three forms of NOS, two of these isoforms, NOS1
and NOS3, are constitutively expressed.
NOS2 (known as inducible NOS (iNOS)) is expressed in skeletal muscle
in response to injury and repair stimulated by bacterial cell wall components
(Wehling et al., 2001). In response to LPS administration, there is an
abundant increase in the NOS2 protein in skeletal muscle fibres between 6
and 48 h (Hussain et al., 1997). Furthermore, restoring the dysfunction
induced by LPS in respiratory muscle by NOS inhibitor is also a proof for the
role of NOS in muscle wasting (Sambe et al., 1998). Recently, Frost et al
demonstrated that LPS was able to increase the NOS2 mRNA expression four
folds comparing with the control group in both myoblasts and myotubes
(Frost et al., 2004). The expression of NOS2 mRNA was transient with
maximal increase at 6 h and this expression is a TLR4 dependent. Moreover,
they showed that the increased NOS2 mRNA expression was mainly through
the proteasomal activity and LPS-NOS2 mRNA increased activity blocked by
MG-132 (proteasomal inhibitor). Although, there is no precise limit for the
NO production that can damage the skeletal muscle, yet further investigation
are required in order to lessen the adverse consequences of sepsis.
1.18 General Hypothesis
The previous literatures have demonstrated that the process of sepsis
induced muscle protein turnover in vivo involves the interaction of many
signalling cascades and transcriptional factors. This makes overall anticipation
of their role is a hard task requires further investigation. In addition, in vivo it
has been shown that sepsis induced decreased PS and increased protein
breakdown was mediated via decreased translation initiation step of protein
synthesis and increased ubiquitin proteasome system activity respectively. In
the context, there is no clear data regarding the correlation between the
changes in the anabolic and catabolic signalling streams and the changes in
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protein synthesis and degradation. In addition, there is no clear collective data
about the direct contribution of Akt and MAPKs (p38 or Erk) signalling
cascades in this process. Moreover, the scarcity of data regarding the effect of
LPS on the primary skeletal muscle cells makes the understanding of this
effect is increasingly important. The effect of natural challenge with
Salmonella serotypes (Gallinarium or Enteritidis) is still unclear and requires
further investigation. Herein, this project was aimed to obtain a
comprehensive idea about the subcellular and molecular regulation of LPS-
induced muscle protein turnover in two in vitro septic models (C2C12-murine
myotubes and avian primary skeletal muscle cells) and how the natural
challenge with Salmonella serotypes (Gallinarium or Enteritidis) will affect the
skeletal muscle gene expression. Furthermore, the beneficial roles of
curcumin as a natural compound in sepsis were evaluated. The overall
exploitation of this project is the creation of a suitable therapeutic
intervention in order to lessen or minimise the adverse effects of sepsis.
1.19 Gaps in the understanding
The previous chapter emphasizes a number of gaps within the
literatures regarding the direct effects of the LPS on protein synthesis and
protein degradation in both C2C12 myotubes and avian primary skeletal
muscle cells.
First, although LPS significantly decreased the PS in septic skeletal
muscle (in vivo), however, there is no clear data regarding the in vitro effect,
and the obtained data are relatively contradictory.
Secondly, the direct contribution of the Akt and MAPKs (p38 or Erk1/2)
signalling cascades in the LPS-induced muscle protein turnover is still unclear,
and there is no collective data about their role in the same model of sepsis.
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Thirdly, the transcription regulation of LPS-induced muscle protein
turnover and the potential role of Akt and MAPKs (p38 or Erk1/2) signalling
cascades require further verification.
Fourthly, there are no clear data about the direct effect of curcumin
on protein metabolism (PS and PD) in vitro. Curcumin (diferuloymethane), one
of the components of spice turmeric (Curcuma longa) that has been used
extensively in the traditional Indian medicine to treat many diseases.
Fifthly, there are no clear data about the signalling cascades involved
in the LPS-induced NO production in both C2C12 myotubes and avian primary
skeletal muscle cells.
Finally, the direct effect of natural challenge with Salmonella on mRNA
expression levels in chicken skeletal muscle is still largely unclear.
1.20 The studys objectives:
x To measure the direct effect of the LPS on the PS in C2C12 myotubes
and the potential role of various signalling cascades including Akt and
MAPKs (p38 or Erk1/2) (Chapter 3).
x To verify the effect of LPS on these signalling cascades using specific
pathways inhibitors (Chapter 3).
x To assess the direct effect of the LPS on the chymotrypsin-like enzyme
activity and the direct involvement of Akt and MAPKs (p38 or Erk1/2)
was assessed using specific pathway inhibitors (Chapter 4).
x The transcriptional regulation of the LPS-induced muscle protein
turnover and the potential role of the Akt and MAPKs (p38 or Erk1/2)
signalling cascades was assessed using specific pathway inhibitors
(Chapter 5).
x To assess the beneficial effects of curcumin in case of sepsis (direct
effect on the protein synthesis and protein breakdown) (Chapter 6).
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x To characterise the effect of LPS on the protein turnover (protein
synthesis and degradation) in avian primary skeletal muscle cells
(Chapter 7).
x The LPS-induced nitric oxide (NO) production in both (C2C12 myotubes
and avian primary skeletal muscle cells) and the potential role of Akt
and MAPKs (p38 or Erk1/2) were evaluated (Chapter 8).
x To access the effect of the natural challenge with two Salmonella
serovars (Gallinarium or Enteritidis) on chicken skeletal muscle protein
metabolism in vivo (Chapter 9).
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2 General Materials and Methodology
2.1 Cell line and animal experiment
2.1.1 C2C12 Murine skeletal muscle myotubes
C2C12 murine myoblasts (Yaffe and Saxel 1977; Blau et al., 1985)
were cultured in Dulbecco

s modified Eagle

s medium (DMEM) supplemented
with 10% (v/v) Foetal Bovine Serum (FBS) and antibiotics (Penicillin and
streptomycin and glutamine) (growth medium, GM) in 5% CO2 at 37
ƕ
C. Upon
reaching 80% confluence, differentiation was induced by changing the
culture medium to DMEM medium supplemented with 2% (v/v) horse serum
(differentiating medium, DM). Cells were then maintained in the DM for up
to six days, the DM was changed every other day until the formation of
myotubes (multinucleated myotubes) was confirmed morphologically using
Leica microscope at the day six of differentiation (Li et al., 2008) (Fig. 2-1). Of
note, in all the experiments of C2C12 myotubes, cells were treated at the day
six of differentiation.
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Figure (2-1) Schematic diagram illustrating the process of C2C12 myoblasts growth
and differentiation (5 and 6 day of differentiation) and the experimental steps.
C2C12
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Chapter 2 General Methodology
63
2.1.2 Avian primary skeletal muscle cells
Cells were a kind gift from Prof. Kin Chow Chang (SVMS, University of
Nottingham). Cells were obtained from 4 weeks old Ross 308 broiler chicks,
for further information how these cells prepared see appendix. Cells were
grown in GM containing DMEM/F-12 (1:1), supplemented with 10% (v/v)
Horse serum (Invitrogen), 4% (v/v) Chicken embryo extract (Biosera), 1%
(v/v) Penicillin and streptomycin and 1% (v/v) Insulin-transferrin-selenium
(Halevy et al., 2004). The cells were then maintained in this media until the
formation of myotubes was confirmed morphologically using Leica
microscope. All the experiments were carried out at the day five of
differentiation. Further information about how these cells prepared are given
in the appendix.
2.2 Cell lysis and Western blotting
C2C12 murine myotubes or avian primary skeletal muscle cells were
treated with LPS (10 ngml
-1
, 100 ngml
-1 ĂŶĚ  ? ʅŐŵů-1) in case of C2C12
ŵǇŽƚƵďĞƐ ? ĂŶĚ ǁŝƚŚ >W^  ? ? ʅŐŵů-1) in case of avian primary skeletal muscle
cells. Cells were then washed three times in cold Phosphate buffer saline
(PBS), then lysed in lysis buffer (76.5 mMTris HCL (pH 6.8), glycerol 10% (v/v),
SDS 2% (w/v)) supplemented with 1 mM Sodium metavanedate (NaVO3), 10
mM leupeptin, 1 mM AEBSF (pefabloc
TM
), supplemented with the protease
inhibitors (Roche protease mini cocktail). In case of the NF-kB experiments
lysis buffer was used to isolate the cytoplasmic fraction from the nuclear
fraction (at low speed centrifugation at 2500 rpm) using Eppendorff
Centrifuge 5417R, composed of 10 mM Tris-HCL (pH7.9), 1 mM EDTA, 60 mM
KCL, 1 mM DTT, 0.075% (v/v) NP40 and 1mM NaVO4, supplemented with
protease inhibitor mixture. The supernatant was then combined with an
equal volume of SDS-PAGE Laemmli buffer (4% (w/v) SDS, 20% (v/v) glycerol,
0.004% (w/v) bromphenol blue and 0.125 M Tris HCL) with final pH 6.8 and
fractionated on a 12% SDS-PAGE gel. The protein concentration of samples
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ǁĂƐŵĞĂƐƵƌĞĚďǇƚŚĞŬŝƚ ?WŝĞƌĐĞ Z ?&ŽƌŝŵŵƵŶŽďůŽƚƚŝŶŐ ? ? ?ʅŐŽĨǁŚŽůĞ ?
cell lysates were separated by sodium dodecyl sulphate-polyacrylamide gel
electrophoresis (PAGE) (Rauch and Loughna 2005; Atherton et al., 2009) and
transferred onto Hypond-LPF Low Fluorescent PVDF membrane (GE
Healthcare). The membrane were then blocked overnight in 5% non-fat dry
milk PBS 0.01% Tween-20. The membranes were then probed with the
appropriate primary antibodies diluted in 2% (w/v) Bovine Serum Albumin in
PBS. Horseradish peroxidase-conjugated secondary antibodies were used to
detect the primary antibodies by the enhanced chemiluminescence system
(GE Healthcare). Bands on the X-ray films were quantified using densitometry
software (Quantity one software, Bio-Rad) (Fig. 2-2). The primary antibodies
used in our experiment were pErk1/2 (Thr202/Tyr204), pAkt1/2/3 (Ser473),
pp38 (Thr180/Tyr182), Erk1(C-16), Akt1/2 (N-19), p38, pIk ?ɲ ZĂďďŝƚ
polyclonal (Ser32), IK ?ɲ ZĂďďŝƚ WŽůǇĐůŽŶĂů ĂŶƚŝďŽĚǇ ? WE& ?Ŭ Ɖ ? ?  ?ƐĞƌ ? ? ? Z
and HRPconjugated secondary antibody (Anti-rabbit HRP conjugated IgG)
(Santa Cruz) and Phosphoplus p70S6 kinase (Thr389, Thr421/Ser424)
Antibody Kit, Phospho-4E-BP1 (Ser65), Phospho-eIF-4E (Ser209) and
WŚŽƐƉŚŽ ?ŵdKZ  ?^Ğƌ ? ? ? ? Z  ?Ğůů^ŝŐŶĂůůŝŶŐ Z ?ɴ ?ĂĐƚŝŶŚĂƐďĞĞŶƵƐĞĚĂƐ ůŽĂĚŝŶŐ
ĐŽŶƚƌŽů ?dŚĞĚĂƚĂǁĞƌĞŶŽƌŵĂůŝǌĞĚƚŽƚŚĞɴ ?ĂĐƚŝŶĂƐĂůŽĂĚŝŶŐĐŽŶƚƌŽů ?&ƵƌƚŚĞƌ
information about the dilutions of the primary and secondary antibodies is
given in the appendix.
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Figure (2-2) Schematic diagram illustrating the western Blotting technique. First,
the proteins were fractionated on 3% (w/v), 10% (w/v) and 12% (w/v) SDS-PAGE gel.
The proteins were then transferred on PVDF membrane using a Semi-dry blotter.
The PVDF membranes were then incubated with the appropriate antibodies. The
membranes were then developed with a chemiluminescence system. The density of
ƚŚĞ ďĂŶĚ ǁĂƐ ŵĞĂƐƵƌĞĚ ďǇ YƵĂŶƚŝƚǇ ŽŶĞ ƐŽĨƚǁĂƌĞ ĂŶĚ ŶŽƌŵĂůŝǌĞĚ ƚŽ ɴ ?ĂĐƚŝŶ
expression.
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2.3 Chicken experiment (in vivo)
This experiment was a joint experiment with one of our group. The
birds were mainly kept to evaluate the effect of natural challenge with
different Salmonella serotypes on the immune response of birds. Three
groups of these birds were selected for the skeletal muscle samples
collection as follows. Thirty one-day-old specificpathogen free Ross 308
broiler chicks were divided into three groups (10 chicks each). The birds were
allocated in three separate rooms receiving sterile drinking water. At day 20,
the birds were given free access to drinking water containing vancomycin
 ? ? ? ?ʅŐ ?ŵů Z ?ĂŶĚƚŚĞďŝƌĚƐǁĞƌĞƚŚĞŶƚƌĞĂƚĞĚŝŶĚŝǀŝĚƵĂůůǇǁŝƚŚ ? ? ?ŵůŽĨ ? ? ?
mg/ml) vancomycin. The vancomycin is an antibacterial drug that inhibits the
intestinal bacterial growth. At day 21, two groups of birds were orally
infected with 0.3 ml of 3x10
8
CFU/ml S. Enteritidis (SE) and S. Gallinarium (SG)
while the third group received 0.3 ml nutrient broth and was kept as control.
The commercial feed (in powder without antibiotics) and drinking water
(without antibiotics) were both available ad libitum. Cleaning and feeding
patterns were maintained to prevent the cross contamination throughout
the experiment. At day 4-post infection, five birds were selected and the
birds were killed by cervical dislocation. Five skeletal muscle samples were
aseptically collected form the petrol and gastrocnemius muscles and
immediately frozen in liquid nitrogen and kept for RNA isolation and RT-PCR
experiments. All the animal experiments were carried out according the
Home Office rules and regulations.
2.4 Chymotrypsin like-enzyme activity assay
The 20S proteasomal activity was determined by measuring the
chymotrypsin-like enzyme activity according to the method previously
described by Orino et al (1991) and recently by Whitehouse and Tisdale
(2003). The proteasomal activity was determined by the release of 7-amino-
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4-methylcoumarin from the fluorogenic peptide succinyl-LLVY-7-amino-4-
methylcoumarin (Sigma).
C2C12 myoblasts and the avian primary skeletal muscle cells were
grown, differentiated and maintained until the formation of the myotubes
was confirmed morphologically as previously described. Fully differentiated
C2C12 ŵǇŽƚƵďĞƐ ǁĞƌĞ ƚŚĞŶ ƚƌĞĂƚĞĚ ĞŝƚŚĞƌ ǁŝƚŚ >W^  ? ? ʅŐŵů-1) alone
(Salmonella Typhimurium cell culture tested, Sigma) or with LPS in
combination with inhibitors or with the inhibitors alone for 5, 30 min, 1, 3, or
18 h. In case of the avian primary skeletal muscle cells, cells were treated
ǁŝƚŚ>W^ ? ?ʅŐŵů-1) alone or with LPS in combination of the inhibitors for 3 h
only. Cells were then washed with cold sterile PBS three times, then lysed in
 ? ? ?ʅůůǇƐŝƐďƵĨĨĞƌ ? ? ?ŵDdƌŝƐ,> ?Ɖ, ? ? ? ? ?ŵDDŐů2, 50 mM DTT and 2
mM ATP and sonicated three times with pulses of 15 seconds with 10
seconds intervals. The cells were then spun down at 15.000 rpm for 15 min
at 4
 ƕ
C. The supernatant was removed and the protein content was
ĚĞƚĞƌŵŝŶĞĚƵƐŝŶŐƌĂĚĨŽƌĚĂƐƐĂǇŵĞƚŚŽĚƵƐŝŶŐ^ĂƐƐƚĂŶĚĂƌĚ ?ĂĐŚ ? ? ? ?ʅů
ĨŝŶĂů ƌĞĂĐƚŝŽŶ ǀŽůƵŵĞ ?  ? ? ʅů ĨůƵŽƌĞƐĐĞŶƚ ƐƵďƐƚƌĂƚĞ ?E ?^ƵĐĐŝŶǇů ?>ĞƵ ?>ĞƵ ?sĂů ?
dǇƌ ? ?ŵŝĚŽ ? ? ?DĞƚŚǇůĐŽƵŵĂƌŝŶ  ?^ŝŐŵĂ Z ?ĂŶĚ ? ? ? ? ? ?ʅŐsystolic protein in 50
mM Tris-Hcl (pH 8) were added. Then samples were added in duplicate to
into a 96 well plate. The plates were read on a flourimeter (BMG flourogenic
plate reader) set for 360 nm excitation and 460 nm emission. The obtained
results were normalised to the protein content of each sample. The
ĐŚǇŵŽƚƌǇƉƐŝŶ ?ůŝŬĞĞŶǌǇŵĞĂĐƚŝǀŝƚǇǁĂƐŵĞĂƐƵƌĞĚƉĞƌʅŐƉƌŽƚĞŝŶ ?
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2.5 Protein Assay Method (Stoscheck 1990)
a- Main method used to determine the protein content of samples (BCA
and Bradford protein assay Method), BSA (Bovine Serum Albumin)
was used as standard.
b- Standard curve preparation
Stock solution= 2 mg/ml BSA.
dŚĞŽƚŚĞƌĐŽŶĐĞŶƚƌĂƚŝŽŶƐƉƌĞƉĂƌĞĚĂƐʅŐƉƌŽƚĞŝŶ ?ŵů
 ? ? ?ŵŐ ?ŵů P ? ? ?ʅůƐƚŽĐŬA? ? ?ʅů,2O
 ? ? ?ŵŐ ?ŵů P ? ? ?ʅůƐƚŽĐŬA? ? ?ʅů,2O
 ? ? ?ŵŐ ?ŵů P ? ? ?ʅůƐƚŽĐŬA? ? ? ?ʅů,2O
 ? ? ?ŵŐ ?ŵů P ? ? ?ʅů ? ? ?ŵŐ ?ŵůA? ? ? ?ʅů,2O
 ? ? ?ŵŐ ?ŵů P ? ? ?ʅů ? ? ?ŵŐ ?ŵůA? ? ? ?ʅů,2O
 ? ? ?ŵŐ ?ŵů P ? ? ?ʅů ? ? ?ŵŐ ?ŵůA? ? ? ?ʅů,2O
 ? ? ?ŵŐ ?ŵů P ? ? ?ʅů ? ? ?ŵŐ ?ŵůA? ? ? ?ʅů,2
1 2 3 4 5 6 7 8 9 10 11 12
A Blank 0 0 0.1 0.1 0.3 0.3 0.6 0.6 0.9 0.9 1.2
B Blank 1 1 1.2
C Blank 2 2 1.5
D Blank 3 3 1.5
E Blank 4 4 1.8
F Blank 5 5 1.8
G 6 6 2.0
H 7 7 2.0
Figure (2-3) Diagram illustrating the layout of one of BCA protein Assay
experiments.
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 ? ? ?A?^ĂŵƉůĞƐ ?ĂĚĚĞĚǁĂƚĞƌ ? ? ?ʅůĞĂĐŚ Z
 ? ? ? ? ?A?^ƚĂŶĚĂƌĚ ?ĂĚĚĞĚůǇƐŝƐďƵĨĨĞƌ ? ? ?ʅůĞĂĐŚ Z
ůĂŶŬA?ǁĂƚĞƌ ?ĂĚĚĞĚůǇƐŝƐďƵĨĨĞƌ ? ? ?ʅůĞĂĐŚ Z
 ? ? ?ʅůŽĨƚŚĞƌĞĂŐĞŶƚǁĂƐĂĚĚĞĚƚŽĞĂĐŚǁĞůů ?ŵĞĂƐƵƌĞƚŚĞĂďƐŽƌďĂŶĐĞ
ĂŶĚĐĂůĐƵůĂƚĞƚŚĞĂŵŽƵŶƚŽĨƉƌŽƚĞŝŶ ?ʅŐ ?ʅů ZĨƌŽŵƚŚĞƐƚĂŶĚĂƌĚĐƵƌǀĞ ?
Figure (2-4) graph illustrates the standard curve obtained from one of the protein
ƐƐĂǇ  ? Z ? dŚĞ ĂŵŽƵŶƚƐ ŽĨ ƉƌŽƚĞŝŶƐ  ?ʅŐ ?ʅů Z ǁĞƌĞ ĚĞƚĞĐƚĞĚ ĨƌŽŵ ƚŚĞ ĞƋƵĂƚŝŽŶ
showed on the graph. The equation corresponding to a linear fit of the absorbance
y=0.3043x
R2= 0.9976
0
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2.6 Colorimetric Determination of Creatine Kinase Activity (CK)
at 340 nm
C2C12 murine myoblasts were grown and differentiated as previously
described above. The media was shifted to 2% (v/v) HS DMEM medium
without phenol red 24 h before the experiment. Cells were then treated with
>W^  ? ? ʅŐŵů-1) for 5, 30 min, 1, 3 and 18 h. The conditioned media was
collected and stored at -80
ƕ
C. The test was carried out according to the
ŵĂŶƵĨĂĐƚƵƌĞ ?Ɛ ƉƌŽƚŽĐŽů ? ƌŝĞĨůǇ ?  ? ? ? ʅů ĐŽŵƉĂŶǇ ?Ɛ ƌĞĂŐĞŶƚ  ?ŝŽƐƐĂǇ
Systems) was added into each well of the 96 wells plate (calibrator and the
samples), then mixed, and incubated at room temperature at 37 C. The plate
was then at 340 nm once after 20 min incubation and again after 40 min. The
CK activity was obtained from the following equation;
CK (U/L) = (OD40 min  OD20 min) / (ODcalibrator ODH2O) X 150
OD, optical reading at 340 nm after 20 min and 40 min
KŶĞƵŶŝƚŽĨ<ǁŝůůƚƌĂŶƐĨĞƌ ?ʅDŽĨƉŚŽƐƉŚŽĐƌĞĂƚŝŶĞƚŽWƉĞƌŵŝŶĂƚƉ,
6.0.
2.7 Protein Synthesis (PS) in Myotubes
Fully differentiated C2C12 myotubes and avian primary skeletal
muscle cell were treated with LPS (1 ȝgml-1) alone, or with LPS (1 ȝgml-1) in
ĐŽŵďŝŶĂƚŝŽŶ ǁŝƚŚ ƚŚĞ ŝŶŚŝďŝƚŽƌƐ Žƌ ǁŝƚŚ ƚŚĞ ŝŶŚŝďŝƚŽƌƐ ĂůŽŶĞ ?  ? ʅŝ3H-
phenylalanine (GE Healthcare) in the case of C2C12 myotubes or
3
H-Tyrosine
(PerkinElmer) in case of avian primary skeletal muscle cells was added for 1 h
before terminating the experiment. The PS was expressed as incorporation of
3
H-phenylalanine per milligram of total 5% Trichloroacetic acid (5% TCA)
percipitable protein as previously described by (Vandenburgh et al., 1991).
ƌŝĞĨůǇ ?ƚŚĞĐĞůůƐǁĞƌĞǁĂƐŚĞĚƚŚƌĞĞƚŝŵĞƐǁŝƚŚĐŽůĚW^ ? ? ? ?ʅů ?A? ?ǁ ?ǀ Zd
was added to cells. The plates were then scraped and washed twice with 400
ʅů  ?A?  ?ǁ ?ǀ Zd ?dŚĞƐĂŵƉůĞƐǁĞƌĞ ƚŚĞŶƉůĂĐĞĚŽŶ ŝĐĞĨŽƌ  ?Ś ?dŚĞƉƌŽƚĞŝŶ
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pellet was then washed three times to remove free
3
H-phenylalanine and
ƚŚĞŶ ĚŝƐƐŽůǀĞĚ ŝŶ  ? ? ? ʅů  ? ? ? DEĂK, ? ^ĂŵƉůĞƐ ǁĞƌĞ ƚŚĞŶ ĞĂƚĞĚ ŝŶ  ? ? ?A?
(w/v) sodium dodecyl sulfate (SDS) for 2 h at 70
ƕ
C to solubilise the
precipitate. The protein concentration of the samples was determined by the
Bradford protein Assay kit-using BSA (Peirce) as standard. The
3
H-
phenylalanine or
3
H-tyrosine incorporation was measured by Liquid
scintillation analyzer (Apackard Bioscience). The obtained values were
normalised to the protein content of each sample. The values were
ĞǆƉƌĞƐƐĞĚ ĂƐ ĐŽƵŶƚƐ ƉĞƌ ʅŐ ?ƉƌĞĐŝƉŝƚĂƚĞĚ ƉƌŽƚĞŝŶ ƉĞƌ ŵŝŶƵƚĞ  ?WD ?ʅŐ
protein).
2.8 Measurement of nitric oxide (NO) using the Griess assay
Nitric oxide production was measured by analysing the supernatant
fluid for the presence of nitrite, using the standard Griess assay method (Ding
et al., 1988; Sung et al., 1991). The absorbance was read at 540 nm. Serial
dilutions of sodium nitrite (Sigma) were used to determine a standard curve.
The test was performed as follow:
1- Composition of the solutions
1-NED Solution (0.1% (w/v) N-napthylethylenediamine dihyrochloride in
water)
2-Sulfanilamide Solution (1% (v/v) Sulfanilamide in 5% (v/v) phosphoric acid).
3-Nitrite standard (0.1 M sodium nitrite in water)
All the reagent were obtained from Sigma company UK
2- Procedures of the test
EKƌĞůĞĂƐĞǁĂƐĚĞƚĞƌŵŝŶĞĚŝŶĂ ? ? ?ǁĞůůƉůĂƚĞďǇŵŝǆŝŶŐ ? ?ʅůŵĞĚŝƵŵ
ǁŝƚŚ  ? ? ʅů ŽĨ ƚŚĞ ^ƵůĨĂŶŝůĂŵŝĚĞ ƐŽůƵƚŝŽŶ ? ĨŽůůŽǁĞĚďǇ ŝŶĐƵďĂƚŝŽŶ Ăƚ ƌŽŽŵ
ƚĞŵƉĞƌĂƚƵƌĞĨŽƌ  ? ? ? ? ?ŵŝŶ ?  ? ?ʅůŽĨ ƚŚĞEƐŽůƵƚŝŽŶǁĂƐ ƚŚĞŶĂĚĚĞĚ ?ǁŝƚŚ
subsequent incubation at room temperature for 10-15 min. The absorbance
was then read at 540 nm (Fig. 2-5). The NO concentration was derived from
the standard curve. Serial dilutions of sodium nitrite were used to determine a
standard curve (Fig. 2-6). The obtained results were normalised to the protein
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content of each sample. The protein content of the samples was determined
by the BCA method using BSA as standard.
1 2 3 4 5 6 7 8 9 10 11 11
A S1 S1 S1 1 1
B S2 S2 S2 2 2
C S3 S3 S3 3 3
D S4 S4 S4 3 3
E S5 S5 S5 4 4
F S6 S6 S6 5 5
G S7 S7 S7 6 6
H Media
(0ʅD)
Media
(0ʅD)
Media
(0ʅD)
7 7
Figure (2-5) Schematic illustration of the plate layout of the nitric oxide experiment
S1-S7. Standard prepared with twofold six serial dilutions starting from (125
ʅDEŝƚƌŝƚĞƚŽ ?ʅDEŝƚƌŝƚĞ Z
1-7. Samples
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Figure (2-6) graph illustrates the standard curve obtained from one of the NO
ĞǆƉĞƌŝŵĞŶƚ ? dŚĞ ĐŽŶĐĞŶƚƌĂƚŝŽŶ ŽĨ ŶŝƚƌŝƚĞ  ?ʅD Z ŝŶ ĞĂĐŚ ƐĂŵƉůĞ ǁĂƐ ŽďƚĂŝŶĞĚ ĨƌŽŵ
the equation showed on the graph. The equation corresponding to a linear fit of the
absorbance.
y = 0.005x
R2 = 0.9993
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2.9 dE& ?ɲĂŶĚ/> ? ?ĞŶǌǇŵĞ ?ůŝŶŬĞĚŝŵŵƵŶŽƐŽƌďĂŶƚĂƐƐĂǇ
C2C12 myotubes were grown and maintained as previously described.
dŚĞ ĐĞůůƐ ǁĞƌĞ ƚŚĞŶ ƚƌĞĂƚĞĚ ǁŝƚŚ >W^  ? ? ʅŐŵů-1) for 5, 30 min, 1, 3, or 18 h
respectively. The conditioned media were collected and stored at -80
ƕ
C. TNF-
ɲĂŶĚ/> ? ?ĐǇƚŽŬŝŶĞůĞǀĞůƐŝŶƚŚĞĐŽŶĚŝƚŝŽŶĞĚŵĞĚŝĂǁĞƌĞŵĞĂƐƵƌĞĚƵƐŝŶŐƚŚĞ
dE& ?ɲ ĂŶĚ /> ? ? >/^ ZĞĂĚǇ ?ƐĞƚ ?'Ž Ŭŝƚ  ?ĞŝŽƐĐŝĞŶĐĞ Z Ă ĐŽƌĚŝŶŐ ƚŽ ƚŚĞ
ŵĂŶƵĨĂĐƚƵƌĞ ?ƐƉƌŽĐĞĚƵƌĞƐ ?ƌŝĞĨůǇ ? ? ?ʅů ?ǁĞůůŽĨƚŚĞŵĞĚŝĂŽƌƐƚĂŶĚĂƌĚǁĞƌĞ
added to the appropriate wells, the plate was sealed and kept overnight at
4
ƕ ?ĨƚĞƌǁĂƐŚŝŶŐƚŚĞǁĞůůƐ ? ? ? ?ʅů ?ǁĞůůŽĨƚŚĞĚĞƚĞĐƚŝŽŶĂŶƚŝďŽĚǇǁĂƐĂĚĚĞĚ ?
sealed and left for 1 h at room temperature. The wells were then washed,
ĨŽůůŽǁĞĚ ďǇ ĂĚĚŝƚŝŽŶ ŽĨ  ? ? ? ʅů ?ǁĞůů ŽĨ ǀŝĚŝŶ ?,ZW ƐĞĐŽŶĚĂƌǇ ĂŶƚŝďŽĚǇ ǁĂƐ
ĂĚĚĞĚ ?ƌĞƐĞĂůƚŚĞƉůĂƚĞĨŽƌ ? ?ŵŝŶĂƚƚŚĞƌŽŽŵƚĞŵƉĞƌĂƚƵƌĞ ?ƚŚĞŶ ? ?ʅů ?ǁĞůů
ŽĨ ƚŚĞ ƐƵďƐƚƌĂƚĞ ǁĞƌĞ ĂĚĚĞĚ ĨŽůůŽǁĞĚ ďǇ  ? ? ʅů ?ǁĞůůŽĨ ƐƚŽƉ ƐŽůƵƚŝŽŶ ?
Absorbance reading was done at 450 nm (Fig. 2-7). The obtained readings
were normalised to the protein content of each sample. The protein content
of the samples was determined by BCA method using BSA as standard.
Figure (2-7) ŐƌĂƉŚ ŝůůƵƐƚƌĂƚĞƐ ƚŚĞ ƐƚĂŶĚĂƌĚ ĐƵƌǀĞ ĨŽƌ ůĞǀĞů ŽĨ dE& ?ɲ ĐǇƚŽŬŝŶĞ ? dŚĞ
ĐŽŶĐĞŶƚƌĂƚŝŽŶŽĨdE& ?ɲŝŶĞĂĐŚƐĂŵƉůĞǁĂƐŽďƚĂŝŶĞĚĨƌŽŵƚŚĞĞƋƵĂƚŝŽŶƐŚŽǁĞĚŽŶ
the graph. The equation corresponding to a linear fit of the absorbance.
y = 0.0018x
R2 = 0.9935
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2.10 Total RNA Extraction from the C2C12 myotubes and avian
primary skeletal muscle cells
C2C12 myoblasts and avian primary skeletal muscle cells were grown,
maintained and differentiated as described above. Cells were then treated
according the experiment (either with LPS (1 ȝgml-1) alone, or with LPS (1
ȝgml-1) in combination with the inhibitors or with the inhibitor alone. Cells
were then washed three times with cold PBS, and then lysed and the RNA
isolated using Nucleospin® RNA II (Fisher Scientific) following the
ŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ ŝŶƐƚƌƵĐƚŝŽŶƐ ? ƌŝĞĨůǇ ?  ? ? ? ʅů >ǇƐŝƐďƵĨĨĞƌ A?  ? ? ? ʅů ɴ ?
mercaptoethanol were added to lyse cells, and then the lysate was filtrated
by centrifuging at 11,000xg (SIGMA (1-14), Scientific Laboratory Supplies
 ?^>^ Z ZĨŽƌ ?ŵŝŶ ?dŚĞďŝŶĚŝŶŐŽĨZEǁĂƐĂĚũƵƐƚĞĚďǇŵŝǆŝŶŐǁŝƚŚ ? ? ?ʅů ? ?A?
Ethanol and mixed. Samples were then spun at 11,000xg for 30 seconds.
ĞƐĂůƚĞĚƚŚĞƐŝůŝĐĂŵĞŵďƌĂŶĞďǇĂĚĚŝŶŐ  ? ? ?ʅůDĞŵďƌĂŶĞĞƐĂůƚŝŶŐƵĨĨĞƌ
(MDB). The columns were then centrifuged at 11,000xg (SIGMA 1-14, SLS) for
 ?ŵŝŶ ?dŚĞŶ ? ? ?ʅůEĂƐĞƌĞĂĐƚŝŽŶŵŝǆƚƵƌĞƐǁĞƌĞĂĚĚĞ ƚŽĚŝŐĞƐƚƚŚĞEĨŽƌ
15 min at room temperature. The RNA bound to the membrane was then
ǁĂƐŚĞĚƚŚƌĞĞƚŝŵĞƐǁŝƚŚƚŚĞZ ?ƐŽůƵƚŝŽŶ ?ĂŶĚůĂƚĞƌƚŚĞŝƚǁĂƐĞůƵƚĞĚŝŶ ? ?ʅů
RNase-free water by centrifuging the columns at 11,000xg (SIGMA 1-14, SLS)
for 1 min. RNA concentration was accessed using the Nanodrop at 260 and
280 nm absorbance (Okamoto and Okabe 2000), and then stored at -80
ƕ
C for
the cDNA synthesis.
2.11 Total RNA Extraction from chicken skeletal muscle using
Trizol reagent
Total RNA was extracted using the standard protocol (Jones et al.,
2004). Briefly, approximately 100 mg of frozen muscle samples were
homogenised using a gentle MACS dissociator (Miltenyi Biotec) in 1 ml ice-
cold Trizol (Invitrogen) for 1 min. To the homogenate, 0.2 ml chloroform was
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added and shaken vigorously for 15 seconds. After incubation for 5 min at
room temperature, the homogenate was then centrifuged at 12000xg
(HERAEUS PIC 17, Thermo Scientific) at 2-8
ƕ
C for 15 min. The aqueous phase
was then removed and kept in clean sterile eppendorff tube. To the aqueous
phase, 0.25 ml isopropanol and 0.25 ml high salt precipitation solution (0.8 M
Sodium Citrate/ 1.2 M NaCL) was added. After incubation for 10 min at room
temperature the mixture was next centrifuged at 12000xg (HERAEUS PIC 17,
Thermo Scientific) for 10 min at 2-8
ƕ
C. The RNA pellet was then washed with
75% ethanol before being centrifuged at 7500xg (HERAEUS PIC 17, Thermo
Scientific) for 5 min at 2-8
ƕ
C. After discarding the ethanol the pellet was then
ĂŝƌĚƌŝĞĚĂŶĚƌĞƐƵƐƉĞŶĚĞĚŝŶ ? ?ʅůZEĂƐĞ ?ĨƌĞĞǁĂƚĞƌ ?dŚĞZEƌĞĐŽǀĞƌĞĚǁĂƐ
quantified using the Nanodrop at 260 and 280 nm absorbance (Okamoto and
Okabe 2000), and the quality of the extraction monitored by the 260:280 nm
ratios, and the RNA was then stored at -80
ƕ
C.
2.12 cDNA Synthesis
Total RNA was Transcripted into complementary DNA (cDNA) using
the Transcriptor First Strand cDNA Synthesis kit (Roche®). Following the
ŵĂŶƵĨĂĐƚƵƌĞ ?ƐƉƌŽĐĞĚƵƌĞƐ ?  ?ʅŐ ƚŽƚĂůZE ?  ?ʅůŽĨ ƌĂŶĚŽŵŚĞǆĂŵĞƌƉƌŝŵĞƌ
(60 ȝD ĨŝŶĂů ĐŽŶĐĞŶƚƌĂƚŝŽŶ Z ?  ? ʅůĞŽǆǇŶƵĐůĞŽƚŝĚĞ Dŝǆ  ?ĚEdWƐ Z  ? ? ŵDĨŝŶĂů
ĐŽŶĐĞŶƚƌĂƚŝŽŶ Z ?  ? ? ? ʅů ƉƌŽƚĞĐƚŽƌ ZEĂƐĞ ŝŶŚŝďŝƚŽƌ  ?ZEĂƐĞ Z  ? ? ? h ?ʅů ĨŝŶĂů
ĐŽŶĐĞŶƚƌĂƚŝŽŶ Z ?  ? ? ? ʅůdƌĂŶƐĐƌŝƉƚŽƌ ZĞǀĞƌƐĞ dƌĂŶƐĐƌŝƉƚĂƐĞ  ?Zd Z  ? ? ? h ?ʅů ĨŝŶĂů
ĐŽŶĐĞŶƚƌĂƚŝŽŶ ZĂŶĚ ?ʅůZEďƵĨĨĞƌĂŶĚƚŚĞƐŽůƵƚŝŽŶǁĂƐĐŽŵƉůĞƚĞĚƚŽ ? ?ʅů
final volume with Rnase-free in PCR tube. Then the tube was placed in
thermal block cycler PCR for 10 min at 25
ƕ
C followed by 30 min at 55
ƕ
C. Table
(2-1) showed how to prepare 50 CDNA samples and the amount of reagents
required.
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Table (2:1) Table showing the amount of each vial required to prepare 50 cDNA
samples using Transcriptor First Strand cDNA Synthesis kit, (Roche®). The reagents
showed in the table were completed in PCR tube to 20 ȝl final volume with Rnase
free water.
cDNA Required Reagents
No of Samples
Vail
ŵŽƵŶƚ ?ʅů ?
from each vial
dŽƚĂů ?ʅů ?ĨƌŽŵ
each vial50
RNA Buffer 4.0 200
Transcriptor Reverse Transcriptase
(RT) 0.5 25
Deoxynucleotide Mix (dNTPs) 2.0 100
Random hexamer primer 2.0 100
Protector Rnase inhibitor 0.5 25
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The following tables show the nucleotides sequences of the primers
and the probes that were used in the RT-PCR experiments and their
accession number and hyperlink to the gene bank.
Table (2:2) Primer sequences (5'-3') used for mRNA quantification by reverse
transcriptase-PCR (RT-PCR) in the case of C2C12 murine skeletal muscle cells
(Roche). The probes were obtained from Roche universal probe library.
Name Probe
number
Forward Reverse
B-actin
(NM_007393.3)
#64
CTAAGGCCAACCGTGAAAAG ACCAGAGGCATACAGGGACA
MuRF1
(AF294790)
#105
GCCAACGACGTCTTCCAG GGACAACCTCGTGCCTACA
Atrogin-1
(AF441120)
#53
AGTGAGGACCGGCTACTGTG GATCAAACGCTTGCGAATCT
dE& ?ɲ
(NM_013693.2)
#49
TGCCTATGTCTCAGCCTCTTC GAGGCCATTTGGGAACTTCT
TLR4
(NM_021297.2)
#2
GGACTCTGATCATGGCACTG CTGATCCATGCATTGGTAGGT
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All the probes were labelled by (5
'
-FAM-3
'
-TAMARA). The primers and
the probes for IL-6, IL-8 and IL-10 were obtained from (Smith et al., 2005),
while the other chicken primers and probes obtained from (Nakashima et al.,
2009). The expression of mRNA was quantified by RT-PCR using a
LightCycler480 instrument (Roche). The expression of 18S was used as an
internal control. The premiers were designed using GenScript Real-time PCR
(TaqMan) Primer Design software. The accession number of the genes used
in both the primary cell experiment and the chicken skeletal muscle
experiment were Chicken18S mRNA (AF173612 Z ? ŚŝĐŬĞŶ dE& ?ɲ ? ŚŝĐŬĞŶ
Atrogin mRNA (NM_001030956), Chicken Caspase-3 mRNA (AF083029),
Chicken Cathepsin mRNA (U18083), Chicken Ubiquitin mRNA (X02650),
Chicken IL-6 mRNA(AJ250838), Chicken IL-8 mRNA (AJ009800) and Chicken
IL-10 mRNA (AJ621614)
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Table (2:3) Primer sequences (5'-3') used for mRNA quantification by reverse transcriptase-PCR (RT-PCR) used in the case of avian primary skeletal muscle
chicken cells and muscle from live chicken bought from Eurogentec company.
Name Forward Reverse Probe
18S (AF173612)
TGGCAAATGCTTTCGTCGCTTT TGTGCCGCTAGAGGTGAAATT GCCCTCCTCCTGGTTTCAG
 ?dE& ?ɲ
CCCTTCTGAGGCATTTGGAA CAGCCTGCAAATTTTGTCTTCTT CAGCGTTCGGAGTGGGCT
C-Atrogin
(NM_001030956)
TTGCTGCAGACCCTCTACAC GCCTGGTGATTTGAATGTTG TTGCCGACCCGTTGAACCAA
C-Caspase-3
(AF083029)
AGCTGAAGGCTCCTGGTTTA TCTGCCACTCTGCGATTTAC TCCTGGCGTGTTCCTTCAGCA
C.Cathepsine
(U18083),
AAGCTCTGTGGCACTTTCCT GTCAAAGGTATCCGGCAAAT CAGGAGCCTTGGGTCCACCC
C-Ubiquitin
(X02650),
GGATGCAGATCTTCGTGAAA GGATCTTGGCCTTCACATTT CACCCTTGAGGTTGAGCCCAGTG
C-IL-6
(AJ250838),
GCTCGCCGGCTTCGA GGTAGGCTGAAAGGCGAACAG AGGAGAAATGCCTGACGAAGCTCTCCA
C-IL-8 (AJ009800),
TGGCACCGCAGCTCATT TCTTTACCAGCGTCCTACCTTGCGACA GCCCTCCTCCTGGTTTCAG
C-IL-10
(AJ621614)
CATGCTGCTGGGCCTGAA CGTCTCCTTGATCTGCTTGATG CGACGATGCGGCGCTGTCA
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2.13 RT-PCR
The fold change in mRNA level was quantified by the Light Cycler 480
(Roche Company). cDNA was obtained as previously mentioned above form
the reverse transcription reaction of mRNA. Real-time PCR analyses were
performed in triplicate using 96-well plate using 2x master mix (Roche
Company). Two microliters of cDNA were used as a template for real-time
WZ ?  ? ? ? ʅů ĨŽƌǁĂƌĚ ƉƌŝŵĞƌ  ? ? ʅD Z ?  ? ? ? ʅů ƌĞǀĞƌƐĞ Ɖŝŵ ƌ  ? ? ʅD Z ? ĂŶĚ  ? ? ? ʅů
ƉƌŽďĞ ? ?ʅD ZǁĞƌĞĂĚĚĞĚƚŽ  ? ?ʅůZŽĐŚĞ ?ǆŵĂƐƚĞƌŵŝǆ ĂŶĚ ?ʅůZŶĂƐĞĨƌĞĞ
ǁĂƚĞƌ ?ZĞĂĐƚŝŽŶƐǁĞƌĞƉĞƌĨŽƌŵĞĚŝŶ ? ?ʅůǀŽůƵŵĞƌĞĂĐƚŝŽŶǀŽůƵŵĞƵŶĚĞƌƚŚĞ
following conditions 1 cycle for the pre-incubation and the activation of the
fast start taq DNA polymerase, followed by denaturation of the DNA at 95
ƕ
C
for 10 min. Then 45 cycles for amplification at (95
ƕ
C for 10 sec, 60
ƕ
C for 15
sec and 72
ƕ
C for 01 sec) and 1 cycle for cooling at 40
ƕ
C for 10 sec. The
ĐŚĂŶŐĞƐ ŝŶ ŵZE ůĞǀĞůƐ ŽĨ ŐĞŶĞ ŽĨ ŝŶƚĞƌĞƐƚ ƌĞůĂƚŝǀĞ ƚŽ ɴ ?ĐƚŝŶ ŵZE ǁĂƐ
determined by advanced relative quantification method using the Light cycler
480 (LC480 1.5.0.39). The amount of the target mRNA was normalised to the
endogenous reference and expressed as a relative to the calibrator according
ƚŽWĨĂĨĨů  ? ? ? ? ? Z ?ɴ ?ĐƚŝŶŚĂƐďĞĞŶƵƐĞĚĂƐĂƌĞĨĞƌĞŶĐĞŐ ŶĞ ŝŶĐĂƐĞŽĨ ? ? ?
myotubes, while in case of the avian primary skeletal muscle cells 18s has
ďĞĞŶ ƵƐĞĚ ? EŽƚĞ ƚŚĂƚ ? ƚŚĞ ĞǆƉƌĞƐƐŝŽŶ ůĞǀĞůƐ ŽĨ ɴ ?ĐƚŝŶ ĂŶĚ  ? ?^ ǁĞƌĞ ŶŽƚ
affected by treatment in all experiments. Examples of the CT values for some
genes in different experiments were shown in appendix.
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2.14 Pathway inhibitors
C2C12 murine myoblasts and the avian primary skeletal muscle cells
were cultured, maintained and differentiated until the formation of
myotubes was confirmed morphologically as previously described above. To
ƚŚĞĨƵůůĚŝĨĨĞƌĞŶƚŝĂƚĞĚŵǇŽƚƵďĞƐ ? ƚŚĞdŽůů ?ůŝŬĞZĞĐƉƚŽƌ  ? /ŶŚŝďŝƚŽƌ ?  ?ʅŐŵů-1
(Polymyxin B, Sigma) was added 2 h before adding LPS, while LY0294002, 50
ʅD  ?W/ ? ?< ?Ŭƚ ŝŶŚŝďŝƚŽƌ ? Ğůů ƐŝŐŶĂůŝŶŐ Z ? W ? ? ? ? ? ? ?  ? ? ʅD  ?D< ?ƌŬ ? ? ?
ŝŶŚŝďŝƚŽƌ ?Ğůů^ŝŐŶĂůŝŶŐ Z ?D' ? ? ? ? ? ? ?ʅD ?ƉƌŽƚĞĂƐŽŵĂůŝŶŚŝďŝƚŽƌ ?^ŝŐŵĂ ZĂŶĚ
^ ? ? ? ? ? ? ? ? ?ʅD ?W ? ?ŝŶŚŝďŝƚŽƌ ?^ŝŐŵĂ ZǁĞƌĞĂĚĚĞĚ ?ŚďĞĨŽƌĞĂĚĚŝŶŐ>W^ ? ?
ʅŐŵů-1). The optimal doses of inhibition was obtained from the previous
literatures: Polymyxin B (Frost et al., 2006), SB203580 (Li et al., 2005; Huang
et al., 2007; Jump et al., 2009), MG-132 (Frost et al., 2003), PD098059,(Shi et
al., 2002; Dehoux et al., 2003; Plaisance et al., 2008) and for LY0294002
(Plaisance et al., 2008) with modification that we used higher dose according
to the manufacture recommendation for PD098059 and LY0294002.
Afterwards the cells treated as described above. Moreover, the theses
kinases inhibitors especially, p38 and Erk1/2 inhibitors are selective for their
respective kinase pathways in C2C12 cells (Frost et al., 2003). LY0294002 is a
potent mTOR inhibitor (Brunn et al., 1996). Curcumin (Sigma) was dissolved
ŝŶ D^K ĂŶĚ ǀĂƌŝŽƵƐ ĐŽŶĐĞŶƚƌĂƚŝŽŶƐ  ? ? ? ?  ? ? ĂŶĚ  ? ? ʅD Z ǁĞƌĞ ƵƐĞĚ ŝŶ ƚŚĞ
experiment. The following diagram illustrates the how these inhibitors block
their relevant pathway (Fig. 2-8).
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Figure (2-8) Diagram showing how the inhibition of Akt and MAPKs (p38 or Erk1/2)
can modulate the PS. Inhibition of PI3-K/Akt activity by LY0294002 decreased PS
through the inhibition of translation initiation mediated via decreased mTOR, p70S6K
and 4E-BP1 phosphorylation. In contrast inhibition of MEK/Erk1/2 by PD098059, and
inhibition of p38 by SB203580 altered the PS via inhibition of MnK1 induced eIF-4
phosphorylation and hence this inhibits the translation initiation.
MEK p38
Akt
PI3-K
Erk1/2
Mnk1
eIF4E
SB203580PD098059
mTOR
4E-BP1
p70S6K
LY0294002
Translation initiation and PS
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2.15 Statistics
Data are expressed as the means r S.E.M unless stated in each graph.
The statistical significant differences among the groups were assessed by
(one and two-way analysis of variance with Turkeys post hoc testing to
locate statistically significant difference at P < 0.05 for the normally
distributed data. To allocate the difference between two groups, Students t-
test was used. While in case of nonparametric data Kruskal-Wallis Test has
been used with the Mann-Whitney test to locate the difference between two
groups. A probability below 0.05 (P < 0.05) considered significant. All the
statistical analysis was done by Prism-4 (Graph Pad), Minitab 15 Statistical
Software and GenStat 12th Edition, University of Nottingham.
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3 Endotoxin transiently inhibits protein synthesis
through Akt and MAPK mediating pathways in C2C12
myotubes
3.1 Introduction
Muscle wasting is a common syndrome associated with severe catabolic
diseases such as sepsis, cancer and AIDS. Sepsis is an inflammatory condition
that causes severe and rapid loss of body protein, much of which originates
from skeletal muscle (Hasselgren 1995). LPS are an integral part of cell wall
components of Gram-negative bacteria, and are potent activators of the
innate immune system through recognition by TLR4 (Raetz 1990). TLR4 is a
part of a large family of receptors that recognize PAMPS, and plays an
indispensable role in the transduction of the LPS signal and subsequently the
stimulation of inflammatory cytokine gene expression (Kaisho and Akira
2000). The dynamic balance between rates of PS and PD governs the skeletal
muscle protein mass maintenance.
To date most studies investigating the effects of sepsis upon skeletal
muscle protein metabolism have examined the regulation of catabolic
pathways that lead to accelerated rate of protein loss (Frost et al., 2003).
Clinical studies in humans and in a variety of animal models clearly
demonstrate that PD contributes to the loss of skeletal muscle protein and
impaired contractile function observed in response to sepsis or endotoxin
administration (Owens et al., 1994). In a number of clinical conditions and
experimental models, it has been shown, however, that a change in rate of PS
is the primary initiator of altered muscle mass (Vary 1998; Lang et al. 2002;
Lang and Frost 2007). The few in vivo studies examining LPS and muscle PS
(Vary and Kimball 1992; Lang et al., 2000) are contradictory while some
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suggest a suppression of PS; others do not. To date, two studies have
examined the direct effect of LPS on PS in cultured muscle cells in vitro (Frost
et al., 2009; Russell et al., 2010). Frost and associates (2009) have shown that,
LPS alone has no effect on protein synthesis, but the combination of LPS and
IFN-Ȗ induced a 80% decrease in the PS. In contrast, Russell et al. (2010)
demonstrated that LPS alone induced a 50-60% decrease in PS in the same cell
line.
PS in skeletal muscle is regulated at the transcriptional or translational
level (Macallan et al., 1996), with the translational control is the common
mechanism in most acute responses (Jepson et al., 1986). One of the most
extensively studied anabolic pathways is the PI3-K/Akt pathway. Akt/protein
kinase B, is a member of a family serine/threonine protein kinases (Datta et
al., 1999) which are stimulated by a number of receptor tyrosine kinases and
often this was mediated by the action of PI3-K (Walsh 2006). Akt has been
shown to be activated by Salmonella enterica serovar Typhimurium in the
epithelial cells (Steele-Mortimer et al., 2000). In skeletal muscle acute
activation of Akt for 2 weeks significantly increased the skeletal muscle fibre
size, and this effect produced in the main through an increase in the PS
pathway (Lai et al., 2004). The contribution of the PI3-K/Akt pathway and their
down-stream effectors including mTOR, P70
S6K
and 4E-BP1 in the regulation of
skeletal muscle mass has been reviewed in detail by Glass (2005). The
translation of mRNA into protein is conventionally divided into three main
stages: initiation, elongation and termination. mTOR controls the initiation
and elongation stages of the protein translation (Wang and Proud 2006)
through its downstream effectors including ribosomal S6Kinase (S6K1) and 4E-
BP1 (Wang and Proud 2006). The direct contribution of the MAPKs family and
their proposed downstream target Mnk1 in the regulation of the translation
initiation process through eIF-4E has also been shown by Fukunaga and
Hunter (1997).
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A number of studies have measured the changes in the signalling
pathways activation that may regulate PS without direct measurement of this
process itself. Recent studies suggest that in some cases changes in the
activation of the pathways that regulate translation may not always
correlated with the expected changes in PS (Miranda et al., 2008; Atherton et
al., 2009). Thus, a better understanding of the role of signalling pathways and
in particular that of the Akt and MAPKs (p38 or Erk1/2) in sepsis is important
for developing successful therapies in order to retard the loss in lean body
mass and reduce morbidity and mortality (Lai et al., 2004; Stitt et al., 2004).
For these reasons, our study aimed to examine the subcellular mechanisms
responsible for the LPS-associated changes in PS in murine C2C12 murine
myotubes, and the possible role of Akt/MAPK signalling pathways. In addition,
we measured the direct effect of LPS alone and with specific pathway
inhibitors on PS as a short-term (3 h) or long-term (18 h) response.
3.2 Hypothesis
LPS has previously been shown to induce decrease in PS in vivo, and this
effect was mediated via decreased translation initiation step of protein
synthesis. Thus we anticipated that this effect could be the same in vitro.
C2C12 myotubes have been extensively used in muscle research because they
can respond to external stimuli (LPS) similarly equal to skeletal muscle. In
addition, it has previously shown that the activity of PI3-K/Akt and MAPKs
(p38 or Erk1/2) can regulate the PS mainly through the control of translation
initiation step of PS. Therefore, the aim of this chapter is to investigate the
direct of LPS on PS (measured as
3
H-phenylalanine incorporation/ȝg 5% TCA
precipitable protein) and the subcellular signalling molecules involved in this
effect in particular the role of Akt and MAPKs (p38 or Erk1/2) was
investigated.
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3.3 Results
3.3.1 LPS induced changes in the activity of Akt and mTOR
To characterise the effect of LPS on the signalling pathways mediating
the protein synthesis, C2C12 myotubes were incubated at various
concentrations of LPS (10 ngml
-1
, 100 ngml
-1ĂŶĚ ?ʅŐŵů-1) at a number of time
points (5, 30 min, 1, 3 and 18 h). The effect of LPS on the activity-related
phosphorylation state of Akt was presented in (Fig. 3-1A). LPS induced a rapid
but transient decrease in the Akt phosphorylation lasting only for 30 min. LPS
significantly decreased the Akt phosphorylation at 5 and 30 min in a dose-
dependent manner (Fig. 3-1A). Later the LPS had no effect on Akt
phosphorylation compared with the control levels at other time points (Fig. 3-
1A). In contrast, LPS induced a long time and dosedependent decrease in
mTOR phosphorylation at all the time points starting early at 5 min and
continued to the 18 h time point (Fig. 3-1B).
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Figure (3-1) Time and dose-dependent changes in A) phospho-Akt and B) phospho-
mTOR. C2C12 myotubes were incubated with LPS (10 ngml
-1
, 100 ngml
-1
and 1
ʅŐ ?ŵů Z ĨŽƌ  ? ? ?  ? ? ŵŝŶ ?  ? ?  ? ? Žƌ  ? ? Ś Z ? sĂůƵĞƐ ƌĞƉƌĞƐĞŶƚ Ě ĂƐ ŵĞĂŶƐ r SEM
(percentage of control) normalised to ȕ-actin as internal loading control. n = 3. Bars
carry asterisks are statistically different from the control cells (
*
P < 0.05,
**
P < 0.01
and
***
P < 0.001). The representative blots illustrated the effect of LPS (10 ngml
-1
,
100 ngml
-1ĂŶĚ ?ʅŐŵů-1) on the activity-related phosphorylation of Akt and mTOR at
30 min.
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3.3.2 LPS induced changes in P38, Erk1/2 and their down-stream
target Mnk1 activity-related phosphorylation
To investigate the possible role of the other signalling pathways known
to regulate the anabolic pathways, the level of phosphorylated p38, Erk1/2
and their substrate Mnk1 were measured in response to LPS administration
(Figs. 3-2A, 3-2B and 3-2C). LPS-induced increases in p38 activity-related
phosphorylation at all time points peaked at 30 min, 1 h and 3 h time points
(Fig. 3-2A). The effect of the LPS on the phospho-Erk1/2 is summarised in (Fig.
3-2B). Incubation of the C2C12 myotubes with LPS (10 ngml
-1
, 100 ngml
-1
and
 ? ʅŐŵů-1) significantly induced a dose-dependent increase in Erk1/2
phosphorylation at all the time points with the exception of the 3 h time point
(Fig. 3-2B). In Figure (3-2C) the activity-related phosphorylation of the Mnk1
was presented. Mnk1 has previously been known as in vitro downstream
target of the MAPKs (p38 or Erk1/2). Incubation of the C2C12 myotubes with
LPS (10 ngml
-1
, 100 ngml
-1ĂŶĚ ?ʅŐŵů-1) increased the Mnk1 phosphorylation
particularly at 1 h and 3 h time points with no further changes observed at the
other time points (Fig. 3-2C).
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Figure (3-2) Time and dose-dependent changes in A) phospho-P38, B) phospho-
Erk1/2 and C) phospho-Mnk1. C2C12 myotubes were incubated with LPS (10
ngml
-1
, 100 ngml
-1 ĂŶĚ  ? ʅŐŵů-1) for (5, 30 min, 1, 3, 0r 18 h. Values are
represented as means r SEM (percentage of control) normalised to ȕ-actin
as an internal loading control. n = 3. Bars carry asterisks are statistically
different from the untreated control cells (
*
P < 0.05,
**
P < 0.01 and
***
P <
0.001). The representative blots illustrated the effect of LPS (10 ngml
-1
, 100
ngml
-1 ĂŶĚ  ? ʅŐŵů-1) on the activity-related phosphorylation of p38 and
Erk1/2 at 30 min time point.
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3.3.3 The effect of LPS on the regulation of translation initiation
signalling molecules in C2C12 myotubes
In vivo, it has previously been shown that, LPS and sepsis significantly
altered the PS via the alteration of the translation initiation step of the protein
synthesis. The effect of the LPS (10 ngml-1, 100 ngml-1 ĂŶĚ  ? ʅŐŵů-1)
administration on the translation initiation signalling streams particularly
p70
S6K
, 4E-BP1 and eIF-4E is summarised in (Figs. 3-3A, 3-3B and 3-3C).
Incubation of the C2C12 myotubes with LPS significantly decreased the p70
S6K
phosphorylation in a dose-dependent manner at the time points, and this
effect was maximally seen at the 5 min and 1 h time points (Fig. 3-3A). In
contrast, LPS only decreased the 4E-BP1 phosphorylation at the 1 h time point
(Fig. 3-3B). The decrease in 4E-BP1 phosphorylation at the 1 h time points was
then followed by a decrease in the eIF-4E phosphorylation at 3 h time point
(Fig. 3-3C).
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Figure (3-3) Time and dose dependent changes in A) phospho-P70S6K; B) phospho-
4E-BP1 and C) phospho-eIF-4E. C2C12 myotubes were incubated with LPS
(10 ngml
-1
, 100 ngml
-1 ĂŶĚ  ? ʅŐŵů-1) for (5, 30 min, 1, 3, or 18 h). Values
represented as means r SEM (percentage of control) normalised to ȕ-actin
as an internal loading control. n = 3. Bars carry asterisks are statistically
different from control cells (
*
P < 0.05 and
**
P < 0.01). The representative
blots illustrated the effect of LPS (10 ngml
-1
, 100 ngml
-1 ĂŶĚ ?ʅŐŵů-1) on the
activity-related phosphorylation of p70
S6K
, 4E-BP1 and eIF-4E at 30 min, 30
min and 1 hr time points respectively.
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3.3.4 The effect of LPS on the Muscle cell PS rate
From the previous results, we can conclude that LPS significantly
decreased the anabolic signalling pathway (Akt/mTOR and their down stream
targets). Thus, the second aim was to measure the direct effect of LPS on the
PS rate (expressed as incorporation of
3
H-phenylalanine per microgram of
total trichloroacetic acid (5%TCA) Precipitable protein) after stimulation of
 ? ? ?ŵƵƌŝŶĞŵǇŽƚƵďĞƐǁŝƚŚ>W^ ? ?ʅŐŵů-1) for 3 h (short-term effect) and 18
h (long-term effect). Our result showed that at 3 h there was a significant
decrease in PS rate by 49% (P < 0.01) compared with the control cells) (Fig. 3-
4. Table.1) with no significant change was observed at 18 h time point (Fig. 3-
6A).
Chapter 3 LPS transiently inhibits PS in C2C12 Myotubes via Akt and MAPK cascades
100
Figure (3-4) Changes in the protein synthesis  ?W^ Z ĐŽƵŶƚƐ ?ʅŐ ƉƌŽƚĞŝŶ ?  ? ? ?
ŵǇŽƚƵďĞƐ ǁĞƌĞ ŝŶĐƵďĂƚĞĚ ĞŝƚŚĞƌ ǁŝƚŚ >W^  ? ? ʅŐŵů-1) alone or with LPS and
WŽůǇŵǇǆŝŶ   ?>W^ ŶĞƵƚƌĂůŝƐŝŶŐ ĂŐĞŶƚ Z  ?WD ?  ? ʅŐŵů-1), or LPS and SB203580 (p38
ŝŶŚŝďŝƚŽƌ Z ?^ ? ? ?ʅD Z ?Žƌ>W^ĂŶĚW ? ? ? ? ? ? ?D< ?ƌŬŝŶŚŝďŝƚŽƌ Z ?W ? ? ?ʅD Z ?Žƌ>W^
ĂŶĚ>z ? ? ? ? ? ? ? ?W/ ?< ?ŬƚŝŶŚŝďŝƚŽƌ Z ?>z ? ? ?ʅD Z ?ŽƌǁŝƚŚWŽůǇŵǇǆŝŶ ?WD ? ?ʅŐŵů-
1 Z ?^ ? ? ? ? ? ? ?^ ? ? ?ʅD Z ?W ? ? ? ? ? ?W ? ? ?ʅD Z ?Žƌ>z  ? ? ? ? ? ? ?>z ? ? ?ʅD ZĂůŽŶĞĨŽƌ
3 h. The protein synthesis rate was determined by measuring the rate of
3
H-
ƉŚĞŶǇůĂůĂŶŝŶĞ ŝŶĐŽƌƉŽƌĂƚŝŽŶ ŝŶƚŽ ƚŚĞ ĐĞůů ƉƌŽƚĞŝŶ ĐŽƵŶƚ ƉĞƌ ŵŝŶƵƚĞ  ?WD Z ?ʅŐ
protein. Values represented as means r SEM. Bars carry asterisks are statistically
different from control cells (
*
P < 0.05). n = 6
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Figure (3-5) Changes in the protein synthesis  ?W^ Z ĐŽƵŶƚƐ ?ʅŐ ƉƌŽƚĞŝŶ ?  ? ? ?
ŵǇŽƚƵďĞƐ ǁĞƌĞ ŝŶĐƵďĂƚĞĚ ĞŝƚŚĞƌ ǁŝƚŚ >W^  ? ? ʅŐŵů-1) alone or with LPS and
WŽůǇŵǇǆŝŶ   ?>W^ ŶĞƵƚƌĂůŝƐŝŶŐ ĂŐĞŶƚ Z  ?WD ?  ? ʅŐŵů-1), or LPS and SB203580 (p38
ŝŶŚŝďŝƚŽƌ Z ?^ ? ? ?ʅD Z ?Žƌ>W^ĂŶĚW ? ? ? ? ? ? ?D< ?ƌŬŝŶŚŝďŝƚŽƌ Z ?W ? ? ?ʅD Z ?Žƌ>W^
ĂŶĚ>z ? ? ? ? ? ? ? ?W/ ? ?< ?ŬƚŝŶŚŝďŝƚŽƌ Z ?>z ? ? ?ʅD Z ?ŽƌǁŝƚŚWŽůǇŵǇǆŝŶ ?WD ? ?ʅŐŵů-
1 Z ?^ ? ? ? ? ? ? ?^ ? ? ?ʅD Z ?W ? ? ? ? ? ?W ? ? ?ʅD Z ?Žƌ>z ? ? ? ? ? ? ?>z ? ? ?ʅD ZĂůŽŶĞĨŽƌ
18 h. The protein synthesis rate was determined by measuring the rate of
3
H-
ƉŚĞŶǇůĂůĂŶŝŶĞ ŝŶĐŽƌƉŽƌĂƚŝŽŶ ŝŶƚŽ ƚŚĞ ĐĞůů ƉƌŽƚĞŝŶ  ?ĐŽƵŶƚ ƉĞƌ ŵŝŶƵƚĞ  ?WD Z ?ʅŐ
protein. Values represented as means r SEM. Bars carry asterisks are statistically
different from control cells (
**
P < 0.01 and
***
P < 0.001). n = 6.
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Table (3:1) the decrease percentage of PS rate compared to the control. C2C12
ŵǇŽƚƵďĞƐǁĞƌĞ ŝŶĐƵďĂƚĞĚĞŝƚŚĞƌǁŝƚŚ>W^  ? ?ʅŐŵů-1 ZĂůŽŶĞŽƌǁŝƚŚ>W^  ? ?ʅŐŵů-1) in
ĐŽŵďŝŶĂƚŝŽŶ ǁŝƚŚ ƚŚĞ ŝŶŚŝďŝƚŽƌƐ ? WŽůǇŵǇǆŝŶ   ?WD ?  ʅŐŵů-1), SB203580 (p38
ŝŶŚŝďŝƚŽƌ Z  ?^ ?  ? ? ʅD Z ? W ? ? ? ? ? ?  ?D< ?ƌŬ ŝŶŚŝďŝƚŽƌ Z  ?W ?  ? ? ʅD Z ĂŶĚ >z ? ? ? ? ? ? ?
 ?W/ ? ?< ?ŬƚŝŶŚŝďŝƚŽƌ Z ?>z ? ? ?ʅD ZĨŽƌ ?ĂŶĚ ? ?Ś ?sĂůƵĞƐĂƌĞƌĞƉƌĞƐĞŶƚĞĚĂƐŵĞĂŶƐr
SEM (percentage of control).
*
P < 0.05,
**
P < 0.01 and
***
P < 0.001 represent the
statistical difference compared with the control group.
Time
point
Treatment
LPS LPS+PMB LPS+SB LPS+PD LPS+LY
3 h 49r
9.29%
*
8 r 15.54% 23r8.14% 39r 14.08% 81r7.42%**
18 h 14r9.93% 16r12.96% 41r7.2%** 59r2.06%*** 80r1.91%***
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Table (3-2) the decrease percentage of PS rate compared to the control. C2C12
ŵǇŽƚƵďĞƐ ǁĞƌĞ ŝŶĐƵďĂƚĞĚ ǁŝƚŚ ŝŶŚŝďŝƚŽƌƐ WŽůǇŵǇǆŝŶ   ?WD ?  ? ʅŐŵů-1), SB203580
 ?Ɖ ? ?ŝŶŚŝďŝƚŽƌ Z ?^ ? ? ?ʅD Z ?W ? ? ? ? ? ? ?D< ?ƌŬŝŶŚŝďŝƚŽƌ Z ?W ? ? ?ʅD ZŽƌ>z ? ? ? ? ? ? ?
 ?W/ ? ?< ?Ŭƚ Z ?>z ? ? ?ʅD ZĂůŽŶĞĨŽƌ ?ĂŶĚ ? ?Ś ?sĂůƵĞƐĂƌĞƌĞƉƌĞƐĞŶƚĞĚĂƐŵĞĂŶƐr SEM
(percentage of control). P < 0.05,
**
P < 0.01 and
***
P < 0.001 represent the statistical
difference compared with the control group.
Time point Treatment
PMB SB PD LY
3 h
37r20.
47%
63r12.48%
**
64r5.05%*
*
66r6.04%**
18 h
8r11.0
8%
40r6.68%* 18r11.77% 76r2.065%***
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Figure (3-6) Changes in the protein synthesis (PS) measured as 3H-phenylalanine
ŝŶĐŽƌƉŽƌĂƚŝŽŶ ?ʅŐƉƌŽƚĞŝŶ ? ? ? ? ŵǇŽƚƵďĞƐǁĞƌĞŝŶĐƵďĂƚĞĚǁŝƚŚ>W^ ? ?ʅŐŵů-1) for 3
or 18 h. Values represented as means r SEM (percentage of control). Bars carry
asterisks are statistically different from control and 18 h LPS-treated cells (*P < 0.05
and
**
P < 0.01). n = 6
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3.3.5 The effect of inhibitors on the muscle cell PS rate
The effect of LPS and signalling pathways was verified using specific
ƉĂƚŚǁĂǇ ŝŶŚŝďŝƚŽƌƐ ? WŽůǇŵǇǆŝŶ   ?WD ?  ? ʅŐŵů-1 Z ? >z ? ? ? ? ? ? ?  ?>z ?  ? ? ʅD Z ?
W ? ? ? ? ? ?  ?W ?  ? ? ʅD Z ĂŶĚ ^ ? ? ? ? ? ?  ?^ ?  ? ? ʅD Z ǁĞƌĞĂĚĚĞĚ ƚŽ ĨƵůůǇ
ĚŝĨĨĞƌĞŶƚŝĂƚĞĚ  ? ? ? ĂůŽŶĞ Žƌ ǁŝƚŚ >W^  ? ? ʅŐŵů-1). Incubation of C2C12
myotubes either with LPS in combination with PMB or with PMB alone
showed no changes in the PS rate compared to the control level at both 3 h
and 18 h time points (Figs. 3-4 and 3-5. Tables. 1 and 2). Incubation of C2C12
myotubes with LPS and SB203580 (Figs. 4 and 5. Table. 1 and 2) significantly
decreased the PS at 18 h by 41% (P < 0.01), but not at 3 h, while incubation of
cells with SB203580 alone significantly decreased protein synthesis at 3 h by
63% (P < 0.01) and at 18 h by 40% (P < 0.05) (Figs. 4 and 5. Table. 2).
Incubation of cells with LPS and PD98059 had no effect on PS at 3 h (Fig. 4.
Table. 1), while it significantly decreased the PS rate by 59% (P < 0.01) at 18 h
time point (Fig. 5. Table. 1). In contrast, incubation of cells with PD98059
alone significantly decreased PS by 64% (P < 0.05) at 3 h time point (Fig. 4.
Table. 2), with no further changes were observed at the 18 h time point (Fig.
3-5. Table. 2). Finally, incubation of cells with LPS with LY0294002 (LY, 50 ȝM)
induced a significant reduction in PS by 81% (P < 0.01) at 3 h and by 80 % (P <
0.001) at 18 h compared with the control cells respectively (Figs. 3-4 and 3-5,
Table. 1). Similarly, incubation of cells with LY0294002 (LY, 50 ȝM) alone
induced a significant decrease in PS by 66% (P < 0.01) and 76% (P < 0.001)
compared with the control untreated cells at 3 and 18 h time points
respectively (Figs. 3-4 and 3-5. Table. 2).
The efficiency of inhibition was verified by the western blotting. Our
western blotting results have shown that incubation of cells with LPS and
LY0294002 or with LPS and PD098059 completely abolished the activity
related phosphorylation of Akt and Erk1/2 with no effect on the total Akt or
the total Erk1/2 respectively (Figs. 3-7A, 3-7C and 3-7D). While, incubation of
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cells with LPS and SB203580 had no effect on the activity related
phosphorylation of p38 (Figs. 3-7B and 3-7D). Interestingly, Incubation of cells
either with LPS and SB203580 (p38 inhibitor) or with LPS and PD098059
(MEK/Erk1/2 inhibitor) significantly decreased the Akt phosphorylation (P <
0.05) (Figs. 3-7A and 3-7D) compared to the control cells. While, incubation of
cells with LPS in combination with Polymyxin B (LPS neutralising agent) had no
effect on the activity related phosphorylation of Akt, p38 and Erk1/2
compared with the control cells (Figs. 3-7A, 3-7B, 3-7C and 3-7D).
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Figure (3-7) Changes in the A) phospho-Akt, B) phospho-p38, C) phospho-Erk1/2
and D)representative blots of phospho-Akt, Erk1/2, and p38 and ȕ-actin as internal
loading control. C2C12 myotubes were incubated either with LPS (1 ȝgml-1) alone or
ǁŝƚŚ>W^ĂŶĚƉŽůǇŵǇǆŝŶ ?>W^ŶĞƵƚƌĂůŝƐŝŶŐĂŐĞŶƚ ? ?ʅŐŵů-1); LPS and SB203580 (p38
ŝŶŚŝďŝƚŽƌ ?  ? ? ʅD Z ? >W^ ĂŶĚ W ? ? ? ? ? ?  ?D< ?ƌŬ ŝŶŚŝďŝƚŽƌ ?  ? ? ʅD Z ? Žƌ >W^ ĂŶĚ
>z ? ? ? ? ? ? ?  ?W/ ? ?< ?Ŭƚ ŝŶŚŝďŝƚŽƌ ?  ? ? ʅD Z ? sĂůƵĞƐ ĂƌĞƌĞƉƌ ƐĞŶƚ Ě ĂƐ ŵĞĂŶƐr SEM
normalised to ȕ-actin as an internal loading control. Bars carry asterisks are
statistically different compared with control cells (
*
P < 0.05,
**
P < 0.01 and
***
P <
0.001). n = 4.
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3.4 Discussion
Sepsis is an acute inflammatory condition characterized by accelerated
rate of protein turnover and decreased protein synthetic rate (Hasselgren
1995). In vivo it has been shown that endotoxin induced a significant decrease
in the rate of PS in the gastrocnemius muscle of the rat (Lang et al., 2000). It
has also been observed that sepsis itself significantly decreased the rate of PS
in the gastrocnemius but not, however, in the slow-twitch soleus muscle (Vary
and Kimball 1992). While, in vitro the effect of LPS was varied, with Frost et
al., (2009) showing no changes in PS rate when the LPS used alone in C2C12
differentiated myotubes, but the subsequent study of Russell et al., (2010)
showing a significant decrease in the PS rate in response to LPS alone in the
same cell line. Our data showed that LPS significantly decreased the PS rate in
C2C12 fully differentiated myotubes by 50% but that this effect was transient
(3 h) and the PS returned to the control levels by18 h time point. These
findings are consistent with the findings of Russell et al. (2010). Studies in
adult animal model of sepsis have shown that, LPS challenge significantly
decreased the skeletal muscle protein synthesis, a reduction occurs as early as
4 h and maintained for 24 h (Vary and Kimball 1992; Lang et al., 2000). While
in case of in vitro model of sepsis, Russell et al. (2010) demonstrated that,
endotoxin decreased skeletal muscle protein synthesis between at 4 h post
LPS administration, while Frost et al., showed that, LPS alone could alter the
skeletal muscle protein synthesis rate either at 10 h or at 14 h time points
(Frost et al., 2009). Thus, we assume that the effect of endotoxin on the
skeletal muscle protein metabolism is the same either in vitro or in vivo. LPS
has been demonstrated to decrease muscle protein content most likely via
decreasing the rate of PS and the translation efficiency (Jepson et al., 1986;
Ash and Griffin 1989; Macallan et al., 1996; Cooney et al., 1997). The effect of
LPS was diminished by the LPS neutralizing agent polymyxin B (PMB) (Frost et
al., 2006). LPS significantly increased TLR4 mRNA in a time-dependent manner
and Polymyxin B abolished this effect (Chapter 5, Figs. 5-4A and 5-4B). This
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strongly suggesting that TLR-4 is the main signalling cascades involved in the
LPS-signals transduction in our septic model (Kaisho and Akira 2000).
The process of PS divided into three distinct stages initiation, elongation
and termination. Sepsis-induced inhibition of PS is a prime result of the
decrease in the translation efficiency not the decrease in the number of
ribosome (Vary and Kimball 1992; Cooney et al., 1999; Lang et al., 2000). The
process of mRNA translation regulation is primarily the function of a group of
eIFs. The active eIF-4F complex controls the peptide-chain initiation by
regulating the recruitment of the 43S pre-initiation complex to mRNA (Pain
1996). The formation of the active eIF-4F complex depends on the availability
of eIF-4E, and the interaction between of eIF-4G and eIF-4E is controlled
partially by the eIF-4E binding protein (BP) 1 (Hara et al., 1997). Increased 4E-
BP1 phosphorylation releases it from eIF-4E, and this facilitates the formation
of active eIF-4F complex (Lang and Frost 2005). Herein, LPS significantly
decreased the basal phosphorylation of 4E-BP1 and subsequently decreased
the availability of eIF-4E. These changes in 4E-BP1 and eIF-4E phosphorylation
are suggestive of a fall in PS and similar to changes observed in vivo (Vary and
Kimball 1992).
The activation of p70
S6K
kinase is essential to obtain a normal muscle
fibre size (Ohanna et al., 2005). A significant time and dose-dependent
decrease in activity-related phosphorylation of p70
S6K
is observed in response
to LPS administration (Fig. 3-3A) which correlates well with in vivo studies
(Vary and Kimball 1992; Lang et al., 2000) but is in contrast to the finding of
Frost et al. (2009) who observed no such decrease in response to LPS alone.
Combined, LPS decreased the phosphorylation of 4E-BP1 and this effect was
associated with an increased amount of the inactive 4E-BP eIF-4E complex. In
addition, LPS significantly decreased p70
S6K
phosphorylation. These findings
are consistent with the previous findings the previously reported in vivo (Lang
et al., 2000; Lang and Frost 2005). Thus, LPS significantly decreased PS rate
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either in vivo or in vitro via the alteration of the translation initiation of mRNA
(Vary and Kimball 1992; Cooney et al., 1999).
Upstream regulators of protein synthesis are known to include Akt and
the MAPKs (p38 or Erk1/2). Although, in the present study, LPS significantly
decreased the phosphorylation of Akt for only 30 min, whereas, its
downstream target mTOR exhibited a decreased activity-related
phosphorylation over a longer time period, this suggests that LPS mediated its
effect on PS mainly through the Akt/mTOR and their down-stream targets
including p70
S6K
, eIF-4E and 4E-BP1 (Gingras et al., 1999; Lang et al., 2000;
Bodine et al., 2001; Orellana et al., 2002; Lang and Frost 2005). Decreased
mTOR phosphorylation has been previously shown in many in vitro studies.
Lang and Frost (2005) have demonstrated that administration of LPS
significantly decreased the basal phosphorylation of mTOR by 50% in rat
skeletal muscle. Therefore, mTOR is considered as one of the LPS downstream
targets molecule, and any alteration of mTOR activity acts as a point of
bifurcation leading to stimulation or inhibition of protein synthesis mostly
likely via 4E-BP1 (Gingras et al., 2001). In the same study they have
demonstrated that one of the downstream targets of mTOR is the 4E-BP1.
Combined, these data indicate that mTOR is one of the key elements
regulating the protein synthesis. mTOR is involved in LPS-induced alteration of
translation initiation via decreased phosphorylation of the translation
initiation repressor (4E-BP1). Conversely, Frost and associates have shown
that LPS alone could not abolish mTOR phosphorylation or protein synthesis in
myocytes (Frost et al., 2004). In order to further investigate the role of Akt
inhibition on PS, we used LY0294002 (PI3-K/Akt inhibitor) (Plaisance et al.,
2008). Incubation of C2C12 myotubes either with LPS and LY0294002 or with
LY0294002 alone dramatically decreased the PS rate (Figs. 3-4 and 3-5),
indicating that Akt plays a key role in the regulation of PS in skeletal muscle.
Decreased Akt total protein has been seen in rodent model of sepsis
(Crossland et al., 2008) as well as in C2C12 model of sepsis (Sandri et al., 2004;
Stitt et al., 2004). Akt is a well known upstream regulator of translation
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initiation, increased Akt phosphorylation increases both eIF-2B and eIF-4F
ĂƐƐĞŵďůǇǀŝĂƚŚĞƉŚŽƐƉŚŽƌǇůĂƚŝŽŶĂŶĚƐƵďƐĞƋƵĞŶƚŝŶĂĐƚŝǀĂƚŝŽŶŽĨ'^< ? ?ɴĂŶĚ
4E-BP1 (Nader et al., 2002). Therefore, the dogma is, LPS significantly
mediated decreased skeletal muscle protein synthesis in vivo and in vitro via
the same mechanism (decreases the protein translation efficiency).
The MAPK family is considered a fundamentally important ubiquitous
intracellular signalling system involved in the regulation of many cellular
processes including cell growth, differentiation and survival (Seger and Krebs
1995). In the present study, LPS significantly increased the p38 and Erk1/2
phosphorylation at all time points in a dose-dependent manner (Figs. 3-2A
and 3-2B). Increased muscle p38 phosphorylation has been shown in many
pro-catabolic conditions including acute quadriplegic myopathy (Di Giovanni
et al., 2004), neurogenic atrophy (Di Giovanni et al., 2004), aging (Williamson
et al., 2003) and sepsis (Li et al., 2005; Jin and Li 2007). Although similar
increases in p38 phosphorylation have been observed in rats administered
LPS, a diminished Erk1/2 and p38 phosphorylation was found by vary et al.,
(2004) in which chronic abdominal sepsis had been induced. Interestingly
however, in the later study, these falls in Erk1/2 and p38 phosphorylation
ǁĞƌĞ ƉƌĞǀĞŶƚĞĚ ǁŚĞŶ ƚŚĞ ĂĐƚŝǀŝƚǇ ŽĨ dE& ?ɲ ǁĂƐ ŝŶŚŝďŝƚĞĚ ďǇ ƚŚĞ
administration of TNF binding protein to the rats with sepsis. One of the
downstream targets of both p38 and Erk1/2 MAP kinases is Mnk1 (Fukunaga
and Hunter 1997; Waskiewicz et al., 1997). Mnk1 has been shown to be
involved in the process of PS in the main via its down-stream target eIF-4E
(Gingras et al. 1999). The data presented in Figures (3-2A, B and C) have
shown that, LPS significantly increased p38 and Erk1/2 phosphorylation and
this effect was associated with increased basal phosphorylation of Mnk1,
suggesting that Mnk1 considered as one of the MAPKs (p38 or Erk1/2)
substrates (Fukunaga and Hunter 1997; Waskiewicz et al. 1997). Although, LPS
increased the phosphorylation of MAPKs (p38 or Erk1/2) and Mnk1, but this
effect was not sufficient to prevent the LPS-induced significant decrease in PS
at the 3 h time point. The most important step in the translation is the
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formation of cap-binding complex, and this step is depends upon the
formation of eIF-4F complex (eIF-4E/eIF-4G). Increased eIF-4E
phosphorylation enhanced its binding with eIF-4G, and this process is
enhanced by hyperphosphorylation of 4E-BP1. Herein, LPS
underphosphorylated 4E-BP1, this impair the formation of eIF-4F complex,
and at this point phosphorylation of eIF-4E cannot occur because the eIF-4E is
no longer a substrate for Mnk1 reviewed in (Pyronnet 2000). Our data showed
that inhibition of MAPKs (p38 or Erk1/2) activity by SB203580 or PD98059
alone respectively significantly decreased the rate of PS (Figs. 3-4 and 3-5),
suggesting that MAPKs directly involved in the regulation of PS preassembly
via Mnk1/eIF-4E cascade. The involvement of the MAPK in the regulation of
PS has been shown in several studies (Kimball et al., 1998; Kleijn and Proud
2000).
MAPK regulates PS in two possible ways. First, MAPK can phosphorylate
the eIF-4E via Mnk1 and eIF-4E phosphorylation regulates the translation
initiation (Waskiewicz et al., 1997). Secondly, MAPK may be involved in the
regulation of the formation of eIF-4F complex (Kleijn and Proud 2000).
Surprisingly, incubation of the cells with both SB203580 (p38 inhibitor) and
PD098059 (MEK/Erk inhibitor) alone significantly decreased the PS rate, but in
combination with LPS, no such decrease in the rate of PS has been observed
at the 3 h time point. The possible explanation, in normal conditions, the PS
maintained at the basal level (control), but when the cells incubated with
SB203580 and PD98059 alone, it significantly decreased PS rate. This effect
was probably mediated via decreased Mnk1 and eIF-4E basal phosphorylation
(Waskiewicz et al. 1997). Incubation of C2C12 myotubes with PD098059 alone
was associated with decreased eIF4G phosphorylation and consequently
eIF4E:eIF4G association formation and this effect was associated with
decreased PS (Williamson et al., 2005). Whereas, in case of combination with
LPS, LPS significantly increased MAPK phosphorylation and subsequently
Mnk1 phosphorylation. Although, this effect was not sufficient to inhibit LPS-
induced decreased PS rate, but this is somewhat modulates the effect of LPS
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on PS rate. There is no absolute correlation between the eIF-4E
phosphorylation and PS. In addition, there is no absolute correlation between
the activity of p38 and eIF-4E phosphorylation. Arsenite and anisomycin
exposure diminishes the translation rate, while eIF-4E phosphorylation is
increased (Wang et al., 1998). This eIF-4E increased phosphorylation can be
attributed to stress-induced p38 increased activity (Pyronnet 2000). In
contrast, other cellular stress including heat shock, are accompanied by a
decrease in eIF-4E despite of p38 increased activity (Duncan et al., 1987).
Nevertheless, it remains unclear and needs further investigation, whether
MAPK regulates PS by mechanism(s) other than the regulation of Mnk1 and
eIF-4E phosphorylation (Shen et al. 2005).
The cross talk between the PI3-K/Akt and MAPKs (p38 or Erk1/2)
pathways has been demonstrated in many tissues (Rommel et al. 1999;
Hausenloy et al. 2004; Drummond et al. 2009). Inhibition of mTOR by
rapamycin significantly decreased the Erk1/2 phosphorylation and the
activation of both mTORC1 and Erk1/2 signalling pathways is critical for
stimulation of protein synthesis in human skeletal muscle (Drummond et al.,
2009). In addition, the activation of the Erk1/2 activates and phosphorylates
rpS6 ser235/236 leading to enhanced translation initiation (Pende et al., 2004;
Roux et al., 2007). The western blotting presented in (Figs. 3-7A, B, C and D)
showed that, Incubation of C2C12 myotubes with LPS in combination with
LY0294002 significantly blocked Akt phosphorylation with no effect on the
total Akt (Figs. 3-7A and 3-7D). Similarly, incubation of C2C12 myotubes with
LPS plus PD98059 (MEK/Erk inhibitor) significantly blocked Erk1/2
phosphorylation with no such effect on the total Erk1/2. In contrast,
incubation of cells with LPS plus SB203580 (p38 inhibitor) could not
diminished LPS-induced p38 phosphorylation, with no such effect on Akt and
Erk1/2 basal phosphorylation. This finding suggesting that, SB203580 had no
effect on p38 phosphorylation but it mainly acted through the inhibition of
the p38 downstream activity Kumar et al. (1999). The data presented in this
chapter showed that, LPS alone significantly decreased the protein synthetic
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rate in C2C12 myotubes (measured as
3, ?ƉŚĞŶǇůĂůĂŶŝŶĞŝŶĐŽƌƉŽƌĂƚŝŽŶ ?ʅŐ ?A?
TCA precipitable protein) by 50%, and this effect was mediated most likely via
Akt/mTOR signalling cascade and the alteration of the translation initiation
efficiency. However, the direct involvement of MAPKs (p38 or Erk1/2) in the
regulation of global PS has been shown.
3.5 Conclusion
The data presented in this chapter are considered important because it
companies the effect of LPS on both the anabolic signalling and the direct
protein synthetic rate. These data showed that, LPS mediated the 50%
decrease in the global PS rate most likely via decreasing the translation
initiation efficiency. The effect of LPS on PS was similar either in vivo or in
vitro. The direct involvement of the MAPK in the regulation of PS and the
cross talk with PI3-K/Akt signalling pathway has been shown. Yet, further
investigation are required to elucidate the mechanism of MAPKs (p38 or
Erk1/2) regulating PS.
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4 LPS-induced the proteasomal activity in C2C12
myotubes via MAPK signalling pathway
4.1 Introduction
Skeletal muscle comprises 60-70% of the total lean body mass, and is
considered as the main pool for the amino acids as an energy substrate in
case of increased need in catabolic conditions including sepsis. The decrease
in the lean body mass in case of acute catabolic conditions such as sepsis,
cancer and AIDS (Hasselgren 1995; Tisdale 1997), is most likely due to a
reduction in the rate of muscle protein synthesis and/or an increased rate of
protein breakdown (Jepson et al., 1986; Hummel et al., 1988; Ash and Griffin
1989; Hasselgren et al., 1989; Lai et al., 2004), with the latter being the
predominant mechanism in most catabolic conditions. Sepsis is an
inflammatory condition which causes severe and rapid loss of body protein,
much of which originates from skeletal muscle (Rosenblatt et al. 1983; Jin and
Li 2007). Accelerated muscle protein degradation in the case of sepsis
provides the necessary amino acids to form the acute phase protein in liver
(Frost and Lang 2008).
The main catabolic system involved in the muscle protein turnover is
the ubiquitin-proteasome pathways (UPS) (Jagoe and Goldberg 2001).
Degradation by this mechanism involves marking of the target protein by four
ubiquitin molecules, followed by breakdown in the central core of the 26S
proteasome (Hershko and Ciechanover 1998). The physiologically active form
of the ubiquitin-proteasome system is the 26 S proteasome. 26S proteasome
is a large proteolytic complex that hydrolyses the protein conjugate, which
composed of the 19S cap structure attached to the 20S core (Hayter et al.,
2005). The 20S (700kDa) proteasome is the active proteolytic machinery in
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which the proteolysis takes place independently of the presence of ATP. The
20 S proteasome has five main catalytic activities including the chymotrypsin-
like activity (Fenteany and Schreiber 1996). The chymotrypsin-like enzyme
activity is considered as the major proteolytic activity of the 20S proteasome
(Gomes-Marcondes et al., 2002). Increased ubiquitin-proteasome activity has
been reported in many catabolic diseases including sepsis (Jin and Li 2007),
and the use of specific proteasome inhibitor (MG-132) has been used to
inhibit the muscle proteolysis in many muscle-wasting conditions (Tawa et al.,
1997), providing a further evidence of the importance of ubiquitin-
proteasome system in sepsis.
LPS-induced muscle wasting involves the input of many transcriptional
factors and signalling pathways including Akt and MAPKs (p38 or Erk1/2) and
NF-kB. The PI3-K/Akt pathway is considered as a key regulator of both muscle
protein synthesis and degradation signals (reviewed by Glass and Wu (Glass
2005; Wu et al., 2010). Anabolic stimuli such as insulin and IGF-I activate Akt,
which leads to suppression of atrogin-1 and MuRF1 expression via a Foxo-
dependent pathway. Conversely, catabolic signals such as glucocorticoids
deactivate Akt leading to up-regulation of atrogin-1 and MuRF1 expression
(Lai et al., 2004; Sandri et al., 2004). Atrogin-1 and MuRF1 are E3 ubiquitin
ligases secreted mainly by skeletal muscle, and their up-regulation has been
demonstrated in many atrophic models including sepsis (Bodine et al., 2001;
Jin and Li 2007). Inflammatory mediators stimulate the activity of atrogin-1
and muRF1 via many signalling cascades including Akt and MAPK streams.
Reduced Akt activity during starvation in the absence of growth factors and in
sepsis, leads to removal of Foxo inhibition and an increase in atrogin-1 and
MuRF1 mRNA expression (Sacheck et al., 2004; Stitt et al., 2004; Crossland et
al., 2008). Thus, the PI3-K/Akt pathway is generally considered a key regulator
of not only the muscle protein breakdown but also protein synthesis and
muscle fibre size (Rommel et al., 2001; Stitt et al., 2004; Glass 2005).
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The regulation of the atrogin-1 and MuRF1 is in a part regulated by
MAPK activity mainly p38 MAPK. The MAPK family is considered the most
important intracellular signalling system involved in the regulation of many
processes such as cell growth, differentiation and survival (Seger and Krebs
1995). p38 MAPK has been recognised as one of the MAPKs signalling factors
that is activated in response to environmental stress factors (Lang and Frost
2005), including ultraviolet light (Han et al., 1994; Yeow et al., 2002), osmotic
stress (Moriguchi et al., 1995; Shapiro and Dinarello 1995), heat shock and
inflammatory cytokines (Haneda et al., 1995; Raingeaud et al., 1995; Karem
et al., 1996; Kohn et al., 1996; Modur et al., 1996; Cuenda et al., 1997;
Hajduch et al., 1998; Igarashi et al., 1999; Hong et al., 2006). Increased p38
phosphorylation and NF-kB translocation is another possible mechanism
which has been implicated in LPS-induced muscle wasting in many catabolic
ĐŽŶĚŝƚŝŽŶƐ ?dE& ?ɲĂŶĚ/> ? ?ɴ ?ĂƌĞƚǁŽŬŶŽǁŶŵĞĚŝĂƚŽƌƐŽĨŵƵƐĐůĞĐĂƚĂďŽůŝƐŵ
mediating the muscle wasting via p38 and NF-kB (Jackman and Kandarian
2004). Increased p38 activity has been reported in a number of pro-catabolic
conditions including sepsis (Childs et al., 2003; Koistinen et al., 2003; Di
Giovanni et al., ? ? ? ? Z ?W ? ?ŵĞĚŝĂƚĞĚdE& ?ɲƵƉ ?ƌĞŐƵůĂƚŝŽŶŽĨĂƚƌŽŐŝŶ ? ?ŵZE
in C2C12 myotubes (Li et al., 2005), and in septic skeletal muscle of rat (Jin
and Li 2007) and SB203580 (p38 inhibitor) significantly diminished this effect.
Another MAPK, Erk1/2 has also been implicated in the cellular proliferation
and differentiation (Olson 1992; Pages et al., 1993), and it has been
recognised as a part of the early biochemical events that are initiated by LPS
treatment of macrophages or their infection by virulent and attenuated
Salmonella strains (Procyk et al.,  ? ? ? ? Z ? dE& ?ɲ ŝƐ Ă ǁĞůů ŬŶŽǁŶ ĐĂƚĂďŽůŝĐ
factor that has been shown to activate Erk (Tantini et al., 2002). Mnk1 is one
of the downstream targets of both p38 and Erk activation in vitro (Fukunaga
and Hunter 1997; Waskiewicz et al. 1997; Scheper and Proud 2002) and
several studies have demonstrated that one of the Mnk1 substrates is eIF-4E
(Gingras et al. 1999). Therefore, the activation of Erk1/2 increased the
protein synthesis in cultured C2C12 myotubes via the activation Mnk1
(Plaisance et al., 2008). Taken together, the activation of Erk1/2 has been
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implicated in many cellular processes including the regulation of protein
ƐǇŶƚŚĞƐŝƐ ? ŝŶ ƚŚĞ ĚĂƚĂ ƉƌĞƐĞŶƚĞĚ ŝŶ ĐŚĂƉƚĞƌ  ? ƐŚŽǁĞĚ ƚŚĂƚ ? >W^  ? ? ʅŐŵů-1)
alone transiently decreased the muscle protein synthetic rate in C2C12
myotubes by 50% at 3 h time point, and this effect mediated via Akt and
MAPKs (p38 or Erk1/2). In contrast, the direct contribution of MAPKs (p38 or
Erk1/2) in LPS-induced muscle proteolysis still unclear and needs further
investigation.
NF-kB is a member of the transcriptional protein family that regulates
the expression of many genes involved in a broad range of cellular processes
including, immune responses, cell growth and cell death (Baeuerle and
Baltimore 1996; Karin 1998). There is considerable evidence that NF-kB
stimulates the protein loss via the UPS (Li and Reid 2000; Li et al., 2003),
mainly through the action of MuRF1 (Cai et al., 2004). The NF-kB is located in
the cytoplasm bound to its inhibitory protein IK ?ɲ ? dE& ?ɲ ƐƚŝŵƵůĂƚĞĚ ƚŚĞ
nuclear translocation of the NF-kB in the differentiated myotubes via the
activation and later proteasomal degradation of the IK ?ɲ ?>ŝet al., 1998), and
LPS significantly increased the NF-kB activation and binding in skeletal muscle
(Penner et al. 2001; Jin and Li 2007).
The involvement of complex signalling cascades in LPS-induced muscle
protein breakdown makes the overall elucidation of these mechanism
difficult. Therefore, the better understanding of these mediators and their
contributions in muscle protein breakdown is important for developing
successful therapies to retard the loss in lean body mass and lessen morbidity
and mortality (Lai et al., 2004). Moreover, there is a scarcity of data regarding
the effect of these signalling modulations on the LPS-induced proteasomal
activity (measured as chymotrypsin-like enzyme activity) in vitro. Therefore,
we addressed the hypothesis that, LPS-increased the proteasomal
degradation of muscle protein via Akt and MAPKs (p38 or Erk1/2).
Furthermore, we anticipated that inhibition of these pathways will affect the
proteasomal activity. In this study, LPS-treated C2C12 myotubes for a period
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ranged from 5 min to 18 h were used. This model has been used to evaluate
the effect of endotoxin on muscle protein degradation, and the possible
contribution of various signalling cascades mainly Akt and MAPKs (p38 or
Erk1/2).
4.2 Hypothesis
The data presented in chapter 3 have shown that, LPS transiently
decreased PS in C2C12 myotubes and this effect was mediated via the two
main signalling cascades PI3-K/Akt and the MAPKs (p38 or Erk1/2). In addition,
the data collected from previous studies have shown that, LPS significantly
decreased Akt activity and this was associated with increased Foxo activity,
the major transcription family factors involved in the activation of the muscle
proteolysis. Furthermore, increased p38 activity in vivo has been shown to
mediate the muscle proteolysis via activation of atrogin-1. Therefore, the aim
in this chapter is to elucidate the direct effect of LPS on muscle proteolysis
(measured as chymotrypsin-like enzyme activity), and the role of PI3-K/Akt
and MAPKs (p38 or Erk1/2) was verified by specific pathway inhibitors. LPS (1
ȝJPO-1) stimulated C2C12 myotubes have been used to test our hypothesis.
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4.3 Results
4.3.1 LPS significantly increased the chymotrypsin-like enzyme
activity
LPS  ? ? ʅŐŵů-1) significantly increased the chymotrypsin-like enzyme
activity (P < 0.01) compared with the control untreated cells at 5, 30 min, 1, 3
and 18 h, with a peak at 30 min and 1 h time points (Fig. 4-1A. Table. 4-1).
While, incubation of cells with LPS plus proteasomal inhibitor (MG-132, 40
ʅD ZƐŝŐŶŝĨŝĐĂŶƚůǇŝŶŚŝďŝƚĞĚƚŚĞĐŚǇŵŽƚƌǇƉƐŝŶ ?ůŝŬĞĞŶǌǇŵĞĂĐƚŝǀŝƚǇďǇ ? ?A? ?P <
0.001) compared with the control cells at all the time points (Fig. 4-1B. Table.
4-1). Incubation of the cells with LPS in combination with Toll-like receptor 4
ŝŶŚŝďŝƚŽƌ  ?WŽůǇŵǇǆŝŶ  ?  ? ʅŐŵů-1) completely prevented the LPS-induced
chymotrypsin-like enzyme activity at all time points except at 30 min (Fig. 4-1.
Table. 4-1).
4.3.2 PI3-K inhibitor (LY0294002) delayed the LPS-induced
proteasomal activity
Incubation of the C2C12 myotubes with LPS  ? ?ʅŐŵů-1) and LY0294002
 ?>z ?  ? ? ʅD Z ƉƌĞǀĞŶƚĞĚ ƚŚĞ ŝŶĐƌĞĂƐĞĚ ĐŚǇŵŽƚƌǇƉƐŝŶ ?ůŝŬĞ ĞŶǌǇŵĞ ĂĐƚŝǀŝƚǇ
observed in response to LPS alone at 5 and 30 min time points. At later time
points (1, 3, and 18 h) LPS still induced a significant increase in the
proteasomal activity compared with control cells despite the presence of
LY0294002 (Fig. 4-1D. Table. 4-1).
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Figure (4-1) Time-dependent changes in chymotrypsin-like enzyme activity
(proteasomal activity). C2C12 myotubes were incubated either with A Z>W^ ? ?ʅŐŵů-1)
alone; B Z>W^ ? ?ʅŐŵů-1 ZĂŶĚD' ? ? ? ? ? ? ?ʅD Z ?C Z>W^ ? ?ʅŐŵů-1) and Polymyxin B (LPS
ŶĞƵƚƌĂůŝƐŝŶŐ ĂŐĞŶƚ Z  ?WD ?  ? ʅŐŵů-1); D Z >W^  ? ? ʅŐŵů-1) and LY0294002 (PI3K/Akt
ŝŶŚŝďŝƚŽƌ Z ?>Ǉ ? ? ?ʅD ZĨŽƌ ? ? ? ?ŵŝŶ ? ? ? ? ?Žƌ ? ?Ś ?sĂůƵĞƐĂƌĞƌĞƉƌĞƐĞŶƚĞĚĂƐŵĞĂŶƐr
SEM (percentage of control). Bars carry asterisks are statistically different from the
control cells (
**
P < 0.01 and
***
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4.3.3 Inhibition of the MAPKs (p38 or Erk1/2) significantly decreased
the LPS-induced proteasomal activity
Incubation of the C2C12 myotubes either with LPS  ? ?ʅŐŵů-1) and p38
ŝŶŚŝďŝƚŽƌ  ?^ ? ? ? ? ? ? ?  ? ? ʅD Z ? Žƌ ǁŝƚŚ >W^ ĂŶĚ D< ?ƌŬ ŝŶŚŝďŝƚŽƌ  ?W ? ? ? ? ? ? ?
 ? ? ʅD Z ƐŝŐŶŝĨŝĐĂŶƚůǇ ĚĞĐƌĞĂƐĞĚ ƚŚĞ ĐŚǇŵŽƚƌǇƉƐŝŶ ?ůŝŬĞ ĞŶǌǇŵĞ ĂĐƚŝǀŝƚǇ  ?P <
0.001) compared with the control cells at all time points (Figs. 4-2A, 4-2B.
Table. 4-1). In contrast, incubation of C2C12 myotubes either with SB203580
 ?^ ?  ? ?  ? ĂŶĚ  ? ? ʅD Z ĂŶĚ W ? ? ? ? ? ?  ?W ?  ? ? ?  ? ? ĂŶĚ  ? ? ʅD Z ĂůŽŶĞ ŚĂĚĞ ŶŽ
effect on the chymotrypsin-like enzyme activity (Fig. 4-3).
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Figure (4-2) Time-dependent changes in the chymotrypsin-like enzyme activity
(proteasomal activity). C2C12 myotubes were incubated either with A Z>W^ ? ?ʅŐŵů-1)
ĂŶĚ^ ? ? ? ? ? ?  ?W ? ? ŝŶŚŝďŝƚŽƌ Z  ?^ ? ? ?ʅD Z ?ŽƌB Z>W^ ? ?ʅŐŵů-1) and PD098059 (MEK
 ?ƌŬ ? ? ?ŝŶŚŝďŝƚŽƌ Z ?W ? ? ?ʅD ZĨŽƌ ? ? ? ?ŵŝŶ ? ? ? ? ?Žƌ ? Ś ?sĂůƵĞƐĂƌĞƌĞƉƌĞƐĞŶƚĞĚĂƐ
means r SEM (percentage of control). Bars carry asterisks are statistically different
from the control cells (
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P < 0.001). n = 6
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Figure (4-3) The dose-dependent changes in the chymotrypsin activity
(proteasomal activity). C2C12 myotubes were incubated either with SB203580
 ?Ɖ ? ?ŝŶŚŝďŝƚŽƌ Z ?^ ? ? ? ?ĂŶĚ ? ?ʅD ZŽƌW ? ? ? ? ? ? ?D< ƌŬ  ? ?ŝŶŚŝďŝƚŽƌ Z ?W ?
 ? ? ?  ? ? ĂŶĚ  ? ? ʅD Z ĂůŽŶĞ ĨŽƌ  ? Ś ? sĂůƵĞƐ ĂƌĞ ƌĞƉƌĞƐĞŶƚĞĚ ĂƐ ŵĞĂŶƐr SEM
(percentage of the control). n = 6
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4.3.4 >W^ ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ ƚŚĞ ŵĞĚŝĂ ĐŽŶĐĞŶƚƌĂƚŝŽŶ ŽĨ dE& ?ɲ
and IL-6
Incubation of the C2C12 myotubes with LPS  ? ? ʅŐŵů-1) significantly
ŝŶĐƌĞĂƐĞĚƚŚĞ ůĞǀĞůŽĨdE& ?ɲďǇ  ? ?A?  ?P < 0.05), 212% (P < 0.05), 287% (P <
0.01), 184% (P < 0.01) and 103% (P < 0.05) at 5 min, 30 min, 1 h, 3 h and 18 h
time points respectively compared with the control cells (Fig. 4-4A). In
contrast, LPS  ? ?ʅŐŵů-1) transiently increased the media concentration level of
IL-6 only at the 18 h time point by 169% (P < 0.001) compared with the control
cells, and this effect is significant compared with the LPS-treated cells (Fig. 4-
4B).
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Figure (4-4) The changes in concentration levels of A ZdE& ?ɲĂŶĚB) IL-6 cytokines
ůĞǀĞůƐ ? ? ? ?ǁĞƌĞŝŶĐƵďĂƚĞĚǁŝƚŚ>W^ ? ?ʅŐŵů-1) for (5, 30 min, 1, 3 and 18 h). The
ĐŽŶĚŝƚŝŽŶĞĚŵĞĚŝĂǁĞƌĞƚŚĞŶĐŽůůĞĐƚĞĚĂŶĚƚŚĞĐŽŶĐĞŶƚƌĂƚŝŽŶůĞǀĞůƐŽĨdE& ?ɲĂŶĚ/> ?
6 was assessed by ELISA. Values are represented as means r SEM. Bars carry asterisks
are statistically different from the control and LPS-treated cells as shown in the graph
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4.3.5 LPS increased the media concentration of the creatine kinase
(CK)
The creatine kinase activity was measured in the conditioned media of
control (untreated) and LPS-treated cells. LPS  ? ?ʅŐŵů-1) significantly increased
the creatine kinase activity at 5, 30 min and 1 h (P < 0.01) compared with
control cells with a peak at 5 min time point with no significant effect was
observed at the 3 or 18 h time points (Fig. 4-5).
Figure (4-5) LPS-induced changes in creatine kinase activity (CK). C2C12 myotubes
ǁĞƌĞŝŶĐƵďĂƚĞĚǁŝƚŚ>W^ ? ?ʅŐŵů-1) for (5, 30 min, 1, 3, or 18 h), and the conditioned
media were then collected and M-CK activity was measured according to the material
and methods. Values are represented as means r SEM (percentage of the control).
Bars carry asterisks are statistically different from the control cells (
**
P < 0.01). n = 5.
KŶĞƵŶŝƚŽĨ<ǁŝůůƚƌĂŶƐĨĞƌ ?ʅŵŽůĞŽĨƉŚŽƐƉŚĂƚĞĨƌŽŵƉŚŽƐƉŚŽĐƌĞĂƚŝŶĞƚŽWƉĞƌ
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4.3.6 LPS significantly increased the Ik ?ɲƉŚŽƐƉŚŽƌǇůĂƚŝŽŶ
Western blotting data showed that, LPS particularly (100 ngml
-1
and 1
ʅŐŵů-1) significantly increased the phosphorylation of Ik ?ɲ Ăƚ Ăůů ƚŚĞ ƚŝŵĞ
points (P < 0.05) compared to the control cells. This effect was accompanied
by decreased level of total Ik ?ɲ ?>W^ƐŝŐŶŝĨŝĐĂŶƚůǇĚĞĐƌĞĂƐĞĚ/k ?ɲĂƚĂůůƚŝŵĞ
points particularly at the 3 and 18 h time points (P < 0.05) compared to the
control cells (Figs. 4-6A and 4-6B).
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Figure (4-6) Time and dose-dependent changes in A) phospho-Ik ?ɲĂŶĚB) total IkB-
ɲ ? ? ? ?ŵǇŽƚƵďĞƐǁĞƌĞŝŶĐƵďĂƚĞĚǁŝƚŚ>W^ ? ? ?ŶŐŵů-1, 100 ngml-1ĂŶĚ ?ʅŐŵů-1) for
(5, 30 min, 1, 3, or 18 h). Values are represented as means r SEM (percentage of the
control) normalised to ȕ-actin as an internal loading control. Bars carry asterisks are
statistically different from the control cells (
*
P < 0.05 and
**
P < 0.01) n = 3
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4.3.7 LPS significantly increased the nuclear translocation of NF-kB
Although LPS increased the nuclear translocation of NF-kB (visual
inspection) however this effect is still insignificant compared with control
cells. The maximal effect of LPS was seen at 18 h time point (Fig. 4-7).
Figure (4-4-7) Time and dose-dependent changes in the NF-kB (nuclear portion).
C2C12 myotubes were incubated with LPS (10 ngml
-1
, 100 ngml
-1
and  ?ʅŐŵů-1) for (5,
30 min, 1, 3 and 18 h). Values are represented as median r IQR. n = 4.
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Table (4:1) Time changes in the chymotrypsin-like enzyme activity (proteasomal
ĂĐƚŝǀŝƚǇ Z ? ? ? ?ŵǇŽƚƵďĞƐǁĞƌĞŝŶĐƵďĂƚĞĚĞŝƚŚĞƌǁŝƚŚ Z>W^ ? ?ʅŐŵů-1) alone; B) LPS
 ? ? ʅŐŵů-1 Z ĂŶĚ D' ? ? ? ?  ?ƉƌŽƚĞĂƐŽŵĂů ŝŶŚŝďŝƚŽƌ Z  ? ? ? ʅD Z ?  Z >W^  ? ? ʅŐŵů-1) and
WŽůǇŵǇǆŝŶ   ?>W^ ŶĞƵƚƌĂůŝƐŝŶŐ ĂŐĞŶƚ Z  ?WD ?  ? ʅŐŵů-1 Z ?  Z >W^  ? ? ʅŐŵů-1) and
>z ? ? ? ? ? ? ?  ?W/ ?< ?Ŭƚ ŝŶŚŝďŝƚŽƌ Z  ?>z ?  ? ? ʅD Z ? >W^  ? ?ʅŐŵů-1) and SB203580 (p38
ŝŶŚŝďŝƚŽƌ Z  ?^ ?  ? ?ʅD Z ?Žƌ>W^  ? ?ʅŐŵů-1) with PD098059 (MEK/Erk inhibitor) (PD, 40
ʅD Z ĨŽƌ  ? ? ?  ? ? ŵŝŶ ?  ? ?  ? ĂŶĚ  ? ? Ś Z ? sĂůƵĞƐ ĂƌĞ ƌĞƉƌĞƐĞŶƚĞĚ ĂƐ ŵĞĂŶƐ r SEM
(percentage of the control). Asterisks represent the statistical difference compared
with control cells (
**
P < 0.01 and
***
P < 0.001). n = 6
Treatment Time points
C 5 min 30 min 1hr 3 hrs 18 hrs
LPS alone 100 187 r
7.23**
284 r
15.26**
271 r
15.87**
179 r
9.24**
187 r
17.88**
LPS and MG-
132
100 16r
3.32***
17r
3.37***
18 r
3.68***
16 r
3.34***
16 r
3.37***
LPS and PMB 100 94 r
2.10
120 r
3.82**
93 r
1.79
93 r
1.91
104 r
2.94
LPS and SB 100 76 r
1.04***
74 r
1.44***
66 r
0.18
***
61 r
1.30***
71 r
0.35***
LPS and PD 100 68 r
0.59***
56 r
0.93***
66 r
0.87***
52 r
1.74***
77 r
0.79***
LPS and LY 100 122 r
0.86
137 r
2.87
238 r
22.87**
179r
9.03**
226 r
21.86***
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4.4 Discussion
The data presented in this chapter demonstrated that, 1) LPS is a strong
catabolic stimulus which significantly increased the proteasomal activity
measured as chymotrypsin-like enzyme activity at all time points between 5
min and 18 h; 2) LPS-induced chymotrypsin activity is totally inhibited by MG-
132 (proteasomal inhibitor) at all time points and also by Polymyxin B (LPS
neutralising agent) with the exception of the 30 minute time point; 3) Akt
inhibition delayed the LPS-induced increased chymotrypsin activity and these
increase was not elevated until after 1 h; 4) Inhibition of MAPKs (p38 and
Erk1/2) in combination with LPS significantly decreased the chymotrypsin-like
enzyme activity to below control level; 5) LPS significantly increased the media
ĐŽŶĐĞŶƚƌĂƚŝŽŶůĞǀĞůƐŽĨdE& ?ɲĐǇƚŽŬŝŶĞĂƚĂůůƚŚĞƚŝŵĞƉŽŝŶƚƐĞǆĂŵŝŶĞĚ ?ĂŶĚ/> ?
6 only at the 18 h time point; 6) LPS transiently increased the creatine kinase
activity for only 1 h after LPS administration; and 7) LPS significantly increased
the phosphorylation and subsequent proteasomal degradation of the IK ?ɲ ?
followed by the nuclear translocation of the NF-kB.
Sepsis is an acute inflammatory condition characterised by excessive
ƉƌŽĚƵĐƚŝŽŶ ŽĨ ƉƌŽ ?ŝŶĨůĂŵŵĂƚŽƌǇ ĐǇƚŽŬŝŶĞƐ ƐƵĐŚ ĂƐ dE& ?ɲ  ?sĂƌǇ ĂŶĚ <ŝŵďĂůů
2000). The data presented in this chapter showed that, LPS significantly
increased the proteasomal functional activity measured as increased
chymotrypsin-like enzyme activity. MG-132 a specific proteasome inhibitor
(Frost et al., 2003) dramatically decreased the LPS-induced chymotrypsin-like
enzyme activity by 80% compared with control cells (Fig. 4-1B). This suggests
that LPSinduced muscle protein breakdown was mediated via the activation
of ubiquitin-proteasome pathway. These results are consistent with the
findings of Russell et al. (2010). The proteasome is a multicatalytic high
molecular weight protease complex responsible for ubiquitin dependent
protein breakdown within cells (Peters 1994; Coux et al., 1996; Hilt and Wolf
1996). LPS has been shown to bind to the proteasome subunits, and activation
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of these subunits has been involved in degradation of incorrectly folded
protein or those specially tagged for degradation (Hirsch and Ploegh 2000;
Reis et al., 2008). LPS significantly increased TLR4 mRNA expression in a time-
dependent manner and Polymyxin B (LPS neutralising agent) (Frost et al.,
2006) significantly abolished this effect (chapter 5, Figs. 5-4A and 5-4B).
Herein, incubation of C2C12 with LPS in combination with Polymyxin B
neutralises the LPS effect on the proteasomal activity, suggesting that LPS
mediated muscle proteolysis is mainly via TLR4 (Frost et al., 2006).
The process of muscle proteolysis is a multifactorial process involving
the interaction of many signalling cascades. At the present time, the overall
potential contribution of these signalling is still unclear, and further
investigation are still required to verify this role.
Akt/protein kinase B is considered as a central regulator of not only
muscle protein synthesis but also muscle turnover (Glass 2005). In skeletal
muscle, activation of the Akt significantly increased the muscle protein
synthetic rate and hence the muscle fibre size (Lai et al., 2004). In contrast,
decreased Akt activity significantly increased muscle protein degradation via
the ubiquitin ligases activation in a Foxo-dependent manner (Van Der Heide et
al., 2004). The data presented in this chapter showed that, incubation of
C2C12 myotubes with LPS in combination with LY0294002 (PI3-K/Akt
inhibitor) (Walker et al., 2000) significantly increased the chymotrypsin-like
enzyme activity. In Chapter 3, incubation of C2C12 myotubes with LY0294002
alone or with LPS significantly decreased the protein synthesis rate by 80%
(chapter 3, Figs. 3-4 and 3-5). Taken together, Akt inhibition can modulate
many fundamental processes in particular protein metabolism (PS and PD)
and cell growth.
The MAPK family is considered as an important intracellular signalling
system involved in the regulation of many cellular processes including cell
growth, differentiation and survival (Seger and Krebs 1995). Increased p38
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activity has been reported in many pro-catabolic conditions and sepsis is one
(Jackman and Kandarian 2004). Sepsis-induced ubiquitin-proteasomal activity
in skeletal muscle is regulated in the main via p38 increased activity (Li et al.,
 ? ? ? ? Z ? /ŶĐŽŶƚƌĂƐƚ ?Ɖ ? ?ďůŽĐŬĂĚĞďǇ^ ? ? ? ? ? ?ƐŝŐŶŝĨŝĐĂŶƚůǇĚĞĐƌĞĂƐĞĚdE& ?ɲ ?
induced atrogin-1 mRNA up regulation (Jin and Li 2007). Herein, incubation of
myotubes with LPS in combination with SB203580 (p38 specific inhibitor) (Li et
al., 2005) significantly decreased the chymotrypsin-like enzyme activity
suggesting that, p38 increased activity is a part of LPS-induced muscle protein
turnover (Jackman and Kandarian 2004).
Another MAPK member is Erk1/2. Increased Erk1 (p44) and Erk2 (p42)
phosphorylation has been involved in the cellular proliferation and
differentiation processes (Olson 1992; Pages et al., 1993), and it has been
recognised as a part of the early biochemical events that are initiated by LPS
treatment of macrophages or their infection by virulent and attenuated
Salmonella strains (Procyk et al., 1999). Furthermore, Erk1/2 increased activity
has been reported in LPS-induced lung injury (Carter et al., 1999). Erk1/2
ĂĐƚŝǀĂƚŝŽŶ ŝŶ ƐŬĞůĞƚĂů ŵƵƐĐůĞ ŵĞĚŝĂƚĞĚ dE& ?ɲ ŝŶĚƵĐĞĚ ƐƚŝŵƵůĂƚŝŽŶ ŽĨ ƐƚƌĞƐƐ ?
related protein (nuclear factor-kB) (Traenckner et al., 1995). In contrast,
Erk1/2 phosphorylation has been involved in the regulation of the protein
synthesis in a mechanism most likely via Mnk1/eIF-4E mechanism
(Waskiewicz et al. 1997; Williamson et al. 2005). In chapter 3 (Figs. 3-2A and
3-2B), LPS significantly increased Erk1/2 phosphorylation and incubation of
C2C12 cells with PD098059 (MEK/Erk inhibitor) (Shi et al., 2002; Plaisance et
al., 2008) significantly decreased muscle protein synthesis rate. In this
ĐŚĂƉƚĞƌ ? ŝŶĐƵďĂƚŝŽŶ ŽĨ  ? ? ? ŵǇŽƚƵďĞƐ ǁŝƚŚ >W^ ĂŶĚW ? ? ? ? ? ?  ? ? ? ʅD Z
significantly decreased LPS-induced proteasomal activity, suggesting that
Erk1/2 activation is crucial to LPS-induced muscle protein breakdown.
Interestingly, incubation of the cells with SB203580 (p38 inhibitor) and
PD098059 (MEK/Erk inhibitor) had no effect on the proteasomal activity
compared to the control level. However, incubation of the cells with these
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inhibitors along with LPS significantly decreased the proteasomal activity
below the control basal levels. Of note, incubation of cells with these
inhibitors alone significantly decreased PS rate compared with control cells
(Figs. 3-4 and 3-5); however, this effect was minor compared with that of Akt
inhibition. Similarly, PD098059 (MEK/Erk inhibitor) blocked protein synthesis
ŝŶ dE& ?ɲ ƐƚŝŵƵůĂƚĞĚ  ? ? ? ŵǇŽƚƵďĞƐ ? ŚŽǁĞǀĞƌ ? ƚŚŝƐ ĞĨĨĞĐƚ ĐŽŵƉĂƌĞĚ ǁŝƚŚ
LY0294002 (PI3-K/Akt inhibitor) considered minor (Plaisance et al., 2008).
Under normal condition their basal proteasomal activity was maintained by
the basal p38 and Erk1/2 activity, and inhibition of these MAPKs despite the
presence of LPS will decrease the proteasomal activity.
/ŶĐƌĞĂƐĞĚ ůĞǀĞůƐ ŽĨ dE& ?ɲ ĂŶĚ /> ? ? ŚĂǀĞ ďĞĞŶ ĚĞŵŽŶƐƚƌĂƚĞĚ ŝŶ ƌĂƚ
skeletal muscle in response to sepsis (Frost et al. 2002; 2003; Crossland et al.
2008; Borge et al. 2009). LPS significantly increased the synthesis and
production of cytokines in many tissues including skeletal muscle (Frost et al.,
 ? ? ? ? Z ? dE& ?ɲ ŚĂƐ ƉƌĞǀŝŽƵƐůǇ ďĞĞŶ ƌĞƉŽƌƚĞĚ ƚŽ ŝŶĐƌĞĂƐĞ ƚŚĞ /> ? ? ŵZE
expression level in C2C12 myoblasts after 8 h (Frost et al., 2002). In our study,
Ă ƐŝŐŶŝĨŝĐĂŶƚ ƌĞůĞĂƐĞ ŽĨ ƚŚĞ dE& ?ɲ ǁĂƐ ŽďƐĞƌǀĞĚ ĂĨƚĞƌ  ? ŵŝŶ ŽĨ >W^
administration, which was followed by a significant release of IL-6 at 18 h. LPS
has been shown to increase the IL-6 release in skeletal myocytes either
ĚŝƌĞĐƚůǇŽƌŝŶĚŝƌĞĐƚůǇǀŝĂdE& ?ɲĂƵƚŽĐƌŝŶĞŵĂŶŶĞƌ ?&ƌŽƐƚet al., 2006), with the
ůĂƚƚĞƌďĞŝŶŐƉƌŽďĂďůǇƚŚĞŵĂŝŶŵĞĐŚĂŶŝƐŵŝŶŽƵƌŵŽĚĞůŽĨƐĞƉƐŝƐ ?dE& ?ɲŚĂƐ
been considered for a long period as a catabolic factor, significantly increased
in many animal and human catabolic conditions. However, it has been
ƌĞĐĞŶƚůǇƐŚŽǁŶƚŚĂƚ ?dE& ?ɲƐŝŐŶŝĨŝĐĂŶƚůǇŝŶĐƌĞĂƐĞĚƉƌŽƚĞŝŶƐǇŶƚŚĞƐŝƐŝŶ ? ? ?
cells (Plaisance et al., 2008). Of note, LPS induced a significant increase in TNF-
ɲ ůĞǀĞůƐ ŝŶ ƚŚĞ ĐŽŶĚŝƚŝŽŶĞĚ ŵĞĚŝĂ Ăƚ Ăůů ƚŝŵĞ ƉŽŝŶƚƐ ? ĂŶĚ ƚŚŝƐ ĞĨĨĞĐƚ ǁĂƐ
correlated with increased proteasomal activity. Together, this suggests that
dE& ?ɲ ƉůĂǇƐ Ă ƐŝŐŶŝĨŝĐĂŶƚ ƌŽůĞ ŝŶ >W^ ?ŝŶĚƵĐĞĚ ŵƵƐĐůĞ ƉƌŽƚĞŽůǇƐŝƐ ŝŶ  ? ? ?
ŵǇŽƚƵďĞƐ ? /ŶĐƌĞĂƐĞĚ dE& ?ɲ ĐŽŶĐĞŶƚƌĂƚŝŽŶ ǁĂƐ ĂƐƐŽĐŝĂƚĞĚ ǁŝƚŚ ŝŶĐƌĞĂƐĞĚ 3
ubiquitin ligases activity in particular atrogin-1 (Li et al., 2005). In addition,
ŝŶĐƌĞĂƐĞĚ ĐŝƌĐƵůĂƚŝŶŐ ĐŽŶĐĞŶƚƌĂƚŝŽŶƐ ůĞǀĞůƐ ŽĨ dE& ?ɲ ǁĂƐ ĂƐƐŽĐŝĂƚĞĚ ǁŝƚŚ
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decreased eIF-4G phosphorylation (Lang and Frost 2007) and this inhibits the
formation of eIF-4F complex which in turn alters the translation initiation.
Although, the effect of MAPKs (p38 or Erk1/2) inhibition on the circulating
ĐŽŶĐĞŶƚƌĂƚŝŽŶƐŽĨdE& ?ɲŝƐŶŽƚĂĚĚƌĞƐƐĞĚŚĞƌĞŝŶ ?ŚŽǁĞǀĞƌ ?ŝŶŚŝďŝƚŝŽŶŽĨƚŚĞƐĞƐ
MAPKs significantly decreased the LPS-induced muscle proteolytic activity. In
addition, pre incubation of C2C12 cells with PD098059 (MEK/Erk inhibitor)
ĂƚƚĞŶƵĂƚĞĚ ƚŚĞ ĞĨĨĞĐƚ ŽĨ dE& ?ɲ ŽŶ ŝŶƐƵůŝŶ ?ƐƚŝŵƵůĂƚĞĚ ƉƌŽƚĞŝŶ ƐǇŶƚŚĞƐŝƐ
(Williamson et al., 2005). Taken together, this makes the inhibition of MAPKs
(p38 or Erk1/2) as a possible target for drug discovery to minimise the sepsis-
induced muscle wasting.
With regard to the role of IL-6 in various muscle-wasting conditions
with some studies have shown a significant role (Strassmann et al., 1992;
Haddad et al., 2005) where others have not (Garcia-Martinez et al., 1994;
Williams et al.,  ? ? ? ? Z ? /> ? ? ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ ƚŚĞ ĞǆƉƌĞƐƐŝŽŶ ŽĨ ɲ ?//
ubiquitin protein, the predominant protein expressed in the skeletal muscle in
cancer cachexia. Therefore, IL-6 may have presumably enhanced the rate of
skeletal muscle protein breakdown mediated via activation of ubiquitin-
proteasome pathway (Acharyya et al., 2004; Kwak et al., 2004). The direct
infusion of IL-6 into skeletal muscle in vivo has been associated with increased
muscle protein turnover rate and a 17% decrease in the myofibrillar protein
(Haddad et al., 2005). Moreover, rat administrated IL-6 for 1 week showed
skeletal muscle atrophy (Janssen et al., 2005). In contrast, IL-6 has many
beneficial effects such as increasing fatty acids oxidation in rat skeletal muscle
(Bruce and Dyck 2004) and in L6 myotubes (Petersen et al., 2005). In addition,
it stimulates lipolysis and fatty acids oxidation in humans (van Hall et al.,
 ? ? ? ? Z ? /Ŷ ƚŚĞ ƉƌĞƐĞŶƚ ƐƚƵĚǇ ? dE& ?ɲ ĐŽŶĐĞŶƚƌĂƚŝŽŶ ůĞǀĞůƐ ĂƌĞ ƐŝŐŶŝĨŝĐĂŶƚůǇ
increased in the media as early as 5 min after LPS administration and
continued for 18 h, while IL-6 media concentration was observed at 18 h time
point. However the proteasomal activity was markedly raised after 5 min of
LPS administration. These data suggest that, in the present model of sepsis
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ƚŚĞ ƌĞůĞĂƐĞ ŽĨ dE& ?ɲ ƉůĂǇƐ Ă ƐŝŐŶŝĨŝĐĂŶƚ ƌŽůĞ ŝŶ >W^ ?ŝŶĚƵĐĞĚ ŝŶĐƌĞĂƐĞĚ
proteasomal activity, and the potential role of IL-6 in this process is minimal.
The creatine kinase (CK) is considered as an essential enzyme for
energy metabolism that reversibly produces phosphocreatine and ATP
(Bessman and Carpenter 1985; Wallimann et al. 1992; Koyama et al. 2008).
Although, the mechanism of CK release from the muscle is still relatively
unclear, however, CK release has been used as an index of muscle breakdown
in the in vitro and in vivo studies (Maglara et al., 2003). The relationship
between the availability of muscle ATP and increased efflux of CK has been
established by Jackson et al (1984). Under abnormal conditions like
malnutrition skeletal muscle decreases its energy consumption mainly by
degradation of CK via the MuRF1 mediated mechanism (Koyama et al., 2008).
Herein, LPS significantly increased the release of CK at 5, 30 min and 1 h with
a peak at 5 min time point (> 20 fold). Increased CK concentration suggesting
that, LPS significantly increased the muscle energy consumption via enhancing
the formation of the phosphocreatine and ATP (Bessman and Carpenter
1985). Therefore, LPS-induced increased CK level in the muscle tissue could
contributes to the high availability of the energy supply (Seraydarian and
Abbott 1976) and the impairment of the contractile functions of the muscle
(Wegmann et al., 1992).
NF-kB is a member of a transcriptional protein family which has been
involved in the regulation of many cellular processes including immune
responses, cell growth and cell death (Baeuerle and Baltimore 1996; Karin
1998). In addition, NF-kB stimulates the protein loss via stimulation of the
ubiquitin proteasome pathway (Li and Reid 2000; Li et al., 2003), mainly
MuRF1 mRNA expression (Cai et al.  ? ? ? ? Z ? dE& ?ɲ ƐƚŝŵƵůĂƚĞƐ ƚŚĞ ŶƵĐůĞĂƌ
translocation of the NF-kB in the differentiated myotubes via the activation
and later proteasomal degradation of the Ik ?ɲ  ?>ŝet al., 1998). LPS
significantly increased the NF-kB activation and binding in skeletal muscle
(Penner et al., 2001; Jin and Li 2007). Our findings showed that, LPS
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significantly increased the phosphorylation and later proteasomal degradation
of Ik ?ɲ ? ǁŚŝĐŚ ŝŶ ƚƵƌŶ ĨŽůůŽǁĞĚ ďǇ ƚŚĞ ŶƵĐůĞĂƌ ƚƌĂŶƐůŽĐĂƚŝŽŶ ŽĨ E& ?Ŭ ?
Collectively, LPS-induced muscle protein breakdown (measured as
chymotrypsin-like enzyme activity) mostly via two probable mechanisms.
Firstly, phosphorylation and proteasomal degradation of Ik ?ɲ ĨŽůůŽǁĞĚ ďǇ
nuclear translocation of NF-kB. Second, via decreased Akt phosphorylation
and increased phosphorylation MAPKs (p38 or Erk1/2), and later stimulation
of ubiquitin ligases mainly atrogin-1 and MuRF1.
4.5 Conclusion
LPS is a strong catabolic stimulus significantly increased the release of
many pro-inflammatory and inflammatory cytokines in skeletal muscle tissue.
LPS-induced proteasomal cleavage of muscle protein via the MAPKs (p38 or
ƌŬ ? ? ? Z ƐŝŐŶĂůůŝŶŐ ĐĂƐĐĂĚĞ ? &ƵƌƚŚĞƌŵŽƌĞ ? ƚŚĞ >W^ ?ŝŶĚƵĐĞĚ ƌĞůĞĂƐĞ ŽĨ dE& ?ɲ
plays a crucial role in LPS-induced proteasomal activity. Finally, IL-6 release
had no role in this process.
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5 The transcriptional regulation of muscle protein
breakdown in LPS-stimulated C2C12 myotubes
5.1 Introduction
Skeletal muscle is the main store of amino acids and energy substrate in
the time of need such as sepsis. Skeletal muscle comprises 60-70% of the total
lean body mass (Frost and Lang 2008). The decrease in the muscle protein in
the case of acute catabolic conditions such as sepsis, cancer, AIDS (Hasselgren
1995; Tisdale 1997), is mostly the result of the reduction in the muscle protein
synthetic rate and/or the increase in the muscle protein breakdown rate
(Jepson et al., 1986; Hummel et al., 1988; Ash and Griffin 1989; Hasselgren et
al., 1989; Lai et al., 2004). Sepsis is an acute inflammatory condition
characterised by severe and rapid loss of body protein, much of which
originates from the skeletal muscle (Rosenblatt et al., 1983), and this effect
was aimed to provide the liver with the necessary amino acids to form the
acute phase protein (Frost and Lang 2008).
Skeletal muscle can respond directly to wide array of stimuli during the
course of infection, these stimuli known as the PAMPS. These molecules can
be recognised by the host defence system mainly TLRs (Netea et al., 2004).
TLRs are transmembrane signalling proteins that are important in recognising
PAMPS (Underhill and Ozinsky 2002; Kopp and Medzhitov 2003), and are
considered as the first line of defence against the bacterial cell wall
components, such as LPS, lipopeptides, as well as RNA and DNA from viruses
and proteins from protozoa in a relatively specific manner (Leaver et al.,
2007). Mouse C2C12 cell line and mouse skeletal muscle express the mRNA of
TLR1 through TLR4 but not TLR9 or TLR10 (Frost and Lang 2008). TLR4 is an
essential component in the host defence through the stimulation of cytokine
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production. LPS or bacterial endotoxin is the main component of Gram-
negative bacterial cell wall, recognized mainly by TLR4 (Akira and Hemmi
2003).
The ubiquitin-proteasome system is the main catabolic pathway
involved in many inflammatory-induced muscle wasting conditions including
sepsis (Attaix et al., 1998; Jagoe and Goldberg 2001), and a significant
reduction in muscle proteolysis in many animal catabolic models has been
reported with specific proteasome inhibitors (Jagoe and Goldberg 2001).
Atrogin-1 and MuRF1 interacts with E214K to attach ubiquitin to protein
substrates according to the N-end rule (Lecker et al., 1999). Atrogin-1 and
MuRF1 are muscle specific genes, and their expression has been up-regulated
in many animal models of muscle atrophy including sepsis (Bodine et al.,
2001), and individual knockout of atrogin-1 or MuRF1 gene resulted in the
attenuation of denervation-induced muscle atrophy (Bodine et al., 2001). This
makes these genes important targets for therapeutic intervention (Jin and Li
2007).
The regulation of theses proteolytic pathways involves the interaction
between many signalling cascades and transcriptional factors; this makes the
overall elucidation of these processes a difficult task. The PI3-K/Akt signalling
cascade is the main pathway controlling the activity of these two genes.
Increased Akt activity leads to decreased expression of atrogin-1 and MuRF1
(Bodine et al., 2001; Sandri et al., 2004; Stitt et al., 2004), in a mechanism
regulated via the Foxo transcription family (for more details see Glass 2005).
MAPKs (p38 or Erk1/2) and NF-kB play a crucial role in sepsis-induced
muscle protein turnover. Increased activity of MAPK p38 and NF-kB
translocation has been implicated in the up-regulation of the atrogin-1 and
MuRF1. Moreover, increased p38 activity has been reported in many pro-
catabolic conditions and sepsis (Childs et al., 2003; Koistinen et al., 2003; Di
Giovanni et al., ? ? ? ? Z ?dE& ?ɲĂŶĚ/> ? ?ɴŵĞĚŝĂƚĞĚƚŚĞŵƵƐĐůĞǁĂƐƚŝŶŐŝŶŵĂŶǇ
catabolic conditions primarily via p38 and NF-kB (Jackman and Kandarian
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2004), and the increased p38 phosphorylation has been shown to mediate
dE& ?ɲŝŶĚƵĐĞĚƵƉ ?ƌĞŐƵůĂƚŝŽŶŽĨĂƚƌŽŐŝŶ ? ?ŵZEŝŶ ? ? ?ŵǇŽƚƵďĞƐ ?>ŝet al.,
2005), and in septic skeletal muscle of rat (Jin and Li 2007).
The fact that the regulation of LPS-induced muscle protein turnover
involves the interaction between many signalling cascades and the cross talk
between them is no doubt exist. This makes the understanding of this process
more difficult and requires further investigation. In addition, there are no
collective in vitro data regarding the effect of these second-messenger
inhibition on the mRNA activity of atrogens (atrogin-1 and MuRF1), TNF-Įand
TLR4 mRNA. Therefore, the LPS-stimulated C2C12 septic model was used to
evaluate this effect, and various compounds were used to verify this effect.
5.2 Hypothesis
The data collected in chapter 3 and 4 have shown that, LPS is a strong
catabolic stimulus transiently decreased PS by nearly 50%, and increased
muscle proteolysis all time points. This effect involves the interaction between
many signalling streams in particular PI3-K/Akt and MAPKs (p38 or Erk)
streams. The data collected in chapter 3 and 4 have shown that, inhibition of
Akt was associated with dramatic decrease in PS and increase in protein
breakdown, and the cross talk with MAPKs (p38 or Erk) has been revealed. In
addition, inhibition of theses signalling molecules significantly altered the
effect of LPS. In the context, there is collective data about the transcriptional
regulation of LPS-induced muscle protein turnover, and the role of these
signalling streams. Herein, we hypothesized that LPS-induced muscle
proteolysis includes the activation of ubiquitin proteasome system in
particular ubiquitin ligases (atrogin-1 and MuRF1), and inhibition of Akt and
DW<Ɛ ?Ɖ ? ?ŽƌƌŬ ZĐĂŶŵŽĚƵůĂƚĞƚŚŝƐĞĨĨĞĐƚ ?dŚĞƌĞĨŽ  ?ƚŚĞdE& ?ɲ ?ĂƚƌŽŐŝŶ ? ? ?
MuRF1 and TLR4 mRNA was measured in LPS-stimulated C2C12 myotubes
over various time points ranged from 30 min to 18 h.
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5.3 Results
5.3.1 >W^ĂůŽŶĞŽƌǁŝƚŚŝŶŚŝďŝƚŽƌƐƐŝŐŶŝĨŝĐĂŶƚůǇƵƉ ?ƌĞŐƵůĂƚĞĚdE& ?ɲŵ
RNA tested by RT-PCR analyses
Incubation of differentiated C2C12 murine myotubes with LPS alone or
with specific pathway inhibitors but not Polymyxin B significantly increased
dE& ?ɲmRNA expression level (Figs. 5-1A, 1B, 1C, 1D and 1E). LPS alone
ƚƌĂŶƐŝĞŶƚůǇ ŝŶĐƌĞĂƐĞĚ dE& ?ɲ ŵZE ĞǆƉƌĞƐƐŝŽŶ Ăƚ  ? ŚďǇ  ? ? ? ? A?  ?P < 0.01)
compared with the control cells (Fig. 5-1A. Table. 5-1), with no further
changes noticed at the other time points. In contrast, Polymyxin B (PMB, 5
ʅŐŵů-1) completely abolished this effect (Fig. 5-1B. Table. 5-2). Incubation of
C2C12 ŵǇŽƚƵďĞƐ ǁŝƚŚ >W^ ŝŶ ĐŽŵďŝŶĂƚŝŽŶ ǁŝƚŚ >z ? ? ? ? ? ? ?  ?>z ?  ? ? ʅD)
ƐŝŐŶŝĨŝĐĂŶƚůǇŝŶĐƌĞĂƐĞĚƚŚĞdE& ?ɲŵZEďǇ ? ? ?A?Ăƚ ? ? Ś ?P < 0.05) compared
to control cells (Fig. 5-1C, Table. 5-3) with no further changes noticed at any
ŽƚŚĞƌ ƚŝŵĞ ƉŽŝŶƚƐ ? /ŶĐƵďĂƚŝŽŶ ŽĨ  ? ? ? ǁŝƚŚ >W^ ĂŶĚ ^ ? ? ? ? ? ?  ?^ ?  ? ? ʅD Z
ƚƌĂŶƐŝĞŶƚůǇ ŝŶĐƌĞĂƐĞĚ ƚŚĞ dE& ?ɲ Ăƚ  ?Ś ďǇ  ? ? ? ?A?  ?P < 0.001) compared with
control cells (Fig. 5-1D. Table. 5-4). Surprisingly, incubation of C2C12
ŵǇŽƚƵďĞƐ ǁŝƚŚ >W^ ƉůƵƐ W ? ? ? ? ? ?  ? ? ? ʅD Z  ?ƌŬ ? ? ? ƐƉĞĐŝĨŝĐ ŝŶŚŝďŝƚŽƌ Z
ƐŝŐŶŝĨŝĐĂŶƚůǇŝŶĐƌĞĂƐĞĚdE& ?ɲŵZEďǇ ? ? ? ?A? ?P < 0.05), 970% (P < 0.05) and
221% (P < 0.05) at the 1, 3, 12 h respectively compared with control cells with
a peak at the 3 h (Fig. 5-1E. Table. 5-5).
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Figure (5-1) dŝŵĞ ĚĞƉĞŶĚĞŶƚ ĐŚĂŶŐĞƐ ŝŶ dE& ?ɲ ŵZE ?  ? ? ? ŵǇŽƚƵďĞƐ ǁĞƌĞ
incubated either with A Z>W^ ? ?ʅŐŵů-1) alone, B Z>W^ ? ?ʅŐŵů-1) with Polymyxin B (LPS
ŶĞƵƚƌĂůŝƐŝŶŐ ĂŐĞŶƚ Z  ?WD ?  ? ʅŐŵů-1), C Z >W^  ? ? ʅŐ ?ŵů Z ĂŶĚ >z ? ? ? ? ? ?  ?W/ ?< ?Ŭƚ
ŝŶŚŝďŝƚŽƌ Z ?>z ? ? ?ʅD Z ? Z>W^ ? ?ʅŐŵů-1 ZĂŶĚ^ ? ? ? ? ? ? ?Ɖ ? ?ŝŶŚŝďŝƚŽƌ Z ?^ ? ? ?ʅD ZĂŶĚ
E Z Žƌ >W^  ? ? ʅŐŵů-1 Z ĂŶĚ W ? ? ? ? ? ?  ?D< ?ƌŬ ŝŶŚŝďŝƚŽƌ Z  ?W ?  ? ? ʅD Z ? sĂůƵĞƐ ĂƌĞ
represented as means r SEM (percentage of control). Bars carry asterisks are
statistically different from control cells (
*
P < 0.05 and
**
P < 0.01) n = 3. Values
ŶŽƌŵĂůŝǌĞĚƚŽɴ ?ĂĐƚŝŶŵZEĂƐĚĞƐĐƌŝďĞĚŝŶŵĂƚĞƌŝĂůĂŶĚŵĞƚŚŽĚƐ
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5.3.2 LPS alone or with pathway specific inhibitors significantly
increased atrogin-1 mRNA
Incubation of C2C12 myotubes with LPS  ? ? ʅŐŵů-1) alone significantly
increased atrogin-1 mRNA in a time-dependent manner by 200% (P < 0.05),
283% (P < 0.05) and 257% (P < 0.01) at the 3, 12 and 18 h time points
respectively compared with untreated control cells (Fig. 5-2A. Table. 5-1). LPS
neutralising agent (PMB, 5 ʅŐŵů-1) failed to inhibit the effect of LPS particularly
at the 18 h time point (Fig. 5-2B. Table. 5-2), LPS significantly increased
atrogin-1 mRNA by 167% (P < 0.05) compared with untreated cells. Incubation
ŽĨĐĞůůƐǁŝƚŚ>W^ĂŶĚ>z ? ? ? ? ? ? ?  ?>z ?  ? ?ʅD ZƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚĂƚƌŽŐŝŶ ? ?
mRNA by 506% (P < 0.05) and 1649% (P < 0.01) compared with control cells at
the 3 and 18 h time points respectively ( Fig. 5-2C. Table. 5-3). In contrast, the
atrogin-1 mRNA expression exhibited a long time course when C2C12
ŵǇŽƚƵďĞƐ ǁĞƌĞ ŝŶĐƵďĂƚĞĚ ǁŝƚŚ >W^ ĂŶĚ ^ ? ? ? ? ? ?  ?^ ? ? ? ʅD Z ? ĂƚƌŽŐŝŶ ? ?
mRNA significantly increased in a time-dependent manner with a peak at the
12 and 18 h time points by 663% and 670% (P < 0.01) compared with control
cells (Fig. 5-2D. Table. 5-4). Likewise, incubation of C2C12 myotubes with LPS
ŝŶ ĐŽŵďŝŶĂƚŝŽŶ ǁŝƚŚ W ? ? ? ? ? ?  ?W ?  ? ? ʅD Z ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ ĂƚƌŽŐŝŶ ? ?
mRNA by 375% (P < 0.05), 306% (P < 0.01), and 317% (P < 0.01) compared
with control cells at the 3, 12, 18 h time points respectively (Fig. 5-2E. Table.
5-5).
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Figure (5-2) Time-dependent changes in atrogin-1 mRNA. C2C12 myotubes were
incubated either with A Z>W^ ? ?ʅŐŵů-1) alone, B Z>W^ ? ?ʅŐŵů-1) and Polymyxin B (LPS
neutralising agent) (PMB, 5 ʅŐŵů-1), C Z >W^  ? ? ʅŐŵů-1) and LY0294002 (PI3K/Akt
ŝŶŚŝďŝƚŽƌ Z ?>z ? ? ?ʅD Z ? Z>W^ ? ?ʅŐŵů-1) ĂŶĚ^ ? ? ? ? ? ? ?Ɖ ? ?ŝŶŚŝďŝƚŽƌ Z ?^ ? ? ?ʅD Z ?Žƌ
E Z >W^  ? ? ʅŐŵů-1) ĂŶĚ W ? ? ? ? ? ?  ?D< ?ƌŬ ŝŶŚŝďŝƚŽƌ Z  ?W ?  ? ? ʅD Z ? sĂůƵĞƐ ĂƌĞ
represented as means r SEM (percentage of control). Bars carry asterisks are
statistically different from control cells (
*
P < 0.05 and
**
P < 0.01) n = 3. Values
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5.3.3 LPS transiently increased MuRF1 mRNA and significantly
increased its expression in combination with SB203580
The expression of MuRF1 mRNA exhibited a different course to that of
atrogin-1 mRNA. LPS alone significantly increased MuRF1 mRNA transiently at
18 h time points by 155% (P < 0.05) compared with control cells with no
further changes were noticed at any other time points (Fig. 5-3A. Table. 5-1).
Surprisingly, MuRF1 exhibited a long time course when the C2C12 myotubes
incubated with LPS plus SB203580 (Fig. 5-3D. Table. 5-4). MuRF1 mRNA
expression was increased in a time-dependent manner with a peak at the 18 h
(280%, P < 0.01 compared with control cells). No further changes were
noticed with the other pathway specific inhibitors (Figs. 5-3B, 5-3C and 5-3E).
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Figure (5-3) Time dependent changes in MuRF1 mRNA. C2C12 myotubes were
incubated either with A Z>W^ ? ?ʅŐŵů-1) alone, B Z>W^ ? ?ʅŐŵů-1) and Polymyxin B (LPS
ŶĞƵƚƌĂůŝƐŝŶŐ ĂŐĞŶƚ Z  ?WD ?  ? ʅŐŵů-1), C Z >W^  ? ? ʅŐ ?ŵů Z ƉůƵƐ >z ? ? ? ? ? ? ?  ?W/ ?< ?Ŭƚ
ŝŶŚŝďŝƚŽƌ Z ?>z ? ? ?ʅD Z ? Z>W^ ? ?ʅŐŵů-1) ĂŶĚ^ ? ? ? ? ? ? ?Ɖ ? ?ŝŶŚŝďŝƚŽƌ Z ?^ ? ? ?ʅD Z ?Žƌ
E Z >W^  ? ? ʅŐŵů-1) ĂŶĚ W ? ? ? ? ? ?  ?D< ?ƌŬ ŝŶŚŝďŝƚŽƌ Z  ?W ?  ? ? ʅD Z ? sĂůƵĞƐ ĂƌĞ
represented as means r SEM (percentage of control cells). Bars carry asterisks are
statistically different from control cells (
*
P < 0.05 and
**
P < 0.01). n = 3. Values
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5.3.4 LPS-stimulated TLR4 mRNA expression only abolished by LPS
neutralising agent (Polymyxin B)
LPS significantly increased TLR4 mRNA in a time-dependent manner
with a peak at the 12 and 18 h time points (155%, P < 0.05 compared with
control cells) (Fig. 5-4A ?dĂďůĞ ?  ? ? ? Z ?/ŶĐŽŶƚƌĂƐƚ ?WŽůǇŵǇǆŝŶ  ?WD ? ?ʅŐŵů-1)
LPS neutralising agent completely abolished this effect (Fig. 5-4B. Table. 5-2).
While incubation of cells with LPS and LY0294002 significantly increased TLR4
mRNA transiently at 18 h by 509% (P < 0.01) compared with control cells (Fig.
5-4C. Table. 5-3). Surprisingly, SB203580 significantly magnified this effect.
TLR4 mRNA significantly increased in a time-dependent manner by 1130% and
1026% (P < 0.001) compared with untreated control cells at the 12 and 18 h
time points (Fig. 5-4D, Table 5-4). Similarly, inhibition of Erk1/2 activity
significantly increased TLR4 mRNA in a time-dependent manner with a peak at
the 18 h (683%, P < 0.001 compared with control cells) (Fig. 5-4E. Table. 5-4).
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Figure (5-4) Time dependent changes in TLR4 mRNA. C2C12 myotubes were
incubated either with A Z>W^ ? ?ʅŐŵů-1) alone, B Z>W^ ? ?ʅŐŵů-1) and Polymyxin B (LPS
ŶĞƵƚƌĂůŝƐŝŶŐ ĂŐĞŶƚ Z  ?WD ?  ? ʅŐŵů-1), C Z >W^  ? ? ʅŐŵů-1) and LY2094002 (PI3K/Akt
ŝŶŚŝďŝƚŽƌ Z ?>z ? ? ?ʅD Z ? Z>W^ ? ?ʅŐŵů-1) ĂŶĚ^ ? ? ? ? ? ? ?Ɖ ? ?ŝŶŚŝďŝƚŽƌ Z ?^ ? ? ?ʅD Z ?Žƌ
E Z >W^  ? ? ʅŐŵů-1) ĂŶĚ W ? ? ? ? ? ?  ?D ?ƌŬ ŝŶŚŝďŝƚŽƌ  Z  ?W ?  ? ? ʅD Z ? sĂůƵĞƐ ĂƌĞ
represented as means r SEM (percentage of control cells). Bars carry asterisks are
statistically different from control cells (
*
P < 0.05 and
**
P < 0.01). n = 3. Values
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Table (5:1) ŚĂŶŐĞƐ ŝŶdE& ?ɲ ?ĂƚƌŽŐŝŶ ? ? ?DƵZ& ? ?ĂŶĚd>Z ?ŵZEĞǆƉƌĞƐƐŝŽŶ ůĞǀĞů ?
 ? ? ?ǁĞƌĞŝŶĐƵďĂƚĞĚǁŝƚŚ>W^ ? ?ʅŐŵů-1) for (30 min, 1, 3, 12 and 18 h). Values are
expressed as means (percentage of control). Asterisks represent the statistical
difference compared with the control cells (
*
P < 0.05,
**
P < 0.01 and
***
P < 0.001). n =
3
Gene
mRNA
Time post LPS administration
C 1 h 3 h 12 h 18 h
TNF-Į 100 1858** 138 98 78
Atrogin-1 100 149 200* 283* 257*
MuRF1 100 108 114 111 155
TLR4 100 110 119* 154* 155*
Table (5:2) ŚĂŶŐĞƐŝŶdE& ?ɲ ?ĂƚƌŽŐŝŶ ? ? ?DƵZ& ? ?ĂŶĚd>Z ?ŵZEĞǆƉƌĞƐƐŝŽŶ ? ? ?
ǁĞƌĞ ŝŶĐƵďĂƚĞĚǁŝƚŚ>W^  ? ?ʅŐŵů-1) and Polymyxin B (LPS neutralising agent) (PMB,
 ?ʅŐŵů-1) for (30 min, 1, 3 and 18 h). Values are expressed as means (percentage of
control). Asterisks represent the statistical difference compared with the control cells
(
*
P < 0.05,
**
P < 0.01 and
***
P < 0.001).n = 3
Gene
mRNA
Time post LPS + PMB
C 30 min 1 h 3 h 18 h
TNF-Į 100 71 85 100 64
Atrogin-1 100 69 88 123 167*
MuRF1 100 111 101 96 145
TLR4 100 67 86 63 153
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Table (5:3) ŚĂŶŐĞƐ ŝŶdE& ?ɲ ?ĂƚƌŽŐŝŶ ? ? ?DƵZ& ? ?ĂŶĚd>Z ?ŵZEĞǆƉƌĞƐƐŝŽŶ ůĞǀĞů ?
 ? ? ?ǁĞƌĞŝŶĐƵďĂƚĞĚǁŝƚŚ>W^ ? ?ʅŐŵů-1) and LY0294002 (PI3-K/Akt inhibitor) (LY, 50
ʅD Z ĨŽƌ  ? ? ? ŵŝŶ ?  ? ?  ? ĂŶĚ  ? ? Ś Z ? sĂůƵĞƐ ĂƌĞ ĞǆƉƌĞƐƐĚ ĂƐ ŵĞĂŶƐ  ?ƉĞƌĐĞŶƚĂŐĞ ŽĨ
control). Asterisks represent the statistical difference compared with the control cells
(
*
P < 0.05 and
***
P < 0.001).n = 3
Gene
mRNA
Time post LPS + LY0294002
C 30 min 1 h 3 h 18 h
TNF-Į 100 32 83 136 291
Atrogin-1 100 102 122 509* 1649*
MuRF1 100 80 64 90 81
TLR4 100 81.38 96.51 54.21 509.16**
Table (5:4) ŚĂŶŐĞƐ ŝŶdE& ?ɲ ?ĂƚƌŽŐŝŶ ? ? ?DƵZ& ? ?ĂŶĚd>Z ?ŵZEĞǆƉƌĞƐƐŝŽŶ ůĞǀĞů ?
 ? ? ?ǁĞƌĞŝŶĐƵďĂƚĞĚǁŝƚŚ>W^ ? ?ʅŐŵů-1) ĂŶĚ^ ? ? ? ? ? ? ?Ɖ ? ?ŝŶŚŝďŝƚŽƌ Z ?^ ? ? ?ʅD Z
for (30 min, 1, 3, 12 and 18 h) .Values are expressed as means (percentage of
control). Asterisks represent the statistical difference compared with the control cells
(
*
P < 0.05,
**
P < 0.01 and
***
P < 0.001). n = 3
Gene
mRNA
Time post LPS + SB203580
C 30 min 1 h 3 h 12 h 18 h
TNF-Į 100 334 559 2150*** 238 262
Atrogin-1 100 176** 182* 445* 663* 670*
MuRF1 100 196* 208** 191* 193* 280**
TLR4 100 189 339 655** 1130*** 1026***
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Table (5:5) ŚĂŶŐĞƐ ŝŶ dE& ?ɲ ? ĂƚƌŽŐŝŶ ? ? ? DƵZ& ? ? ĂŶĚ d>Z ? ŵZE ĞǆƉƌĞƐƐŝŽŶ
ůĞǀĞů ? ? ? ? ǁĞƌĞ ŝŶĐƵďĂƚĞĚ ǁŝƚŚ >W^  ? ? ʅŐŵů-1) and PD098059 (MEK/Erk inhibitor)
 ?W ?  ? ? ʅD Z ĨŽƌ  ? ? ? ŵŝŶ ?  ? ?  ? ?  ? ? ĂŶĚ  ? ? Ś Z ? sĂůƵĞƐ ĂƌĞ ĞǆƉƌĞƐƐ Ě ĂƐ ŵĞĂŶƐ
(percentage of control). Asterisks represent the statistical difference compared with
the control cells (
*
P < 0.05 and
**
P < 0.01).n = 3
Gene
mRNA
Time post LPS + PD098059
C 30 min 1 h 3 h 12 h 18 h
TNF-Į 100 415 1706* 970* 221* 241
Atrogin1 100 298 207 375* 306** 317**
MuRF1 100 289 112 155 221 269
TLR4 100 283 184 240 409 683**
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5.4 Discussion
The data presented here is considered as a comprehensive study aimed
mainly to elucidate the effect of endotoxin alone and endotoxin plus specific
pathway inhibitors on the transcription regulation of muscle protein
breakdown in vitro using C2C12 myotubes septic model. The major findings of
the study can be summarised as the following 1) LPS is a strong stimulator of
dE& ?ɲ ?ĂƚƌŽŐŝŶ ? ? ?DƵZ& ?ĂŶĚd>Z ?ŵZEĞǆƉƌĞƐƐŝŽŶ ŝŶ ? ? ?ĚŝĨĨĞƌĞŶƚŝĂƚĞĚ
myotubes; and Polymyxin B (PMB) neutralises this effect; 2) LY0294002 (PI3-
< ?Ŭƚ ŝŶŚŝďŝƚŽƌ Z ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ dE& ?ɲ ? ĂƚƌŽŐŝŶ ? ? ĂŶĚ d>Z ? ŵZE ďƵƚ
not MuRF1; 3) SB203580 (p38 inhibitor) significantly magnified the effect of
>W^ĂŶĚŝƚƐŝŐŶŝĨŝĐĂŶƚůǇŝŶĐƌĞĂƐĞĚƚŚĞdE& ?ɲ ?ĂƚƌŽŐŝŶ ? ? ?DƵZ& ?ĂŶĚd>Z ?ŵZE
expression in a time-dependent manner; 4) PD098059 (MEK/Erk1/2 specific
ŝŶŚŝďŝƚŽƌ Z ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ ŽŶůǇ dE& ?ɲ ? ĂƚƌŽŐŝŶ ? ? ĂŶĚ d>Z ? ŵZE
expression but not the MuRF1 and finally 5) the up-regulation of atrogin-1 is
the main feature in our model of sepsis and it might be the key regulator of
LPS-induced muscle protein breakdown.
Skeletal muscle comprises nearly 45% of the body weight and nearly
around 70% of sepsis-induced body protein loss originates from the skeletal
muscle (Plank et al., 1998). Sepsis-induced protein wasting was derived mainly
from the imbalance between the rate of protein synthesis and protein
degradation. The Loss of muscle mass in sepsis is derived primarily from the
accelerated muscle protein degradation rate via the ubiquitin-proteasome
pathways (Jagoe and Goldberg 2001). Selecting a particular protein to be
ubiquitinated is the function of ubiquitin ligases. The ubiquitin ligases protein
(also called an E3 ubiquitin ligases) is a protein in combination with an E2
(Ubiquitin-conjugating enzyme) which causes the attachment of ubiquitin to a
lysine on a target protein substrates for degradation in the proteasome
(Lecker et al., 1999). The ubiquitin ligase proteins atrogin-1 and MuRF1 are a
rate limiting for muscle protein loss in many catabolic conditions. The muscle
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expression of these proteins has been increased during sepsis (Voisin et al.,
1996; Fischer et al., 2000). The activity of atrogin-1 and MuRF1 is reciprocal to
the activity of Foxo transcription family. The activity of Foxo transcription
family is mainly controlled by Akt activity. Decreased activity of Akt in C2C12
myotubes was shown to activate Foxo transcription family, which in turn
increases the activity expression of muscle specific ubiquitin ligases atrogin-1
and MuRF1, and vice versa. LPS injection was associated with dramatic
increase in the expression of muscle specific genes atrogin-1 and MuRF1
(Bodine et al., 2001). During muscle atrophy, atrogin-1 inhibits the binding of
Met-tRNA to the 40S ribosome via the ubiquitination and later proteasomal
degradation of the eukaryotic initiation factor 3, subunit 5 (eIF3-F), while
MuRF1 targets the myosin heavy chain protein, troponin and other
myofibrillar proteins (Clarke et al., 2007), and suppressed the muscle protein
synthesis (Koyama et al., 2008).
,ĞƌĞŝŶ ?>W^ƐŝŐŶŝĨŝĐĂŶƚůǇŝŶĐƌĞĂƐĞĚƚŚĞůĞǀĞůƐŽĨdE& ?ɲ ?ĂƚƌŽŐŝŶ ? ? ?DƵZ& ?
mRNA, this is consistent with the findings of (Frost et al., 2002), and this effect
was mediated mainly via TLR4. LPS is considered as a potent stimulus of
cytokines synthesis and accumulation of their mRNA occurs in the classical
immune cells (Shindoh et al., 1995; Saghizadeh et al., 1996), and in the
skeletal muscle mediated via TLR4 (Frost et al., 2006). These data are
ŝŶĐŽŶƐŝƐƚĞŶƚ ǁŝƚŚ ƚŚĞ ĨŝŶĚŝŶŐ ƚŚĂƚ >W^ ĂůŽŶĞ ĨĂŝů ƚŽ ŝŶĚƵĐĞ dE& ?ɲ ƌĞůĞĂƐĞ ŝŶ
 ? ? ? ŵǇŽƚƵďĞƐ ĂŶĚ ƚŚƵƐ ? dE& ?ɲ ĞǆƉƌĞƐƐŝŽŶ ŝƐ ĐŽŶƐŝĚĞƌĞĚ ĂƐ Ă ŐĞŶĞƌĂůŝƐĞĚ
response of skeletal muscle to LPS administration (Fernandez-Celemin et al.,
 ? ? ? ? Z ?dE& ?ɲŝƐĂƉƌŽ ?ŝŶĨůĂŵŵĂƚŽƌǇĐǇƚŽŬŝŶĞŽƌŝŐŝŶĂůůǇĐĂůůĞĚĐĂĐŚĞĐƚŝŶĂŶĚŝƐ
one of the intensively studied cytokines plays an indispensable role in the host
defence against invading pathogens (Tisdale 1997). Elevated circulating levels
ŽĨ dE& ?ɲ ŚĂǀĞ ďĞĞŶ ƌĞƉŽƌƚĞĚ ŝŶ ŵĂŶǇ ĐĂƚĂďŽůŝĐ ĐŽŶĚŝƚŝŽŶƐ ŝŶĐůƵĚŝŶŐ ƐĞƉƐŝƐ
(Cooney et al., 1999), and accompanied with a reduction in skeletal muscle
protein and a loss of muscle mass (Williamson et al.,  ? ? ? ? Z ? dE& ?ɲ ŝŶĚƵĐĞĚ
muscle catabolism either by decreasing protein synthesis and myogenesis in
C2C12 myoblasts (Guttridge et al., 2000; Langen et al., 2001) or increasing the
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contractile protein proteolysis particularly myosin heavy chain via activation
of ubiquitin-proteasome pathway (Li and Reid 2000) in a mechanism
mediated via activation of p38 (phosphorylation) and NF-kB activation
(Fernandez-Celemin et al., 2002; Li et al., 2005). Conversely, it has recently
ďĞĞŶ ƐŚŽǁŶ ƚŚĂƚ dE& ?ɲ ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ ƉƌŽƚĞŝŶ ƐǇŶƚŚĞƐŝƐ ŝŶ Ă ĚŽƐĞ ?
dependent manner via MEK signalling cascade in C2C12 myotubes (Plaisance
et al., 2008). LPS significantly increased TLR4 mRNA which was diminished by
Polymyxin B in cultured skeletal muscle cells. Although, Lang et al failed to
detect any changes in TLR4 mRNA in septic skeletal muscles of rat (Lang et al.
2003), however the subsequent study of Frost and others demonstrated that
LPS stimulated expression of TLR4 mRNA in both C2C12 myoblasts and
differentiated myotubes (Frost et al., 2004). Hence, LPS affects cytokine
expression at multiple levels including transcription (Learn et al., 2000),
translational (Rausch et al., 1994) processing and secretion (Mehta et al.,
2001), an effect mediated most likely via TLR4 signalling cascade.
Akt has been shown to regulate the expression of atrogin-1 and MuRF1
mRNA in a mechanism mediated via the Foxo pathway. Decreased Akt activity
was associated with increased atrogin-1 and MuRF1 expression (Glass 2005).
The atrogin-1 mRNA significantly increased when the C2C12 myotubes were
incubated with LPS in combination with LY0294002. This result is consistent
with the result of Moylan et al., (2008), blocking of PI3-K/Akt pathway with
wortmannin could not diminish the expression of atrogin-1 mRNA (+340%).
Moreover, inhibition of Akt by LY029004 significantly increased atrogin-1
mRNA in dexamethasone-stimulated C2C12 cells (Sacheck et al., 2004).
Conversely, transient activation of Akt was involved in the PIF (proteolysis
induced factor)-induced muscle proteolysis and inhibition of Akt by LY029004
significantly decreased the proteolytic activity (measured as chymotrypsin-like
enzyme activity for more details see (Russell et al., 2008). This suggests that
Akt is the a crucial key element regulating not only the protein synthesis but
also protein degradation in skeletal muscle (Glass 2005). The fact that the
expression of atrogin-1 is one the predominant features of our septic models
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argue the impotence of the E3 atrogin-1 during the atrophy process. This
makes atrogin-1 is a target for future drug discovery to decrease sepsis-
induced muscle wasting.
P38 MAPK has been known as a potential regulator of muscle
catabolism, and elevated p38 activity in skeletal muscle has been reported in
many pro-catabolic conditions (Tracey 2002; Childs et al., 2003; Di Giovanni et
al.,  ? ? ? ? Z ? W ? ? ŵĞĚŝĂƚĞĚ ƚŚĞ dE& ?ɲ ƵƉ ?ƌĞŐƵůĂƚŝŽŶ ŽĨ ĂƚƌŽŐŝŶ ? ? ŵZE ŶŽƚ
MuRF1 in rat skeletal muscle (Li et al., 2005; Jin and Li 2007). SB203580, a
selective p38 inhibitor (Cuenda et al., 1995), failed to block the LPS up-
ƌĞŐƵůĂƚŝŽŶ ŽĨ dE& ?ɲ ? ĂƚƌŽŐŝŶ ? ? ? DƵZ& ? ĂŶĚ d>Z ? ŵZE ? dŚĞƐĞ ĨŝŶĚŝŶŐƐ ĂƌĞ
inconsistent with the findings of Li et al., (2005), that SB203580 significantly
ďůŽĐŬĞĚ ƚŚĞ dE& ?ɲ ?Ɖ ? ? ŵĞĚŝĂƚĞĚ ƵƉ ?ƌĞŐƵůĂƚŝŽŶ ŽĨ ƚŚĞ ĂƚƌŽŐŝŶ ? ? ŵZE ŝŶ
skeletal muscle (Li et al., 2005). The western blotting data (chapter 3, Figs. 3-
7B and 3-7D)) showed that SB203580 had no effect on the p38 activity related
phosphorylation, and this is consistent with the findings of Kumar et al.,
(1999). In contrast, SB203580 significantly decreased the Akt phosphorylation
compared with untreated cells (P < 0.05). Therefore, the assumption is that
incubation of C2C12 myotubes with LPS and SB203580 significantly decreased
Akt, and Akt is considered as the regulatory key of muscle protein degradation
mediated most likely via atrogin-1 (Glass 2005).
Beside p38, Erk1/2 is an another MAPK that is involved in many cellular
functions including cellular proliferation and differentiation (Olson 1992;
Pages et al., 1993). In skeletal muscle, Erk1/2 activation has been associated
ǁŝƚŚĐŽŶƚƌŽǀĞƌƐŝĂůĨƵŶĐƚŝŽŶƐ ?dE& ?ɲŝŶĚƵĐĞĚŵƵƐĐůĞŽƐƐŝƐƉƌŝŵĂƌŝůǇĂƐƐŽĐŝĂƚĞĚ
with the activation of Erk1/2 MAPK, which in turn stimulates stress-related
protein NF-kB (Traenckner et al., 1995; Ueki et al., 2004). Conversely, the role
of the Erk1/2 in the stimulation of translation initiation via Mnk1 downstream
eIF-4E has been shown by Waskiewicz et al., (1997). Inhibition of p38 and
ƌŬ ? ? ? ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ ƚŚĞ ƵƉ ?ƌĞŐƵůĂƚŝŽŶ ŽĨ dE& ?ɲ ? ĂƚƌŽŐŝŶ ? ? ĂŶĚ
MuRF1 mRNA expression. These data is inconsistent with the findings of
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Sacheck et al. that inhibition of MEK has no effect on the atrogin-1 mRNA
level (Sacheck et al., 2004). This data showed the direct contribution of the
MAPKs (p38 or Erk1/2) in LPS-induced atrogens up regulation and
consequently muscle proteolysis. The significant increase in the atrogin-1
mRNA was the main feature of our septic model. The western results
presented in chapter 3 (Figs. 3-7B and 3-7C) showed that, inhibition of the
Erk1/2 and p38 significantly decreased the Akt phosphorylation (P < 0.05)
compared with the control cells (Figs. 3-7A and 3-7D). This suggests that there
is a cross talk between these various signalling pathways. The crosstalk
between the Akt and Erk1/2 signalling pathways has been demonstrated in
many studies (Hausenloy et al., 2004; Drummond et al., 2009). Drummond et
al (2009) demonstrated that, inhibition of mTOR activity significantly
decreased the Erk1/2 phosphorylation, and the activation of both mTORC1
and Erk1/2 signalling pathways is required for the stimulation of protein
synthesis in human skeletal muscle. In contrast, inhibition of MAPKs (p38 or
Erk1/2) might alter PS in an effect mediated via the Mnk1/eIF-4E pathway
(Fukunaga and Hunter 1997; Waskiewicz et al., 1997; Plaisance et al., 2008).
The LPS-induced muscle protein breakdown was thus mediated mainly via the
Akt, and Akt is considered as the central regulator of both muscle protein
synthesis and muscle protein breakdown (Glass 2005). Although, inhibition of
MAPKs (p38 or Erk1/2) significantly increased the activity of ubiquitin ligases
mainly atorgin-1 and too less extend MuRF1, this effect was mediated mainly
via decreased Akt activity. The data presented in chapter 4 and 5, showed
that, there is no absolute correlation between the proteasomal proteolytic
activity (chymotrypsin-like enzyme activity) and the expression of atrogens
(atrogin-1 and MuRF1) in our septic model. In other words, inhibition of
MAPKs (p38 or Erk1/2) significantly decreased LPS-induced proteasomal
activity (Fig. 4-2), while it significantly increased the expression of atrogens in
particular atrogin-1 (Fig. 5-2). This makes the use of the atrogen-1 and MuRF1
expression as a marker of muscle proteolysis is a poor indicator. Recently it
has been reviewed in Attaix and Baracos (2010), the controversial
observations regarding the link between muscle proteolysis and the
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expression of these atrogens. However, the obtained data suggests that the
atrogin-1 is the key player in many cases of muscle wasting including our
C2C12 model, cancer (Gomes et al., 2001), and sepsis (Li et al., 2005), and its
transcriptional regulation involves the interaction of many signalling
pathways. This makes these genes the target for further therapeutic
intervention in order to retard the adverse outcomes of sepsis (Jin and Li
2007).
5.5 Conclusion
LPS significantly increased the production and release of cytokine in
ďŽƚŚ ŝŵŵƵŶĞ ĂŶĚ ŶŽŶ ŝŵŵƵŶĞ ƚŝƐƐƵĞƐ ? >W^ ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ dE& ?ɲ ?
atrogin-1, MuRF1 and TLR4 in C2C12 differentiated myotubes. There was a
cross-talk between the MAPKs (p38 or Erk1/2) and Akt signalling pathways.
The most important signalling cascade involved in LPS-mediated up-regulation
ŽĨ dE& ?ɲ ? ĂƚƌŽŐŝŶ ? ? ? DƵZ& ? ĂŶĚ d>Z ? ŵZE ŝƐ ƚŚĞ d>Z ? ?Ŭƚ ƐŝŐŶĂůůŝŶŐ
cascade. The predominant ubiquitin protein ligases unregulated in our model
of sepsis (C2C12 myotubes) is atrogin-1. The data presented in this chapter
highlighted the importance of atrogin-1 knockout as an effective therapy in
order to lessen the protein turnover in case of sepsis.
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6 Curcumin prevented the LPS-induced protein
degradation in C2C12 myotubes
6.1 Introduction
Sepsis is an acute catabolic condition resulting in severe consequences
including, increased rate of protein degradation and/or decreased rate of
protein synthesis (Jepson et al., 1986; Hummel et al., 1988; Ash and Griffin
1989; Hasselgren et al., 1989; Lai et al., 2004). The increased rate of protein
degradation is mediated via increased ubiquitin-proteasome activity pathway
(Jagoe and Goldberg 2001) and for more details regarding the contribution of
ubiquitin and ubiquitin ligases in this process see Hershko and Ciechanover
(1998). Briefly, the targeted protein first linked and marked by a chain of four
ubiquitin molecules, and later it degraded in the 26S proteasome central core.
^ĞƉƐŝƐŝƐĂƐƐŽĐŝĂƚĞĚǁŝƚŚŝŶĐƌĞĂƐĞĚƐĞĐƌĞƚŝŽŶŽĨdE& ?ɲĂŶĚ/> ? ?ɴ ?ĂƌƵďŝŶĂŶĚ
Han 2005), which in turn increases the activity of p38 and NF-kB leading to an
excessive muscle protein degradation (Jackman and Kandarian 2004). This
effect mediated via the up-regulation of the ubiquitin ligases (atrogin-1 and
MuRF1) mRNA. The regulation of the skeletal muscle protein degradation is a
complicated process, involved the interaction between many signalling
pathways, but the predominant mechanism in case of catabolic diseases
ŝŶǀŽůǀĞƐ dE& ?ɲ ?Ɖ ? ? ? ĂƚƌŽŐŝŶ ? ?  ?>ŝet al. ?  ? ? ? ? Z ? ĂŶĚ ƚŚĞ dE& ?ɲ ?/k ?ɲ ? DƵZ& ?
pathways (Li & Reid, 2000; Cai et al., 2004).
Curcumin is the principle curcuminoid of the popular Indian spice
turmeric, has been used for a long time in the traditional Indian medicine to
treat many diseases. During the last two decades, many studies have been
carried out to explore the beneficial effects of curcumin, and nearly all these
studies have been promising. Curcumin inhibits the p38 activity (Carter et al.,
2003) and consequently this inhibits the up-regulation of atrogin-1 ubiquitin
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ligase in C2C12 myotubes (Li et al., 2005). Moreover, curcumin inhibits the NF-
kB activity mediated by decreasing phosphorylation and proteasomal
degradation of IK ?ɲ ?ĂŶĚƚŚŝƐŬĞĞƉƐƚŚĞE& ?ŬďŽƵŶĚƚŽŝƚƐŝŶŚŝďŝƚŽƌǇƉƌŽƚĞŝŶ
IK ?ɲŝŶƚŚĞĐǇƚŽƉůĂƐŵ ?:ŽďŝŶet al., 1999), leading to a considerable decrease
in the inflammation-stimulated muscle protein degradation mediated via p38
and NF-kB pathways. In addition, along with these positive effects of
curcumin, it has no known toxic effects, even at very high doses (Chainani-Wu
2003).
IL-6 is a cytokine which has pro and ant-inflammatory properties
(Ikemoto et al., 2000), and is mainly secreted from the classical immune
tissues, such as liver, spleen (Luo et al., 2003), and septic skeletal muscle
(Frost et al., 2002). The data regarding the role of IL-6 in the regulation of
muscle protein degradation in various muscle wasting conditions are still
contradictory with some studies showed no role (Garcia-Martinez et al., 1994;
Williams et al., 1998), while others suggested a contribution (Strassmann et
al., 1992; Haddad et al., 2005). Taking into consideration, the results of these
studies and the growing importance of IL-6 in the regulation of muscle protein
metabolism, the understanding of the regulation of IL-6 production in muscle
becomes increasingly important. Developing appropriate and safe therapeutic
intervention that decreases the complications of sepsis with minimal side
effects has become increasingly important. In addition, there are a paucity of
studies regarding the direct effect of curcumin on the rate of muscle protein
degradation and protein synthesis in vivo. Therefore, our study aimed to
ĞǆƉůŽƌĞƚŚĞĚŝƌĞĐƚĞĨĨĞĐƚŽĨƚŚƌĞĞĐƵƌĐƵŵŝŶĐŽŶĐĞŶƚƌĂƚŝŽŶƐ ? ? ? ? ? ?ĂŶĚ ? ?ʅD Z
on the protein synthesis and protein degradation in the LPS-C2C12 myotubes
as an in vitro ŵŽĚĞů ŽĨ ƐĞƉƐŝƐ ? KƵƌ ƐƚƵĚǇ ƐŚŽǁĞĚ ƚŚĂƚ ? ĐƵƌĐƵŵŝŶ  ? ?  ʅD Z
significantly decreases the LPS-induced protein degradation (measured as
chymotrypsin-like enzyme activity) with no effect on the LPS-induced
decreased PS (measured as
3, ?ƚǇƌŽƐŝŶĞŝŶĐŽƌƉŽƌĂƚŝŽŶ ?ʅŐ ?A?dWƌĞĐŝƉŝƚĂďůĞ
protein) in the same time with no side effects on the myotubes.
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6.2 Hypothesis
The data presented in chapters 3, 4 and 5 have shown that, LPS is a
strong catabolic agent increased the protein breakdown and decreased the
protein synthesis particularly at the 3 h time point. This effect involves the
activation of ubiquitin ligases in particular atrogin-1 and MuRF1. In addition,
LPS significantly increased the production of pro-inflammatory cytokines in
skeletal muscle mainly TNF-Į The role of Akt and MAPKs (p38 or Erk) has
been shown. Curcumin has been shown to have anti-inflammatory effect
mediated via inhibition of p38 activity. In vivo studies have demonstrated that
curcumin significantly decreased atrogin-1 ubiquitin ligase and this effect was
mediated via decreased p38 activity. Furthermore, there is no data regarding
the direct role of curcumin on protein synthesis and protein breakdown in
vitro. Therefore, three curcumin concentrations (12, 25 and 50 ȝM) were
used in 3 h LPS stimulated C2C12 myotubes to investigate the beneficial
effects of curcumin.
6.3 Results
6.3.1 Curcumin increases the Akt phosphorylation
The first experiment was to assess the effect of LPS alone and LPS in
ĐŽŵďŝŶĂƚŝŽŶǁŝƚŚĐƵƌĐƵŵŝŶ ? ? ? ? ? ?ĂŶĚ ? ?ʅD ZĂŶĚĐƵƌĐƵŵŝŶĂůŽŶĞŽŶƚŚĞŬƚ
activity-related phosphorylation. The data showed that LPS alone significantly
decreased the Akt phosphorylation by -25% (P < 0.05) compared with the
control cells (Figs. 6-1 and 6-5A). While, incubation of C2C12 myotubes with
>W^ ĂŶĚ ĐƵƌĐƵŵŝŶ  ? ? ? ?  ? ? ĂŶĚ  ? ? ʅD Z ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ ƚŚĞ Ŭƚ
phosphorylation compared with LPS-treated cells but this effect is still
insignificant compared with the control cells. Interestingly, incubation of cells
ǁŝƚŚ >W^ ĂůŽŶŐ ǁŝƚŚ ĐƵƌĐƵŵŝŶ  ? ? ? ʅD Z ƐŝŐŶŝĨŝĐĂŶƚůǇŝŶĐƌĞĂƐĞĚ Ŭƚ
phosphorylation by 43% (P < 0.05) compared with control cells, while
ŝŶĐƵďĂƚŝŽŶŽĨĐĞůůƐǁŝƚŚĐƵƌĐƵŵŝŶ ? ? ?ʅD ZĂůŽŶĞƐŝŐŶ ĨŝĐĂŶƚůǇŝŶĐƌĞĂƐĞĚƚŚĞŬƚ
phosphorylation by 62% (P < 0.01) compared to control cells.
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Figure (6-1) LPS and curcumin induced changes in phospho-Akt. C2C12 myotubes
ǁĞƌĞŝŶĐƵďĂƚĞĚĞŝƚŚĞƌǁŝƚŚ>W^ ? ?ʅŐŵů-1 ZĂůŽŶĞ ?ŽƌǁŝƚŚ>W^ ? ?ʅŐŵů-1) and Curcumin
 ? ? ? ?  ? ? ĂŶĚ  ? ? ʅD Z ? Žƌ ƵƌĐƵŵŝŶ  ? ? ? ?  ? ? ĂŶĚ  ? ? ʅD ZĂůŽŶĞ ĨŽƌ  ? Ś ? sĂůƵĞƐ ĂƌĞ
represented as means r SEM arbitrary unit normalised to ȕ-actin as an internal
loading control. Bars carry asterisks are statistically significant from control and LPS-
treated cells (
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6.3.2 Curcumin blocked the LPS-induced decreased ribosomal protein
(70KD) P70
S6K
Phosphorylation
The level of phosphorylated P70
S6K
has been measured to evaluate the
effect of curcumin on the translation initiation step of PS in C2C12 myotubes.
The data presented in (Figs. 6-2 and 6-5B) showed that, LPS alone significantly
decreased p70
S6K
phosphorylation by -31 % (P < 0.05) compared to control
cells, while incubation of C2C12 myotubes with LPS and curcumin (12 and 25
ʅD Z ĐŽƵůĚ ŶŽƚ ƐŚŝĨƚ ƚŚŝƐ ĞĨĨĞĐƚ ƚŽ ƚŚĞŶŽƌŵĂů ďĂƐĂů ůĞǀĞůƐ  ?&ŝŐ ?  ? ? ? Z ? EŽƚĂďůǇ ?
ŝŶĐƵďĂƚŝŽŶ ŽĨ  ? ? ? ŵǇŽƚƵďĞƐ ǁŝƚŚ >W^ ĂůŽŶŐ ǁŝƚŚ ĐƵƌĐƵŵŝŶ  ? ? ? ʅD Z
significantly decreased the P70
S6K
activity by -56% (P < 0.01) compared with
the control cells (Figs. 6-2 and 6-5B).
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Figure (6-2) LPS and curcumin induced changes phospho-P70S6K. C2C12 myotubes
ǁĞƌĞŝŶĐƵďĂƚĞĚĞŝƚŚĞƌǁŝƚŚ>W^ ? ?ʅŐ ?ŵů Z ?ŽƌǁŝƚŚ>W^ ? ?ʅŐŵů-1) and Curcumin (12,
 ? ? ĂŶĚ  ? ? ʅD Z ? Žƌ ǁŝƚŚ ƵƌĐƵŵŝŶ  ? ? ? ?  ? ? ĂŶĚ  ? ? ʅD ZĂůŽŶĞ ĨŽƌ  ? Ś ? sĂůƵĞƐ ĂƌĞ
represented as means r SEM arbitrary unit normalised to ȕ-actin as an internal
loading control. Bars carry asterisks are statistically significant from control cells (
**
P
< 0.01). n = 5
C
LP
S
M
Cu
rc
um
in
P
LP
S+
12
M
Cu
rc
um
in
P
LP
S +
25
M
Cu
rc
um
in
P
LP
S +
50
M
Cu
rc
um
in
P
12
M
Cu
rc
um
in
P

M
Cu
rc
um
in
Ps
0.0
0.5
1.0
1.5
2.0
**
**
P7
0S
6K
Ph
o
s
ph
o
ry
la
tio
n
/E -
a
c
tin
(a
.
u
)
Chapter 6 The effect of the curcumin on protein metabolism in C2C12 myotubes
165
6.3.3 The effect of curcumin on the activity-related phosphorylation
of p38 and Erk1/2
The effect of LPS and LPS with curcumin and curcumin alone on the
phospho-p38 and phospho-Erk1/2 was summarised in (Figs. 6-3A, 6-3D, 6-5C
and 6-5D). Incubation of cells with LPS alone significantly increased p38
phosphorylation by 44% (P < 0.01) compared to the control cells. While, LPS
ǁŝƚŚ ĐƵƌĐƵŵŝŶ  ? ? ? ?  ? ? ĂŶĚ  ? ? ʅD Z ƐŝŐŶŝĨŝĐĂŶƚůǇ ĚĞĐƌĞĂƐ Ě ƚŚĞ Ɖ ? ?
phosphorylation (P < 0.001) compared with the LPS-treated group (Figs. 6-3A
and 6-5C). Similarly, incubation of C2C12 myotubes with curcumin (12, 25 and
 ? ? ʅD Z ĂůŽŶĞ ƐŝŐŶŝĨŝĐĂŶƚůǇ ĚĞĐƌĞĂƐĞĚ Ɖ ? ? ƉŚŽƐƉŚŽƌǇůĂƚŝŽŶ ĐŽŵƉĂƌĞĚ ƚŽ ƚŚĞ
LPS-treated. Regarding the phospho-Erk1/2, incubation of cells with LPS for 3
h significantly increased the Erk1/2 phosphorylation by 94% (P< 0.01)
compared with the control cells. Likewise, incubation of cells with LPS and
ĐƵƌĐƵŵŝŶ  ? ? ? ?  ? ? ĂŶĚ  ? ? ʅD Z ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ ƚŚĞ ƉŚŽƐƉŚŽƌǇůĂƚŝŽŶ ŽĨ
Erk1/2 by (100% (P < 0.05), 56% (P < 0.001) and 144% (P < 0.01), respectively)
compared to the control cells. Similarly, The Erk1/2 phosphorylation has been
ŝŶĐƌĞĂƐĞĚƐŝŐŶŝĨŝĐĂŶƚůǇǁŚĞŶƚŚĞĐĞůůƐǁĞƌĞŝŶĐƵďĂƚĞĚǁŝƚŚĐƵƌĐƵŵŝŶ ? ? ?ʅD Z
by 95% (PAM ? ? ? ? ZĂŶĚĐƵƌĐƵŵŝŶ ? ? ?ʅD ZďǇ ? ? ?A? ?P < 0.05) compared to the
control cells (Figs. 6-3B and 6-5D).
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Figure (6-3) LPS and curcumin induced changes in A) phospho-p38 and B) phospho-
ƌŬ ? ? ? ? ? ? ? ŵǇŽƚƵďĞƐǁĞƌĞ ŝŶĐƵďĂƚĞĚĞŝƚŚĞƌǁŝƚŚ >W^  ? ?ʅŐŵů-1) alone, or with
>W^ ? ?ʅŐ ?ŵů Z ?ŽƌǁŝƚŚƵƌĐƵŵŝŶ ? ? ? ? ? ?ĂŶĚ ? ?ʅD Z ?ĂŶĚ ƵƌĐƵŵŝŶ ? ? ? ? ? ?ĂŶĚ ? ?
ʅD ZĂůŽŶĞĨŽƌ ?Ś ?sĂůƵĞƐĂƌĞƌĞƉƌĞƐĞŶƚĞĚĂƐŵĞĂŶƐr SEM arbitrary unit normalised
to ȕ-actin as an internal loading control. Bars carry asterisks are statistically
significant from control and LPS-treated cells (
*
P < 0.05,
**
P < 0.01 and
***
P < 0.001).
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6.3.4 The effect of curcumin on the Ik ?ɲƉŚŽƐƉŚŽƌǇůĂƚŝŽŶ
Incubation of C2C12 myotubes with LPS significantly increased the
activity related phosphorylation of Ik ?ɲďǇ ? ?A? ?P < 0.05) and decreased the
total Ik ?ɲďǇ  ? ? ?A?(P < 0.05) compared with control cells (Figs. 6-4A and 6-
4B Z ? /ŶĐƵďĂƚŝŽŶ ŽĨ ĐĞůůƐ ǁŝƚŚ >W^ ĂŶĚ ĐƵƌĐƵŵŝŶ  ? ? ? ĂŶĚ  ? ? ʅD Z ƐŝŐŶŝĨŝĐĂŶƚůǇ
decreased the Ik ?ɲphosphorylation by -31% (P < 0.01) and -28% (P < 0.05)
compared to the LPS-treated cells (Figs. 6-4A and 6-5E). Incubation of C2C12
ŵǇŽƚƵďĞƐĞŝƚŚĞƌǁŝƚŚ>W^ŝŶĐŽŵďŝŶĂƚŝŽŶǁŝƚŚĐƵƌĐƵŵŝŶ ? ? ? ? ? ?ĂŶĚ ? ?ʅD ZŽƌ
ǁŝƚŚ ĐƵƌĐƵŵŝŶ  ? ? ? ?  ? ? ĂŶĚ  ? ? ʅD Z ĂůŽŶĞ ŚĂĚ ŶŽ ĞĨĨĞĐƚ ŽŶ ĞŝƚŚĞƌ /k ?ɲ
phosphorylated and total level compared with control cells (Figs. 6-4A, 6-4B
and 6-5E).
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Figure (6-4) >W^ĂŶĚĐƵƌĐƵŵŝŶŝŶĚƵĐĞĚĐŚĂŶŐĞƐŝŶ ZƉŚŽƐƉŚŽ ?/Ŭ ?ɲĂŶĚ ZƚŽƚĂů/kB-
ɲ ? ? ? ?ŵǇŽƚƵďĞƐǁĞƌĞ ŝŶĐƵďĂƚĞĚĞŝƚŚĞƌǁŝƚŚ>W^  ? ?ʅŐŵů-1) alone, or with LPS (1
ʅŐ ?ŵů ZĂŶĚƵƌĐƵŵŝŶ ? ? ? ? ? ?ĂŶĚ ? ?ʅD Z ?ŽƌǁŝƚŚƵƌĐƵŵŝŶ ? ? ? ? ? ?ĂŶĚ ? ?ʅD ZĂůŽŶĞ
for 3 h. Values are represented as means r SEM arbitrary unit normalised to ȕ-actin
as an internal loading control. Bars carry asterisks are statistically significant from
control and LPS-treated cells (
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P < 0.05 and
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Figure (6-5) Representative blots of A) Akt, B) p70S6K, C) p38, D) Erk 1/2 and E) Ik ?ɲ ?
 ? ? ? ŵǇŽƚƵďĞƐ ǁĞƌĞ ŝŶĐƵďĂƚĞĚ ĞŝƚŚĞƌ ǁŝƚŚ >W^  ? ? ʅŐŵů-1) alone, or with LPS (1
ʅŐŵů-1 ZĂŶĚƵƌĐƵŵŝŶ ? ? ? ? ? ?ĂŶĚ ? ?ʅD Z ?ŽƌǁŝƚŚƵƌĐƵŵŝŶ ? ? ? ? ? ?ĂŶĚ ? ?ʅD ZĂůŽŶĞ
for 3 h. values are normalised to the ȕ-actin as an internal loading control.
Total Akt
B-actin
pAkt
LPS - + + + + - - -
12 ȝ0     
25 ȝ0     
ȝ0      
A
P-p70S6K
B-actin
LPS - + + + + - - -
12 ȝ0     
25 ȝ0     
ȝ0      
B
B-actin
LPS - + + + + - - -
12 ȝ0     
25 ȝ0     
ȝ0      
P-p38
Total p38
C
S,.%Į
ǺDFWLQ
,.%Į 7RWDO
LPS - + + + + - - -
12 ȝ0     
25 ȝ0     
ȝ0      
E
pERK1/2
LPS - - - + + + + -
12ȝ0     
25 ȝ0     
ȝ0     
B-actin
D
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6.3.5 ƵƌĐƵŵŝŶĚĞĐƌĞĂƐĞƐƚŚĞůĞǀĞůŽĨdE& ?ɲĂŶĚ/> ? ?ĐǇƚŽŬŝŶĞƐ
Incubation of cells with LPS significantly increased the production of
dE& ?ɲ ĐǇƚŽŬŝŶĞ ďǇ  ? ?A?  ?P < 0.05) compared with the control cells. While,
ŝŶĐƵďĂƚŝŽŶ ŽĨ ĐĞůůƐ ǁŝƚŚ >W^ ŝŶ ĐŽŵďŝŶĂƚŝŽŶ ǁŝƚŚ ĐƵƌĐƵŵŝŶ  ? ? ? ?  ? ? ?  ? ? ʅD Z
ƐŝŐŶŝĨŝĐĂŶƚůǇ ĚĞĐƌĞĂƐĞĚ ƚŚĞ dE& ?ɲ ƉƌŽĚƵĐƚŝŽŶ ďǇ  ? ?A? ?  ? ?A? ĂŶĚ  ? ?A?
respectively (P < 0.001) compared with the LPS-treated cells. Interestingly
ŝŶĐƵďĂƚŝŽŶŽĨĐĞůůƐǁŝƚŚ>W^ĂŶĚĐƵƌĐƵŵŝŶ ? ? ?ʅD ZƐŝŐŶŝĨŝĐĂŶƚůǇĚĞĐƌĞĂƐĞĚƚŚĞ
dE& ?ɲ ƉƌŽĚƵĐƚŝŽŶ ďǇ  ? ? ?A?  ?P < 0.01) compared to the control group.
/ŶĐƵďĂƚŝŽŶŽĨĐĞůůƐǁŝƚŚĐƵƌĐƵŵŝŶ ? ? ?ĂŶĚ ? ?ʅD ZĂůŽŶĞƐŝŐŶŝĨŝĐĂŶƚůǇĚĞĐƌĞĂƐĞĚ
ƚŚĞdE& ?ɲƉƌŽĚƵĐƚŝŽŶďǇ ? ? ?A?ĂŶĚ ? ? ?A?ƌĞƐƉĞĐƚŝǀĞůǇ(P < 0.01) compared with
the control cells (Fig. 6-6). Regarding the IL-6, our data in (Fig. 6-7) showed
that, LPS significantly increase the IL-6 cytokine by 175% (P < 0.001) compared
to the control cells. Likewise, incubation of cells with LPS and curcumin (12, 25
ʅD ZƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚƚŚĞ /> ? ?ƉƌŽĚƵĐƚŝŽŶďǇ ? ?A?ĂŶĚ  ? ?A?ƌĞƐƉĞĐƚŝǀĞůǇ
(P < 0.05) compared to the control cells. Comparing this effect LPS-treated
ĐĞůůƐ ? ŝŶĐƵďĂƚŝŽŶ ŽĨ ĐĞůůƐ ǁŝƚŚ >W^ ĂůŽŶŐ ǁŝƚŚ ĐƵƌĐƵŵŝŶ  ? ? ? ?  ? ? ĂŶĚ  ? ? ʅD Z
significantly reduced the LPS mediated up-regulation of IL-6 by -37%, -40%,
and -70% respectively (P < 0.001,). Finally, incubation of cells with curcumin
 ? ? ?ĂŶĚ ? ?ʅD ZƐŝŐŶŝĨŝĐĂŶƚůǇƌĞĚƵĐĞĚ>W^ ?ŝŶĚƵĐĞĚ/> ? ?ƉƌŽĚƵĐƚŝŽŶďǇ ? ? ?A? ?P <
0.001) compared with control cells.
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Figure (6-6) ĨĨĞĐƚ ŽĨ >W^ ĂŶĚ ƵƌĐƵŵŝŶ ŽŶ ƚŚĞ ůĞǀĞů ŽĨ dE& ?ɲ ĐǇƚŽŬŝŶĞ ?  ? ? ?
myotubes incubated either with LPS  ? ?ʅŐŵů-1), or with LPS  ? ?ʅŐŵů-1) and curcumin
 ? ? ? ?  ? ?ĂŶĚ  ? ?ʅD Z ?ŽƌǁŝƚŚĐƵƌĐƵŵŝŶ  ? ? ? ?  ? ?ĂŶĚ  ? ?ʅD ZĂůŽŶĞĨŽƌ  ?Ś ?sĂůƵĞƐĂƌĞ
represented as means r SEM. Bars carry asterisks are statistically significant from
control and LPS-treated cells (
*
P < 0.05,
**
P < 0.01 and
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Figure (6-7) Effect of LPS and Curcumin on the media concentration levels of IL-6.
 ? ? ? ŵǇŽƚƵďĞƐ ǁĞƌĞ ŝŶĐƵďĂƚĞĚ ĞŝƚŚĞƌ ǁŝƚŚ >W^  ? ?ʅŐŵů-1) or with LPS  ? ? ʅŐŵů-1)
ĂŶĚĐƵƌĐƵŵŝŶ ? ? ? ? ? ?ĂŶĚ ? ?ʅD Z ?ŽƌǁŝƚŚĐƵƌĐƵŵŝŶ ? ? ? ? ? ?ĂŶĚ ? ?ʅD ZĂůŽŶĞĨŽƌ ?Ś ?
Values are represented as means r SEM. Bars carry asterisks are statistically
significant from control and LPS-treated cells (
*
P < 0.05,
**
P < 0.01 and
***
P < 0.001). n
= 6
C
L
PS M
)
P
L
PS
+
cu
rc
um
in
(1
2
M
)
P
L
PS
+
cu
rc
um
in
(2
5
M
)
P
L
PS
+
cu
rc
um
in
(5
0
M
)
P
C
ur
cu
m
in
(1
2
M
)
P
C
ur
cu
m
in
(2
5
M
)
P
C
ur
cu
m
in
(5
0
0
100
200
300
400
500
600
700
***
*
**
***
** ** **
IL
-6
(p
g
/m
l)
Chapter 6 The effect of the curcumin on protein metabolism in C2C12 myotubes
173
6.3.6 Incubation of C2C12 myotubes with LPS and Curcumin (25 ȝM)
decreases the LPS-induced chymotrypsin-like enzyme activity
Incubation of C2C12 cells with LPS alone significantly increased
chymotrypsin-like activity by 37% (P < 0.01) compared with control cells.
tŚŝůĞ ? ŝŶĐƵďĂƚŝŽŶ ŽĨ ĐĞůůƐ ǁŝƚŚ >W^ ĂůŽŶŐ ǁŝƚŚ ĐƵƌĐƵŵŝŶ  ? ? ? ĂŶĚ  ? ? ʅD Z
significantly increased chymotrypsin-like activity by 39% (P < 0.05) and 58% (P
< 0.001) compared with control cells (Fig. 6-8) respectively. Interestingly,
ŝŶĐƵďĂƚŝŽŶŽĨĐĞůůǁŝƚŚ>W^ĂŶĚĐƵƌĐƵŵŝŶ ? ? ?ʅD ZƐŝŐŶ ĨŝĐĂŶƚůǇĚĞĐƌĞĂƐĞĚƚŚĞ
chymotrypsin-enzyme like activity compared to cells treated LPS alone and
>W^ǁŝƚŚĐƵƌĐƵŵŝŶ ? ? ?ĂŶĚ ? ?ʅD Z ?&ŝŐ ? ? ? ? Z ?/ŶĐƵďĂƚŝŽŶŽĨĐĞůůƐǁŝƚŚĐƵƌĐƵŵŝŶ
 ? ? ?ĂŶĚ ? ?ʅD ZĂůŽŶĞŚĂƐŶŽĞĨĨĞĐƚŽŶƚŚĞĐŚǇŵŽƚƌǇƉƐŝŶ ?ĞŶǌǇŵĞůŝŬĞĂĐƚŝǀŝƚǇ
 ?&ŝŐ ? ? ? ? Z ?ǁŚŝůĞĐƵƌĐƵŵŝŶ ? ? ?ʅD ZĂůŽŶĞƐŝŐŶŝĨŝĐĂŶƚůǇŝŶĐƌĞĂƐĞĚĐŚǇŵŽƚƌǇƉƐŝŶ ?
like enzyme activity by 64% (P < 0.05) compared to the control cells (Fig. 6-8).
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Figure (6-8) Effect of LPS and Curcumin on the chymotrypsin-like enzyme activity.
C2C12 myotubes incubated either with LPS  ? ?ʅŐŵů-1), or with LPS  ? ?ʅŐŵů-1) and
ĐƵƌĐƵŵŝŶ  ? ? ? ?  ? ? ĂŶĚ  ? ?ʅD Z ?Žƌ ǁŝƚŚ ĐƵƌĐƵŵŝŶ  ? ? ? ? ? ? ĂŶĚ  ? ?ʅD Z ĂůŽŶĞ ĨŽƌ  ? Ś ?
Values are represented as means r SEM. Bars carry asterisks are statistically
significant from control cells (
*
P < 0.05,
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P < 0.01 and
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P < 0.001), n = 6
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6.3.7 Curcumin had no effect on protein synthesis rate in C2C12
myotubes
The final experiment was to elucidate the direct effect of curcumin on
the PS rate in LPS-stimulated C2C12 myotubes model. Incubation of C2C12
with LPS alone decreased the PS by -20% (P > 0.05) compared with control
cells (Fig. 6-9). Whereas, incubation of cells with LPS in combination with
ĐƵƌĐƵŵŝŶ  ? ? ? ʅD Z ƐŝŐŶŝĨŝĐĂŶƚůǇ ĚĞĐƌĞĂƐĞĚ ƚŚĞ W^ ƌĂƚĞ ďǇ  ? ? ?A?  ?P < 0.05)
compared with the control cells (Fig. 6-8). Likewise, incubation of cells with
ĐƵƌĐƵŵŝŶ ? ? ?ʅD ZĂůŽŶĞƐŝŐŶŝĨŝĐĂŶƚůǇĚĞĐƌĞĂƐĞĚƚŚĞW^ ƌĂƚĞ ?ŵĞĂƐƵƌĞĚĂƐ3H-
Tyrosine incorporation) by -35% (P > 0.5) compared with the control cells (Fig.
6-9).
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Figure (6-9) Effect of LPS and Curcumin on protein synthesis rate. C2C12 myotubes
were incubated either with LPS  ? ?ʅŐŵů-1) or with LPS  ? ?ʅŐŵů-1) and curcumin (12,
 ? ? ĂŶĚ  ? ? ʅD Z Žƌ ǁŝƚŚ ĐƵƌĐƵŵŝŶ  ? ? ? ?  ? ? ĂŶĚ  ? ? ʅD Z ĂůŽŶĞ ĨŽƌ  ? Ś ? sĂůƵĞƐ ĂƌĞ
represented as means r SEM. Bars carry asterisks are statistically significant from the
control cells (
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6.4 Discussion
Decreased lean body mass is a well known outcome of sepsis. This
decrease results originally from an accelerated rate of protein degradation
and decreased rate of PS. The ubiquitin-proteasome pathway is most
important catabolic pathway activated in many acute catabolic conditions
(Bodine et al., 2001). There is has been a remarkable increase in our
knowledge regarding the factors involved in maintenance the skeletal muscle
protein balance during the last two decades however, a better understandings
is needed to develop appropriate therapeutic interventions to lessen the
adverse effects of sepsis is needed. Thus, the aim was to investigate the direct
role of curcumin in maintaining the balance between the protein degradation
and PS rates. We have used the LPS-stimulated C2C12 myotubes model to test
our hypothesis.
The obtained data along with others in vivo studies (Jin and Li 2007;
Poylin et al., 2008) demonstrated the value of curcumin as a possible
intervention for sepsis-induced muscle wasting. Our model is an in vitromodel
which has shown for the first time the direct role curcumin in preventing the
protein degradation with no effect on the LPS-induced decreased PS. Our data
have shown that:1) curcumin significantly increased the phosphorylation of
Akt, while it could not change the LPS-induced decreased P70
S6K
phosphorylation; 2) curcumin significantly decreased the LPS-induced
increased P38 activity, while it significantly increased the Erk1/2
phosphorylation; 3) Curcumin could not abolish the LPS-induced decreased PS
rate in C2C12 myotubes; 4) curcumin significantly decreased the LPS-induced
IK ?ɲ ƉŚŽƐƉŚŽƌǇůĂƚŝŽŶ ĂŶĚ ƉƌĞǀĞŶƚĞĚ ƚŚĞ >W^ ?ŝŶĚƵĐĞĚ ĚĞŐƌĂĚĂƚŝŽŶ ŽĨ ƚŽƚĂů
Ik ?ɲ ? ? ZĐƵƌĐƵŵŝŶƐŝŐŶŝĨŝĐĂŶƚůǇďůŽĐŬĞĚ>W^ ?ŝŶĚƵĐĞĚdE& ?ɲĂŶĚ/> ? ?ĐǇƚŽŬŝŶĞƐ
production; 6) only curcumin (25 ȝM) significantly decreased the
chymotrypsin-like activity in an effect mediated possibly via the p38 and IK ?ɲ
pathways.
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Although, Our data have shown that only curcumin (25 ȝM) decreased
the LPS-induced accelerated proteasomal activity with no effect on the LPS-
induced decreased PS, this suggests curcumin as a potential therapy in sepsis-
induced muscle wasting with no side effects even at high doses (Chainani-Wu
2003). Curcumin abolished the LPS-induced proteolytic activity and hence it
restore LPS-induced muscle breakdown. This effect was similar to that
obtained in vitro; curcumin significantly decreased LPS-induced decreased
protein content in gasterocnemius muscle (Jin and Li 2007). The data in
presented herein and in chapter 3 (Fig. 3-1A) with others (Crossland et al.,
2008; Frost et al., 2009) have shown that, LPS is a potent catabolic stimulus
which suppresses Akt and its down-stream effectors mTOR and the translation
initiation mediator (p70
S6K
, eIF-4E and 4E-BP1). Decreased Akt
phosphorylation leads to increased protein breakdown via the activation of
the ubiquitin-proteasome system mainly atrogin-1 ubiquitin ligase (Sandri et
al., 2004; Stitt et al., 2004). Herein, curcumin effectively blocked the LPS-
ŝŶĚƵĐĞĚ ĚĞĐƌĞĂƐĞĚ Ŭƚ ƉŚŽƐƉŚŽƌǇůĂƚŝŽŶ ? ŵŽƌĞŽǀĞƌ ĐƵƌĐƵŵŝŶ  ? ? ? ʅD Z ĂůŽŶĞ
significantly increased Akt phosphorylation in C2C12 myotubes (in vitro), while
in case of the in vivo study that carried out by Jin and Li (2007), curcumin
could not alter the LPS-induced decreased Akt activity in mice skeletal muscle.
Increased Akt has been implicated in many fundamental cellular processes
including protein synthesis via mTOR and their downstream molecules
(translation initiation mediators mainly, p70
S6K
, 4E-BP1 and eIF-4E) for more
details see (Glass 2005; Wu et al., 2010).
Increased Erk1/2 activity has also been implicated in the stimulation of
the protein translation initiation through a pathway that most likely involves
the phosphorylation of eIF-4E mediated through the Mnk1 phosphorylation
(Waskiewicz et al. 1997; Ueda et al. 2004). Herein, curcumin (12, 25 and 50
ʅD Z ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ ƌŬ ? ? ? ƉŚŽƐƉŚŽƌǇůĂƚŝŽŶĚĞƐƉŝƚĞ ƚŚĞ ƉƌĞƐĞŶĐĞ ŽĨ
>W^ ?/ŶĂĚĚŝƚŝŽŶ ?ĐƵƌĐƵŵŝŶ ? ? ?ĂŶĚ ? ?ʅD ZĂůŽŶĞƐŝŐŶŝĨŝĐĂŶƚůǇŝŶĐƌĞĂƐĞĚƌŬ ? ? ?
phosphorylation. In chapter 3, we have shown that inhibition of Akt and
Erk1/2 significantly decreased the PS in C2C12 myotubes. In this chapter,
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although curcumin significantly increased Akt and Erk1/2 phosphorylation,
however this effect was not sufficient to abolish the catabolic effect of LPS on
the PS. Incubation of the cells with LPS alone decreased the PS by -20% (P >
0.05) compared with the control cells. This suggesting that, the correlation
between the activity of anabolic signalling and the PS does not always exist
(Miranda et al. 2008; Atherton et al. 2009). Taken together, LPS is a strong
catabolic stimulus altering muscle protein metabolism mainly via decreased
PS and increased PD rates.
Increased p38 phosphorylation has been reported in many pro-catabolic
conditions including limb immobilization (Childs et al., 2003), Type 2 diabetes
(Koistinen et al., 2003) and aging (Williamson et al., 2003). The results
included in this chapter showed that, LPS is a strong stimulus of p38 activity,
this is consistent with the finding of Jin and Li (2007). The positive correlation
between the increased p38 and increased atrogin-1 mRNA has been
demonstrated in many in vivo studies (Li et al., 2005; Jin and Li 2007).
Moreover, increased NF-kB activity in skeletal muscle has been shown during
sepsis (Penner et al., 2001) or in cultured myotubes treated with pro-
inflammatory cytokines (Li and Reid 2000; Ladner et al., 2003). NF-kB a
transcriptional factor family protein which when bound to NF-kB inhibitory
protein (Ik ?ɲ Z ƉůĂǇƐ Ă ƐŝŐŶŝĨŝĐĂŶƚ ƌŽůĞ ŝŶ ƚŚĞ ƐĞƉƐŝƐ ?ŝŶĚƵĐĞĚ ŵƵƐĐůĞ ǁĂƐƚŝŶŐ
(Cai et al., 2004). Taken together, LPS significantly increased the
phosphorylation of p38 and Ik ?ɲ ? ǁŚŝůĞ ĐƵƌĐƵŵŝŶ ďůŽĐŬĞĚ ƚŚĞ >W^ ?ŝŶĚƵĐĞĚ
p38 and Ik ?ɲƉŚŽƐƉŚŽƌǇůĂƚŝŽŶ ?dŚŝƐƐƵŐŐĞƐƚƐƚŚĂƚ ?ĐƵƌĐƵŵŝŶĐĂŶŝŶŚŝďŝƚŵĂŶǇ
proteolytic pathways activated in sepsis (Poylin et al., 2008), and this leading
to a significant reduction in the LPS-induced proteasomal activity.
>W^ ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ ƚŚĞ dE& ?ɲ ĂŶĚ /> ? ? ƉƌŽĚƵĐƚŝŽŶ ŝŶ ƐŬĞůĞƚĂů
ŵƵƐĐůĞŝŶĂƚŝŵĞĂŶĚĚŽƐĞ ?ĚĞƉĞŶĚĞŶƚǁĂǇ ?ĂŶĚŝŶĐƵďĂƚŝŽŶŽĨĐĞůůƐǁŝƚŚdE& ?ɲ
has been shown to increase the expression of IL-6 mRNA (Frost et al., 2002).
dŚĞ ƌĞƐƵůƚƐ ƌĞŐĂƌĚŝŶŐ ƚŚĞ ƌŽůĞ ŽĨ dE& ?ɲ ŝŶ ŵƵƐĐůĞ ƉƌŽƚĞŝŶ ĚĞŐƌĂĚĂƚŝŽŶ ĂƌĞ
controversial. Some studies (Costelli et al., 1993; Garcia-Martinez et al., 1993),
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ĚĞŵŽŶƐƚƌĂƚĞĚ ƚŚĂƚ ? dE& ?ɲ ĞŶŚĂŶĐĞĚ ŽĨ ƉƌŽƚĞŝŶ ĚĞŐƌĂĚƚŝŽŶ ŝŶ ƌĂƚ ƐŬĞůĞƚĂů
muscle, and this effect is mediated via p38 and NF-kB pathway (Jin and Li
2007). Recently, Plaisance et al ? ? ? ? ? ? ZĚĞŵŽŶƐƚƌĂƚĞĚƚŚĂƚdE& ?ɲƐŝŐŶŝĨŝĐĂŶƚůǇ
increased the protein synthesis in myotubes, and this effect was mediated via
the stimulation of the Akt/Erk1/2 and their down-stream translation initiation
mediators. Similarly, IL-6 plays a controversial role, with some studies showing
its contribution while the other does not. Herein, curcumin significantly
ĂůƚĞƌĞĚƚŚĞ>W^ ?ƐƚŝŵƵůĂƚĞĚdE& ?ɲĂŶĚ /> ? ?ƉƌŽĚƵĐƚŝŽŶ  ?&ŝŐƐ ?  ? ? ?ĂŶĚ ? ? ? ZĂŶĚ
this effect is associated with significant reduction in the chymotrypsin-like
activity especially with curcumin (25 ȝM). This suggests that, the LPS-induced
dE& ?ɲ ĂŶĚ /> ? ? ƉƌŽĚƵĐƚŝŽŶ ŝŶ  ? ? ? ŚĂƐ ďĞĞŶ ůŝŶŬĞĚƚŽ ƚŚĞ ŵƵƐĐůĞ ƉƌŽƚĞŝŶ
degradation, and the reverse of muscle protein can be achieved when these
cytokines are blocked.
Thus, although curcumin (25 ȝM) significantly decreased LPS-induced
proteasomal activity but this had no positive effect on the LPS-induced
decreased PS, nevertheless, these effects are still promising but further in
vitro investigation are needed. Of note, this effect of curcumin on skeletal
muscle protein balance (decreasing protein degradation) in addition to the in
vivo findings of Polyin et al. (2008), does not encourage the use of curcumin
as a drug of muscle wasting in sepsis but encourages using curcumin in a
preventive capacity. Although, herein curcumin (25 ȝM) significantly
decreased the protein degradation in LPS-stimulated C2C12 myotubes, a
similar finding obtained from in vitro studies, yet, further investigation are
required before applying the curcumin as a drug in septic patients, and to
validate the beneficial effects of curcumin obtained from our study and other
in vivo studies (Jin & Li, 2007; Poylin et al., 2008).
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6.5 Conclusion
LPS is a potent catabolic stimulus significantly induced muscle
proteolysis along with decrease rate of protein synthesis. This effect was
mediated mainly via increased p38 and Ik ?ɲƉŚŽƐƉŚŽƌǇůĂƚŝŽŶĂůŽŶŐǁŝƚŚƚŚĞ
ůŝďĞƌĂƚŝŽŶ ŽĨ ŵĂŶǇ ƉƌŽ ?ŝŶĨůĂŵŵĂƚŽƌǇ ĐǇƚŽŬŝŶĞƐ ŝŶ ƉĂƌƚŝĐƵůĂƌ dE& ?ɲ ĂŶĚ /> ? ? ?
Curcumin (25 ȝM) significantly abolished this effect and thus leads to
significant reduction in the proteasomal activity. In contrast, although
curcumin significantly increased the phosphorylation of Akt and Erk1/2,
however this effect was not sufficient to abolish the LPS-induced decreased
PS.
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7 Avian primary skeletal muscle cell resist the effect of
LPS
7.1 Introduction
Primary cultures of skeletal muscle are considered as an ideal model
for studying terminal cellular differentiation, and extensively used for the
study of the in vitro myogenesis (Richler and Yaffe 1970; Braun et al., 1989).
The primary cultures of skeletal muscle have been widely used in the study of
animal models of muscular and neuromuscular diseases and parasitic
cytogenesis (Fong et al., 1990; Metzinger et al., 1993; Passaquin et al., 1993;
Bouzakri et al., 2003; Guimaraes et al., 2008). Under normal conditions, the
balance between the rate of protein degradation and synthesis controls the
maintenance of the lean body mass. Sepsis is an acute inflammatory
condition characterised by accelerated rate of protein degradation with or
without decreased rate of PS.
The regulation of the muscle protein metabolism has been measured
either in vitro using C2C12 murine skeletal myotubes (Frost et al., 2009;
Russell et al., 2010), or in vivo using a septic rat model (Lang et al., 2000; Vary
and Kimball 2000; Lang and Frost 2007), and in primary cultured myotubes
(Vandenburgh and Kaufman 1980; Janeczko and Etlinger 1984; Gulve and
Dice 1989). The skeletal muscle cells can be grown as a primary cultures
(Konigsberg 1979), with similar features as the embryonic muscle, for more
details see (Fischbach et al., 1974; Sandra and Przybylski 1979; Siegelbaum et
al., 1984). Therefore, cultured muscle cells are considered as a unique model
to study various catabolic conditions where the net nitrogen balance can
range from positive to negative(Gulve and Dice 1989). In vivo studies have
shown that, LPS significantly decreased the PS rate in the gastrocnemius
muscle of rat (Lang et al., 2000). In addition, sepsis significantly decreased
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the rate of PS in the gastrocnemius but not in the slow-twitch soleus muscle
(Vary and Kimball 1992). In vitro studies using C2C12 myotubes remain
controversial. Frost et al. (2009) showed that LPS alone had no effect on PS in
 ? ? ?ŵǇŽƚƵďĞƐ ?ǁŚŝůĞ>W^ŝŶĐŽŵďŝŶĂƚŝŽŶǁŝƚŚ/&E ?ɶƐŝŐŶŝĨŝĐĂŶƚůǇĚĞĐƌĞĂƐĞĚ
PS by 80%. In alter study by Russell et.al (2010) a significant 50-60%
decreases in the PS rate in response to LPS in the same cell line was shown.
Previous in vitro and in vivo studies demonstrated that sepsis increased the
rate of protein degradation and decreased the rate of PS acting on the
translation initiation level (Vary et al., 1994; Jurasinski et al., 1995; Lang et
al., 2000; Lang and Frost 2007), not the reduction in the elongation (Vary and
Kimball 1992). Similarly, the available data about the regulation of the
protein breakdown in primary chick myotubes (Vandenburgh and Kaufman
1980; Janeczko and Etlinger 1984; McElligott and Dice 1984) and in
myoblasts from the L6 rat cell line (Ballard 1982; Ballard and Francis 1983;
Ballard et al., 1986), propose that both protein synthesis and degradation are
subjected to regulation. This regulation has been carefully compared by
Ballard (1982). The process of protein synthesis includes three main steps:
initiation, elongation, and termination. Akt is one of the most extensively
studied anabolic signalling pathways. Increased Akt activity is associated with
skeletal muscle hypertrophy via increased protein synthesis (Lai et al., 2004).
In contrast, decreased Akt activity has been demonstrated in burn-induced
muscle atrophy (Sugita et al., 2005). The direct contribution of Akt in both
muscle atrophy and hypertrophy has been discussed in details in (Glass 2005;
Wu et al. 2010). The translation initiation step of protein synthesis controlled
by a group of eIFs. The eIF-4E is bound to 4E-BP1. This limits the availability
of eIF-4E for the formation of eIF4E/eIF4G active complex. This effect is
withdrawn by the phosphorylation of 4E-BP1 (Flynn and Proud 1996). In
sepsis the amount of eIF4E/4E-BP1 inactive complex is increased in
gastrocnemius muscle by 80% and later it significantly decreased the amount
of the active eIF4E/eIF4G active complex by a 65% (Lang and Frost 2007).
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LPS increases the skeletal muscle protein breakdown via stimulation
of the ubiquitin proteasome pathway (Hershko and Ciechanover 1998). This
effect is preceded by increased cytokines synthesis and accumulation of their
mRNA in the skeletal muscle mediated via TLR4 (Frost et al., 2002). It has
previously been shown that, LPS significantly increased the release and
ƉƌŽĚƵĐƚŝŽŶ ŽĨ dE& ?ɲ ĂŶĚ /> ? ?ɴ  ?sĂƌǇ  ? ? ? ? ? >ĂŶŐet al., 2003) two main
mediators implicated in the muscle proteolysis. However, it still unclear, how
the avian primary skeletal muscle cells respond to LPS.
The use of primary cells has been used to mimic the in vivo state and
generate more physiologically relevant data and has become a common
technique. Once differentiation has occurred, cultured skeletal muscle
myotubes may respond to factors that modulate protein degradation and
synthesis in adult skeletal muscle (Vandenburgh and Kaufman 1980).
In the previous chapters (3 & 4), that the data presented showed that
LPS increases the chymotrypsin-like enzyme activity and decreases the rate
of PS in C2C12 myotubes. LPS significantly decreased the rate of PS by 50%
but this effect is transient lasting for 3 h, and is mediated by TLR4 and the Akt
signalling cascades. It was also demonstrated that, LPS increased the
ƐǇŶƚŚĞƐŝƐĂŶĚƚŚĞƌĞůĞĂƐĞŽĨŵĂŶǇĐǇƚŽŬŝŶĞƐŝŶĐůƵĚŝŶŐ ?dE& ?ɲĂŶĚ/> ? ? ?&ŝŶĂůůǇ ?
LPS increased the mRNA level of the atrogin-1, MuRF1 and TLR4. In the
present chapter the aim was to explore the effect of LPS on the avian primary
skeletal muscle protein metabolism (protein synthesis and breakdown).
dŚĞƌĞĨŽƌĞ ? >W^  ? ? ʅŐŵů-1)-stimulated avian primary skeletal muscle cells
model was used for 3 h and 18 h. Prof. Kin Chaw Chang generously provided
the avian primary skeletal muscle cells.
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7.2 Hypothesis
In the previous chapters, the data presented have shown that LPS
mediated increased protein breakdown and decreased protein synthesis. This
effect involves the interaction of many signalling pathways including PI3K/Akt
and MAPKs (p38 or Erk). In contrast, there is no clear data regarding the effect
of LPS on primary skeletal muscle cells. We assume that the effect of LPS on
avian primary skeletal muscle will not be the same. Therefore, LPS stimulated
avian primary skeletal muscle cells septic model for 3 h has been used. We
have only one time point (3 h) because the maximal changes in PS in C2C12
myotubes were observed at this time point.
7.3 Results
7.3.1 LPS effect on Akt, 4E-BP1 and eIF-4 phosphorylation
Incubation of the primary skeletal muscle with LPS for 3 h decreased
Akt and eIF-4E phosphorylation but this effect was not significant compared
to the untreated control cells (Figs. 7-1A and 7-1C). While, LPS significantly
increased the activity related phosphorylation of 4E-BP1 (P < 0.01) compared
to the untreated control cells (Fig. 7-1B).
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Figure (7-1) Changes in A) phospho-Akt , B) phospho-4E-BP1, and C) phospho-eIF-
4E. Avian primary skeletal muscle cells were incubated with LPS  ? ?ʅŐŵů-1) for 3 h.
Then western blotting method was used to measure the level of phosphorylated
protein. Values are represented as arbitrary unit means r SEM normalized to the
ůĞǀĞůƐŽĨɴ ?ĂĐƚŝŶĂƐĂŶ ŝŶƚĞƌŶĂů ůŽĂĚŝŶŐĐŽŶƚƌŽů ?ĂƌƐĐĂƌƌǇĂƐƚĞƌŝƐŬƐĂƌĞ ƐƚĂƚŝƐƚŝĐĂůůǇ
significant from control cells (
**
P < 0.01). n = 6
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7.3.2 LPS significantly decreased the proteasomal activity
LPS decreased the chymotrypsin-like enzyme activity (P < 0.05)
compared with the untreated control cells (Fig. 7-2). The effect of LPS on the
chymotrypsin-like enzyme activity verified using specific inhibitors. MG-132,
the specific proteasome inhibitor decreased the chymotrypsin-like enzyme
activity (P < 0.001) compared with the untreated control cells. Similarly,
ŝŶĐƵďĂƚŝŽŶŽĨƚŚĞĐĞůůƐǁŝƚŚ>W^ĂŶĚWŽůǇŵǇǆŝŶ ? ?ʅŐŵů-1), or with LPS and
ĐƵƌĐƵŵŝŶ  ? ? ? ʅD Z ƐŝŐŶŝĨŝĐĂŶƚůǇ ĚĞĐƌĞĂƐĞĚ ƚŚĞ ĐŚǇŵŽƚƌǇƉƐŝŶ ?ůŝŬĞ ĞŶǌǇŵĞ
activity (P < 0.01 and P < 0.001 compared to the control cells respectively)
(Fig. 7-2). In contrast, incubation of the primary skeletal muscle cells with the
>W^ ĂŶĚ >z ? ? ? ? ? ? ?  ? ? ? ʅD Z ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ ƚŚĞ ĐŚǇŵŽƚƌǇƉƐŝŶ ůŝŬĞ
activity compared with the untreated control cells (P < 0.05), and compared
with the LPS-treated cells (P < 0.001) (Fig. 7-2). Incubation of cells with LPS
ĂŶĚ ^ ? ? ? ? ? ?  ?^ ?  ? ? ʅD Z Žƌ W ? ? ? ? ? ?  ?W ?  ? ? ʅD Z ŚĂĚ ŶŽ ĞĨĨĞĐƚ ŽŶ ƚŚĞ
chymotrypsin-like enzyme activity (Fig. 7-2).
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Figure (7-2) Changes in chymotrypsin-like enzyme activity (proteasomal degrdation
of muscle protein). Avian primary skeletal muscle cells were incubated either with
LPS ( ? ʅŐŵů-1) ĂůŽŶĞ ? >W^ ĂŶĚ D' ? ? ? ?  ?ƉƌŽƚĞĂƐŽŵĂů ŝŶŚŝďŝŽƚƌ Z  ? ? ? ʅD Z >W^ ĂŶĚ
>z ? ? ? ? ? ? ? ?W/ ? ?< ?ŬƚŝŶŚŝďŝƚŽƌ Z ?>z ? ? ?ʅD Z ?>W^ĂŶĚ^ ? ? ? ? ? ? ?Ɖ ? ?ŝŶŚŝďŝŽƚƌ Z ?^ ? ? ?
ʅD Z ?>W^ĂŶĚW ? ? ? ? ? ? ?D< ?ƌŬŝŶŚŝďŝƚŽƌ Z ?W ? ? ?ʅD Z >W^ ĂŶĚWŽůǇŵǇǆŝŶ ?>W^
ŶĞƵƚƌĂůŝƐŶŐĂŐŶĞƚ Z  ?WD ?  ?ʅŐŵů-1 Z ?Žƌ>W^ĂŶĚĐƵƌĐƵŵŝŶ  ? ? ?ʅD ZĨŽƌ ?Ś ?sĂůƵĞƐĂƌĞ
represented as means r SEM (percentage of control). Bars carry asterisks are
statistically significant from the control cells (
*
P < 0.05,
**
P < 0.01 and
***
P < 0.001). n
= 3
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7.3.3 >W^ŚĂƐŶŽĞĨĨĞĐƚŽŶƚŚĞdE& ?ɲŵZE
Incubation of the avian primary skeletal muscle with LPS alone or in
ĐŽŵďŝŶĂƚŝŽŶǁŝƚŚWŽůǇŵǇǆŝŶ ? ?ʅŐŵů-1 Z ?^ ? ? ? ? ? ? ?^ ? ? ?ʅD Z ?W ? ? ? ? ? ?
 ?W ? ? ?ʅD Z ?Žƌ>z ? ? ? ? ? ? ? ?>z ? ? ?ʅD ZŚĂĚŶŽĞĨĨĞĐƚŽŶƚŚĞdE& ?ɲŵZE
expression level (Fig. 7-3).
Figure (7-3) ŚĂŶŐĞƐ ŝŶ dE& ?ɲ ŵZE ? ǀŝĂŶ ƉƌŝŵĂƌǇ ƐŬĞůĞƚĂů ŵƵƐĐůĞ ĐĞůůƐ ǁĞƌĞ
incubated either with LPS  ? ?ʅŐŵů-1) ĂůŽŶĞ ?ĞǆĂŵĞƚŚĂƐŽŶĞ ?y ? ? ?ʅD Z ?>W^ĂŶĚ
>z ? ? ? ? ? ? ? ?W/ ?< ?ŬƚŝŶŚŝďŝƚŽƌ Z ?>z ? ? ?ʅD Z ?>W^ĂŶĚ^ ? ? ? ? ? ? ?Ɖ ? ?ŝŶŚŝďŝƚŽƌ Z ?^ ? ? ?
ʅD Z ?>W^ĂŶĚW ? ? ? ? ? ?  ?D< ?ƌŬ ŝŶŚŝďŝƚŽƌ Z  ?W ? ? ?ʅD Z >W^ĂŶĚWŽůǇŵǇǆŝŶ  ?>W^
ŶĞƵƚƌĂůƐŝŶŐĂŐĞŶƚ Z ?WD ? ?ʅŐŵů-1 Z ?Žƌ>W^ĂŶĚĐƵƌĐƵŵŝŶ ? ? ?ʅD ZĨŽƌ ?Ś ?sĂůƵĞƐĂƌĞ
represented as means r SEM (percentage of control). n = 3
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7.3.4 LPS has no effect on the atrogin-1 mRNA activity
Incubation of cells with LPS alone had no effect on atrogin-1 mRNA.
Likewise, incubation of cells with LPS in combination with Polymyxin B (PMB,
 ?ʅŐŵů-1 Z ?^ ? ? ? ? ? ? ?^ ? ? ?ʅD ZĂŶĚW ? ? ? ? ? ? ?W ? ? ?ʅD ZŚĂĚŶŽ ĞĨĨĞĐƚŽŶ
the atrogin-1 mRNA. On the contrary, incubation of the cells with LPS and
>z ? ? ? ? ? ? ?  ?>z ?  ? ? ʅD Z ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ ĂƚƌŽŐŝŶ ? ? ŵZE ďǇ  ? ? ? ? ?r
84.62% compared with untreated control cells (P < 0.01), and compared with
LPS-treated cells (P < 0.001). The effect of LPS on atrogin-1 mRNA was
compared against dexamethasone, where it significantly increased atrogin-1
mRNA by 475.1 r 85.36% (P < 0.001) compared with the untreated control
cells (Fig. 7-4).
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Figure (7-4) Changes in atrogin-1 mRNA expression. Avian primary skeletal muscle
cells were incubated either with LPS  ? ? ʅŐŵů-1) alone, Dexamethasone (DEXA, 10
ʅD Z ? >W^ ĂŶĚ >z ? ? ? ? ? ? ?  ?W/ ? ?< ?Ŭƚ ŝŶŚŝďŝƚŽƌ Z  ?>z ?  ? ? ʅD Z ? >W^ ĂŶĚ ^ ? ? ? ? ? ?  ?Ɖ ? ?
ŝŶŚŝďŝƚŽƌ Z  ?^ ?  ? ?ʅD Z ?>W^ĂŶĚW ? ? ? ? ? ?  ?D< ?ƌŬ ŝŶŚŝďŝƚŽƌ Z  ?W ?  ? ?ʅD Z ?>W^ĂŶĚ
WŽůǇŵǇǆŝŶ ?>W^ŶĞƵƚƌĂůƐŝŶŐĂŐĞŶƚ Z ?WD ? ?ʅŐŵů-1 Z ?Žƌ>W^ĂŶĚĐƵƌĐƵŵŝŶ ? ? ?ʅD ZĨŽƌ
3 h. Values are represented as means r SEM (percentage of control). Bars carry
asterisks are statistically different the control cells (
**
P < 0.01 and
***
P < 0.001). n = 3
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7.3.5 LPS has no effect on the expression level of the IL-6, caspase-3 and
ubiquitin mRNA
Incubation of cells with LPS alone or in combination with specific
inhibitors had no effect on the expression levels of the IL-6 mRNA (Fig. 7-5),
caspase-3 mRNA (Fig. 7-6) and ubiquitin mRNA (Fig. 7-7).
Figure (7-5) Changes in IL-6 mRNA expression. Avian primary skeletal muscle cells
ǁĞƌĞŝŶĐƵďĂƚĞĚĞŝƚŚĞƌǁŝƚŚ>W^ ? ?ʅŐŵů-1 ZĂůŽŶĞ ?ĞǆĂŵĞƚŚĂƐŽŶĞ ?y ? ? ?ʅD Z ?>W^
ĂŶĚ >z ? ? ? ? ? ? ?  ?W/ ? ?< ?Ŭƚ ŝŶŚŝďŝŽƚƌ Z  ?>z ?  ? ? ʅD Z ?>W^ ĂŶĚ ^  ? ? ? ? ?  ?Ɖ ? ? ŝŶŚŝďŝƚŽƌ Z
 ?^ ? ? ?ʅD Z ?>W^ĂŶĚW ? ? ? ? ? ? ?D< ?ƌŬŝŶŚŝďŝƚŽƌ Z ?W ? ? ?ʅD Z ?>W^ĂŶĚWŽůǇŵǇǆŝŶ
 ?>W^ŶĞƵƚƌĂůƐŝŶŐĂŐĞŶƚ Z ?WD ? ?ʅŐŵů-1 Z ?Žƌ>W^ĂŶĚĐƵƌĐƵŵŝŶ ? ? ?ʅD ZĨŽƌ ?Ś ?sĂůƵĞƐ
are represented as means r SEM (percentage of control). n = 3
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Figure (7-6) Changes in caspase-3 mRNA expression Avian primary skeletal muscle
cells were incubated either with LPS  ? ? ʅŐŵů-1) alone, Dexamethasone (DEXA, 10
ʅD Z ? >W^ ĂŶĚ >z ? ? ? ? ? ? ?  ?W/ ?< ?Ŭƚ ŝŶŚŝďŝƚŽƌ Z  ?>z ?  ? ? ʅD Z  >W^ ĂŶĚ ^ ? ? ? ? ? ?  ?W ? ?
ŝŶŚŝďŝƚŽƌ Z  ?^ ?  ? ?ʅD Z ?>W^ĂŶĚW ? ? ? ? ? ?  ?D< ?ƌŬ ŝŶŚŝďŝƚŽƌ Z  ?W ?  ? ?ʅD Z ?>W^ĂŶĚ
WŽůǇŵǇǆŝŶ ?>W^ŶĞƵƚƌĂůƐŝŶŐĂŐĞŶƚ Z ?WD ? ?ʅŐŵů-1 Z ?Žƌ>W^ĂŶĚĐƵƌĐƵŵŝŶ ? ? ?ʅD ZĨŽƌ
3 h. Values are represented as means r SEM (percentage of control). Bars carry
asterisks are statistically different from control cells (
*
P < 0.05). n = 3
C
L
PS
g/
m
l)
P
L
PS
+
PM
B
(
M
)
P
L
PS
+
SB
(1
0
M
)
P
0
L
PS
+
PD
(
M
)
P
L
PS
+
C
ur
cu
m
in
(1
M
)
P
0
L
Y
(
+
L
PS
M
)
P
D
E
X
A
(1
0
0
100
200
300
400 *
C
a
sp
a
se
-3
m
R
N
A
(%
C
o
n
tr
o
l)
Chapter 7 Avian primary skeletal muscle cells resist the effect of LPS
194
Figure (7-7) Changes in Ubiquitin mRNA expression. Avian primary skeletal muscle
cells were incubated either with LPS  ? ? ʅŐŵů-1) alone, Dexamethasone (DEXA, 10
ʅD Z ? >W^ ĂŶĚ >z ? ? ? ? ? ? ?  ?W/ ?< ?Ŭƚ ŝŶŚŝďŝƚŽƌ Z  ?>z ?  ? ? ʅD Z  >W^ ĂŶĚ ^ ? ? ? ? ? ?  ?Ɖ ? ?
ŝŶŚŝďŝƚŽƌ Z  ?^ ?  ? ?ʅD Z ?>W^ĂŶĚW ? ? ? ? ? ?  ?D< ?ƌŬ ŝŶŚŝďŝƚŽƌ Z  ?W ?  ? ?ʅD Z ?>W^ĂŶĚ
WŽůǇŵǇǆŝŶ ?>W^ŶĞƵƚƌĂůŝƐŶŐĂŐĞŶƚ Z ?WD ? ?ʅŐŵů-1 Z ?Žƌ>W^ĂŶĚĐƵƌĐƵŵŝŶ ? ? ?ʅD ZĨŽƌ
3 h. Values are represented as means r SEM (percentage of control). n = 3
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7.3.6 LPS significantly increased the rate of PS
The data presented before showed that LPS significantly decreased
the chymotrypsin-like enzyme activity and that it has no effect on the major
catabolic mediators. Therefore, the next experiment was mainly to evaluate
the direct effect of LPS on the rate of PS expressed as percentage
3
H-Tyrosine
incorporation/ ȝg 5% TCA precipitable protein. It was found that LPS
increased the rate of PS by 251 % (P < 0.001) after 3 h treatment (Fig. 7-8)
with no further change was observed at the 18 h time point.
Figure (7-8) Changes in PS rate expressed as the direct incorporation of 3H-
Tyrosine. Avian primary skeletal muscle cells were incubated with LPS  ? ? ʅŐŵů-1)
alone for 3 and 18 h. Values are represented as means r SEM (percentage of
control). Bars carry asterisks are significantly significant from the control and 18 h
LPS-treated cells (
***
P < 0.001). n = 6.
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7.4 Discussion
The data presented here in this chapter suggest that, the effect of LPS
on the avian primary skeletal muscle cells is not the same as what we have
seen in the C2C12 myotubes (chapters 3, 4; 5 and 6). Herein, the effect of LPS
on the avian primary skeletal muscle cells can be summarised as the
following 1) LPS significantly decreased the chymotrypsin-like enzyme
activity; 2) LPS significantly increased the protein synthetic rate; 3) LPS has
ŶŽ ĞĨĨĞĐƚ ŽŶ ƚŚĞ ŵZE ůĞǀĞůƐ ŽĨ dE& ?ɲ ? /> ? ? ? ĂƚƌŽŐŝŶ ? ? ? ĐĂƐƉĂƐĞ ? ? ĂŶĚ
ubiquitin.
The regulation of muscle protein synthesis and degradation in
cultured myotubes have been measured as a response to various anabolic
stimulus such as serum, insulin and insulin-like growth factors (Vandenburgh
et al., 1991), foetal bovine serum, human or bovine colostrums (Ballard
1982), and multiplication-stimulating activity (Janeczko and Etlinger 1984).
These data presumes that, both protein synthesis and degradation are
subject to regulation. Incubation of cultured myotubes (primary cultures of
chicken embryo skeletal muscles) with 10%(v/v) horse serum decreased the
protein turnover compared with serum free media (Janeczko and Etlinger
1984).
The data presented in this chapter demonstrated that LPS significantly
decreased the chymotrypsin-like enzyme activity in avian primary skeletal
muscle cells. In contrast, we have shown in chapter 4 (Fig 4-1A) that LPS
significantly increased its activity in a time-dependent manner in C2C12
murine myotubes. Although, LPS is a strong catabolic stimulus significantly
increased the muscle proteolysis (Jepson et al., 1986; Hummel et al., 1988;
Ash and Griffin 1989; Hasselgren et al., 1989; Lai et al., 2004). However, avian
primary skeletal robustly resist this effect. Interestingly, incubation of the
avian primary chicken skeletal muscle cells with LPS for 3 h significantly
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increased the PS (P < 0.001). While, in case of C2C12 myotubes (chapter 3)
LPS significantly decreased the rate of PS at 3 h by 50% (P < 0.05) (Fig. 3-4).
Also, LPS in combination with and IFN-J significantly induced 80% decrease in
the (Frost et al., 2009). The data obtained either from in vivo (Lang et al.,
2000; Vary and Kimball 2000; Lang et al., 2002; Lang and Frost 2007;
Crossland et al., 2008), or in vitro C2C12 myotubes (Frost et al., 2009) studies
have demonstrated that, LPS altered the muscle protein synthesis via Akt
signalling pathway and later impaired the translation initiation mediators. In
the chapter 3, LPS decreased the Akt/mTOR phosphorylation and later
decreased the translation initiation molecules (p70
S6K
, 4E-BP1 and eIF-4E) in
C2C12 myotubes (Figs. 3-1A, 1B, 3-3A, 3B and 3C). In this chapter, LPS
decreased the Akt phosphorylation and significantly increased 4E-BP1
Phosphorylation (Figs. 7-1A and 7-1B). Increased 4E-BP1 phosphorylation
increases the availability of eIF-4E to form the eIF-4F complex. The formation
of eIF-4f complex initiates the binding of the mRNA to the 43S preinitiation
complex (43 S ribosome and eIF-4F complex), and this step is considered as
rate-limiting step in translation initiation (Shen et al., 2005). Therefore, we
assume that LPS-induced increased PS in avian primary skeletal muscle
model was initiated primarily from increased 4E-BP1 phosphorylation and
consequently the translation initiation.
The data collected from our previous experiments in chapters 3 & 4
showed that, LPS significantly increased the production and accumulation of
ŵZE ŽĨ ŵĂŶǇ ĐǇƚŽŬŝŶĞƐ ĂŶĚ ĂƚƌŽŐĞŶƐ ŝŶ ƐŬĞůĞƚĂů ŵƵƐĐůĞ ŝŶĐůƵĚŝŶŐ dE& ?ɲ ?
ĂƚƌŽŐŝŶ ? ĂŶĚ DƵZ& ? ? /ŶĐƌĞĂƐĞĚ dE& ?ɲ ŵZE ĐŽŶƚĞŶƚƐ ŝŶ  ? ? ?myoblasts
has been shown in LPS-stimulated myoblasts (Frost et al ? ?  ? ? ? ? Z ? dE& ?ɲ
significantly increased atrogin-1 mRNA up-regulation via p38 (Jin and Li 2007)
and Foxo4 (Moylan et al., 2008). Atrogin-1 is a muscle specific ubiquitin ligase
significantly up regulated in many muscle-wasting models (Bodine et al.
2001). LPS significantly increased the up-regulation of atrogin-1 and MuRF1
mRNA (Wray et al., 2003). Nevertheless, in this chapter LPS had no effect on
ƚŚĞ ůĞǀĞů ŽĨ dE& ?ɲ ? ĂƚƌŽŐŝŶ ? ? ĂŶĚ ƵďŝƋƵŝƚŝŶ ŵZE ŝŶ ĂǀŝĂŶ ƉƌŝŵĂƌǇ ƐŬĞůĞƚĂů
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muscle cells. This suggesting that, there is a correlation between the
expression of atrophic genes and the proteasomal activity in LPS-stimulated
avian primary skeletal muscle cells inconsistent with the findings of Moylan
et al., (2008) and ours in the chapter 4. This discrepancy in response to LPS
has been shown in different muscle fibre types. LPS decreased PS in the fast-
twitch muscle fibre but not in the slow-twitch muscle (Vary and Kimball
1992).
Caspase-3 was involved in significant morphological changes of
apoptosis including chromatin condensation, DNA fragmentation and
cytoskeletal destruction (Hengartner 2000). Caspase-3 activation is
considered as the step in sepsis-induced muscle proteolysis in vitro and in
skeletal muscle via the cleavage of actinomysin (Du et al., 2004). In this
chapter, LPS had no effect on the caspase-3 mRNA in avian primary skeletal
muscle cells (Fig. 7-6). This result is consistent with the findings of Wei et al
that, sepsis did not alter the caspase-3 activity and mRNA level (Wei et al.,
2005).
The role of IL-6 in the sepsis induced muscle breakdown has been
reviewed in details in the chapter 2 and chapter 5. In this chapter we have
shown that LPS had no effect on IL-6 mRNA (Fig. 7-5). In contrast, LPS
significantly increased IL-6 mRNA in C2C12 myoblasts (Frost et al., 2002). In
addition, LPS increased the IL-6 media level in C2C12 myotubes (chapter 4,
Fig. 4-4B).
Taken together, the effect of LPS is seems to a cell-specific, yet further
investigation are required to verify this. The avian primary skeletal muscle
cells were derived from broiler chickens. These animals have been genetically
selected for rapid growth and accelerated muscle mass (Nakashima et al.,
2009) because of the lower protein degradation rate than that observed in
layers (Hayashi et al., 1985; Maeda et al., 1987). Of note, the avian primary
skeletal muscle cells were incubated with insulin transferrin selenium, while
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C2C12 myotubes were incubated with DMEM media supplemented with
serum and antibiotics. Therefore, the most appropriate explanation for this
difference in response between C2C12 myotubes and avian primary cells
could be attributed to the presence of insulin in the media of the avian
primary skeletal muscle cells. Insulin is a strong anabolic stimulus has
previously been shown to induce muscle hypertrophy mediated via
acceleration of translation initiation. One limitation must be drawn that is:
we have tested the effect of LPS on the avian primary skeletal muscle cells
for only 3 h. This because, our previous results in chapter 3 showed that LPS
maximal effect was seen at the 3 h time point. Therefore, further
investigation are potentially required to establish an acceptable theory about
the effect of endotoxin on the primary skeletal muscle cells protein
metabolism.
7.5 Conclusion
Our study showed that, LPS effect on muscle protein of the primary
skeletal muscle cells was not same as in C2C12 myotubes. LPS significantly
decreased chymotrypsin-like enzyme activity and increased the PS rate. LPS
ŚĂĚ ŶŽ ĞĨĨĞĐƚ ŽŶ ƚŚĞ ŵZE ůĞǀĞůƐ ŽĨ dE& ?ɲ ? ĂƚƌŽŐŝŶ ? ?  ĐĂƐƉĂƐĞ ? ? ? ƵďŝƋƵŝƚŝŶ
and IL-6. The response to LPS is might be a cell specific response, although
further investigation are required to verify this hypothesis.
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8 Inhibition of second-messenger signalling modulates
endotoxin-induced nitric oxide production in skeletal
muscle cells
8.1 Introduction
Nitric oxide (NO) is an important intracellular signalling molecule with
many diverse physiological and pathological effects. NO is synthesized from
the oxidation of L-arginine, a process regulated by the nitric oxide synthase
(NOS) class of enzymes (Frost et al., 2004). In skeletal muscle, NO regulates
many diverse functions including force production, regulation of the blood
flow, myocyte differentiation, respiration and glucose homeostasis (Stamler
and Meissner 2001).
LPS is the main component of the cell wall of Gram-negative bacteria,
and is a potent activator of the host innate immune system including cytokine
production through recognition by TLR4 (Raetz 1990). LPS has previously been
shown to increase NOS2 mRNA expression in C2C12 myoblasts (Frost et al.,
2004), and NOS2 protein in skeletal muscle fibres (Hussain et al., 1997).
LPS-induced signal transduction involves the interaction of several
signalling cascades and in particular PI3-K/Akt and MAPKs (p38 or Erk1/2).
Akt, is a central key element involved in the regulation of many fundamental
cellular processes including protein synthesis and cell growth (Wu et al.,
2010). LPS alone can decrease Akt activity in rodent skeletal muscle (Crossland
et al. 2008) and in C2C12 myotubes (chapter 3). In addition, we have also
shown that LPS significantly increased p38, Erk1/2 phosphorylation and
induced the nuclear translocation of NF-KB (Chapter 4).
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Curcumin has been used for a long time in traditional Indian medicine to
treat many diseases. Curcumin inhibits p38 activity (Carter et al., 2003), and
consequently inhibits the ubiquitin ligases activity in C2C12 myotubes (Li et
al., 2005). Moreover, curcumin has anti-NF-kB activity (Jobin et al., 1999).
How the inhibition of these signalling cascades can modulate the LPS-induced
NO production in skeletal muscle is still largely unclear. Thus, LPS-induced NO
ƉƌŽĚƵĐƚŝŽŶǁĂƐŵĞĂƐƵƌĞĚĂƐʅDŽĨŶŝƚƌŝƚĞĂƐĂŶŝŶĚŝĐĂƚŽƌŽĨEKƉƌŽĚƵĐƚŝŽŶŝŶ
the conditioned media of LPS-stimulated C2C12 myotubes and avian primary
skeletal muscle cells. The intracellular pathways initiated by LPS were
investigated using specific inhibitors. In addition, the inhibitory effect of
curcumin as anti-p38 and NF-kB activity on the LPS induced nitric oxide
production was assessed using three different concentrations (12, 25 and 50
ȝM).
8.2 Hypothesis
The LPS-induced muscle protein turnover in C2C12 myotubes
includes the production and accumulation of many pro-inflammatory
cytokines in skeletal muscle in particular TNF-Į, while, the role of IL-6 is
considered as minor. In contrast, there is a paucity of data about the role of
nitric oxide (NO) in this process. In addition, there is no data regarding the
signalling cascades involved in the nitric oxide production, and how inhibition
of these second-messengers can modulate the nitric oxide production.
Therefore, two septic models (C2C12 myotubes and avian primary skeletal
muscle cells) were used to investigate these signalling streams and their
inhibition can alter the LPS induced nitric oxide production.
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8.3 Results
8.3.1 LPS increases nitric oxide production
/ŶĐƵďĂƚŝŽŶ ŽĨ ƚŚĞ  ? ? ? ŵǇŽƚƵďĞƐ ǁŝƚŚ >W^  ? ? ʅŐŵů-1) significantly
increased the production of nitric oxide at 5 min (P < 0.01) and at 1 h and 3 h
time points (P < 0.05) with no changes observed at any other time points (Fig.
8-1).
Figure (8-1) LPS  ? ? ʅŐŵů-1)-induced nitric oxide (NO) production in C2C12
myotubes. Cells were incubated with LPS for various time points (namely 5, 30 min, 1
h, 3 h and 18 h) and the NO concentration was assessed in the conditioned media ( as
in the material and methods section). Data are expressed as means r SEM
(percentage of control). n = 6. Bars carrying asterisks are significantly significant from
control
*
P < 0.05 and
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8.3.2 Inhibition of second-messenger signalling blocked LPS-induced
NO production in C2C12 myotubes
Incubation of C2C12 myotubes with LPS in combination with
Polymyxin B (LPS neutralising agent), LY0294002 (PI-3K inhibitor), SB203580
(p38 inhibitor) and PD098059 (MEK/Erk inhibitor) abolished the effect of LPS
at both 1 and 3 h time points compared with LPS-treated cells (Figs. 8-2A and
8-2B).
8.3.3 Curcumin decreases nitric oxide production in C2C12 myotubes
From the previous experiment the maximal effect of LPS was seen at 3
h. Thus, the effect of curcumin on NO production was also measured at 3 h.
Incubation of C2C12 myotubes with LPS for 3 h significantly increased NO
production compared to untreated cells (P < 0.05), while incubation of the
ĐĞůůƐ ǁŝƚŚ >W^ ĂůŽŶŐ ǁŝƚŚ ĐƵƌĐƵŵŝŶ  ? ? ? ?  ? ? ĂŶĚ  ? ? ʅD Z ĂďŽůŝƐŚĞĚ ƚŚĞ >W^ ?
induced NO production. Similarly, incubation of the cells with curcumin (12,
 ? ?ĂŶĚ ? ?ʅD ZĂůŽŶĞŚĂĚŶŽĞĨĨĞĐƚŽŶƚŚĞ>W^ ?ŝŶĚƵĐĞĚEKƉƌŽĚƵĐƚŝŽŶ ?&ŝŐ ? ? ?
3). Curcumin even at higher doses had no adverse effect on myotubes upon
morphological testing (data not shown).
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Figure (8-2) Effect of LPS alone and LPS combined with second-messenger inhibitors
on NO production, A) Effect of 1 h incubation; B) effect of 3 h incubation. C2C12
myotubes were incubated either with LPS alone, or with LPS and Polymyxin B (LPS
ŶĞƵƚƌĂůŝƐŝŶŐĂŐĞŶƚ Z ?WD ? ?ʅŐŵů-1 Z ?>W^ĂŶĚ^ ? ? ? ? ? ? ?Ɖ ? ?ŝŶŚŝďŝƚŽƌ Z ?^ ? ? ?ʅD Z ?>W^
ĂŶĚ W ? ? ? ? ? ?  ?D< ?ƌŬ ŝŶŚŝďŝƚŽƌ Z  ?W ?  ? ? ʅD Z ? Žƌ >W^ ĂŶĚ >z ? ? ? ? ? ? ?  ?W/ ? ?< ?Ŭƚ
ŝŶŚŝďŝƚŽƌ Z ?>z ? ? ?ʅD ZĂƚĂĂƌĞĞǆƉƌĞƐƐĞĚĂƐŵĞĂŶƐr SEM (percentage of control). n
= 6. Bars carry asterisks are significantly different from control and LPS-treated cells
as shown in graph (
**
P < 0.01 and
***
P < 0.001).
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Figure (8-3) Effect of LPS alone and LPS in combination with curcumin (12, 25 and 50
ʅD ZĂŶĚĐƵƌĐƵŵŝŶĂůŽŶĞŽŶEKƉƌŽĚƵĐƚŝŽŶ ? ? ? ?ŵǇŽƚƵďĞƐǁĞƌĞŝŶĐƵďĂƚĞĚĞŝƚŚĞƌ
with LPS  ? ? ʅŐŵů-1) ĂůŽŶĞ ? Žƌ ǁŝƚŚ >W^ ĂŶĚ ĐƵƌĐƵŵŝŶ  ? ? ? ?  ? ? ĂŶĚ  ? ? ʅD Z ? Žƌ ǁŝƚŚ
ĐƵƌĐƵŵŝŶ  ? ? ? ?  ? ? ĂŶĚ  ? ? ʅD Z ĂůŽŶĞ ĨŽƌ  ? Ś ? ĂƚĂ ĞǆƉƌĞƐƐĞĚ ĂƐ ŵĞĂŶƐ r SEM
(percentage of control). n = 6. Bars carrying asterisks are significantly significant
compared with control and LPS-treated cells as shown in figure,
*
P < 0.05
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8.3.4 LPS alone and with inhibitors increase nitric oxide production in
avian primary skeletal muscle cell line
The effect of LPS on NO production in avian skeletal muscle cells was
measured at 3 h. Incubation of cells with LPS alone increased NO production
by 31% compared with the control cells. Incubation of the cells with LPS in
ĐŽŵďŝŶĂƚŝŽŶ ĞŝƚŚĞƌ ǁŝƚŚ WŽůǇŵǇǆŝŶ   ?WD ?  ? ʅŐŵů-1), or LY0294002 (LY, 50
ʅD Z ? Žƌ W ? ? ? ? ? ?  ?W ?  ? ? ʅD Z ? Žƌ ^ ? ? ? ? ? ?  ?^ ?  ? ? ʅD Z ? Žƌ ĐƵƌĐƵŵŝŶ  ? ? ?
ʅD ZŝŶĐƌĞĂƐĞĚƚŚĞEKƉƌŽĚƵĐƚŝŽŶďǇ ? ?A? ?P < 0.01), 50% (P < 0.001), 37% (P <
0.01), 41% (P < 0.001) and 35% (P < 0.001), respectively compared with the
control cell (Fig. 8-4).
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Figure (8-4) Effect of LPS alone and LPS combined with second messenger inhibitors
on NO production. Avian primary skeletal muscle cells were incubated with LPS (1
ʅŐŵů-1 ZĂůŽŶĞ ?ŽƌǁŝƚŚ>W^ĂŶĚWŽůǇŵǇǆŝŶ ?>W^ŶĞƵƚƌĂůŝƐŝŶŐĂŐĞŶƚ Z ?WD ? ?ʅŐŵů-1);
>W^ĂŶĚ^ ? ? ? ? ? ? ?Ɖ ? ?ŝŶŚŝďŝƚŽƌ Z ?^ ? ? ?ʅD Z ?>W^ĂŶĚW ? ? ? ? ? ? ?D< ?ƌŬŝŶŚŝďŝƚŽƌ Z
 ?W ?  ? ? ʅD  Z ? >W^ ĂŶĚ >z ? ? ? ? ? ? ?  ?W/ ?< ?Ŭƚ ŝŶŚŝďŝƚŽƌ Z  ?>z ?  ? ? ʅD  Z ? Žƌ >W^ ĂŶĚ
ĐƵƌĐƵŵŝŶ ?  ? ? ʅD ĨŽƌ  ? Ś ? ĂƚĂ ĂƌĞ ĞǆƉƌĞƐƐĞĚ ĂƐ ŵĞĂŶƐ r SEM (percentage of
control); n = 3. Bars carrying asterisks are significantly significant from control cells,
**
P < 0.01 and
***
P < 0.001.
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8.3.5 The effect of the inhibitors alone on NO production
C2C12 fully differentiated myotubes were incubated with either the
ŝŶŚŝďŝƚŽƌƐĂůŽŶĞŽƌǁŝƚŚǀĂƌŝŽƵƐĐŽŶĐĞŶƚƌĂƚŝŽŶƐŽĨD^K ? ?ĂŶĚ ?ʅůŵů-1) for 3
h. There were no significant changes in NO production (Fig. 8-5).
7
Figure (8-5) The effect of various inhibitors on the NO production. C2C12-murine
ĚĞƌŝǀĞĚŵǇŽƚƵďĞƐǁĞƌĞŝŶĐƵďĂƚĞĚǁŝƚŚĞŝƚŚĞƌŶŽƚƌĞĂƚŵĞŶƚ ?D^K ? ?ʅůŵů-1), DMSO
 ? ? ʅůŵů-1 Z ? WŽůǇŵǇǆŝŶ   ?>W^ ŶĞƵƚƌĂůŝƐŝŶŐ ĂŐĞŶƚ Z  ?WD ?  ?ʅŐŵů-1), SB203580 (p38
ŝŶŚŝďŝƚŽƌ Z  ?^ ?  ? ? ʅD Z ? W ? ? ? ? ? ?  ?D< ?ƌŬ ŝŶŚŝďŝƚŽƌ Z  ?W ?  ? ? ʅD Z ? Žƌ
>z ? ? ? ? ? ? ? ?W/ ?< ?Ŭƚ Z  ?>z ?  ? ? ʅD Z ĨŽƌ  ? Ś ? ĂŶĚ ŵĞĚŝĂĐŽůůĞĐƚĞĚ ĂŶĚ EK ĂƐƐĂǇ ǁĂƐ
done as in material and method section. Values are represented as means r SEM. n =
4
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8.4 Discussion
The C2C12 murine-derived cell line is a well-established myocyte model
that has been used extensively in skeletal muscle research (Sharples et al.,
 ? ? ? ? Z ? KƵƌ ƐƚƵĚǇ ĚĞŵŽŶƐƚƌĂƚĞĚ ƚŚĂƚ ? >W^  ? ? ʅŐŵů-1) alone significantly
increased the NO production at 5 min, 1 h and up to 3 h. In contrast, Williams
et al., (1994) observed that LPS alone did not induce NO production in C2C12
myocytes and myotubes. LPSinduced NO production can cause cellular
damage (Frost and Lang 2008). Skeletal muscle releases NO as a part of the
host immune response to kill invading micro-organisms, but excess NO
production can contribute to muscle wasting and impair the contractile
functions of the muscle (Sambe et al., 1998). However, depending on its
concentration, studies have also shown that NO plays a significant role in the
process of muscle regeneration including the myogenicprogramme activated
by insulin-like growth factor (IGF)-II (Kaliman et al., 1999; Carrasco et al.,
2002), or the stimulation of myoblast fusion and satellite cell activation
(Pisconti et al., 2006). In addition, Sciorati et al., (2006) demonstrated that NO
exerts multiple actions aimed at limiting muscle damage.
Herein, this moderate increase in the NO production in LPS-stimulated
C2C12 myotubes model is most likely to be a part of the host immune
response (Sambe et al. 1998). LPS-induced NO production in our septic model
is consistent with the findings of Fernandez et al ? ? ? ? ? ? Z ƚŚĂƚ ŶĞŝƚŚĞƌ dE& ?ɲ
ŶŽƌ/&E ?ɶŝŶĐƌĞĂƐĞĚƚŚĞEKŝŶ ? ? ?ŵǇŽƚƵďĞƐ ?ǁŚŝůĞďŽƚŚƚŽŐĞƚŚĞƌŝŶĚƵĐĞĚ
marked increase in NO (47-fold) compared with control. This suggests that LPS
is a strong catabolic stimulus increased NO production alone in C2C12
myotubes. The fact that Polymyxin B (LPS neutralising agent) abolished the
effect of LPS and inhibited the production of NO, suggested that LPS-induced
NO production in C2C12 myotubes is mediated via TLR4 signalling cascade.
The role of PI3-K/Akt and MAPKs (p38 or Erk1/2) signalling pathways in the
LPS-induced NO production was also evaluated. Incubation of the cells with
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LPS along with LY0294002 (PI3-K/Akt inhibitor) completely blocked the LPS-
induced NO production at 1 and 3 h time points.
Akt is a serine/threonine kinase ubiquitously expressed in many tissues
with Akt1 and Akt2 predominantly expressed in skeletal muscle. Akt activity
regulates many functions in skeletal muscle such as muscle contraction,
muscle glucose metabolism, muscle protein synthesis and degradation (for
review see, Wu et al., 2010). There is however, a paucity of data regarding the
relationship between the Akt activity and NO production in skeletal muscle.
JP05-induced NO production in the brain endothelial cells is mediated via Akt
and Erk activation (Son et al. 2010). In addition, Akt has been shown to be
implicated in the regulation of iNOS in the vascular smooth muscle cells
(Isenovic et al., 2002), and Wang and associates have demonstrated that iNOS
and endothelial nitric oxide synthase (eNOS) are downstream targets of Akt
activation (Wang et al., 2004). In addition, Kim et al. demonstrated that
LY0294002 (PI3-K/Akt inhibitor) significantly inhibited the LPS-induced
macrophage NO production via NF-kB signalling cascades not PI3-K (Kim et al.,
2005).
The MAPKs plays an important role in many physiological and
behavioural phenomena through various cytokines (Kahn et al., 2005; Long
and Zierath 2006). Our results show that, inhibition of p38 or Erk1/2 blocked
LPS-induced NO production and are consistent with the findings of Frost et al.,
(2004). Our data are the first that show that direct inhibition of PI3-K/Akt and
MAPKs (p38 or Erk1/2) can modulate NO production in skeletal muscle.
Curcumin is the principal curcuminoid of the popular Indian spice
turmeric (Ammon and Wahl 1991), and has been used for more than a
century in the traditional Indian medicine. During the last two decades, many
studies have explored the beneficial effects of curcumin. Curcumin has anti-
p38 activity (Carter et al., 2003), and anti-NF-kB activity (Wang et al., 1999)
and can thus act to decrease inflammation-stimulated muscle protein
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degradation. In addition, curcumin has no known toxic effects even at very
high doses (Chainani-Wu 2003). Our data showed that curcumin significantly
blocked LPS-induced NO production compared with LPS-treated cells. We
have shown that curcumin blocked LPS-induced p38 phosphorylation (chapter
6).This suggested a direct role of p38 in the LPS-induced NO production in
C2C12 myotubes. Although, we have shown for the first time that, inhibition
of p38 activity modulated the LPS-induced NO production in C2C12 myotubes.
However, further investigation are still required to validate this effect in vivo.
The primary cultures of skeletal muscle have been used as a model to
study of the muscular and neuromuscular diseases and parasitic cytogenesis
(Fong et al., 1990; Metzinger et al., 1993; Passaquin et al., 1993; Bouzakri et
al., 2003; Guimaraes et al., 2008). In our study, incubation of avian primary
skeletal muscle cells with LPS alone for 3 h increased NO production. Thus,
LPS is considered as a potent stimulus of NO in avian primary skeletal muscle
cells. Surprisingly however, none of the specific inhibitors we used could
abolish this effect in these cells, suggesting that the regulation of NO
production is different in these avian primary cells to that in the C2C12 cell
line. This response might be due to the fact that these cells were derived from
the broiler chickens. These animals have been genetically selected for rapid
growth and in particular the accretion of muscle mass (Nakashima et al.,
2009). These chickens are characterised by a lower protein degradation rate
than that observed in layers (Hayashi et al., 1985; Maeda et al., 1987). Thus,
the fractional rates of protein synthesis in the broiler chicken are greater than
in the layers (Maeda et al., 1984). The discrepancy in response to LPS has
been shown in different muscle fibres (fast and low twitch muscle). LPS
administration significantly increased the NOS activity in the gastrocnemius
muscle (fast twitch muscle) but not in the soleus (slow twitch muscle) (Vary
and Kimball 1992; Kapur et al., 1997; el-Dwairi et al., 1998). Taken together,
this might explain the diversity in response to LPS. Although, LPS is generally
catabolic, however, the avian primary skeletal muscle cells may be resisting
this effect. We have observed that, incubation of the avian primary skeletal
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muscle cells with LPS significantly decreased the proteasomal activity and
increased the protein synthesis (chapter 3&4). Although, this study shows the
diverse modulation of NO production in LPS-induced sepsis model. Further
investigation are still required to explore the effect of LPS on the NO
production not only in broilers but in muscle from chickens with a different
genetic background such as layers.
8.5 Conclusion
LPS is a strong activator of NO production in both C2C12 myotubes and
avian primary skeletal muscle cells. The regulation of NO production in C2C12
myotubes involves the interaction of many signalling cascades, mainly Akt and
MAPKs (p38 or Erk1/2). Inhibition of these signalling cascades modulated NO
production in the C2C12 myotubes, while in the chicken skeletal muscle cells
it had no effect. Thus, we suggest that the regulation of NO production is a
cell-specific process. Although, we have shown inhibition of second-
messenger signalling modulated NO production, further investigation is still
required to test this hypothesis.
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9 Effect of natural challenge with Salmonella
Gallinarium and Salmonella Enteritidis on the
skeletal muscle protein metabolism
9.1 Introduction
Salmonella is a Gram-negative rod-shaped enterobacteria mainly
found in the intestine of human, and animals including birds. Salmonella can
produce a broad range of clinical symptoms range from a symptomatic
carrier state to life-threatening sepsis (Leveque et al., 2003), this makes
Salmonella as a major issue in relation to poultry industry (Barrow 2007), in
particular S. enterica serovar Enteritidis (Rodrigue et al., 1990).
According to the pathogenesis, there are two main groups of the
genus Salmonella. The first group consists of, S. enterica serovar
Typhimurium and serovar Enteritidis (non-typhoidal Salmonella), non-host
specific, can colonise in the gut and causes food poisoning in human. The
second group (typhoidal Salmonella), host-specific Salmonella, including S.
Pullorum and S. Gallinarium which causes pullorum disease and fowl typhoid
in poultry (Chao et al., 2007).
There are many factors determine the severity of the Salmonella
infection including, the strain of Salmonella, route of infection, birds strain,
age of the bird and the immune status of the bird. The younger the bird the
higher mortality rate is. Experimental infection of 3 weeks old chicks with S.
Gallinarium results in 60% mortality rate (Jones et al., 2001), while S.
Pullorum causes substantial mortality but less frequent mortality in birds of
more than a week old (Wigley et al., 2001). In case of S. pullorum infection, S.
pullorum persists in the reproductive tract until sexual maturity and then
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infects the eggs leading to vertical transmission another economic problem
(Barrow 2007).
The current knowledge about the Salmonella pathogenesis has been
derived in the main from the experimental infection studies using S.
Typhimurium-infected mice model. In contrast, the situation is still relatively
unclear concerning Salmonella infected chicken model (Barrow 2007).
Generally, salmonellosis in chicken includes three main phases.
9.2 Phases of avian salmonellosis
Generally, avian systemic salmonellosis has three main phases
including, intestinal invasion, establishment of the systemic infection in
macrophages, and clearance by the immune system (Chappell et al., 2009).
During the intestinal invasion phase, following the faecal-oral infection,
Salmonella adapt to the acidic pH to pass through the crop via proventriculus
to gizzard reaching the intestine. In the small intestine there are lymphoid
aggregates and Peyers patches. There are no M cells in the lymphoid
aggregates, and their role in Salmonella infection still unclear (Smith and Beal
2008). Following the infection of GI tract with S. Typhimurium, a rapid influx
of heterophils and inflammation occurs in contrast to infection with S.
Pullorum (Henderson et al., 1999).
The second phase is the development of systemic infection that
followed the invasion phase. Salmonella is taken up by the macrophages and
dendritic cells via the lymphatic system to the spleen and liver (Mastroeni
and Menager 2003). The ability of the Salmonella to survive in the
macrophages depends upon Salmonella pathogencity island 2 (SP1-2) type III
secretion system (Hensel 2000). Complete attenuation of systemic infection
with S. Gallinarum, S. Pullorum, or S. Typhimurium occurs in the absence of a
functional SPI-2 system (Jones et al., 2001; Wigley et al., 2002; Jones et al.,
2007). Therefore, survival of the Salmonella in the macrophages is the first
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step in the initiation of systemic infection in both mammals and birds
(Barrow et al., 1994).
The clearance, persistence, or death phase is a phase following the
invasion and the establishment of systemic infection. The fate of Salmonella
infection in chicken is either, clearance or control of the replication of
bacteria in resistant inbred chicken, or later clearance the infection via
adaptive immunity (Chappell et al., 2009).
9.3 The role of cytokines in the pathogenesis of salmonellosis
Cytokines are a large and diverse family of polypeptides mainly
produced by the immune cells, acting as signalling molecules involved in the
cell communication and signals transduction. Cytokines are considered as a
key regulators of the host response to intracellular pathogens (Liles and Van
Voorhis 1995). Cytokines stimulate immune cell migration, proliferation, and
interactions; this enhances the host immunity against the invading
microorganism (Kaufmann 1993; Liles and Van Voorhis 1995). Salmonella
components (LPS, flagellin, porins, and outer membrane proteins) stimulate
the immune system and later enhance cytokine expression (Henderson et al.,
1996; Ciacci-Woolwine et al., 1998; Wilson et al., 1998). Following systemic
infection, Salmonella become localised in the large blind caecum. The caecal
tonsils are considered as the largest secondary lymphoid organ of the
chicken GI tract and the main target for most Salmonella serovars
(Withanage et al., 2005). Experimental chicken infection with S. Typhimurium
ŝŶĚƵĐĞƐĞǆƉƌĞƐƐŝŽŶŽĨƉƌŽ ?ŝŶĨůĂŵŵĂƚŽƌǇĐǇƚŽŬŝŶĞƐĂŶĚĐŚĞŵŽŬŝŶĞƐ/> ? ?ɴ ?/> ?
6, CXCLi1, and CXCLi2 (previously known as IL-8) (Withanage et al., 2004).
Following oral infection of mice with S ?dǇƉŚŝŵƵƌŝƵŵ ?/&E ?ɶƐƚŝŵƵůĂƚĞƐ
macrophage anti-bacterial activity (Ramarathinam et al.,  ? ? ? ? Z ? /&E ?ɶ
significantly decreased the severity of Salmonella infection in mice if
administrated in the early days after challenge with a virulent strain (Gould
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and Sonnenfeld 1987; Muotiala and Makela 1990), and treatment of mice
ǁŝƚŚ ƚŚĞ ĂŶƚŝ ?/&E ?ɶ ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ ƚŚĞ ƐĞǀƌŝƚǇ ŽĨ ƚŚĞ ŝŶĨĞĐƚŝŽŶ
(Muotiala and Makela 1990).
ZĞŐĂƌĚŝŶŐ ƚŚĞ ĞĨĨĞĐƚ ŽĨ ƐĂůŵŽŶĞůůŽƐŝƐ ŽŶ dE& ?ɲ ĞǆƉƌĞƐƐŝŽŶ ? ƚŚĞ
collected data are controversial. With some studies have showed no systemic
ƌĞůĞĂƐĞŽĨdE& ?ɲŚĂƐďĞĞŶĚĞƚĞĐƚĞĚŝŶSalmonella infected mice (Kumazawa
et al., 1991) or calves (Peel et al., 1990), while others showed it has been
detected during Salmonella-infection in mice (Klimpel et al.,  ? ? ? ? Z ? dE& ?ɲ
may have a role in the host immune response against salmonellosis by its
cytotoxic activity against Salmonella-infected cells (Klimpel et al., 1990). The
ĚĞƉůĞƚŝŽŶŽĨdE& ?ɲƐŝŐŶŝĨŝĐĂŶƚůǇŝŶĐƌĞĂƐĞƚŚĞƐĞǀĞƌŝƚǇŽĨSalmonella infection
and decreases host survival (Nauciel and Espinasse-Maes 1992; Gulig et al.,
 ? ? ? ? Z ?dE& ?ɲƉůĂǇƐĂŶŝŵƉŽƌƚĂŶƚƌŽůĞŝŶƚŚĞƌĞĐĂůůŽĨƚŚĞŝŵŵƵŶĞƐǇƐƚĞŵĂŶĚ
contributes to the maturation of the dendritic cells in mice orally infected
with Salmonella (for further information see ,Lembo et al., 2003). Concerning
ƚŚĞĞĨĨĞĐƚŽĨƚŚĞdE& ?ɲŽŶƚŚĞŵƵƐĐůĞƉƌŽƚĞŝŶŵĞƚĂďŽůŝƐŵ ?ƐĞĞĐŚĂƉƚĞƌ ? ? ZĨŽƌ
more details.
IL-6 is a multifunctional pro-inflammatory cytokines with similar
functions in both mammals and chickens (Kaiser et al., 2000). IL-6 stimulates
the synthesis of acute phase protein, differentiation of B-lymphocytes,
cytotoxic T cells and the growth of T cells (Hirana 1994). Invasion of avian
cells with S. Typhimurium and S. Enteritidis significantly increased the
production of IL-6 mRNA, while S. Gallinarium caused no increase (Kaiser et
al., 2000). S. Enteritidis down regulates IL-6 mRNA in chicken peripheral
blood mononuclear cells (Kaiser et al., 2006). Additionally, incubation of the
chicken heterophils with LPS significantly increased IL-6 mRNA (Kogut et al.,
2005). In addition, higher levels of IL-6 mRNA have been observed at day 14-
post vaccination with S. Enteritidis vaccine (Okamura et al., 2004) which is
very late for pro-inflammatory cytokine. In conclusion, IL-6 plays a
controversial role in the immunity against Salmonella infection.
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Several other cytokines with a controversial role have been studied in
the pathogenesis of Salmonella infection, including IL-8 (Carvajal et al., 2008;
Cheeseman et al., 2008; Figueiredo et al., 2009; Popa et al., 2009; Salerno-
Goncalves and Sztein 2009), and IL-15 (Nishimura et al., 2000; Eckmann and
Kagnoff 2001; Nishimura et al., 2001; Ashkar et al., 2009). Up to date, there
are no studies regarding the effect of Salmonella infection on the expression
level of these cytokines in skeletal muscle. Thereby, our final experiment was
aimed to explore the effect of natural Salmonella infection on the expression
ůĞǀĞůƐ ŽĨ ŵĂŶǇ ŐĞŶĞƐ ŵZE ŝŶĐůƵĚŝŶŐ dE& ?ɲ ? ĂƚƌŽŐŝŶ ? ?  /ů ? ? ? /> ? ? /> ? ? ? ?
ubiquitin and caspase-3 mRNA.
9.4 Hypothesis
The data continued in the previous chapters have demonstrated that
when C2C12 myotubes incubated with LPS, a significant decrease in protein
synthesis and increase in protein breakdown was observed. In contrast, avian
primary skeletal muscle seems to be resistant to LPS either because their
origin or different incubation condition (presence of insulin in case of primary
cells). In addition, the data regarding natural challenge with Salmonella were
related to the stimulation of immune system, no clear data regarding the
effect of natural challenge on skeletal muscle protein metabolism. Therefore,
skeletal muscles (pectoral and gastrocnemius) from two different groups of
birds were challenged with two Salmonella serotypes (Gallinarium or
Enteritidis) were investigated by RT-PCR to evaluate the effect of natural
challenge on muscle protein metabolism.
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9.5 Results
9.5.1 Natural infection with S. Gallinarum and S. Enteritidis significantly
ĚĞĐƌĞĂƐĞĚdE& ?ɲŵZE
ŽŶĐĞƌŶŝŶŐƚŚĞĞǆƉƌĞƐƐŝŽŶŽĨdE& ?ɲŵZE ?ƚŚĞƌĞǁĂƐŶŽĞǆƉƌĞƐƐŝŽŶ
detected in the pectoral muscle. While, in case of gastrocnemius muscle,
infection with Salmonella serovars Gallinarum or Enteritidis significantly
ĚĞĐƌĞĂƐĞĚ dE& ?ɲ ŵZE ďǇ ŶĞĂƌůǇ  ? ?A?  ?P < 0.01) compared to untreated
control group (Fig. 9-1).
Figure (9-1) ŚĂŶŐĞƐŝŶdE& ?ɲŵZEĞǆƉƌĞƐƐŝŽŶƌĂƚĞŝŶƚŚĞŐĂƐƚƌŽĐŶĞŵŝƵƐŵƵƐĐůĞ
as a result of natural infection with Salmonella Enteritidis (SE) or Salmonella
Gallinarum (SG) for 4 days. Values represented as means r SEM (percentage of
control). Stars represent significance difference control chicken (**P < 0.01). n = 5.
Data were normalised to 18S mRNA (previously mentioned in material and
methods).
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9.5.2 Natural infection with S. Gallinarum and S. Enteritidis significantly
decreased atrogin-1 mRNA
Challenge of the chicks with Salmonella serovars Gallinarum or
Enteritidis had no effect on the atrogin-1 mRNA in pectoral muscle, while it
significantly deceased its expression in the gastrocnemius muscle by nearly
50% and 75% (P < 0.001) compared with the control group (Figs. 9-2A and 9-
2B).
Figure (9-2) Changes in atrogin-1 mRNA expression rate in A) the pectoral (Breast
muscle) and B) gastrocnemius muscle as a result of natural infection with Salmonella
Enteritidis (SE) or Salmonella Gallinarum (SG) for 4 days. Values are represented as
means r SEM (percentage of control). Stars represent significance difference from
control chicken (
***
P < 0.001). n= 5
C SE SG
0
100
200
300
400
A
A
tr
o
g
in
-1
m
R
N
A
(%
C
o
n
tr
o
l)
C SE SG
0
25
50
75
100
***
***
B
A
tr
o
g
in
-1
m
R
N
A
(%
C
o
n
tr
o
l)
A
tr
o
g
in
-1
m
R
N
A
(%
C
o
n
tr
o
l)
A
tr
o
g
in
-1
m
R
N
A
(%
C
o
n
tr
o
l)
Chapter 9 The effect of Natural Challenge with Salmonella on the skeletal muscle protein
220
9.5.3 Natural infection with S. Gallinarum and S. Enteritidis significantly
decreased caspase-3 mRNA
Interestingly, the expression of the caspase-3 mRNA was significantly
decreased in the both the pectoral and the gastrocnemius. In the pectoral
muscle, challenge of the birds with S. Gallinarum or S. Enteritidis significantly
decreased the caspase-3 mRNA by nearly 50% and 60% respectively (P <
0.001) compared with control group. While, in the gastrocnemius muscle the
caspase-3 mRNA expression was significantly decreased by nearly 70% and
60% respectively, (P < 0.01) compared with control group (Figs. 9-3A and 9-
3B)
Figure (9-3) Changes caspase-3 mRNA expression rate in A) the pectoral (Breast
muscle) and B) gastrocnemius muscle as a result of natural infection with Salmonella
Enteritidis (SE) or Salmonella Gallinarum (SG) for 4 days. Values represented as
means r SEM (percentage of control). Stars represent significance difference from
control chicken (
**
P < 0.01 and
***
P < 0.001). n = 5
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9.5.4 Natural infection with S. Gallinarum or S. Enteritidis had no effect
on the ubiquitin mRNA expression level
There were no significant changes detected in the expression level of
the ubiquitin mRNA in both the pectoral and gastrocnemius muscle
compared with the untreated control group (Figs. 9-4A and 9-4B).
Figure (9-4) Changes in ubiquitin mRNA expression rate in A) the pectoral (Breast
muscle) and B) gastrocnemius muscle as a result of natural infection with Salmonella
Enteritidis (SE) or Salmonella Gallinarum (SG) for 4 days. Values represented as
means r SEM (percentage of control). .n = 5
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9.5.5 Natural infection with S. Gallinarum or S. Enteritidis significantly
decreased the IL-6 mRNA expression
We could not detect any expression of IL-6 mRNA in the pectoral
muscle. In contrast, challenge with S. Gallinarum or S. Enteritidis significantly
decreased the IL-6 mRNA in gastrocnemius muscle by nearly a 60% (P < 0.01)
and a 90% (P < 0.001) compared with the control group (Fig. 9-5A).
Figure (9-5) Changes in the IL-6 mRNA expression rate in gastrocnemius muscle as
a result of natural infection with Salmonella Enteritidis (SE) or Salmonella
Gallinarum (SG) for 4 days. Values represented as means r SEM (percentage of
control). Stars represent significance difference from untreated control chicken (
**
P
< 0.01 and
***
P < 0.001). n = 5
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9.6 Discussion
In the present chapter, two groups of chicken were challenged with
Salmonella serovars S. Gallinarium (host-specific serotype) and S. Enteritidis
(non-host specific serotype). The result obtained from this study in total
showed that natural challenge with Salmonella serovars Gallinarum and
ŶƚĞƌŝƚŝĚŝƐ ƐŝŐŶŝĨŝĐĂŶƚůǇ ĚĞĐƌĞĂƐĞĚ ƚŚĞ ĞǆƉƌĞƐƐŝŽŶ ŽĨ dE& ?ɲ ? /> ? ? ? ĂƚƌŽŐŝŶ ? ? ?
caspase-3 and ubiquitin mRNA in chicken skeletal muscle.
These Salmonella serovar Enteritidis colonise the caecum and is
responsible for human food-borne mainly via consumption of contaminated
chickens egg and meat (Berndt et al., 2007). S. Gallinarum dose not colonise
the intestine but the point of invasiveness, S. Gallinarum more invasive than
S. Enteritidis (Bumstead and Barrow 1993).
Salmonella infection significantly changes the expression of many
cytokines, particularly in the intestine and caecum of the birds (Berndt et al.,
2007; Cheeseman et al., 2008; Fasina et al., 2008; Haghighi et al., 2008).
Challenge of chicken with S. Typhimurium results in the expression of many
cytokines in many cells including macrophages and many other tissues
including the cecal tonsils, ileum, spleen and liver (Beal et al. 2004;
Withanage et al. 2004; Withanage et al. 2005). In addition, the pattern of
cytokine expression was correlated with the host resistance against S.
Typhimurium (Haghighi et al., 2008). The first cytokines stimulated by
Salmonella are /&E ?ɶ ? /> ? ? ? ĂŶĚ /> ? ? ĂŶĚ ƚŚĞŝƌ ŵĂŝŶ ƌŽůĞ ŝƐ ƚŚĞ ƉƌŽƚĞĐƚŝŽŶ
against Salmonella, while IL-4 and IL-10 down regulate the pro-inflammatory
responses to the bacterium (Eckmann and Kagnoff 2001).
To date, nearly all the studies concerning the immune response and
the host resistance have focused on the immune tissues including liver,
spleen and tonsils, whereas in the present context the effect of the natural
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infection on the skeletal muscles gene expression remains largely unclear.
Skeletal muscle has been shown to produce cytokines in the same way as the
immune cells in response to various stimuli (Frost et al., 2003). Moreover,
>W^ ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ ƚŚĞ ƐǇŶƚŚĞƐŝƐ ŽĨ ŵĂŶǇ ĐǇƚŽŬŝŶĞƐ ŝŶĐůƵĚŝŶŐ /> ? ?ɴ ?
dE& ?ɲ ĂŶĚ /> ? ? ŝŶ ŵƵƐĐůĞ  ?&ƌŽƐƚet al., 2002; Lang et al., 2003; Huey et al.,
2008). In addition, the pro-inflammatory cytokines mainly IL-6 produced
locally by muscle and thus have a systemic role (Steensberg et al., 2000;
Pedersen et al., 2001; Febbraio and Pedersen 2002).
dE& ?ɲ ŚĂƐ Ă ĐǇƚŽƚŽǆŝĐ ĂĐƚŝǀŝƚǇ ĂŐĂŝŶƐƚSalmonella-infected cells
(Klimpel et al., 1990), and promotes the maturation of the dendritic cells in
mice orally infected with Salmonella (Lembo et al., 2003). The depletion of
dE& ?ɲ ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ ƚŚĞ ƐĞǀĞƌŝƚǇ ŽĨSalmonella infection and
decreased the host survival (Nauciel and Espinasse-Maes 1992; Gulig et al.,
 ? ? ? ? Z ? /Ŷ ƚŚĞ ĐĂƐĞ ŽĨ ƐŬĞůĞƚĂů ŵƵƐĐůĞ dE& ?ɲ ŝƐ ĐŽŶƐŝĚĞƌĞĚ ĂƐ Ă ƉƌŽ ?
inflammatory cytokine involved in the process of muscle wasting (Frost and
>ĂŶŐ  ? ? ? ? Z ?dŚĞĞǆĐĞƐƐŝǀĞƉƌŽĚƵĐƚŝŽŶŽĨdE& ?ɲŝƐĂƐƐŽĐŝĂƚĞĚǁŝƚŚĞŶŚĂŶĐĞĚ
rate of muscle protein breakdown both in vitro (Li et al., 2000) and in vivo
(Flores et al.,  ? ? ? ? ? 'ŽŽĚŵĂŶ  ? ? ? ? Z ? ,ĞƌĞŝŶ ? ƚŚĞ ĞǆƉƌĞƐƐŝŽŶ ŽĨ ƚŚĞ dE& ?ɲ
mRNA is significantly decreased; this suggests that natural challenge with
these Salmonella ƐĞƌŽǀĂƌƐ ĐŽƵůĚ ŶŽƚ ŝŶĚƵĐĞ ƐŝŐŶŝĨŝĐĂŶƚ dE& ?ɲ ƌĞůĞĂƐĞ ? dŚĞ
possible explanation is that, skeletal muscle samples were collected 4 days
post infection. In the study carried out by Arnold and Holt (1996) have shown
ƚŚĂƚƚŚĞŵĂǆŝŵĂůĞĨĨĞĐƚŽĨdE& ?ɲǁĂƐƐĞĞŶŝŶ^ŝŶĨĞĐƚĞĚŚĞŶƐ ? ?ŚƌĂŶĚ ? ?
days after infection. Therefore, further time points are still required in order
to build a complete notion about the direct link between natural challenge
with SalmonellaĂŶĚƚŚĞůŽĐĂůƌĞůĞĂƐĞŽĨdE& ?ɲŝŶƐŬĞůĞƚĂůŵƵƐĐůĞ ?
IL-6 a multifunctional pleiotropic pro-inflammatory cytokine,
stimulating the synthesis of acute phase protein, differentiation of B-
lymphocytes, cytotoxic T cells and the growth of T cells (Hirana 1994). In our
study, chickens infected with S. enterica serovars Enteritidis and Gallinarum
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caused a significant decrease in the IL-6 mRNA in gastrocnemius muscle by
nearly a 60% (P < 0.01) and 90% (P < 0.001) respectively compared with the
control group. This indicates that the down-regulation of IL-6 mRNA in
skeletal muscle seems to be a specific effect of S. Gallinarum and S.
Enteritidis. The production of cytokines by macrophages and tissues,
including caecal tonsils, ileum, spleen and liver has been reported in chicken
following challenge with Salmonella (Beal et al., 2004; Withanage et al.,
2004; Withanage et al., 2005). In caecal tonsils, challenge with S.
Typhimurium significantly increased IL-6 by day 21 post infection (pi)
(Withanage et al., 2005). This explains why we could not find any significant
increase in lL-6 mRNA in our model at day 4pi. Similarly, in the same tissue
(caecal tonsils), there is no changes in the level of IL-6 mRNA were observed
at day 1, day 3 and day 5pi with S. Typhimurium (Haghighi et al., 2008). Of
note, the severity of infection of infection was greater in younger chickens
compared with older ones. Herein, we have used S. Typhimurium and
Enteritidis serovras and the infection of chickens with theses S. serovar is
associated with transient systemic infection mainly in newly hatched chicks
(Barrow 2000). Thus, we assume that older birds (21 days) are more resistant
and this explains why natural infections with serovars could not trigger any
pro-inflammatory reactions in skeletal muscle of infected chickens.
Moreover, the experimental infection of chickens with these serovars was
insufficient to induce enough circulation of ether the microrganism or its
toxin. The fact that, Salmonella is an intracellular organism (Suter and
Ramseiar 1964; Popiel and Turnbull 1985). Therefore, the number of isolated
microorgnism form the visceral organs was correlated with the severity of
infection. In case of skeletal muscle, there is a scarcity of data about the
effect of natural infection with Salmonella on the IL_6 mRNA level. However,
the data obtained from in vitro studies have demonstrated that Stimulation
of C2C12 myoblasts directly with LPS significantly increases the production
and release of IL-6 (Frost et al., 2002; Lang et al., 2003). In chapter 4 have
shown that, LPS significantly increased the production of IL-6 in C2C12 a
consistent findings with that obtained by Strle et al. (2007). In skeletal
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ŵƵƐĐůĞ ? ĞǆĐĞƐƐŝǀĞ ƉƌŽĚƵĐƚŝŽŶ ŽĨ /> ? ? ? /> ? ?ɴ ĂŶĚ dE& ?ɲ ĂůƚĞƌ ƚŚĞ ƉƌŽƚĞŝŶ
balance by changing the rate of protein synthesis and protein degradation
(Argiles et al., ? ? ? ? ?&ƌŽƐƚĂŶĚ>ĂŶŐ ? ? ? ? Z ?ůƚŚŽƵŐŚ ?/> ? ?ɴĂŶĚdE& ?ɲŚĂǀĞĂ
pro-inflammatory properties, IL-6 possesses both the pro- and anti-
inflammatory properties (Tilg et al., 1997) and excessive production of IL-6
significantly increased the expression of the anti-inflammatory cytokines like
IL-10 (Steensberg et al., 2003). The direct infusion of IL-6 has been implicated
in the induction of muscle protein catabolism in rats (Haddad et al., 2005).
The fact that natural challenge of chicken with Salmonella was associated
ǁŝƚŚĚĞĐƌĞĂƐĞĚdE& ?ɲĂŶĚ/> ? ?ŵZEĞǆƉƌĞƐƐŝŽŶŝŶƐŬĞůĞƚĂůŵƵƐĐůĞƐƵŐŐĞƐƚƐ
that natural infection with S. Gallinarum and S. Enteritidis does not trigger
strong immune or inflammatory responses in skeletal muscle.
Caspase activity is considered as the central step of the apoptotic
pathway and elimination of the caspase activity significantly delays or
prevents apoptosis (Earnshaw et al., 1999). Caspase-3 is involved in
remarkable morphological changes of apoptosis including chromatin
condensation, DNA fragmentation and cytoskeletal destruction (Hengartner
2000). Caspase-3 cleaves actinomyosin in vitro and in vivo (Du et al., 2004),
and this facilitates the actomyosin degradation by the ubiquitin proteasome
system. Thus, increased caspase-3 activity is the first step in skeletal muscle
protein breakdown. Our findings showed that natural infection with S.
Gallinarum and S. Enteritidis significantly decreased the caspase-3 mRNA
expression, suggesting that natural infection does induce neither any
apoptotic activity nor any actomyosin degradation in the skeletal muscle of
chicken
Ubiquitination is the predominant mechanism implicated in protein
degradation and includes the activation of specific ubiquitin enzymes E1
(ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme) and E3
(ubiquitin-protein ligase) (Hough et al., 1987). The predominant ubiquitin
enzyme, which determines the specificity of the degraded protein is the E3
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ubiquitin-protein ligase (Hershko and Ciechanover 1998). The ubiquitination
process, in addition controls various cellular processes including cell cycle,
vesicle trafficking and signal transduction (Hough et al., 1987). The
expression of the atrogin-1 mRNA is only limited to the skeletal muscle and
atrogin-1 knockout significantly blocked the denervation-induced muscle
wasting on the skeletal muscle (Bodine et al., 2001). Others and we in
chapter 4 have shown that, LPS stimulated the expression of atrogin-1 mRNA
in skeletal muscle in vivo and in vitro (Gomes et al., 2001; Jin and Li 2007).
The expression of atrogin-1 mRNA has been dramatically increased in many
other catabolic conditions like food deprivation (Jagoe et al., 2002), and
denervation (Bodine et al., 2001). Therefore, the use of ubiquitin mRNA is
considered as suitable marker for ubiquitin-proteasome activation The fact
that challenge with S. Gallinarum and S. Enteritidis significantly decreased
the expression of atrogin-1 in gastrocnemius muscle by 50% and 75%
respectively (P < 0.001) compared with control group respectively, this
suggests that natural infection had a little or no effect on the skeletal muscle
protein. Combined, natural challenge could not induce muscle proteolysis
(measured as expression of the atrophic genes), this emphasises the
importance of presence of LPS (main part of Gram negative bacterial cell
wall) rather than the presence of the live bacteria in the circulation.
Therefore, the data presented in this chapter suggest that natural challenge
with Salmonella serotypes could not induce significant increase in the
circulating levels of LPS and thus it had no effect on muscle protein. In the
study carried out by Barrow and associates (1999), natural challenge of
commercial ducks with the Salmonella strains (Typhimurium and Enteritidis),
these strains are invasive and been isolated from different oranges with a
variable counts, however, almost no or low level of LPS IgG was detected by
ELISA. The data presented in this chapter was not similar to that we have
obtained in cultured C2C12 myotubes. Thus, further investigation are still
needed to verify this discrepancy taken in the consideration the difference in
relation to the muscle fibre type. Previous studies have demonstrated that
the response of the muscle protein metabolism to catabolic stimuli was
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differed according to the muscle fibre type (for more details see,Vary and
Kimball 1992). In the context there is a paucity of data about the effect of
natural infection with Salmonella, and all the data about the effect of LPS on
skeletal muscle were obtained from rat and mice studies (mentioned in
details in the previous chapters). Therefore, we assume that the appropriate
model will be direct injection of chicken with LPS.
9.7 Conclusion
In the present study, natural infection with two invasive Salmonella
enterica serovars Gallinarium and Enteritidis significantly decreased the
ĞǆƉƌĞƐƐŝŽŶ ŽĨ ŵĂŶǇ ĐǇƚŽŬŝŶĞƐ ŝŶĐůƵĚŝŶŐ dE& ?ɲ ĂŶĚ /> ? ? ŵZE ĂŶĚ ŵĂŶǇ
atrophic genes such as atrogin-1, caspase-3 and ubiquitin mRNA. Thus, we
think that this model is not the appropriate model to study the pathogenesis
of muscle wasting in chicken, and to build up a hypothesis about the natural
infection a better model most likely will be either maintaining the birds for
longer or direct intramuscular injection of the chicken with the LPS.
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10 General Summary
10.1 General summary
As stated in the end of the introduction, the specific aims of the study
were:
1- To examine the direct effect of the LPS (bacterial endotoxin) alone on
the signalling pathways that control the process of the protein
synthesis in C2C12 murine myotubes involving PI3-K/Akt and MAPKs
(p38 or Erk1/2) signalling cascades and their downstream targets i.e.
mTOR, p70
S6K
, 4E-BP1 and eIF-4E.
2- To examine the rate of protein synthesis (PS) (expressed as a direct
3, ?ƉŚĞŶǇůĂůĂŶŝŶĞŝŶĐŽƌƉŽƌĂƚŝŽŶ ?ʅŐ ?A?dƉĞƌĐĞƉƚŝďůĞƉƌŽƚĞŝŶ ZĂĨƚĞƌ
3 h (short-time response) and 18 h (long-term response) LPS
exposure.
3- To examine the effect of LPS on muscle protein degradation
(measured as chymotrypsin-like enzyme activity) and the signalling
cascades that involved in C2C12 murine myotubes septic model.
4- To validate the effect of LPS on protein synthesis and protein
degradation by using specific signalling pathways inhibitors.
5- To examine the beneficial effects of curcumin (as a natural
compound) on the rates of protein synthesis and protein degradation
in LPS-stimulated C2C12 murine myotubes for 3 h.
6- dŽĞǆĂŵŝŶĞ>W^ ?ŝŶĚƵĐĞĚƉƌŽĚƵĐƚŝŽŶŽĨdE& ?ɲ ?/> ? ?ĂŶĚŶŝƚƌŝĐŽǆŝĚĞŝŶ
the conditioned media of LPS-stimulated C2C12 myotubes.
7- To examine the effect of LPS on the protein metabolism of the avian
primary skeletal muscle cells.
8- To assess the effect of natural infection of chicken with S. Gallinarum
or S. Enteritidis on the skeletal muscle protein metabolism.
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10.2 The effect of the LPS on the anabolic signalling and the PS
rate in C2C12 myotubes
The aim stated in chapter 3, was to examine the subcellular
mechanisms involved in LPS-induced decreased PS rate. This include the
study of intracellular signalling molecules (second messengers) involving i.e.
Akt, mTOR, 4E-BP1, eIF-4E, p38, Erk1/2 and Mnk1.
10.2.1 Anabolic Signalling
In chapter 3, LPS-stimulated C2C12 murine derived myotubes model
was used to examine our hypothesis. Different LPS concentrations (10 ngml
-1
,
100 ngml
-1ĂŶĚ ?ʅŐŵů-1) were used at different time points (namely 5, 30 min
and 1, 3 and 18 h).
LPS significantly decreased Akt phosphorylation, this effect was
started early at 5 min with a peak at 30 min (P < 0.001) in a time and dose-
dependent manner. While, mTOR phosphorylation decreased over a longer
time course lasting up to 18 h in a time and dose-dependent manner. This
effect was followed by decreased p70
S6K
, 4E-BP1 and eIF-4E phosphorylation.
This effect suggests that, LPS-induced decreased PS was mediated via
alteration of the translation initiation step of protein synthesis to which Akt
is considered as a key regulator of this process. In addition, it suggests that
mTOR is considered as bifurcation point for the activation of both p70
S6K
and
4E-BP1 in vitro. This effect is similar to that obtained from in vivo studies
(Lang et al., 2007; Bentzinger et al., 2008).
The effect of LPS on the MAPKs (p38, Erk1/2 and Mnk1) activity-
related phosphorylation was measured in chapter 3. LPS significantly
increased the phosphorylation of MAPKs (p38 and Erk1/2) in a time and
dose-dependent manner. While, their downstream target Mnk1
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phosphorylated after 1 h and lasting for 3 h. Increased Mnk1
phosphorylation was related to eIF-4E phosphorylation and hence increases
the translation initiation step of PS process. However, this effect was not
sufficient to inhibit the transient decrease in PS after 3 h LPS exposure. In
contrast, increased Mnk1 phosphorylation following MAPKs (p38 or Erk1/2)
phosphorylation here in and in other studies suggested that, Mnk1 is the
downstream target of MAPKs (p38 or Erk1/2) in vitro.
10.2.2 Direct protein synthesis
The data presented in chapter 3 showed that incubation of the C2C12
ŵǇŽƚƵďĞƐǁŝƚŚ>W^ ? ?ʅŐŵů-1) alone transiently decreased the PS rate by 50%
compared with the control cells (P < 0.05) at the 3 h time point (short-term
response). Afterwards, the PS returned to the normal basal levels at the 18 h.
This effect was correlated with the decreased activities of the anabolic
signalling molecules mainly Akt and its down-stream targets (mTOR, p70
S6K
,
4E-BP1 and eIF-4E). This effect is similar to that obtained from many in vivo
studies. Thus, we can conclude that the LPS-induced decreased PS in skeletal
muscle is a multifactorial process and involving the input of many signalling
cascades, and that a cross talk exists between them. This makes the overall
elucidation of this process a hard task which requires further investigation.
10.3 The effect of LPS on the protein degradation
In chapter 3 the data presented have demonstrated that LPS
transiently decreased PS and this effect involved Akt/mTOR/ p70
S6K
, 4E-BP1
and eIF-4E signalling molecules, and the input of MAPKs (p38 or Erk1/2)
signalling cascade was essential. Therefore, the requisite was to elucidate the
direct effect of LPS on protein breakdown (chymotrypsin-like enzyme
activity).
dŚĞ ĚĂƚĂ ƉƌĞƐĞŶƚĞĚ ŝŶ ĐŚĂƉƚĞƌ  ? ƐŚŽǁĞĚ ƚŚĂƚ >W^  ? ?ʅŐŵů-1)
significantly increased the chymotrypsin-like enzyme activity (P < 0.001)
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compared with the control cells at all time points. This effect was preceded
by increased phosphorylation and subsequent decreased amount of the total
Ik ?ɲ ?dŚŝƐĞĨĨĞĐƚǁĂƐƚŚĞŶĨŽůůŽǁĞĚďǇƚŚĞŶƵĐůĞĂƌƚĂŶƐůŽĐĂƚŝŽŶŽĨƚŚĞE& ?
Ŭ ?/ŶĂĚĚŝƚŝŽŶ ?>W^ƐŝŐŶŝĨŝĐĂŶƚůǇŝŶĐƌĞĂƐĞĚdE& ?ɲŵĞĚŝĂĐŽŶĐĞŶƚƌĂƚŝŽŶƐĂƚĂůů
the time points (5, 30 min, 1, 3 and 18 h). This was followed by increased
media concentration of IL-6 after 18 h. Increased circulating concentration
ůĞǀĞůƐŽĨdE& ?ɲŝŶ>W^ ?ƚƌĞĂƚĞĚĐĞůůƐĂƚĂůůƚŚĞƚŝŵĞƉŽŝŶƚƐǁĂƐĐŽƌƌĞůĂƚĞĚǁŝƚŚ
ŝŶĐƌĞĂƐĞĚƉƌŽƚĞĂƐŽŵĂůĂĐƚŝǀŝƚǇ ?ƐƵŐŐĞƐƚŝŶŐƚŚĂƚdE& ?ɲŝƐŝŶǀŽůǀĞĚŝŶƚŚĞ>W^ ?
induced muscle turnover herein. In addition, incubation of the cells with LPS
significantly increased the CK for 1 h. This suggests that, LPS might alter the
energy metabolism of the skeletal muscle via increased production and
release of CK. These data with that presented in chapter 3 have
demonstrated that LPS-induced muscle protein imbalance in C2C12
myotubes was mediated through decreased protein synthesis together with
increased protein breakdown rates. The LPS-induced decrease in PS was
mediated mainly through alteration of the translation initiation, while PD
was mediated via the activation of the ubiquitin-proteasome system. In
addition, the deactivation of one signalling cascade may alter the activation
of many diverse cellular functions, i.e. deactivation of Akt significantly
decreased PS and increased PD. The data presented in chapter 3 and 4 have
shown that, the mechanism of LPS-induced protein turnover requires the
activation of many signalling streams. These signalling streams are cross
talked with other. The better understanding of this cross talk will help in the
developing of the appropriate therapeutic intervention that ameliorates the
sepsis-induced muscle wasting.
10.4 Transcriptional regulation of LPS-induced proteasomal
activity
The transcriptional regulation of LPS-induced proteasomal activity was
addressed in chapter 5. We examined the effect of LPS on the mRNA
ĞǆƉƌĞƐƐŝŽŶ ůĞǀĞůƐ ŽĨ dE& ?ɲ ? ĂƚƌŽŐŝŶ ? ? ? DƵZ& ? ĂŶĚ d>Z ? ?  ? ? ? ŵǇŽƚƵďĞƐ
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ǁĞƌĞ ŝŶĐƵďĂƚĞĚ ǁŝƚŚ >W^  ? ? ʅŐŵů-1) up to 18 h. LPS increased the levels of
dE& ?ɲ ? ĂƚƌŽŐŝŶ ? ? ? DƵZ& ? ĂŶĚ d>Z ? ŵZE ŝŶ Ă ƚŝŵĞ ?ĚĞƉŶĚĞŶƚ ŵĂŶŶĞƌ ?
These results suggested that skeletal muscle can respond directly to LPS, and
that the LPS increase the synthesis and the accumulation of cytokines in
skeletal muscle mediated by the TLR4 signalling pathway.
The combined results of chapter 3 & 4 and 5 demonstrate that, LPS is a
potent catabolic stimulus that increases protein breakdown and decreases
protein synthesis.
10.5 Validation of the effect of LPS on the protein degradation
and protein synthesis
The results that obtained in the chapter 3, 4 and 5 raised the
following questions what are
1- The signalling cascades involved in LPS-induced decreased of PS
rate and increased rate of muscle protein breakdown in C2C12
myotubes.
2- The potential role of TLR4 in the LPS signal.
3- The direct role of the ubiquitin-proteasome system in the LPS-
induced muscle protein breakdown.
4- What are the contributions of MAPKs (p38 or Erk1/2).
The components of these questions were examined in the chapters 3, 4 and
5.
The in vitro studies showed that TLR4 plays the main role in the signal
transduction induced by LPS. In chapter 3, 4 and 5 incubation of C2C12
ŵǇŽƚƵďĞƐǁŝƚŚ>W^ĂůŽŶŐǁŝƚŚWŽůǇŵǇǆŝŶ  ?>W^ŶĞƵƚƌĂůŝƐŝŶŐĂŐĞŶƚ Z  ? ?ʅŐŵů-1)
significantly decreased the chymotrypsin-like enzyme activity, and abolished
the effect of LPS on PS. In addition, it significantly blocked LPS induced up-
ƌĞŐƵůĂƚŝŽŶ ŽĨ dE& ?ɲ ? DƵZ& ? ĂŶĚ d>Z ? ŵZE ǁŚŝůĞ ŝƚ ƉĂƌƚŝĂůůǇ ŝŶŚŝďŝƚĞĚ
atrogin-1 mRNA expression at 18 h time point. Taken together, these results
indicate that TLR4 is the main pathogen recognition receptor involved in LPS
signals transduction in muscle cells.
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The role of the ubiquitin-proteasome system was evaluated by the
MG-132 (specific proteasomal inhibitor). Incubation of the cells with LPS in
combination with MG-132 significantly blocked the LPS-induced increased
chymotrypsin-like enzyme activity below the normal basal levels (Fig. 4-1B).
This suggests that the proteasomal pathway is the main proteolytic system
involved in the LPS-induced muscle protein turnover. This result consistent
with the other findings that, the proteasome is the main catabolic system
involved in LPS-induced muscle proteolysis and inhibition of the proteasomal
activity significantly blocked this effect.
The role of Akt was verified using LY0294002 (PI3-K/Akt inhibitor).
Incubation of C2C12 myotubes with LPS in combination with LY0294002
ĚĞůĂǇĞĚ>W^ ?ŝŶĚƵĐĞĚƵƉ ?ƌĞŐƵůĂƚŝŽŶŽĨdE& ?ɲĂŶĚĂƚƌŽŐŝŶ ? ?ŵZE ? ? ?ĂŶĚ ? ?
h post LPS administration). Moreover, inhibition of Akt significantly increased
the atrogin-1 mRNA expression level; this suggests that atrogin-1 is the main
ubiquitin ligase involved in LPS-induced protein breakdown. Furthermore,
inhibition of Akt alone or with LPS significantly decreased the PS rate by 80%
compared with untreated cells (P < 0.001). Together, these data
demonstrated that Akt pathway is a key regulator of both of the protein
synthesis and the protein degradation in skeletal muscle.
Although, incubation of the cells with LPS along with either SB203580
(p38 inhibitor) or PD098059 (MEK/Erk inhibitor) significantly decreased the
ƉƌŽƚĞĂƐŽŵĂů ĂĐƚŝǀŝƚǇ ? ŝƚ ƐŝŐŶŝĨŝĐĂŶƚůǇ ŝŶĐƌĞĂƐĞĚ ƚŚĞ ĞǆƉƌĞƐƐŝŽŶ ŽĨ dE& ?ɲ ĂŶĚ
atrogin-1 mRNA. Thus, it seems that there is no absolute correlation between
the activity of these atrophic genes and the proteasomal activity. Similarly,
the inhibition of MAPKs decreased the PS rate; this gave the evidence for the
direct involvement of MAPKs (p38 or Erk1/2) in the protein synthesis process.
In addition, the cross talk between the PI3-K/Akt and MAPKs (p38 or Erk1/2)
was revealed by the western blotting technique. The data presented in
chapter 3 showed that, inhibition of MAPKs (p38 or Erk1/2) significantly
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decreased the phosphorylation of Akt (P < 0.05). Therefore, we assumed that,
the direct involvement of MAPKs (p38 or Erk1/2) in the PS was mediated via
the regulation of both Akt and Mnk1 signalling cascades. These results
demonstrated the importance of the Akt as a key regulator not only for the
protein synthesis but also for protein degradation. In addition, there is a cross
talk between these signalling cascades; this makes the understanding of the
LPS-induced decreased PS rate a complicated matter that requiring further
investigation. Collectively, these results suggest the importance of MAPKs
(p38 or Erk1/2) in the regulation of many diverse cellular processes in both
normal and disease conditions.
The data presented in Chapter 3, 4 and 5 showed that LPS is a potent
catabolic stimulus accelerates the rate of muscle proteolysis (expressed as
chymotrypsin-like enzyme activity) and decreases the rate of PS (
3
H-
phenylalanine incorporation/ȝg 5%TCA precipitable protein). This effect was
mediated via Akt and MAPKs (p38 or Erk1/2) and their downstream targets.
There is however there is more than one limit in this study. Firstly, the effect
D' ? ? ? ?  ?ƉƌŽƚĞĂƐŽŵĂů ŝŶŚŝďŝƚŽƌ Z ŽŶ ƚŚĞ ůĞǀĞů dE& ?ɲ ?ĂƚƌŽŐŝŶ ? ? ? DƵZ& ? ĂŶĚ
TLR4 mRNA was not addressed. To answer this question, we have addressed
whether there is a correlation between the proteasomal activity and the
mRNA expression level of the ubiquitin ligases (atrogin-1 and MuRF1). We
assume that the dramatic decrease in the proteasomal by 80% (P < 0.001) in
the presence of LPS and MG-132 compared with LPS alone (chapter 4)
associated with decreased ubiquitin ligases activity.
The second limit was that, we did not address the effect of second-
ŵĞƐƐĞŶŐĞƌ ŝŶŚŝďŝƚŝŽŶ ŽŶ ƚŚĞ ŵĞĚŝĂ ĐŽŶĐĞŶƚƌĂƚŝŽŶ ŽĨ dE& ?ɲ ? dŚĞ ĂŶƐǁĞƌ ŽĨ
this should be the topic of future research. The third limit concerning the NF-
kB-DNA binding activity by the Electrophoresis mobility shift assay (EMSA). In
this study, we have determined only the nuclear translocation of NF-kB
rather than electro mobility shift assay (EMSA). EMSA has bee used as a
indication of the translocated NF-kB is already bound to DNA and this
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enables the alteration of many genes transcription. However, in the study
carried out by Jin and Li, the absolute correlation between the NF-kB binding
activity and the increased ubiquitin ligases activity is not always the case (Jin
and Li 2007). Jin al Li demonstrated that, although curcumin significantly
abolished the sepsis-induced atrogin-1, however it had no effect on the NF-
kB DNA binding activity.
10.6 The role of curcumin in LPS-induced muscle protein turnover
Data presented in chapter 3, 4 and 5 showed that the LPS-induced
decreased PS and increased protein degradation rates is a multifactorial
process involving the interaction of many signalling cascades in particular Akt
and MAPKs (p38 or Erk1/2) and their downstream effectors. In addition, the
cross talk between them has been shown in chapter 3 and the inhibition of
these signalling cascades differentially modulated the LPS-induced muscle
protein turnover. Additionally, many studies that showed the value in
curcumin as an anti-inflammatory, anti p38 activity and anti-NF-kB activity
natural compound. Curcumin has previously been shown to decrease the
dE& ?ɲ ?Ɖ ? ?ŵĞĚŝĂƚĞĚƵƉ ?ƌĞŐƵůĂƚŝŽŶŽĨĂƚƌŽŐŝŶ ? ?in vivo. However, the direct
effect of curcumin on protein degradation and PS in vitro is still unclear and
needs further investigation. This was the main aim of chapter 6.
The data presented in chapter 6 showed that, curcumin has anti-p38
and anti IK ?ɲ ĂĐƚŝǀŝƚǇ ? dŚŝƐ ĞĨĨĞĐƚ ǁĂƐ ĂƐƐŽĐŝĂƚĞĚ ǁŝƚŚ ĚĞĐƌĞĂƐĞĚ >W^ ?
induced proteasomal activity especially curcumin (25 ȝM). Surprisingly,
although curcumin abolished the LPS-induced decreased Akt and P70
S6K
phosphorylation and significantly increased Akt and Erk1/2 phosphorylation,
however, this effect was not sufficient to provoke any significant changes in
LPS-induced decreased PS rate. The data presented in the chapter 6 along
with that in chapter 3 demonstrated that, LPS is a strong catabolic stimulus
that significantly decreased the PS in C2C12 myotubes. In addition, the value
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of curcumin as preventive should be considered and further studies are
required to validate the curcumin as therapy in human.
10.7 The effect of LPS on the avian primary skeletal muscle cells
This was addressed in chapter 7. LPS significantly decreased
chymotrypsin-like enzyme activity (P < 0.05) and increased the PS rate at 3 h
(P < 0.001) compared with untreated and 18 h LPS-treated cells. This was not
ƐƵƌƉƌŝƐŝŶŐ>W^ŚĂĚŶŽĞĨĨĞĐƚŽŶƚŚĞĞǆƉƌĞƐƐŝŽŶůĞǀĞůŽĨdE& ?ɲ ?/> ? ? ?ĂƚƌŽŐŝŶ ? ? ?
caspase-3, ubiquitin mRNA, but it significantly increased the phosphorylation
4E-BP1 switching on the translation initiation of PS. Inhibition of Akt,
significantly increased the atrogin-1 mRNA level and this suggests again that
Akt is the main signalling pathway involved in this process. In conclusion, the
data generated in chapter 7 suggesting that effect of LPS is cell specific, and
further investigation are still required to validate this effect with different
primary skeletal muscle cells. The possible explanation for this discrepancy in
response to LPS is that, the avian primary skeletal muscle cells have been
derived from the broiler chickens that with different genetic background.
These chicken were grown up to give a high body mass in a short period of
time (few weeks), characterised by high protein synthesis rate and low
protein breakdown rate. This suggests that these birds might robustly
resistant the effect of LPS. An interesting point concerns the difference in the
ability of specific inhibitors to inhibit the individual intracellular pathways in
different cell types. Another possible cause could be the presence of the
Insulin in case of avian primary cells, and insulin has previously been known
as an anabolic stimulus significantly increased the PS via the acceleration of
the translation initiation. This has been shown in the data collected (Fig. 7-
1B). Although the cells were incubated with LPS, however, the 4E-BP!
Phosphorylation has been increased and this means that the translation
initiation is switches on. Therefore, further investigation are required to
verify the responses in avian primary skeletal muscle cells using different
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incubation conditions (without insulin) and compare this effect with that of
the C2C12 cells.
10.8 Modulation of the nitric oxide production in LPS-stimulated
skeletal muscle cells
In chapter 3, 4, 5 and 6, the presented data demonstrated that LPS
significantly increased protein breakdown and decreased protein synthesis in
C2C12 myotubes, but not in avian primary skeletal muscle cells. In addition,
we have shown that LPS increased the synthesis and production of many
cytokines in skeletal muscle. In chapter 8 we have addressed the effect of the
LPS on nitric oxide production and how the inhibition of second-messenger
signalling can modulate this effect.
The results obtained in chapter 8 demonstrated that LPS increased the
nitric oxide production in C2C12 myotubes and avian primary skeletal muscle
cells. However, this transient moderate increase in nitric oxide production
suggested that nitric oxide has a minor role in LPS-induced protein
breakdown.
There are no clear data regarding the role of different signalling
cascades in, particular PI3-K/Akt and MAPKs (p38 or Erk1/2) in LPS-induced
nitric oxide production. Therefore, the effect of inhibition of these signalling
molecules was elucidated. Inhibition of these second messengers abolished
the effect the LPS-induced nitric oxide production in C2C12 myotubes but not
in the avian primary skeletal muscle cells. This discrepancy could result from
the fact that the avian primary skeletal muscle cells were derived from broiler
chickens of different genetic background. In addition, the data obtained in
vivo showed that, LPS altered the PS and NOS2 activity in the fast twitch
muscle (gastrocnemius) not in the slow twitch muscle (soleus).
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Taken together, the data presented in chapter 6 have shown that the
inhibition of second-messenger signalling modulated the nitric oxide
production in C2C12 myotubes but not in the avian primary skeletal muscle
cells. However, further investigation are still required to verify this effect in
different primary cell lines including skeletal muscle obtained from layers.
The main limit we did not measure the effect of LPS on the NOS mRNA
(the enzyme required for the production of nitric oxide). This is could be
answered the presence of the nitric oxide in the media suggesting that the
NOS mRNA is biologically translated into an active compound (nitric oxide),
herein we have found that LPS increased NO production in the media and we
assume that this effect was preceded by increased NOS mRNA levels.
10.9 The effect of natural challenge with S. Gallinarum or S.
Enteritidis
The data presented in chapter 7 along with these of chapter 3 & 4
raised the following question: will natural challenge of broiler chicken with
Salmonella affect the skeletal muscle protein metabolism.
Natural challenge with S. Gallinarum or S. Enteritidis decreased the
ĞǆƉƌĞƐƐŝŽŶŽĨdE& ?ɲ ?/> ? ?ĂŶĚĐĂƐƉĂƐĞ ? ?ŵZE ?ǁŚŝůĞŝƚ ĂƐŶŽĞĨĨĞĐƚŽŶƚŚĞ
ubiquitin mRNA. There was no expression of IL-8 or IL-10 mRNA detected in
the skeletal muscle of chicken. The data presented in this chapter showed
that, the challenge with Salmonella serotypes was not associated with any
pro-inflammatory responses in skeletal muscle. Moreover, this particular
model is not the most appropriate model for the studying the relationship
between the salmonellosis and the muscle wasting syndrome. In addition,
this emphasises the importance of LPS presence in the circulation rather than
the live bacteria in order to detect significant alteration of muscle protein
metabolism.
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10.10 Future work
In the current study, the main aim was to elucidate the direct effect of
LPS on the muscle protein synthesis and degradation and the signalling
streams that involved in. Our data demonstrated that:
1- LPS alone decreased the PS rate by 50% and increased the protein
degradation rate simultaneously in C2C12-murine derived myotubes.
Therefore, herein our septic model has shown that LPS induced
muscle-wasting was a result of accelerated rate of muscle proteolysis
along with decreased rate of PS a similar effect to that obtained in
vivo studies.
2- Akt is the key element involved in the control of both protein
synthesis and protein degradation signalling streams.
3- LPS alone increased the TLR4 mRNA in vitro. Thus, LPS mediated its
effect via TLR4.
4- LPS increased the cytokines synthesis and accumulation in the
cultured skeletal muscle myotubes in particular TNF-Į.
5- The ubiquitin proteasome system in particular atrogin-1 is the main
proteolytic system involved in LPS-induced muscle proteolysis in
C2C12 myotubes.
6- There is no absolute correlation between the activity of atrophic
genes (atrogin-1 and MuRF1) and the overall proteasomal activity
especially in case of MAPKs (p38 or Erk1/2) inhibition. However,
elevated levels of atrogin-1 mRNA is still the predominant feature of
our septic model.
7- Cross talk exists between MAPKs (p38 or Erk1/2) and PI3-K/Akt
signalling cascades in protein synthesis.
8- Curcumin (25 ȝM) significantly decreased proteasomal activity in LPS-
stimulated C2C12 myotubes. In contrast, it had no beneficial effects
on PS.
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9- LPS is a strong catabolic stimulus increased NO production in both
two septic model (C2C12 myotubes and avian primary skeletal muscle
cells). The transient and moderate increase in NO production was
seems to be a part of the host immune response toward LPS and had
no or minimal effect on muscle protein turnover. In addition, the LPS-
induced NO production was modulated by the second-messenger
inhibition in C2C12 murine-derived myotubes not in the avian primary
skeletal muscle cells.
10- LPS significantly decreased the proteasomal activity and increased the
PS rates in the avian primary skeletal muscle cells.
11- Natural challenge of chicken with Salmonella is not the appropriate
model to study the pathogenesis of muscle wasting in salmonellosis.
Therefore, the future work will be
1- The effect of sepsis on the other proteolytic system activity in
particular, the effect of sepsis on the calpain activity and how far the
second-messenger inhibition will modulate this effect. This because,
increased calpain activity has been linked to increased proteasomal
activity, and considered as an essential step for disassembly of
sarcomere components in particular actin and myosin. This
afterwards facilitates the ubiquitination and proteasomal activation
of the actin and myosin.
2- The effect of various concentrations of recombinant IL-6 on protein
metabolism in the C2C12 myotube and avian primary skeletal muscle
cells. There is no clear data about the role of IL-6 on muscle protein
turnover.
3- The effect of LPS on short and long-lived proteins degradation rates
and the potential role of second-messenger inhibition of particular
that of Akt and MAPKs (p38 or Erk1/2). This because the myofibrillar
proteins comprises two third of the whole skeletal muscle protein. In
addition, evaluation of this effect will leads to a comprehensive
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overview about the overall LPS-induced muscle proteolysis. This in
turn helps in developing an appropriate therapeutic intervention.
4- The effect of intramuscular injection of LPS in chicken and how it will
affect the skeletal muscle protein metabolism. Herein, the use of
natural challenge model with Salmonella serotypes was not
associated with any pro-inflammatory effects in skeletal muscle.
5- The effect of Salmonella Systemic infection in chicken and explore the
effect on muscle protein metabolism.
6- The effect of viral infection of skeletal muscle upon the muscle
protein metabolism. In addition, elucidation of the signalling cascades
that possibly involved in these process.
7- The incubation of skeletal muscle specimen (in vitro) with various
concentrations of LPS and recombinant IL-6 and to explore the effect
on the muscle protein metabolism.
8- The effect of endotoxin on the activity of skeletal muscle satellite
cells. The value of the satellite cells in the process of skeletal muscle
regeneration has been shown in many studies.
9- The relationship between nitric oxide production and muscle protein
metabolism using NO donors and NO specific inhibitors to build up a
comprehensive idea about the NO contribution in LPS-induced muscle
proteolysis.
10-Microarray transcriptional analysis of LPS-stimulated cultured
myotubes (C2C12-murine derived myotubes and avian primary
skeletal muscle cells) and septic chicken skeletal muscle (in vivo) to
built a comprehensive overview about the effect of sepsis in different
in vivo and in vitromodels.
11- The proteomic analysis of LPS-stimulated cultured skeletal muscle
myotubes and septic chicken skeletal muscle. This important in
determining which protein is abundantly increased or decreased in
response to sepsis (identification by peptide mass mapping) using the
database search program.
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Appendix
1-Extraction and culture of primary chicken muscle cells.
Cut 1 centimetre square of tissue (skeletal muscle), and wash in sterile.
Then the tissue was chopped with sterile scalpel as fine as possible and then it
transfer into a falcon tube with collection media. Then 30 ml of sterile PBS
were added, the falcon tube was shacked and left to settle and pour off PBS.
This process was repeated with the same amount of sterile PBS. Then pour
the PBS and replaced with 30 ml of the collection media, then the tube was
centrifuged at 1200 rpm for 5 min at room temperature. This step was
repeated again, and then pours the supernatant and split the tissue into 2 or 3
falcon tubes (depending on how much the tissue), adds to each tube 30 ml of
the Dissociation media supplemented with 1% pronase (1.4 mg/ml) to
dissociation media (300ul of pronase). The falcon tubes were then Put in roller
at 4 degrees for 2 hours. To each tube, half the pronase added before (150ul)
was added and left to roll overnight at 4 degrees. In the next day, the tubes
were left to settle for 5 min. Then the content of the tubes were transferred
with a pipette to a new 50 ml falcons and then centrifuge 1200rpm for 6 min.
Remove the supernatant and add 20 ml 10% fetal calf serum (FCS) + P/S
(penicillin/streptomycin) + fungizone mix and Centrifuge again. This step was
repeated again and centrifuge. Then, tip off liquid and resuspend the pellet in
20 ml chicken culture media (CCM) supplemented with extra fungizol 1% (200
ul for 20 ml). Then, transfer 20 ml of the content to a new collagen coated
flask T75 (of note, rinse with PBS the collagen coated flask before transferring
the cells, then incubate the flasks at 37
ƕ
C 5% CO2 for one day and then
change media. The first harvest of these is the avian primary skeletal muscle
cell.
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The composition of the media:
1-Collection media:
DMEM+glutamax
1% P/S
1% fungizone
2-Dissociation media:
DMEM/F-12(1:1)
1% P/S
1% fungizone
0.5ml of ciprofloxacin per 500ml of media.
3-Chicken culture media (CCM)
DMEM/F-12(1:1)
5% FCS
1% P/S
1% insulin-transferrin-selenium
2% Chicken embryo extracts (CCE)
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2-Table show the dilutions of the primary and secondary antibodies
Antibodys name Company Catalogue number Dilution
4E-BP1 (ser65) Cell signalling #9451 1:1000
ȕ-actin Cell Signalling #4970 1:1000
Anti-rabbit IgG
HRP-linked
Antibody
Cell Signalling #7074 1:2500
Akt1/2/3 Santa Cruz Sc-1619 1:500
Phospho-Akt1/2/3 Santa Cruz R:sc-7985-R 1:500
Erk1/2 Santa Cruz Sc-93 1:500
Phosph-Erk1/2
(Thr202/Tyr204)
Santa Cruz Sc-16982 1:500
3Į Cell signalling #2371 1:1000
p-p38
(Thr180/Tyr182)
Santa Cruz R:sc-17852-R 1:500
,N%Į& Santa Cruz Sc-371 1:500
3KRVSKR,N%Į Santa Cruz Sc-7977 1:500
Phosphoplus
p70S6Kinase
(Thr389,
Thr421/Ser424)
Antibody Kit
Cell signalling #9430 1:1000
Phospho-eIF4E
(Ser209)
Cell Signalling #9741 1:1000
Phospho-mTOR
(Ser2448)
Cell Signalling #2971 1:1000
Phospho-NF-kB Santa Cruz sc-33022 1:500
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Table represents the CTvalues for LPS alone. C2C12 myotubes were treated
with LPS alone for various time points
Table represents the CT values for LPS and SB203580 (p38 inhibitor). C2C12
myotubes were treated with LPS in combination with SB203580 for various
time points
Gene LPS alone
C 1 h 3 h 12 h 18 h
dE& ?ɲ 34.64336 30.19144 34.55953 35.58322 34.93385
Atrogin-1 25.74232 26.49701 22.85326 22.27426 25.41691
MuRF1 31.17995 31.11185 31.22126 31.49557 30.33128
TLR4 28.33817 28.24394 28.29932 28.29369
27.54996
Gene LPS + SB203580
C 30 m 1 h 3 h 12 h 18 h
dE& ?ɲ 34. 31817 35.18493 33.89269 31.75619 36.61537 35.67907
MuRF1 32.21235 29.71146 29.56991 29.68474 30.66979 29.63457
TLR4 32.23125 26.76082 25.89496 25.50416 25.09408 24.66654
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Table represents the CTvalues for LPS and PD098059 (MEK/Erk inhibitor).
C2C12 myotubes were treated with LPS in combination with SB203580 for
various time points.
Table represents CT values fro some genes that used in the avian primary
skeletal muscle cells. Cells were treated with LPS alone or LPS in
combination with inhibitors for 3 h.
Gene Treatment
C LPS LPS+
PMB
LPS+
SB
LPS+
PD
LPS+
LY
LPS+
Curcumin
Dexa
Atrogin-
1 28.62 28.4 28.71 28.96 30.49 27.87 28.68 27.090
Caspase 26.48 26.52 26.62 26.34 27.44 26.69 26.10 25.83
Ubiquitin 22.50 22.36 22.84 22.46 24.12 22.34 22.47 23.00
Gene LPS + PD098090
C 30 m 1 h 3 h 12 h 18 h
dE& ?ɲ 34. 21817 35.38521 33.13956 22.28769 32.14607 36.27319
Atrogin1 31. 21881 26.29536 26.51023 25.21639 26.34388 26.38619
TLR4 32.12233 26.6181 27.02856 26.48498 26.06186 25.60501
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Table represents CT values for some genes that used in the chicken
experiment. Chicken were challenged with Salmonella Gallinarium (SG) or
Salmonella Enteritidis (SE) for 4 days.
Gene Treatment
C SG SE
Atrogin-1 26.24894 28.11036 28.15522
Caspase-3 29.10884 30.56068 35.05839
Ubiquitin 25.53715 23.75329 33.10558
